Vous êtes sur la page 1sur 81

PUSHING

BOUNDARIES
STAYING AHEAD
Abbott India Limited | Annual Report 2017-18

Scan the QR code or download


“Abbott India Ltd Annual Report”
(AR app)* from Playstore to view
the augmented 3D experience on
this page

*The AR app shall go live on July 18, 2018.


CORPORATE INFORMATION TABLE OF CONTENTS
BOARD OF DIRECTORS
Munir Shaikh - Chairman
REGISTERED OFFICE
3, Corporate Park
02
ABBOTT INDIA
Ambati Venu - Managing Director Sion - Trombay Road
R A Shah - Independent Director
Krishna Mohan Sahni - Independent Director
Mumbai - 400 071
Tel No: +91-22-6797 8888 05
Anisha Motwani - Independent Director Fax: +91-22-6797 8727 CHAIRMAN’S MESSAGE
Jawed Zia - Non-Executive Director Email: investorrelations.india@abbott.com
Kaiyomarz Marfatia - Non-Executive Director 09
Rajiv Sonalker - CFO and Whole-time Director CORPORATE OFFICE MANAGING DIRECTOR’S MESSAGE

12
16th Floor, Godrej BKC
KEY MANAGEMENT TEAM
Plot C- 68, “G” Block
Ambati Venu - Managing Director Bandra-Kurla Complex PUSHING BOUNDARIES, STAYING AHEAD
Rajiv Sonalker - CFO and Whole-time Director Bandra (East), Mumbai 400 051 13 | Accelerated Growth Delivers Business Performance
Sandeep Khandelwal - Commercial Director Tel No: +91-22-3816 2000 22 | Future-Focused
Milind Tendulkar - Commercial Director Fax: +91-22-3816 2400 32 | Culture of Collaboration
Ramanathan V - Commercial Director
Burjor Dadachanji - Commercial Director
Nitu Bhushan - Director - Human Resources
FACTORY 42
L-18/19, Verna Industrial Estate, Goa AWARDS
Mahadeo Karnik - Director - Finance
Dr Srirupa Das - Director - Medical Affairs
Dr Vijay Patil - Associate Director - NPI and TAS REGISTRAR & SHARE TRANSFER AGENT 44
Karvy Computershare Private Limited
STATUTORY REPORTS
COMPANY SECRETARY 44 | Board of Directors Report and Management
Karvy Selenium Tower B
Discussion And Analysis
Krupa Anandpara Plot 31-32, Gachibowli 72 | Business Responsibility Report
Financial District 84 | Corporate Governance Report
Nanakramguda
STATUTORY AUDITORS
96
Hyderabad - 500 032
S R B C & CO LLP, Chartered Accountants Tel No: +91-40-6716 2222
Fax No: +91-40-2344 0674 FINANCIAL REPORTS
INTERNAL AUDITORS 96 | Independent Auditor's Report
102 | Balance Sheet
M/s KPMG, Chartered Accountants ANNUAL GENERAL MEETING f=^K^OWOX^YP:\Y ^KXN6Y]]
Date: July 18, 2018, Wednesday 104 | Statement of Changes in Equity
COST AUDITORS 105 | Statement of Cash Flow
Time: 3:30 p.m.
M/s Kishore Bhatia & Associates, Cost Accountants Venue: RAMA WATUMULL AUDITORIUM 107 | Notes to the Financial Statements

146
K C College, 124, Dinshaw Wachha Road
SECRETARIAL AUDITOR Vidyasagar Prin. K. M. Kundnani Chowk
Ms Neena Bhatia, Practicing Company Secretary
Churchgate, Mumbai - 400 020 NOTICE

FORWARD - LOOKING STATEMENT


In this Annual Report, we might have disclosed forward-looking statements that set out anticipated results based on the management’s ON THE COVER - FEEL THE EXPERIENCE
plans and assumptions. We cannot guarantee that these forward–looking statements will be realised, although we believe we have been
prudent in our assumptions. The achievements of results are subject to risks, uncertainties, and even inaccurate assumptions. We undertake Digital is at the heart of most innovations at Abbott India. The cover provides an augmented 3D experience, which would
no obligation to publicly update any forward–looking statements, whether as a result of new information, future events or otherwise. allow you to step inside our journey, feel the exuberance and get a glimpse of how we push boundaries and stay ahead.
Every Single Day.
Download the App “Abbott India Ltd Annual Report” (AR app) from Google Playstore.
References to “Abbott India” in this Annual Report shall mean “Abbott India Limited”. The AR app shall go live on the date of Annual General Meeting - July 18, 2018.
ABBOTT INDIA

HELPING PEOPLE LEAD THE BEST


LIFE THROUGH GOOD HEALTH
Abbott India, part of Abbott’s Global
Pharmaceutical business, is one of India’s
most admired and fastest-growing
pharmaceutical companies.

We, at Abbott India, provide consumers


with market-leading, trusted, global and
local products across various therapeutic
categories such as Women’s Health,
Gastroenterology, CNS, Metabolics,
General Care, Vitamins, Vaccines, etc.

WHAT MAKES US UNIQUE?

IN INDIA, FOR INDIA LOCAL R&D FOR LOCALIZED EXPANSIVE HEALTH NETWORK A LEGACY OF EXCELLENCE
SOLUTIONS
Our products are manufactured in Our in-house development and medical Our mission to enhance the health and From creating an excellent workplace
India and also sourced from local teams work passionately to advance well-being of Indians extends beyond our to making a positive impact on the
third-party manufacturers in India. health by addressing the country’s products to innovative methodologies health of people, we are proud of the
We have a manufacturing facility at unique challenges. We launched over and platforms across distribution work we do in India with the help of
Goa and are engaged with over 40 XOaZ\YN_M^]N_\SXQ^ROVK]^ `O channels. Through the distribution over 3,300 talented people.
third-party manufacturers in India. years for meeting the increasing network of over 25 carrying and
healthcare needs of society. forwarding service providers and hubs,
we reach out to millions of Indians.

2 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 3
CHAIRMAN’S
Try the augmented
experience on this page
through the AR app.

MESSAGE
A HOLISTIC APPROACH TOWARDS
GROWTH, DEVELOPMENT, HEALTH
AND WELLNESS

We, at Abbott India, are


redoubling our efforts to make
quality branded pharmaceutical

THIS IS
products accessible to more
people in the country. We
launched 21 new products

ABBOTT INDIA
this year and are gearing up to
introduce over 100 new products
SX^ROXOb^ `OcOK\]9_\
efforts to spread education and
awareness about various diseases
are also intensifying. Our
knowledge sharing initiatives
WE PROVIDE TOMORROW’S with Healthcare Professionals -
doctors, medical fraternities and
HEALTHCARE SOLUTIONS TODAY pharmacists - are also expanding.
AND CONTINUE TO OUTPERFORM Our commitment to helping
people unlock life’s possibilities
through the power of health
\O
OM^ONSX630/>9>2/
0?66/=>S]KMYWWS^WOX^^RK^
is intrinsically aligned with a
prosperous and healthy India.

MUNIR SHAIKH
Chairman

Abbott India Limited | Annual Report 2017-18 | 5


Dear Shareholders, >RO1Y`O\XWOX^YP3XNSKRK]^KUOX]SQXS MKX^ knowledge sharing initiatives will further
steps towards the promotion of this industry in strengthen your Company’s positioning as a
India. ‘Pharma Vision 2020’ aims at making India committed, capable and compassionate organisation.
We, at Abbott India, have always worked with a
N_KVPYM_]x>RO \]^S]Y_\WS]]SYX^YROVZZOYZVO
a global leader in end-to-end drug manufacture. ` 3,424
crores
` 401
crores
Approval time for new facilities has been reduced CY_\-YWZKXc^\_Vc`KV_O]S^]OWZVYcOO]AO
lead healthier and better lives and the second is to TOTAL PROFIT
to boost investments. The single-window facility have an employee pool of over 3,300 talented
continuously reward our shareholders by excelling REVENUE AFTER TAX
has been announced to expedite new drug and committed workforce, which is one of our
SXY_\ XKXMSKVKXNL_]SXO]]ZO\PY\WKXMOCY_\
approvals and is expected to give a push to the most valuable assets. Their hard work and
Company successfully accomplished both these
“Make in India” initiative. commitment has helped the Company to push
objectives. Once again, we achieved a remarkable
all boundaries and stay ahead of the curve, even
Sales growth of 12.8% over the prior year, which
During the year, all our business units performed in a very volatile and competitive environment.
was 1.6 times# the market growth.
well and contributed to the overall success of the Altogether, we have a holistic approach towards 11.7% 26.1%
Company. Eight out of our top ten products growth, development, health and wellness. PAT (% OF RETURN ON
As I look back, this was a landmark year for REVENUES) AVG CAPITAL
remained at No 1* in their respective therapy EMPLOYED
economies across the globe and India. As per
segments and these ten products contributed to I am proud to announce that your Company
the IMF, the world economy posted a growth
over 70% of the core business. also won several prestigious awards this year
of 3.8% in 2017, with a notable rebound in global
including the most prestigious “Best Companies
trade. At US $2.6 trillion, the Indian economy
CY_\.S\OM^Y\]RK`OZ\YZY]ONK XKVNS`SNOXNYP To Work For” by Business Today.
became the sixth largest in the world. The
`50 and special dividend of `5 per equity share of
country is well positioned to accelerate its growth On behalf of the entire Board, I thank all our valued
`10 each for the year ended March 31, 2018. We sincerely recognise the contributions of our
^Y!SX^ROM_\\OX^ ]MKVKXN^Y!"XOb^ partners – our bankers, doctors, pharmacists and
business partners and continue rewarding them
year, as it recovers from the twin impacts of vendors who have always been very supportive and
We, at Abbott India, are redoubling our efforts to SX`K\SY_]aKc]0Y\SX]^KXMOaOaO\O^RO \]^
demonetisation and GST roll out. important contributors to our success.
make quality branded pharmaceutical products company to compensate our stockists to cover their
accessible to more people in the country. We losses on account of transition to GST, thereby also
The Indian Pharmaceutical Market is estimated I am also thankful to all members of the Abbott
launched 21 new products this year and are ensuring continuous availability of medicines at
to be about 3.3% of the global Pharmaceutical family - our customers, employees and above all,
gearing up to introduce over 100 new products the market place. Such initiatives help us build long
Industry in value and 10% in volume. This our shareholders who have continued to place
SX^ROXOb^ `OcOK\]9_\OPPY\^]^Y]Z\OKN lasting relationships with our business partners.
is expected to grow to US $55 billion by faith in the Management of the Company.
education and awareness about various diseases
2020, thereby emerging as the sixth largest
are also intensifying. Our knowledge sharing Next year will mark the completion of 75 years
pharmaceutical market globally.
initiatives with Healthcare Professionals - of your Company in India - another landmark in
doctors, medical fraternities and pharmacists - our history. We have once again developed strong
TOTAL REVENUE are also expanding. Our commitment to helping strategies to ensure our business continues to
(` IN CRORES) people unlock life’s possibilities through the outperform. Our focus remains on entering new, MUNIR SHAIKH
ZYaO\YPROKV^R\O
OM^ONSX630/>9>2/ high-potential therapy areas while maintaining Chairman
3,424

FULLEST. - is a commitment that is intrinsically leadership in the areas we dominate. We will


aligned with a prosperous and healthy India. continue to push in under leveraged geographies
2,996

and rural markets and remain committed to be


In order to deepen our patient commitment, responsive and agile.
2,696

we are foraying into sub-therapies within our


established therapeutic domains. Our beyond-the- With deep regret, we inform you about the
pill orientation is aimed at giving much more than untimely demise of Mr Ranjan Kapur. We
just medicine to our customers. ]SXMO\OVcKZZ\OMSK^ORSWPY\RS]]SQXS MKX^
contributions. Mr Bhasker Iyer and Ms Nancy
Our emphasis is on creating a sustainable growth Berce resigned as Directors upon their
blueprint, which is futuristic and viable. Our retirement from Abbott. We thank them for their
2016 2017 2018 constant focus on innovation, diversifying the contributions and wish them good health and
product portfolio, maintaining brand excellence, success in their future endeavours. We welcome
technology driven initiatives and value-added Ms Anisha Motwani and Mr Jawed Zia, who
#
core business have recently joined the Board.
6 | Abbott India Limited | Annual Report 2017-18 * Source: IMS Health Abbott India Limited | Annual Report 2017-18 | 7
MANAGING
Try the augmented
experience on this page
through the AR app.

DIRECTOR’S
MESSAGE
PLAYING ON A STRONG WICKET

PUSHING
BOUNDARIES,
STAYING AHEAD Our Sales growth of 12.8% was driven by multiple
L_]SXO]]SWZO\K^S`O]>RO \]^KXNPY\OWY]^aK]
restructuring our product portfolio into key
business areas – Women’s Health, Gastroenterology,
Consumer Care, CNS, Metabolics, General Care and
Vaccines. Among these, Women’s Health grew by
19.1%, Vaccines grew by 59.7% and Metabolics grew
by 15.3%.

AMBATI VENU
Managing Director

8 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 9
Dear Shareholders, Relentless drive +8O^:\Y ^YP`401 Crores, our highest ever Future-Focused
We continued to take on the mantle of launching Z\Y ^\O
OM^ONKQ\Ya^RYPKLY_^Y`O\^RO As we set our eye on the future, rapid inroads into
The promise of enabling fuller, healthier lives previous year. With our relentless efforts and
market shaping initiatives in collaboration sub-therapies, accelerated new product launches,
is worth pursuing in every possible way, every differentiated approach, we consistently remain
with cross-industry players and technology innovative marketing and deployment of digital
single day. At Abbott India, we continue to ahead of the market.
partners, even when we encountered challenging tools, steady deepening of relationships with
SX^OX]SPcY_\MYWWS^WOX^^YP_V V^ROZ\YWS]OYP
circumstances on a few fronts. the doctor, pharmacist, patient trio, continued
human potential by helping people achieve their /X\SMRSXQ^ROVS`O]YPY_\ZK^SOX^] strengthening and expansion of our brand
best health at every stage of their life. We have
In less than 8 months, the Indian economy We continued our engagement with patients. portfolio, and the collective living of a shared
had yet another year of excellent performance
encountered two powerful disruptors, both of During the last year, we were able to vaccinate vision by an over 3,300 strong employee pool,
and I am happy to share the highlights with you
which would go on to become positive enablers over 20 Lakh people against Swine Flu and will continue to be the central levers of our
through this Annual Report 2017-18.
of economic growth and formalization, but we conducted Thyroid screening for over 21 Lakh growth momentum.
emerged stronger with renewed focus on core people pan-India.
Powerful business performance
operational excellence. We introduced multiple I thank you for your continued trust and
We know how to deliver high-quality healthcare, \]^SXSXN_]^\cWY`O]KXNMY_X^O\WY`O]^RK^ Real Film. Real Heroes MYX NOXMOSXY_\KLSVS^SO]3MYXQ\K^_VK^OY_\
and our heritage is proof that we are committed ensured that economic changes did not come in Abbott India family on scripting another stellar
We also continued to strengthen our brand identity,
for the long-term. Our Sales growth of 12.8% was the way of expectations. ZO\PY\WKXMOSX0C!"KXN^RKXUWcPOVVYa
through our much appreciated campaign “Real
driven by multiple business imperatives. The board members for their valuable guidance
Film. Real Heroes”, depicting how breakthrough
\]^KXNPY\OWY]^aK]\O]^\_M^_\SXQY_\Z\YN_M^ We have an endless drive to bring meaningful and contributions. The future looks even more
innovations from Abbott have helped people
portfolio into key business areas – Women’s Health, innovation to our markets – in both medicines exciting and promising to me and I seek your
live fuller and healthier lives. The campaign,
Gastroenterology, Consumer Care, CNS, Metabolics, and the services that go along with them – to help support to co-create a healthier India and a
coupled with our value-added knowledge sharing
General Care and Vaccines. Among these, Women’s people live healthier, fuller lives. We give people value-creating company.
initiatives, has ensured that the Company
Health grew by 19.1%, Vaccines grew by 59.7% and a reason to choose our medicines, and this model remains at the forefront with consumers and
Metabolics grew by 15.3%. Clearly, the foundation of has led to consistent, exceptional growth. Healthcare Professionals.
our business, is our brands and our people.
At Abbott India, our 360 degree efforts to further Beyond Pills
Our brands are trusted by millions of patients and fortify our brand leadership in the chosen
and doctors across therapies. All our key brands therapies helped us deliver another market
We are here to help people lead fuller, healthier AMBATI VENU
have shown strong growth during the year and lives. And in this mission, it is imperative for us to Managing Director
beating performance in the year gone by. At
continue to lead in the market place. gain patient insights. We also leverage technology
`3,424 Crores, our Total Revenues grew by 14.3%.
to connect and engage with various stakeholders.
Notable initiatives include Thyroweight, the
country’s largest Thyroid Awareness program
BUSINESS DIVISIONS* Key Brands
where we reached 3.5 Crore people this year and
Duphaston | Udiliv ^RO7Y^RO\]KQKSX]^3X
_OXdK7+3MKWZKSQX
Women's Health & Gastrointestine (WH & GI), that aimed at increasing awareness about the need
Cremaffin | Duphalac |
Gastroenterology, GI Prospera and GI Advance for vaccination. Another high impact campaign in
Creon | Heptral
the year was breaking taboos with #Constipation
Specialty Care (Metabolics and Thyronorm | Vertin Conversations.
Central Nervous System) Prothiaden
Strong and motivated workforce
DYVP\O]Rf3X
_`KM 9_\ZYaO\P_V^OKW]LY^RSX^RO OVNKXNhead
GenNext and
Enteroshield | Brufen YP MORK`OMYX^\SL_^ON]SQXS MKX^Vc^Y^RO
Vaccines Company’s success. During the year, we
Arachitol Nano
introduced various talent management and
Digene | Citrosoda | leadership initiatives aimed at attracting and
Consumer Care retaining top talent and empowering them
Rashfree
through several development programs.
*The Company operates in a single reportable segment i.e. Pharmaceuticals.
* Source: IMS Health
10 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 11
PUSHING
BOUNDARIES, 1
STAYING
ACCELERATED GROWTH DELIVERS
BUSINESS PERFORMANCE

AHEAD
Continuing tradition, Total While overall revenue grew by 14.3% to `3,424 Crores in
Abbott India has delivered Revenue 0C!", Z\Y ^Q\OaLcAORK`OLOOXKLVO^Y
yet another strong business ` 3,424 grow at 1.6 times# the market, 8* of our top 10 brands are
ZO\PY\WKXMOSX0C!" Crores market leaders in their respective segments.

2
FUTURE-FOCUSED
We realise that the business OX`S\YXWOX^S]MRKXQSXQ\KZSNVcKXN^OMRXYVYQcS]\ONO XSXQRYa
we interact with people around us. Abbott India took an important step this year of ensuring a
technologically connected organisation with a plan to launch

iPADS Over
2,500 FIELD FORCE
FOR

Also, we facilitated better engagement with doctors and patients through technology-led innovative
solutions in the form of augmented reality and virtual reality.

3
CULTURE OF COLLABORATION
Employees play a vital role in building an inclusive culture across our business operations. Various
We, at Abbott India, have always training and leadership development programs were conducted during the year to help them maximise
challenged the limits of what is possible their potential. The Company reached out to help the broader community through programs such
as the iCARE Road Safety Drive, Nirmal Dhara Dairy Project and SEWA, an initiative for creating a
and offered value through our products
Sustainable Healthcare Delivery Model through Livelihoods.
and services. Our commitment remains
to help Indians lead healthier lives.
#
core business
* Source: IMS Health

12 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 13
1
Accelerated Growth Delivers Business Performance

10 Year Financial Highlights All amounts in ` Lakhs, unless otherwise stated

PREVIOUS GAAP IND AS @

OPERATING RESULTS 2008 2009 2010(13M) 2011* 2012 2014 (15M) 2015 2016 2017 2018
TOTAL REVENUE# 701,21 795,93 1031,97 1528,07 1696,93 2358,39 2364,56 2696,23 2996,33 3424,11
MATERIAL COST 454,62 504,17 647,30 861,21 971,65 1297,41 1311,96 1492,03 1712,06 1904,74
EMPLOYEE BENEFIT EXPENSE 48,92 62,37 111,20 167,35 206,20 299,74 305,40 341,09 345,27 393,69
OTHER EXPENSES# 96,32 102,80 168,03 304,32 294,97 444,68 387,40 448,14 484,04 484,19
DEPRECIATION AND AMORTISATION 6,98 9,01 11,25 15,00 19,49 21,93 14,94 14,44 16,43 16,19
FINANCE COST 2 20 4 3 2 8 50 2,52 2,04 3,82
PROFIT BEFORE TAX AND EXCEPTIONAL ITEMS 94,35 117,38 94,15 180,16 204,60 294,55 344,36 398,01 436,49 621,48
EXCEPTIONAL ITEMS - - - - 10,39 - - - - -
PROVISION FOR TAXATION 31,49 39,87 33,21 59,77 70,29 96,10 115,40 142,76 159,84 220,26
PROFIT AFTER TAX AND EXCEPTIONAL ITEMS 62,86 77,51 60,94 120,39 144,70 198,45 228,96 255,25 276,65 401,22
EARNING PER SHARE - BASIC & DILUTED (`) 43.62 56.68 44.56 56.66 68.10 93.39 107.75 120.12 130.19 188.81
DIVIDEND PER SHARE (`) 14.00 17.00 17.00 17.00 17.00 23.00 31.00 35.00 40.00 55.00**

ASSETS EMPLOYED
FIXED ASSETS (NET) 50,63 49,15 50,57 80,02 109,18 99,52 99,95 111,29 115,88 83,55
OTHER ASSETS (NET) 171,38 222,41 254,82 464,12 537,68 688,33 837,58 1084,31 1271,06 1609,21
TOTAL ASSETS 222,01 271,56 305,39 544,14 646,86 787,85 937,53 1195,60 1386,94 1692,76
FINANCED BY
SHARE CAPITAL 13,68 13,68 13,68 21,25 21,25 21,25 21,25 21,25 21,25 21,25
OTHER EQUITY 207,57 257,88 291,71 522,89 625,61 766,60 916,28 1174,35 1365,69 1671,51
TOTAL EQUITY 221,25 271,56 305,39 544,14 646,86 787,85 937,53 1195,60 1386,94 1692,76
BORROWINGS 76 - - - - - - - - -
NUMBER OF SHAREHOLDERS 13,689 13,422 14,461 19,354 20,826 18,270 19,407 21,250 23,004 22,583
NUMBER OF EMPLOYEES 1,150 1,308 1,767 2,425 2,667 2,766 2,867 2,956 3,083 3,322
**Includes special dividend of `5/- per share.
* Post Merger with Solvay Pharma India Limited.
# Inclusive of Excise duty on sales / net of GST.
@
The Company transitioned into IND AS from April 1, 2015, hence these numbers are not comparable with previous years.

14 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 15
1 DIVIDEND PER SHARE EMPLOYEE COST (` IN LAKHS)
Accelerated Growth Delivers Business Performance `55* ` 393,69
EARNING PER SHARE (`) EMPLOYEES (NOS)
55.00*
393,69

Key 35.00
40.00
341,09
345,27

Performance 31.00

188.81
305,40

Indicators

3,322
23.00

130.19

3,083
120.12

2,956
299,74

107.75

2,867
93.39

2,766
2014 2015 2016 2017 2018
(15M) 2014 2015 2016 2017 2018
*Includes special dividend of ` 5/- per share (15M)

RESERVES AND SURPLUS CONTRIBUTION TO


REVENUE GROWTH EBITDA MARGINS GROWTH# EXCHEQUER (` IN LAKHS)
14.3% 18.7% 22.4% ` 644,65
REVENUE (` IN LAKHS) EBITDA (` IN LAKHS) RESERVES AND SURPLUS (` IN LAKHS)
14.3% 18.7% 22.4%
11.1%
16.4%
14.0% 15.2%
15.4% 28.3%

25.3%* 15.2% 19.5%

1675,46
3424,11

641,49

644,65
2996,33

1368,57
11.2%* 13.4%
2696,23

454,96

499,81
1175,35
414,97
22.5%

437,23
2364,56

916,28
359,80

372,40
2358,39

316,56

766,60

350,25
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
2014 2015 2016 2017 2018
(15M) (15M) (15M) (15M)
* Annualised percentage #Excluding Other Comprehensive Income (OCI)
RETURN ON AVG. CAPITAL
PAT MARGINS EMPLOYED BOOK VALUE GROWTH SHARE PRICE (AS AT MARCH 31)
11.7% 26.1% 22.1% `5,449
PAT (` IN LAKHS) AVG. CAPITAL EMPLOYED (` IN LAKHS) BOOK VALUE PER SHARE (`) MARKET CAPITALISATION ( ` IN LAKHS)
11.7% 22.1% 5,449
26.1%

16.0% 4,708
9.2% 21.4%
4,639
9.5% 27.7%
23.9%
9.7% 18.9% 3,948
26.5%

11578,96
401,22

1539,85

797

10003,11
1291,27
276,65

8.4%

653

9857,23
27.7%
255,25

1066,57

563
22.0% 1,753

8390,07
228,96

441
862,69
198,45

717,36

3724,47
371
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
2014 2015 2016 2017 2018
(15M) (15M) (15M)
(15M)

16 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 17
1
Accelerated Growth Delivers Business Performance VALUE ADDED STATEMENT FY 2017-18
@KV_OKNNONS]NO XONK]^RO`KV_OM\OK^ONLc^ROKM^S`S^SO]YPKL_]SXO]]KXNS^]OWZVYcOO]
(` in Lakhs)

Revenue STAKEHOLDERS 2017-18 2016-17

Distribution (%) Payment to Exchequer 644,65 499,81

Payment to Employees 393,69 345,27

Payment to Shareholders* 116,87 85,00


FY 2017-18
Total Revenue `3424,11 Lakhs Contribution to Society 9,12 7,14
RETAINED EARNINGS & OCI*
7.6 % Towards replacement and expansion# 275,43 188,90
TAX
6.4 %
DIVIDEND
Total Value Added 1439,76 1126,12
OTHER EXPENSES (Includes Dividend Distribution Tax)
14.0 % 4.1 %
*Dividend excluding Dividend Distribution Tax
#Replacement and expansion is Retained earnings + Depreciation
DEPRECIATION
0.5 % EMPLOYEE COST
11.5 %

MATERIAL COST
ENVIRONMENT CSR PEOPLE
55.6 %

EXCISE DUTY ON SALES


0.3 %

Goa Plant – Zero Waste Spend of Over


^Y6KXN VVSXZ_\`SOa
of waste disposal ` 9,12 6KUR] 3,300
FY 2016-17 employees
Total Revenue `2996,33 Lakhs
RETAINED EARNINGS & OCI*
Goa Plant received
u,O]^/X`S\YXWOX^KV
115.9%
of mandatory spend
Awarded ‘Best
6.0 % Companies to work for’
TAX Practices Award”
5.3 %
by Business Today
OTHER EXPENSES DIVIDEND Collaborated with 17
15.0 %
(Includes Dividend Distribution Tax)
3.4 %
Waste Management schools covering 18,823 <YL_]^ OVN^\KSXSXQKXN
DEPRECIATION
0.5 % EMPLOYEE COST
11.5 %
50%
Reduction in total waste
students, Over 15 Lakh
people connected through
iCARE Road Safety Drive
Leadership development
programs

MATERIAL COST
Various initiatives on
57.1 % Over 1,500 smallholder diversity and inclusion
Water Usage NKS\cPK\WO\]LOXO ^^ON such as Women Leaders

30%
EXCISE DUTY ON SALES
1.2 % through Nirmal Dhara of Abbott (WLA)
Dairy Program
Reduction in total 0VObSLVO,OXO ^]
water intake Program for Abbott
Employees
*Other Comprehensive Income (OCI)

18 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 19
1
Accelerated Growth Delivers Business Performance PERFORMANCE OF TOP 10 BRANDS @

Therapy-leading BRAND MARKET SHARE (%)# RANK#

products 24.3 1

Abbott India stands for quality, trust and partnership. We deliver quality healthcare
through high-quality products. Our top 10 brands are leaders (at number 1 or
51.7 1
2 position* ) in their respective segments. Our relentless pursuit of invention is
delivering an unprecedented number of advances that will extend our impact and
sustain our growth for years to come.
15.1 2

29.8 1

9.5 2

13.7 1

##
14.4 1

51.4 1

34.8 1

7.3 1

@
Source : IMS Health
#In Respective Participated Market
##Digene Range

Disclaimer: All products displayed/mentioned on this page are for illustration purpose only. Consult your doctor for
*Source: IMS Health professional medical advice.

20 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 21
2
Future-Focused
NEW PRODUCTS
PRODUCT THERAPY AREA BUSINESS UNIT
6K_XMRSXQXOaZ\YN_M^]^Y Polycystic Ovary Syndrome Women's Health

address unmet patient needs Ovulation Women's Health

Gut Health Gastroenterology


New products have not only been a source of growth for the business but have
addressed medical gaps in multiple therapy areas. In FY 2017-18 we launched Constipation Gastroenterology
21 new products / product extensions. This shows our commitment to expanding
our portfolios. We aim to continue this pace of growth in the future as well. NAFLD Gastroenterology

Lemon Flavour Laxative Gastroenterology

Diaper Rash Cream Consumer Care

Paan Flavour Antacid Consumer Care

Digestive Consumer Care

Laxative Consumer Care

Pain Relief Consumer Care

Constipation GI Advance

Irritable Bowel Syndrome GI Advance

Diarrhoea / Hepatic Encephalopathy GI Advance

ALD/NALD GI Advance

Hepatitis C GI Prospera

Pain Management in Chronic Pancreatitis GI Prospera

ALD/NAFLD GI Prospera

Probiotic (Bacterial Vaginosis) Metabolics

20 Migraine CNS

Stroke / Brain Injury CNS


Above new product launches also include line extensions. In addition to our new product launches,
we also upgraded the packaging for Creamaffin, Udiliv and Duphaston.

Disclaimer: All products displayed/mentioned on this page are for illustration purpose only. Consult your doctor for
professional medical advice.
22 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 23
2
Future-Focused
SERVICE OPERATIONS
The plant continues to operate at a high service A number of operational improvements were

A safe, green and level. The Key Performance Indicator for service
is measured in terms of 'On Time In Full', which
undertaken at the plant to enhance productivity
KXNMY]^\ON_M^SYX0Y\^RO-\OWKP X\KXQO^RO

MY]^OP MSOX^ S]#"8Oa=5?]SX-\OWKP X?NSVS`KXN


Duphalac were launched. A key project underway
batch size was increased from 5.5KL to 10KL to
KMRSO`OYZO\K^SYXKVKXNMY]^OP MSOXMSO]AOKV]Y

manufacturing facility is to bring all tablet production in-house from


third party manufacturers.
SX]^KVVONXOa`YV_WO^\SMVS[_SN VVSXQWKMRSXO]
to improve performance and yields.

+LLY^^3XNSKt]1YKZVKX^\OMOS`ONK]SQXS MKX^_ZQ\KNOSX0C!">ROZVKX^S]M\S^SMKV Manufacturing facility at Goa


SXWKX_PKM^_\SXQYPUOcZ\YN_M^]]_MRK]-\OWKP X._ZRKVKM,\_POXKXN.SQOXO

TABLET
VOLUME
1,250 million
DOSAGE
FORMS
Tablets and
liquids

LIQUIDS
VOLUME
3,900 56
NUMBER
OF EMPLOYEES
171

WE FOCUSED ON FOUR CRITICAL AREAS FOR IMPROVEMENT –


SAFETY, QUALITY, SERVICE AND OPERATIONS

SAFETY QUALITY
A number of safety initiatives such as disposal The plant continuously strives to improve the
of hazardous waste and sludge to Ultratech quality of products manufactured. A number
cement factories for co-processing, a successful of licenses were renewed as well as audits by
Factory Mutual global inspection of safety WHO and Abbott Quality and Regulatory teams
procedures and launch of ‘Stop for Safety’ aO\OMYXN_M^ON6S[_SN^KXU]aO\OWYNS ON
program for creating awareness of safety among for better product management and skilled staff
employees were completed. The Goa plant is a were recruited for critical production equipment.
MO\^S ON]KPOaY\UZVKMOKXNRKNXY\OZY\^KLVO Lastly, a number of engineering updates were also
or loss time incident during last 5 years. made to improve hygiene and work environment.

24 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 25
2
Future-Focused
THYROWEIGHT
This campaign aims to increase awareness

Creating value through among women (in the age group of 25-40)
around the correlation between weight

differentiated services gain and thyroid disorders. A persona-led


integrated marketing communication plan
was deployed that aimed at easy and early
diagnosis for clinicians and patients and to
Abbott India has taken a leadership role in the industry in implementing patient
create more awareness amongst patients
awareness and doctor engagement programs. We use the latest technology tools
living with hypothyroidism.
and adopt innovative, integrated, omni-channel marketing strategies. These efforts
help our sales force create a unique positioning for Abbott India in the minds of our
stakeholders. Some of our notable projects in FY 2017-18 were:

GUTFIT

1_^0S^S]3XNSKt] \]^SX^OQ\K^ONVSPO]^cVO PARTNERSHIP


WYNS MK^SYXZ\YQ\KWKNN\O]]SXQQKZ]SX
WITH KEY OPINION
Gastrointestinal disease management.
6SPO]^cVOS]^RO \]^VSXOYP^\OK^WOX^PY\
13NS]Y\NO\]KXNROXMOaOSXNOX^S ON^RS]
LEADERS 500
framework. A comprehensive program was
ASSISTED
created, which enrolled high-risk patients
and provided them with virtual counseling,
wearable devices for tracking health metrics
PATIENTS 5.4
6KUR]
and customised diet plans.

TELEVISION
REACH
130 6KUR]

15
THERAPIES COVERED
PUBLIC RELATIONS
CONNECT 6KUR]

HEALTHCARE
PROFESSIONAL
REACH
0.26KUR]

TWITTER
VISITORS
120 6KUR]
CONSTIPATION FATTY LIVER ACIDITY IBS PANCREATITIS

AWARENESS | DIAGNOSIS | TREATMENT | COMPLIANCE


26 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 27
2
Future-Focused
EXPERIENTIAL MARKETING
FOR DUPHASTON
NO. OF DOCTORS
REACHED
3
6KUR]

#MOMVSFLU
0.6
The complex process of manufacturing
PHYSICIAN
MOTHERS AGAINST Duphaston came alive through experimental
^OMRXYVYQcAO]O^_ZQKWS MK^SYXKXN`S\^_KV ENGAGEMENT
INFLUENZA CAMPAIGN reality experience zones at key conferences to
6KUR]

to allow participants to create the Duphaston


>RO7Y^RO\]+QKSX]^3X
_OXdK7+3MKWZKSQX molecule through the gaming console. We
was launched to make mothers aware of the also conceptualised an immersive story telling
need for vaccination, in order to protect the fetus experience using advanced mixed reality
and the new born till the age of 3 years against to travel through time and experience the
SX
_OXdK+]KZK\^YP^RS]MKWZKSQXSX
_OXMO\ invention process of Duphaston.
led (mother bloggers, women twitterati)
conversations, with information shared by
doctors, were started on digital media. We also
M\OK^ON]RY\^ VW]^RK^RSQRVSQR^^ROOPPOM^]YP

_SXMRSVN\OX

VERTIN HEAD
Vertin is our 50-year-old brand and is a
therapy leader in Vertigo management.
We designed Vertin Head, which is a pioneer
initiative, by using 3D Printing Technologies
TWITTER
IMPRESSIONS
510 6KUR]
to impart knowledge among patients about
various vestibular habituation therapy exercises
for better management of vertigo. The Vertin
Head helped doctors demonstrate detailed

46
information on how to perform various
UNIQUE PEOPLE excercises to patients in clinic.
REACH 6KUR]

28 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 29
2
Future-Focused
#CONSTIPATION
CONVERSATIONS
Considering the need to make people feel
MYX NOX^KXNMYWPY\^KLVOKLY_^RK`SXQ
#ConstipationConversations, we engaged with
LIGHT DELIGHTS – consumers through an omni-channel (print,
CELEBRATING LOVE FOR FOOD digital, mobile, onground) approach. We also
conducted an on-ground event and bloggers
Choosing a healthy diet, especially low in lipids, meet, around #ConstipationConversations with
is essential for certain patients (such as IBS the celebrity therapy ambassador and women
patients) to ensure a healthy lifestyle. With tasty LVYQQO\]%^RS]aK]PYVVYaONLcKXSX
_OXMO\VON
food playing a major role in diet decisions, we (mom blogger) Tweet chat conversation, and
reached out to help these patients by providing KXYP
SXOMKWZKSQXN\S`OXLc^ROMYWZKXc
them healthy low-lipid recipes. For this, we tied A #FirstinPharma social experiment was
up with a Michelin star chef, Vikas Khanna, who also created.
penned a book with over 20 healthy low-lipid
food recipes from across India. This book, Light
Delights, was shared with over 2.7 Lakh patients.

PANCRECARE
This is a Mobile App based interactive platform
to support patients who suffer from Pancreatic
/bYM\SXO3X]_P MSOXMc2OKV^RMK\O:\YPO]]SYXKV]
through this app, have access to monitor real
time patient health outcomes. Patients can get
counseling on diet and pain management.

FACEBOOK
IMPRESSIONS
15
6KUR]

TWITTER
IMPRESSIONS
350 6KUR]

TWITTER
VISITORS
32
6KUR]

30 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 31
3
Culture of Collaboration

Creating a best-in-class Abbott India instituted multiple initiatives to improve the work environment and
provide a better workplace for employees. Our goal is to enhance workplace productivity

work environment and provide adequate motivation to employees to excel in their day-to-day activities.

ONE ABBOTT WORKPLACE FLEXIBLE BENEFITS PROGRAM WOMEN LEADERS OF ABBOTT BETTER DETAILING AND
(WLA) CONNECTIVITY
Abbott employees spread across different Abbott India provides a wider bouquet YPLOXO ^]
locations in Mumbai came under one roof in for employees. Employees have the choice to Abbott India's WLA employee network helps Another key initiative and investment made by
^RO \]^[_K\^O\YP^ROcOK\>ROYP MORK]LOOX NOMSNO^ROS\YaXLOXO ^]P\YWKWK]^O\VS]^ female employees to : Abbott India has been the launch of the iPad
coined as the One Abbott Workplace, with according to their needs at their life stages, and Z\YQ\KWaRO\O OVNOWZVYcOO]aSVVLOO[_SZZON
OWZVYcOO]KM\Y]]KVVNS`S]SYX]KXNYP MO]SX L_c^RO]OLOXO ^]aS^RZYSX^]Y\^YZ_Z INSPIRE with 6th generation iPads. This technological
Mumbai now being able to collaborate closely with cash. Meaningful and enabling work advancement ensures that our employees are
with each other. This initiative is viewed as a environment better connected with one another and can
]SQXS MKX^Z\YN_M^S`S^cOXRKXMOWOX^WY`O
use some of the latest tools to engage with our
customers. This also enables us to move to a
CONNECT paper-free doctor detailing model with enhanced
That is all about creating engaged and
interactivity for better communication.
inclusive work culture

GROW
Enriching the gender
diversity ratio

32 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 33
3
Culture of Collaboration

At Abbott India, we believe that the driving force of our business is its people.

Shaping future >RO2_WKX<O]Y_\MO2<^OKWRK]L_SV^]ZOMS MZ\YQ\KW]aRSMROXMYWZK]]^ROOX^S\O


employee lifecycle; attracting best talent and retention via career management, rewards

leaders and development across all cadres. Some of the initiatives undertaken in FY 2017-18 include:

IN-STRIDE MANAGEMENT TRAINING /bOM_^S`O:\YQ\KWSX=KVO]7K\UO^SXQ TRACKS


IN COLLABORATION WITH /:=7
The In-Stride program is aimed at strengthening We also launched an Executive Program in Tracks is a sales force career development
the leadership pipeline towards senior leadership
IIM-CALCUTTA Sales and Marketing from IIM Calcutta for high framework to source talent internally and establish
positions (quality and quantity). This ensures potential Second Line Managers. This is an open a career path for key functions/roles. It provides a
8Ob^1OX6OKNO\]RSZ:\YQ\KW816: program and mode of delivery is through an
business continuity for high potential talent clear and objective guideline for career movements
In line with our Employee Value Proposition interactive online learning platform.
through simulations, e-Learning, group along with cross-functional exposure to build
(EVP) of providing best-in-class exposure,
mentoring, individual stretch assignments leadership skills.
access and accelerated development for high
and mentorship.
performers, we launched a Professional
Development Program in Sales & Marketing
LEADERSHIP for our First Line Managers called MANAGEMENT TRAINEE
PROGRAMS Next Generation Leadership Program. PROGRAM
This included a tie up with IIM-Calcutta, At Abbott India, our emphasis on building a key
one of India’s Best B-Schools, for a 9-month differentiator via our marketing practices and
CREATING LEARNING MO\^S MK^SYXZ\YQ\KWSX=KVO]KXN7K\UO^SXQ OPPY\^]S]YP]SQXS MKX^`KV_OAS^R^ROSX^OX^YP
OPPORTUNITES 3^S]^RO \]^YPS^]USXNZ\YQ\KWSX^RO building a future-ready talent pool of marketers
healthcare industry in India. we have redesigned the ‘Management Trainee
Program’ targeting the premier MBA colleges
in India.

34 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 35
3
Culture of Collaboration

Board of Directors
MUNIR SHAIKH AMBATI VENU JAWED ZIA KAIYOMARZ MARFATIA
Chairman Managing Director 8YX/bOM_^S`O.S\OM^Y\ 8YX/bOM_^S`O.S\OM^Y\

ANISHA MOTWANI R A SHAH KRISHNA MOHAN SAHNI RAJIV SONALKER


Independent Director Independent Director Independent Director CFO and Whole-time Director

Ranjan Kapur, Independent Director

With deep regret and profound grief, we report the sad and untimely demise of
Mr Ranjan Kapur. The Company places on record its sincere appreciation for the invaluable
contributions and guidance received from him towards the progress of the Company.

36 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 37
3
Culture of Collaboration

Key
Management
Team
Left to Right :
Milind Tendulkar,
Ramanathan V,
Dr Sripupa Das,
Rajiv Sonalker,
Sandeep Khandelwal,
Nitu Bhushan,
Mahadeo Karnik,
Ambati Venu,
Burjor Dadachanji,
Krupa Anandpara,
Dr Vijay Patil

AMBATI VENU RAJIV SONALKER joining Abbott India, he worked BURJOR NITU BHUSHAN DR SRIRUPA DAS
Managing Director CFO and Whole-time with Marico as Head-Sales for DADACHANJI Director - Human Director – Medical Affairs
Venu comes with over Director Nature and Personal Care. Commercial Director - Resources Dr Das has over 15 years of
25 years of experience in Rajiv has over 29 years -YWWO\MSKV/bMOVVOXMOKXN Nitu has over 14 years of experience in Medical Research,
GlaxoSmithKline Consumer of experience in the RAMANATHAN V International Business experience in human resources Clinical Research and Drug
Healthcare (GSK Consumer) Pharmaceutical, FMCG and Commercial Director - Burjor has over 14 years of across organisations such Development. Prior to joining
in various leadership positions Engineering industries. Prior to Specialty Care diverse experience across as Asian Paints, HSBC and Abbott India, she was associated
across the Indian sub-continent, joining Abbott India, he worked pharma, management Mondelez International with Fresenius Kabi, Lupin and
Middle East, North Africa and with Bristol-Myers Squibb as Ramanathan has over 21 years Sun Pharma.
consulting, banking and (formerly Cadbury India). In her
Asia. His last role till September Director – Finance. He was also of experience in Sales and
operations. Prior to joining last role, she worked as Head
Marketing in companies such
2015 was Regional Vice associated with Voltas, Johnson
as Dr. Reddy’s Laboratories, Abbott India, he was associated – Talent Acquisition, India, DR VIJAY PATIL
President & General Manager – 4YRX]YX=KXY +`OX^S]SX with Abbott Healthcare, Indonesia, Philippines, Japan Associate Director – New
Asia, GSK Consumer. India and Germany. Ranbaxy and Zydus Cadila.
The Boston Consulting Group and ANZ with Mondelez. Product Introductions and
Prior to joining Abbott India,
he worked with Zydus Cadila and JPMorgan Chase. Therapy Area Strategy
MILIND TENDULKAR SANDEEP as Vice President – Sales and MAHADEO KARNIK Dr Patil has over 34 years of
Commercial Director - KHANDELWAL Marketing of the Cardiva KRUPA ANANDPARA Director - Finance experience in Pharmaceuticals
GenNext and Vaccines Commercial Director division. Associate Director - Mahadeo has over 20 years of KXN>OMRXSMKV OVN:\SY\^Y
Milind has over 27 years - Women’s Health, Secretarial & Company experience, in Finance. Prior joining Abbott India, he was
of experience in Sales and Gastroenterology, Secretary to joining Abbott India, he associated with Schering Plough,
Marketing. Prior to joining GI Prospera, GI Advance Krupa has over 16 years of was associated with Roche Fulford, Aventis, German
Abbott India, he was associated and Consumer Care experience and expertise in Diagnostics, Unilever and Remedies and Novartis.
with Abbott Healthcare, Zydus handling company secretarial United Phosphorus.
Sandeep has over 14 years of
Cadila, Emcure and Ipca Labs. compliance streams. Prior
experience in the Consumer
Products Industry. Prior to to joining Abbott India, she
worked with Borosil Glass
Works and Wimco.
38 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 39
3
Culture of Collaboration NIRMAL DHARA DAIRY In 2017, iCARE Road Safety Drive also extended
PROGRAM its reach by collaborating with 17 schools to
educate 18,823 students on pedestrian safety and

Working with India is the world’s largest producer of milk,


and nearly half of rural households depend on
road safety awareness.

communities to build dairy farming for at least part of their income.


Despite this, many dairy farmers continue to be
IMPROVING ACCESS TO
a better India
marginalized, limited by middlemen and lack
of technology and methods to produce higher
QUALITY AND AFFORDABLE
quality milk for a better price.
HEALTHCARE
Abbott India is engaged with multiple community support programs. Right from Working with Prabhat, a local dairy supplier, and
helping farmers earn a better livelihood to imparting road safety awareness and >OMRXY=O\`OKXYXZ\Y ^Y\QKXSdK^SYXaORK`O Abbott India has initiated a project in partnership
helping Indians lead safe lives. directly reached out to nearly 1,500 smallholder with SEWA (Self-Employed Women’s Association)
dairy farmers, half of whom are women, in to improve access to quality healthcare in
Maharashtra and Gujarat. We developed the India. This program aims to improve health
infrastructure required to expand capacity for outcomes, generate livelihoods and create an
milk production and delivered robust training on ecosystem with all stakeholders and key partners
topics ranging from the basics of ensuring high- (Doctors, Pharmacies, Labs), while ensuring both
quality milk to technical dairying skills. affordability of services for SEWA members,
K]aOVVK]K XKXMSKVVc]_]^KSXKLVOROKV^RMK\O
AOKV]Y\_X^\KSXSXQ]]ZOMS MKVVcPY\aYWOX ecosystem.
farmers and have established transparent
pricing mechanisms. The program will educate SEWA members
on various health conditions while training
community healthcare workers on providing
consistent, community-based care. It will
iCARE ROAD SAFETY DRIVE KV]YSWZ\Y`OKMMO]]^Y[_KVS ONNYM^Y\]KXN
pharmacies in order to develop a healthcare
India has one of the worst records of road ecosystem to provide quality and affordable
safety in the world. Road Safety has been a part healthcare facilities and eventually improve
of Abbott’s global focus, targeted at avoiding health-seeking behaviour in communities.
accidents and improving lives. Abbott’s iCARE
Road Safety Drive is geared towards spreading
awareness about road safety measures to prevent
road accidents and save lives.

Over the years, we have reached more than


15 Lakh people through this initiative. In 2017,
more than 3,000 members of our workforce
educated people they met in medical clinics,
hospitals and schools about safe driving practices.
They used this opportunity to share simple,
actionable steps for reducing road accidents and
injuries, like wearing a helmet and a seat belt,
staying alert, obeying speed limits and avoiding
mobile phone use while driving.

40 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 41
3
Culture of Collaboration

Awards &
Recognition
Abbott India continues to receive recognition from multiple industry bodies and leading
media organisations. We also received multiple awards for excellence at a brand level. AWACS AWARDS IN
BUSINESS TODAY MARKETING EXCELLENCE
‘Best Companies to Work For’
NO.1 BRAND OF THE YEAR
(GOLD)
Udiliv

FIRST RUNNER UP (SILVER)


Duphaston

BEST USE OF TECHNOLOGY


for Training Excellence in The Production
of Learning Content

SILVER FOR DIGITAL


MARKETING EXCELLENCE
for Abbott India Radio

GOA STATE POLLUTION


BEST MARKETING CONTROL BOARD
CAMPAIGN
#Constipation Conversations Goa Plant - “Best Environmental
Practices Award”

Abbott India Limited | Annual Report 2017-18 | 43


ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BOARD OF DIRECTORS REPORT


AND MANAGEMENT DISCUSSION AND ANALYSIS
TO THE MEMBERS MANAGEMENT DISCUSSION AND ANALYSIS OPPORTUNITIES AND THREATS REVIEW OF OPERATIONS
Your Directors have pleasure in presenting their Seventy-fourth ECONOMIC OVERVIEW >RO PYVVYaSXQ PKM^Y\] K\O VSUOVc ^Y SWZKM^ ^RO 3:7 SX ^RO XOb^ Financial Performance
Annual Report and the Audited Financial Statements of the
-YWZKXcPY\^RO XKXMSKVcOK\!" IX ^RO 3X^O\XK^SYXKV 7YXO^K\c 0_XNt] 370 +Z\SV " AY\VN POacOK\]$
Total Revenue
/MYXYWSM9_^VYYU3XNSKt]Q\Ya^R\K^OS]Z\YTOM^ON^YLO!SX
FINANCIAL HIGHLIGHTS " KXN !" SX # >RO VK^O]^ O]^SWK^O ]OO] 3XNSK \OOWO\QO w Draft Pharmaceutical Policy, 2017 - >RO +_Q_]^ ! >Y^KV<O`OX_OPY\^ROcOK\OXNON7K\MR"S]` "#
(` in Lakhs) K] ^RO PK]^O]^ Q\YaSXQ OMYXYWc Y_^ZO\PY\WSXQ Y^RO\ OWO\QSXQ \OVOK]O YP ^RO N\KP^ ZYVSMc Z\OZK\ON Lc ^RO .OZK\^WOX^ YP 6KUR] `S]K`S] ` ##  6KUR] VK]^ cOK\ \OMY\NSXQ K \YL_]^
Particulars For the year ended For the year ended WK\UO^]]_MRK]-RSXK<_]]SKKXN,\KdSV :RK\WKMO_^SMKV] ]O^] Y_^ UOc YLTOM^S`O] ]_MR K] SXM\OK]SXQ Q\Ya^RYPY`O\^ROZ\O`SY_] XKXMSKVcOK\
March 31, 2018 7K\MR! 3XNSKt] Q\Ya^R RK] \OMY`O\ON P\YW ^RO ^OWZY\K\c NSZ ZY]^ ^RO KMMO]] K^ KPPY\NKLVO Z\SMO] PY\ O]]OX^SKV N\_Q] WKXNK^Y\c
Net Sales 3273,90.01 #! ! SWZVOWOX^K^SYX YP ^RO 1YYN] KXN =O\`SMO] >Kb 1=> VK]^ 4_Vc 8O^ =KVO] PY\ ^RO XKXMSKV cOK\ !" Q\Oa Lc " Y`O\ ^RO
,SY+`KSVKLSVS^c KXN ,SY/[_S`KVOXMO ,+,/ ^O]^] PY\ KVV
Other Operating Income 33,22.16   KMRKXQO^RK^S]ObZOM^ON^YVOKN^YOK]OSXNYSXQL_]SXO]]KXN Z\O`SY_] cOK\ ^Y ` !# 6KUR] KX SXM\OK]O YP ` !
N\_QWKX_PKM^_\SXQZO\WS]]SYX]LcMOX^\KVY\]^K^O\OQ_VK^Y\]
Other Income L\YKNOXSXQYP^RO^KbLK]O^R\Y_QRMYX`O\]SYXYP3XNSKSX^YYXO 6KUR]N\S`OXWKSXVcLc`YV_WO]
116,98.72 ! " KXNOX]_\SXQ^RK^KVVWKX_PKM^_\SXQ_XS^]KNYZ^A2917:
Total Income 3424,10.89 ##  MYWWYXWK\UO^
KXN16:]^KXNK\N] Other Income
:\Y ^,OPY\O>Kb 621,48.26  #! >RO37=2OKV^R7K\UO^:\YQXY]S]<OZY\^RSQRVSQR^ON^RK^\S]SXQ
:\Y ^+P^O\>Kb 401,21.78 !  "" Z\S`K^OMYX]_WZ^SYXPY\OMK]^ON^YQ\YaK^"aSVVLO^ROQ\OK^O]^ w Price Controls - :\SMO] aSVV \OWKSX _XNO\ Z\O]]_\O K] ^RO >RO]SQXS MKX^SXM\OK]OSX9^RO\3XMYWOS]WKSXVcYXKMMY_X^YP
MYX^\SL_^SYX^YQ\Ya^R7Y\OY`O\K]^RO#OVOM^SYXKZZ\YKMRO] scope of price controls increased under the Drug Price Control SXMYWOQOXO\K^ONP\YWK]]SQXWOX^YP^\KNOWK\U]KWY_X^SXQ^Y
Retained Earnings and
Other Comprehensive 1Y`O\XWOX^]ZOXNSXQS]ObZOM^ON^YSXM\OK]O ` 6KUR]
+WOXNWOX^ 9\NO\ .:-9 PYVVYaSXQ ^RO _ZNK^O YP ^RO
Income (OCI) 3XNSKt] ZYZ_VK^SYX Q\Ya^R \K^O S] ObZOM^ON ^Y ]VYa KV^RY_QR ^RO 8K^SYXKV 6S]^ YP /]]OX^SKV 7ONSMSXO] 86/7 -_\\OX^Vc # 3X^O\O]^YXSX^O\MYWZKXcVYKX^Y+VO\O7ONSMKV:\S`K^O6SWS^ON
,KVKXMOL\Y_QR^PY\aK\N 1047,45.13 ""#" X_WLO\] aSVV ]^SVV Q\Ya Lc KVWY]^ !! WSVVSYX Lc  ^Y \OKMR
^RO\KZO_^SMMVK]]O]K\OMY`O\ONLc^ROVS]^3^S]ObZOM^ON^RK^ 3XNSK KWY_X^SXQ ^Y `  6KUR] S] KV]Y SXMV_NON SX 9^RO\
:\Y ^+P^O\>Kb 401,21.78 !  "" LSVVSYX
P_^_\O \O`S]SYX] YP 86/7 aSVV OX]_\O Z\SMO MYX^\YV] K\O XY^ 3XMYWO
OCI arising from
INDIAN HEALTHCARE ENVIORNMENT NSV_^ON>RO.OZK\^WOX^YP:RK\WKMO_^SMKV]S]KV]YKWOXNSXQ
re-measurement of (1,07.64) "!  >RO -YWZKXc MYX^SX_ON ^Y SX`O]^ SX bON NOZY]S^] aS^R ,KXU]
OWZVYcOOLOXO ^] IX3XNSKKV^RY_QRROKV^RMK\OS]Z\Y`SNONLcKWSbYPLY^RZ_LVSM ^RO.:-93^S]VSUOVc^RK^]YWOYP^ROKWOXNWOX^]aSVVZY]O
KXN Z\S`K^O PKMSVS^SO] S^ S] ^RO Z\S`K^O ]OM^Y\ ^RK^ KMMY_X^] PY\ RK`SXQ RSQR M\ONS^ \K^SXQ] aS^R K `SOa ^Y ]KPOQ_K\NSXQ ^RO
.S`SNOXN0C ! (84,99.72) - P_\^RO\MRKVVOXQO]^Y^ROSXN_]^\c Z\SXMSZKV KXN WKSX^KSXSXQ VS[_SNS^c 3XMYWO P\YW ,KXU .OZY]S^]
!" YP Y_^ZK^SOX^ MK\O KXN   YP SXZK^SOX^ MK\O
.S`SNOXN0C - !!  >RO PONO\KV 7SXS]^\c YP 2OKV^R KXN 0KWSVc AOVPK\O 7920A Q\OaLc"3X`O]^WOX^]^\K^OQcS]\O`SOaONZO\SYNSMKVVcLc^RO
-Y\ZY\K^O.S`SNOXN>Kb (17,30.34) 
w National Health Protection Scheme - +c_]RWKX ,RK\K^
S] \O]ZYX]SLVO PY\ P\KWSXQ KXN MYY\NSXK^SXQ ROKV^RMK\O ZYVSMc 0SXKXMO-YWWS^^OO>RO-YWZKXcRK]KXSX`O]^WOX^ZY\^PYVSYYP
>\KX]PO\^Y<O]O\`O] aRSVO ]^K^O KXN NS]^\SM^ K_^RY\S^SO] Y`O\]OO ^RO KNWSXS]^\K^SYX S] 8K^SYXKV 2OKV^R :\Y^OM^SYX =MROWO aRSMR S] KWLS^SY_]Vc
(40,12.18) ! # ` #"!6KUR]K]K^7K\MR"
Balance carried forward 1305,17.03 ! KXNNOVS`O\cYP]O\`SMO]^Y^ROS\ZK^SOX^ZYZ_VK^SYX].OZK\^WOX^ KSWSXQ^YOb^OXNROKV^RSX]_\KXMOMY`O\KQOYP_Z^Y`6KUR
YP:RK\WKMO_^SMKV]7SXS]^\cYP-ROWSMKV]KXN0O\^SVSdO\]P\KWO] ZO\ PKWSVc ZO\ KXX_W ^Y Y`O\  -\Y\O PKWSVSO] P\YW ^RO Material Cost
INDIAN ACCOUNTING STANDARDS (IND AS) KXNSWZVOWOX^]\OQ_VK^SYX]PY\3XNSKX:RK\WKMO_^SMKV]3XN_]^\c `_VXO\KLVOKXN_XNO\Z\S`SVOQON]OM^SYX]YP]YMSO^cO[_K^SXQ
EPPOM^S`O +Z\SV    ^RO -YWZKXc RK] KNYZ^ON KVV ^RO 3XN += +XOa8K^SYXKV2OKV^R:YVSMcZ_LVS]RONSX7K\MR!MKVV]PY\KX >ROSWZ\Y`ON]KVO]WSbKXNWK\QSXKVQ\Ya^RSX]KVO]Z\SMO\OKVS]K^SYX
^Y K\Y_XN  -\Y\O LOXO MSK\SO] O[_S`KVOX^ ^Y  YP ^RO
=^KXNK\N] KXN ^RO KNYZ^SYX aK] MK\\SON Y_^ SX KMMY\NKXMO aS^R SXM\OK]OSXQY`O\XWOX^]ZOXNSXQYXZ_LVSMROKV^RObZOXNS^_\O^Y resulted in decrease in Material Cost as a percentage of Sales from
ZYZ_VK^SYX
3XN+=s0S\]^^SWOKNYZ^SYXYP3XNSKX+MMY_X^SXQ=^KXNK\N]t YP^RO1.:SXK^SWOLY_XNWKXXO\3^KV]YKSW]K^OX]_\SXQ #SX XKXMSKVcOK\ !^Y"SX^ROM_\\OX^cOK\
aS^R+Z\SVK]^RO^\KX]S^SYXNK^O>RO^\KX]S^SYXaK]MK\\SON SWZ\Y`ONKMMO]]KXNKPPY\NKLSVS^cYP[_KVS^c]OMYXNK\cKXN^O\^SK\c
out from Indian Accounting Principles generally accepted in India MK\O ]O\`SMO] >RO :YVSMc] _V^SWK^O VYXQ^O\W QYKV S] KMRSO`SXQ
w Uniform Code of Pharmaceuticals Marketing Practices
Employee Cost
K] Z\O]M\SLON _XNO\ =OM^SYX  YP ^RO +M^ \OKN aS^R <_VO ! YP _XS`O\]KV ROKV^R MY`O\KQO KXN S] `SOaON K] ^RO aY\VNt] VK\QO]^ (UCPMP) - ?-:7: M_\\OX^Vc `YV_X^K\c S] ObZOM^ON ^Y
^RO -YWZKXSO] +MMY_X^] <_VO]  31++: aRSMR aK] ^RO ROKV^RMK\OSXS^SK^S`OLc^RO]ROO\X_WLO\YPZY^OX^SKVLOXO MSK\SO] LOMYWOWKXNK^Y\c]RY\^Vc+WKXNK^Y\c-YNOS]ObZOM^ON^Y ARSVO ^RO -YWZKXc SXM\OK]ON S^] OWZVYcOO ]^\OXQ^R Lc !" ^Y
Z\O`SY_]1++: >RO 8K^SYXKV 6S]^ YP /]]OX^SKV 7ONSMSXO] 86/7 aRSMR aK] Z\Y`SNO K VO`OV ZVKcSXQ OVN KXN O^RSMKV WK\UO^SXQ Z\KM^SMO] ^RO/WZVYcOO-Y]^K]KZO\MOX^KQO^Y=KVO]RK]WK\QSXKVVc
\O`S]ONSX.OMOWLO\LcKNNSXQWY\ON\_Q]S]ObZOM^ON^Y]OO aY_VNLOPYVVYaONLcKVVMYWZKXSO] SXM\OK]ON P\YW # SX XKXMSKV cOK\  ! ^Y  SX ^RO
DIVIDEND
WY\OP\O[_OX^\O`S]SYX]KXNKNNS^SYX] M_\\OX^cOK\
CY_\.S\OM^Y\]\OMYWWOXNK XKVNS`SNOXNYP` KXN]ZOMSKV
w Increasing Digital Penetration - >RO ObZYXOX^SKV Q\Ya^R
dividend of ` ZO\/[_S^c=RK\OPY\^ROcOK\OXNON7K\MR INDUSTRY STRUCTURE AND DEVELOPMENT >RO SXM\OK]O SX /WZVYcOO -Y]^ Lc  Y`O\ ^RO VK]^ cOK\ S]
" YX # P_VVc ZKSN_Z /[_S^c =RK\O] YP `  OKMR SX^ROKNYZ^SYXYPWYLSVOKXNNSQS^KVWONSKaSVVMYX^SX_O^Y
>RO 3XNSKX :RK\WKMO_^SMKV 7K\UO^ 3:7 aK] O]^SWK^ON ^Y LO mainly due to merit increases and impact of change in monetary
>RO Z\YZY]ON NS`SNOXN SP KZZ\Y`ON K^ ^RO +XX_KV 1OXO\KV LOKXSWZY\^KX^^YYVPY\ZK^SOX^OXQKQOWOX^KXNKWONS_W^Y
` LSVVSYXSX!aS^RKQ\Ya^RYP,c3XNSKS]VSUOVc MOSVSXQPY\1\K^_S^c
7OO^SXQ aSVV KL]Y\L K ]_W YP `  "! 6KUR] :\O`SY_] cOK\ $ \KS]ONS]OK]OKaK\OXO]]AOObZOM^^RS]^\OXN^YMYX^SX_OKXN
^YLOKWYXQ^RO^YZ^R\OOZRK\WKMO_^SMKVWK\UO^]LcSXM\OWOX^KV
` "##!6KUR]KXN-Y\ZY\K^O.S`SNOXN>KbYP` 6KUR]
Q\Ya^RKXN^RO ^RVK\QO]^WK\UO^QVYLKVVcSXKL]YV_^O]SdO QKSXSWZY\^KXMO
:\O`SY_]cOK\$` !6KUR]>RO-Y\ZY\K^O.S`SNOXN>KbS] Other Expenses
Z\Y`SNONK^^RO\K^OKZZVSMKLVOYX^RONKcYXaRSMR^ROKMMY_X^] 3XM\OK]OSX^ROX_WLO\YPWSNNVOMVK]]RY_]ORYVN]MY_ZVONaS^R
aO\OKZZ\Y`ONLc^RO,YK\NYP.S\OM^Y\] SWZ\Y`OWOX^ SX WONSMKV SXP\K]^\_M^_\O \S]SXQ KaK\OXO]] KXN w Regulation of OTC Drugs - >RO 9>- WK\UO^ S] Q\YaSXQ 9^RO\/bZOX]O]SXMV_NSXQObMS]ON_^cYX=KVO].OZ\OMSK^SYXKXN
SXM\OK]OSXZOXO^\K^SYXYPROKV^RSX]_\KXMOSX^ROMY_X^\caSVVKV]Y ]^\YXQVc K^  KXN aS^R Q\OK^O\ aSVVSXQXO]] ^Y 0SXKXMO -Y]^ SXM\OK]ON Lc  Y`O\ ^RO VK]^ cOK\ >RO SXM\OK]O
DIVIDEND DISTRIBUTION POLICY SX
_OXMO^ROQ\Ya^RYPZRK\WKMO_^SMKV]]OM^Y\ ]OVPWONSMK^O ^RO \OQ_VK^Y\c K_^RY\S^SO] K\O VYYUSXQ K^ YXKMMY_X^YPYP MOVOK]O\OX^KV]PY\9XO+LLY^^YP MOS]ZK\^SKVVc
>RO-YWZKXcRK]PY\W_VK^ON.S`SNOXN.S]^\SL_^SYX:YVSMcSX^O\W] >ROWK\UO^S]RSQRVcP\KQWOX^ONaS^R^RO^YZMYWZKXSO]MYX]^S^_^SXQ M\OK^SXQ K Z\YZO\Vc NO XON 9>- ]OM^Y\ >RO M\OK^SYX YP K YPP]O^LcNOM\OK]OSXObMS]ON_^cYX=KVO]ZY]^SWZVOWOX^K^SYXYP
YP\O[_S\OWOX^]_XNO\^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK ]RK\OYP^RO3:7KXN^RO^YZMYWZKXSO]KMMY_X^SXQPY\#! aOVVNO XONKXN\OQ_VK^ON9>-WK\UO^MY_ZVONaS^R]^\SM^O\ 1=> 9^RO\ /bZOX]O] K] K ZO\MOX^KQO ^Y =KVO] \ON_MON ^Y 
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX] YP^RO3:7>RO3:7S]Z\SWK\SVcWKNO_ZYP3XNSKXMYWZKXSO]aS^RK ^RS]cOK\MYWZK\ON^Y!PY\^RO XKXMSKVcOK\ !YaSXQ^Y
OXPY\MOWOX^ YP Z\O]M\SLSXQ KXN NS]ZOX]SXQ \OQ_VK^SYX] aSVV
 >RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^ ]RK\OYP!#YP^ROWK\UO^aRSVOKM_^O^RO\KZSO]MYX^SX_O^YNYWSXK^O
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV N\S`OQ\Ya^RYP^RO9>-WK\UO^ RSQRO\=KVO]SX^ROM_\\OX^cOK\
^ROWK\UO^MYX]^S^_^SXQ YP^RO3:7

44 ANNUAL REPORT 2017-18 45


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

:\Y ^,OPY\O>Kb - Gastroenterology (iii) GenNext and Vaccines Division ._\SXQ^ROcOK\^RO-YWZKXcObOM_^ONXOa]^_NSO]Z_LVS]RON


Z_LVSMK^SYX]SXWKTY\SXNObONTY_\XKV]KXNWKNO!SX^O\XK^SYXKV
:\Y ^ ,OPY\O >Kb PY\ ^RO cOK\ OXNON 7K\MR  " K^ ` "  >RS],_]SXO]]?XS^ZY]^ONK]^\YXQQ\Ya^RYPN_\SXQ^RO This Division includes the therapy areas of Pain Management and
congress presentations. The health authority of India approved
6KUR]Q\Oa^Y#YP=KVO]K]MYWZK\ON^YSX^ROZ\O`SY_]cOK\ cOK\ WKSXVc N\S`OX Lc L\KXN] -\OWKP X -\OWKP X :V_] KXN Vitamins. It comprises multi-specialty drugs and applications, and
3 studies submitted and presented by the Company. The Company
6SL\Kb is primarily aimed at general physicians. The key brands include
Goods and Services Tax (GST) received approvals to conduct phase 3 studies in adults/elderly
Brufen (pain killer), Duvadilan (peripheral vasodilator), Zolfresh
._\SXQ^ROcOK\XOaZ\YN_M^]._ZRKVKM,_VU1_^2OKV^R (sleep management), Arachitol Nano (Vitamin D preparations) KXN ZONSK^\SM] SX ZK\KVVOV PY\ S^] 3X
_`KM ;_KN\S`KVOX^ @KMMSXO
1=> ^RO LSQQO]^ SXNS\OM^ ^Kb \OPY\W YP 3XNSK aK] \YVVONY_^
._ZRKZ\Y -YX]^SZK^SYX ?NSVS`  8+06. KXN ._ZRKVKM and Digecaine (antacid anaesthetic). ;3@:\YQ\KW>RO-YWZKXcKV]YMYXN_M^ON 1-:aY\U]RYZ]
OPPOM^S`O 4_Vc  ! >RS] ^\KX]PY\WK^SYXKV \OPY\W ]SQXS MKX^Vc
6OWYX0VK`Y\6KbK^S`OaO\OVK_XMRON to raise awareness on clinical trials.
SWZKM^ON KVV K\OK] YP L_]SXO]]O] KM\Y]] `K\SY_] ]OM^Y\] SXMV_NSXQ
The Company has a licensing arrangement with Bharat Biotech
^RO ZRK\WKMO_^SMKV SXN_]^\c >RO KZZVSMKLVO \K^O YP 1=> YX N\_Q] Some of the notable studies are in therapy segments of Migraine,
- GI Prospera India Limited to market vaccines in immunology segment.
SX QOXO\KV S]  KXN PY\ VSPO ]K`SXQ N\_Q] S]  /K\Vc KXKVc]S] YP Metabolic Syndrome, Constipation, Insomnia and Preterm which
>RO UOc L\KXN] SX `KMMSXO ZY\^PYVSY K\O 3X
_`KM SX
_OXdK
ZY^OX^SKV 1=> SWZKM^ YX L_]SXO]] Z\YKM^S`O Z\OZK\ONXO]] SX ^RO >RS],_]SXO]]?XS^Q\OaLc#N_\SXQ^ROcOK\>ROQ\Ya^RaK] were presented/published at different national/international
vaccine), Enteroshield (typhoid vaccine) and Rotasure (rotavirus
3> ]c]^OW OXRKXMOWOX^] KXN =_ZZVc -RKSX YZO\K^SYX] ROVZON ^RO WKTY\VcN\S`OXLcL\KXN]-\OYX2OZ^\KVKXN<YaK]K congresses during the year under review.
diarrhea vaccine).
-YWZKXc ^Y LO 1=> MYWZVSKX^ \SQR^ P\YW ^RO 1=> \YVVY_^ NK^O
._\SXQ ^RO cOK\  XOa Z\YN_M^]  @OVZKMVOK\ 2OZK^S^S] - OUTLOOK
>RO-YWZKXc_]ON^RS]WOQK\OPY\WK]KXYZZY\^_XS^c^Y_ZQ\KNO - GenNext
+X^YbSZKX :KSX 7KXKQOWOX^ SX MR\YXSM ZKXM\OK^S^S] KXN
the systems and also launched many initiatives such as providing This Buisness Unit has shown a negative growth of 2.6%; IMS Health has forecasted the Indian Pharmaceutical Market to
2OZ^\KV>+6.8+06.aO\OVK_XMRON
^\KSXSXQ] ^Y ^\KNO ZK\^XO\] KXN Y^RO\ ]^KUORYVNO\] ^R_] OXQKQSXQ however, Arachitol Nano and Duvadilan have shown positive grow at a compounded annual growth rate of 9.7% between 2017
aS^R ^ROW ^Y ]OM_\O KX OPPOM^S`O 1=> MYWZVSKX^ OX`S\YXWOX^ - GI Advance growth. Zolfresh retains number 1* position in its participated KXN\OKMRSXQKZZ\YbSWK^OVc` 2000 billion by 2022.
>RO -YWZKXc RK] ^KUOX K VOKN SX WKUSXQ ]O`O\KV \OZ\O]OX^K^SYX] market.
>RS] ,_]SXO]] ?XS^ aK] PY\WON SX 4KX_K\c " ^Y L_SVN XOa For the near future, after an in-depth overview of our strength and
^Y ^RO 1Y`O\XWOX^ K_^RY\S^SO] YX ^RO UOc MYXMO\X K\OK]
Z\YN_M^]YXKL_SVNYZO\K^O^\KX]PO\WYNOV+]YP7K\MR" - Vaccines Y_\WK\UO^VOKNSXQZY]S^SYXaO SNOX^S ON]ZOMS MYZZY\^_XS^SO]
MRKVVOXQO]PKMONLc^ROZRK\WKMO_^SMKVSXN_]^\cKXNWKNOMO\^KSX
 XOa Z\YN_M^]  -YX XOb -YX]^SZK^SYX -\OWKZOQ 3\\S^KLVO to leverage for growth. Some of these are :
\OMYWWOXNK^SYX]^YOK]OMYWZVSKXMO This Business Unit showed growth of 59.7% and contributed
,YaOV =cXN\YWO .S\SPK .SK\\RYOK2OZK^SM /XMOZRKVYZK^Rc - Shape therapies to accelerate existing key brands :
Division-wise Performance 3.4% of Sales for the year. The double digit growth was driven by
KXN1B +6.8+6.aO\OVK_XMRON
KVVUOcL\KXN]SX^RS]_XS^3X
_`KMKMRSO`ON8YZY]S^SYXSXS^]
>RO -YWZKXc YZO\K^O] SX K ]SXQVO \OZY\^KLVO L_]SXO]] ]OQWOX^   MMOVO\K^O Q\Ya^R YP ObS]^SXQ L\KXN] ^R\Y_QR PYM_]ON
+
(ii) Specialty Care Division participated market this year.
SOu:RK\WKMO_^SMKV]v brand building, innovative marketing campaigns and
(iv) Consumer Care Division partnerships to help patients and physicians. This will
>RO-YWZKXct]L_]SXO]]YZO\K^SYX]K\ONS`SNONSX^YPY_\NS`S]SYX] >RS] .S`S]SYX MYX]S]^] YP K MYWZ\OROX]S`O \KXQO YP Z\YN_M^] PY\
ensure we continue growing faster than the market and
SO S AYWOXt] 2OKV^R  1K]^\YSX^O]^SXO 1K]^\YOX^O\YVYQc ^\OK^WOX^ YP WO^KLYVSM NS]Y\NO\] KXN MOX^\KV XO\`Y_] ]c]^OW This Division is present in the Over The Counter (OTC) antacid drive our therapy leadership.
13:\Y]ZO\KKXN13+N`KXMOSS=ZOMSKV^c-K\OSSS1OX8Ob^KXN SVVXO]]O] KXN MY`O\] ^RO\KZc K\OK] VSUO RcZY^Rc\YSNS]W `O\^SQY segment and mainly promotes all variants of Digene (antacid –
@KMMSXO]KXNS`-YX]_WO\-K\O NOZ\O]]SYX KXN WSQ\KSXO >RO UOc L\KXN] SX ^RS] NS`S]SYX KX^S
K^_VOX^x^KLVO^]VS[_SN]KXNZYaNO\] - Provide services that go beyond just the pill :
K\O >Rc\YXY\W ^Rc\YSN Z\OZK\K^SYX] @O\^SX KX^S`O\^SQY The Division focuses on connecting with patients through
>RO UOc ZO\PY\WKXMO RSQRVSQR^] YP OKMR ,_]SXO]] .S`S]SYX PY\   O RK`O ^K\QO^ON SX^O\`OX^SYX] K^ OKMR ]^KQO KVYXQ ^RO
A
:\Y^RSKNOXKX^SNOZ\O]]KX^KXN3XNO\KVWSQ\KSXOZ\YZRcVKbS] positioning of its products mainly through mass media, social
^RO XKXMSKVcOK\!"K\OK]PYVVYa]$ sMYX^SX__W YP MK\Ot PY\ ZK^SOX^] 0Y\ ObKWZVO aO RK`O
=YWO YP ^RO]O OXTYc WK\UO^ VOKNO\]RSZ ZY]S^SYX] SX ^ROS\ media and point of sale promotion. New advertisement and
developed a holistic end-to-end solution in the gut space
(i) Women’s Health & Gastrointestine, Gastroenterology, \O]ZOM^S`O^RO\KZO_^SMK\OK] marketing strategies will help sustaining the growth of this
MKVVON s1_^ ^t aRSMR SX`YV`O] ]YV_^SYX] ]_MR K] MY_X]OVVSXQ
GI Prospera and GI Advance Division portfolio. The Division showed growth of 10.6% over the previous
- Metabolics year. and nutrition advice for patients.
>RS].S`S]SYXYPPO\]KWSbYPY_\QVYLKVKXN3XNSK]ZOMS ML\KXN]
>RS] ,_]SXO]] ?XS^ Q\Oa Lc  N_\SXQ ^RO cOK\ >RO Q\Ya^R During the year, 5 new products - Rashfree Natural Cream (Diaper - Increase portfolio depth through the launch of new
KM\Y]] Z\OQXKXMc MYX]^SZK^SYX KXN VS`O\ NS]OK]O] ]OQWOX^]
aK]WKSXVcN\S`OXLc>Rc\YXY\WaRSMR\O^KSX]
KQ]RSZZY]S^SYX Rash Cream), Digene Paan Flavour (Antacid), Digene Pudina Pearls products in our existing therapy areas :
=O`O\KV YP ^RO -YWZKXct] VK\QO]^ L\KXN] ]_MR K] ._ZRK]^YX
.SQO]^S`O -\OWKP X 0\O]R 6KbK^S`O KXN ,\_POX +M^S`O :KSX
AYWOXt]2OKV^R2Y\WYXO._ZRKVKM6KbK^S`O?NSVS`2OZK^SM SXS^]]OQWOX^ During the year, we have launched 21 new products and have a
Relief Ointment) were launched.
:\Y^OM^S`O -\OWKP X 6KbK^S`O -\OWKP X :V_] 6KbK^S`O During the year  XOa Z\YN_M^  -YWLSXY\W :\YLSY^SM x robust plan for future launches.
-\OYX.SQO]^S`O/XdcWO]2OZ^\KV+VMYRYVSMVS`O\NS]OK]OKXN MEDICAL RESEARCH AND KNOWLEDGE SHARING
,KM^O\SKV@KQSXY]S]aK]VK_XMRON - Focus on internal talent development, engagement,
<YaK]K3X
KWWK^Y\c,YaOV=cXN\YWOPY\WZK\^YP^RS]NS`S]SYX INITIATIVES
retention and capability building :
- Women’s Health & Gastrointestine - Central Nervous System
>RO-YWZKXc]SQXS MKX^Vc]_ZZY\^]<OKVAY\VN/`SNOXMOE<A/G
Generation Studies and Registration Studies for innovative   O \_X ]_MMO]]P_V WKXKQOWOX^ ^\KSXOO Z\YQ\KW] MYXN_M^
A
>RS] ,_]SXO]] ?XS^ ZY]^ON K ]^\YXQ Q\Ya^R YP # N_\SXQ >RS] ,_]SXO]] ?XS^ Q\Oa Lc "" N_\SXQ ^RO cOK\ @O\^SX KXN
products developed by Innovation and Development (I&D) teams, _XSPY\W K]]O]]WOX^] PY\ \]^ VSXO KXN ]OMYXN VSXO WKXKQO\
^RO cOK\ ._ZRK]^YX ?NSVS` KXN ._ZRKVKM RK`O MYX^\SL_^ON :\Y^RSKNOX MYX^SX_O] K] ^RO WK\UO^ VOKNO\ KXN RK] ]RYaX
aRSMR ROVZ SX K^^KSXSXQ S^] MYWWS^WOX^ PY\ ZY\^PYVSY ObZKX]SYX \YVO]KXNRK`O^ROSXN_]^\c]YXVc^SO\MO\^S MK^SYXZ\YQ\KW
]SQXS MKX^Vc^YY`O\KVVQ\Ya^R NY_LVONSQS^Q\Ya^R
In addition, training imparted to Healthcare professionals (HCPs) PY\Y_\ OVNPY\MO>RS]cOK\aOVK_XMRON^ROAYWOX6OKNO\]
._\SXQ ^RO cOK\  XOa Z\YN_M^]  Cystofert (Polycystic Ovary ._\SXQ ^RO cOK\  XOa Z\YN_M^]  3XNO\KV  7SQ\KXO KXN during clinical studies via Good Clinical Practice (GCP), drives the YP+LLY^^A6+SXS^SK^S`O^YROVZPOWKVOOWZVYcOO]K^+LLY^^
=cXN\YWOKXN6O^\YVSPO9`_VK^SYXaO\OVK_XMRON -O\OLSYX=^\YUO,\KSX3XT_\caO\OVK_XMRON -YWZKXct]]^KXNSXQK]K]MSOX^S MMYWZKXc 3XNSKWKbSWSdO^ROS\ZY^OX^SKV
 *
=Y_\MO]$37=2OKV^R Sources : IMS Health

46 ANNUAL REPORT 2017-18 47


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

- Digital differentiation and use of technology : +NNS^SYXKVVc ]SQXS MKX^ SX^O\XKV K_NS^ YL]O\`K^SYX] KXN India Talent Strategy Coaching Culture
WKXKQOWOX^KM^SYX]^RO\OYXK\O\OZY\^ON^Y^RO+_NS^-YWWS^^OO Pursuing an integrated approach to talent management helps us to >RO -YWZKXc MYX]^KX^Vc PYM_]O] YX Z\YZKQK^SXQ K MYKMRSXQ
3 ^ MYWZVOWOX^ Y_\ Z\YN_M^] ^Y N\S`O OXQKQOWOX^ aS^R YX K [_K\^O\Vc LK]S] +X SXNOZOXNOX^ KXN OWZYaO\ON +_NS^
5Oc 9ZSXSYX 6OKNO\] KXN ZK^SOX^] PY\ ObKWZVO SXMVSXSM K^^\KM^^ROLO]^^KVOX^KXNKV]YNO`OVYZP_^_\OVOKNO\]P\YWaS^RSX M_V^_\O KM\Y]] ]KVO] RSO\K\MRc 9XTYLMYKMRSXQ S] YXO YP ^RO
-YWWS^^OO \O`SOa] ^RO YL]O\`K^SYX] KXN K]]O]]O] ^RO KNO[_KMc ^RO Y\QKXS]K^SYX AO VO`O\KQO NSPPO\OX^SK^ON ^KVOX^ RS\SXQ _]SXQ SWZY\^KX^ VO`O\] YP L_SVNSXQ SXNS`SN_KV MKZKLSVS^SO] KXN N\S`O
engagement through augmented and virtual reality interfaces
YP^ROKM^SYX]Z\YZY]ONK]aOVVK]WYXS^Y\]^ROS\SWZVOWOX^K^SYX W_V^SZVOMRKXXOV]SXMV_NSXQZ\OWSO\L_]SXO]]]MRYYV]SX3XNSKKXN OWZVYcOO WY^S`K^SYX KXN OXQKQOWOX^ u-YKMRSXQ 9VcWZSKNv S]
]_MRK]^RO@O\^S1Y+ZZ>R\Y_QR^RO\YVVY_^YPS:KN]^Y OVN
ARSVO ^RO 3X^O\XKV +_NS^Y\] MYXN_M^ K [_K\^O\Vc PYVVYa _Z PY\ KL\YKN3XS^]PY_\^RcOK\YPObOM_^SYXY_\3XNSK>KVOX^=^\K^OQc a very innovative initiative aimed at identifying and recognising
PY\MOYP^R\OOYPY_\,_]SXO]]?XS^]aORK`OWY\OOXQKQSXQ
SWZVOWOX^K^SYX\OWONSK^SYX YP KVV K_NS^ \OMYWWOXNK^SYX] KXN KSW]$ u,O]^-YKMRO]vSX^RO]KVO]^OKW]+^Y^KVYPLO]^MYKMRO]aO\O
KXNNSPPO\OX^SK^ONMYX^OX^^Y]RYaMK]O^YNYM^Y\]
^RO]^K^_]\OZY\^S]Z\O]OX^ON^Y^RO+_NS^-YWWS^^OO\OQ_VK\Vc \OMYQXS]ONN_\SXQ^ROLSQQO]^KXX_KV]KVO]MYXPO\OXMOK \]^SX
w ^ YLO^ROOWZVYcO\YPMRYSMOSX^RO3XNSKX2OKV^RMK\O3XN_]^\c
RISKS AND CONCERNS >RO-YWZKXcRK]SWZVOWOX^ONLY^RZ\O`OX^K^S`OKXNNO^OM^SYX SXN_]^\cSXS^SK^S`O
SX ^O\W] YP K^^\KM^SXQ KXN \O^KSXSXQ ^RO \SQR^ [_KX^S^c KXN
>ROSWZVSMK^SYXYP\S]URK]]^OKNSVcSX^OX]S ONQS`OX^RO`YV_WO MYX^\YV] KXN KZZ\YZ\SK^O MY\\OM^S`O KM^SYX] ^Y \ON_MO ^RO \S]U] [_KVS^c^KVOX^% Prevention of Sexual Harassment at Workplace
KXNMYWZVObS^cYPMRKXQO^ROZRK\WKMO_^SMKVSXN_]^\cMYX^SX_O] SXMV_NSXQ$
w ^ YKMRSO`OY_\K]ZS\K^SYX^YMYX^SX_O^YQ\YaPK]^O\^RKX^RO >RO -YWZKXc RK] KX 3X^O\XKV -YWZVKSX^] -YWWS^^OO 3--
^Y PKMO LY^R SX 3XNSK KXN ^RO aY\VN <OQ_VK^Y\c MRKVVOXQO] K\O w  LLY^^ -YNO YP ,_]SXO]] -YXN_M^ -9,- \O[_S\O] KXX_KV
+ WK\UO^]aOYZO\K^OSXKXNNOVS`O\Z\ONSM^KLVOZO\PY\WKXMO SX ZVKMO K] \O[_S\ON _XNO\ ^RO =Ob_KV 2K\K]]WOX^ YP AYWOX K^
MYWZY_XNON Lc O`YV`SXQ \OQ_VK^SYX] KXN XOa VOQS]VK^SYX]
MO\^S MK^SYXLcKVVOWZVYcOO]% AY\UZVKMO :\O`OX^SYX :\YRSLS^SYX KXN <ON\O]]KV +M^ 
ARSVO \OQ_VK^Y\] K\O MYWWS^^ON ^Y M\OK^O KX OX`S\YXWOX^ >RO -YWZKXc LOVSO`O] SX WY^S`K^SXQ KXN OXQKQSXQ OWZVYcOO]
MYXN_MS`O PY\ ZRK\WKMO_^SMKV MYWZKXSO] ^Y NY L_]SXO]] ]cXM w  YWZVSKXMO-YWWS^^OOS]PY\WONaS^R\OZ\O]OX^K^S`O]P\YW
- ^R\Y_QR]RK\ONQYKV]MKZKLSVS^cL_SVNSXQSXS^SK^S`O]MK\OO\Q\Ya^R +ZZ\YZ\SK^O^\KSXSXQS]SWZK\^ON^YOWZVYcOO]>RS]^\KSXSXQKV]Y
LO^aOOXZYVSMcKXNYZO\K^SYX]aSVVLOKXK\OK^YaK^MR KVV^ROYZO\K^SXQQ\Y_Z]% YZZY\^_XS^SO]KXNKXOX`S\YXWOX^YP^\KX]ZK\OXMcKMMY_X^KLSVS^c PY\W]KZK\^YP8Oa/WZVYcOO9\SOX^K^SYX:\YQ\KW>RO\OaO\O
KXNZY]S^S`O\OSXPY\MOWOX^ XY MYWZVKSX^] \OMOS`ON Lc ^RO -YWZKXc3-- N_\SXQ ^RO cOK\
>RO 8K^SYXKV :RK\WKMO_^SMKV :\SMSXQ +_^RY\S^c 8::+ aSVV w Senior Management have oversight of the compliance _XNO\^ROKPY\O]KSN+M^
continue to play an active role of regulator for drug prices and Z\YQ\KW]% Women Leaders of Abbott
P_\^RO\ MRKXQO] K\O ObZOM^ON ^Y LO SX^\YN_MON ^Y ^RO Z\SMSXQ >Y^KVX_WLO\YPOWZVYcOO]K]YX7K\MR"S]
w  _]SXO]] -YWZVSKXMO -OVV S] K]]SQXON aS^R \O]ZYX]SLSVS^c
, 2OVZSXQ aYWOX K^ +LLY^^ WKbSWSdO ^ROS\ ZY^OX^SKV KXN \OKVS]O
]c]^OW7Y\OP\O[_OX^\O`S]SYX]^Y^RO8K^SYXKV6S]^YP/]]OX^SKV
YP ^\KSXSXQ WYXS^Y\SXQ KXN OX]_\SXQ MYWZVSKXMO YP ^RO greater achievement and advancement throughout their careers is DIRECTORS’ RESPONSIBILITY STATEMENT
7ONSMSXO]86/7K\OObZOM^ON
-YWZKXc]:YVSMSO]KXN:\YMON_\O]Lc OVNOWZVYcOO]% ^ROWS]]SYXYPAYWOX6OKNO\]YP+LLY^^A6+>R\Y_QR`K\SY_]
:_\]_KX^ ^Y =OM^SYX  YP ^RO -YWZKXSO] +M^  cY_\
Although no concrete proposals to introduce direct controls on Z\YQ\KW] SXS^SK^S`O] KXN ]ZOKUO\ ]O\SO] A6+ MYXXOM^] aYWOX
w >RO-YWZKXcRK]KARS]^VO,VYaO\WOMRKXS]WSXZVKMO% .S\OM^Y\]]^K^O^RK^$
ZK^OX^ONZ\YN_M^Z\SMO]RKNLOOXWKNOZ_LVSMK]YPOK\Vc"S^ OWZVYcOO]KXNYPPO\]^YYV]KXN^YZSM]^YROVZ^ROWWKbSWSdO^ROS\
S]ZY]]SLVO^RK^KZK^OX^ONN\_QZ\SMOZYVSMcMY_VNLOSX^\YN_MON w  _]SXO]] .S`S]SYX] RK`O K [_K\^O\Vc WOO^SXQ aS^R .S\OM^Y\ 
, MK\OO\]K^+LLY^^ K S X^ROZ\OZK\K^SYXYP^RO+XX_KV+MMY_X^]PY\^ROcOK\OXNON
9P MOYP/^RSM]KXN-YWZVSKXMO^YWYXS^Y\KXNNS]M_]]^RO 7K\MR"^ROKZZVSMKLVOKMMY_X^SXQ]^KXNK\N]RK`OLOOX
8_WO\Y_] Z\YPO]]SYXKV Y\QKXS]K^SYX] KXN QY`O\XWOX^ LYNSO] >ROYLTOM^S`OYP^RS]SXS^SK^S`OS]^YM\OK^OKZVK^PY\WPY\K^^\KM^SXQ
MYWZVSKXMOaS^R`K\SY_]L_]SXO]]Z\YMO]]O] PYVVYaONKXN^RO\OK\OXYWK^O\SKVNOZK\^_\O]P\YW^RO]KWO%
RK`O \OZOK^ONVc MKVVON PY\ NYM^Y\] ^Y Z\O]M\SLO VYa MY]^ QOXO\SM retaining and advancing female talent in the organisation
WONSMSXO] ^Y ZK^SOX^] >RS] S] YXO KWYXQ K ]O\SO] YP WOK]_\O] >RO -YWZKXc 7KXKQOWOX^ RK] K]]O]]ON ^RO OPPOM^S`OXO]] YP KXN ^RO\OLc LOMYWSXQ ^RO /WZVYcO\ YP -RYSMO PY\ POWKVO L ^ ROcRK`O]OVOM^ON]_MRKMMY_X^SXQZYVSMSO]KXNKZZVSON^ROW
ZVKXXONLc^ROROKV^RWSXS]^\c^Y\OQ_VK^O^ROMY]^YPWONSMKVMK\O SX^O\XKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ PY\ ^RO cOK\ OXNON OWZVYcOO]KXNMYX^\SL_^SXQZY]S^S`OVc^YL_]SXO]]]_MMO]] MYX]S]^OX^Vc KXN WKNO T_NQWOX^] KXN O]^SWK^O] ^RK^ K\O
KXNWKUOROKV^RMK\OWY\OKPPY\NKLVOSX3XNSK>ROSX^\YN_M^SYX 7K\MR  " KXN LK]ON YX ^RO K]]O]]WOX^ LOVSO`O ^RK^ ^RO
Leadership Programs \OK]YXKLVOKXNZ\_NOX^]YK]^YQS`OK^\_OKXNPKS\`SOaYP^RO
YPQOXO\SMZ\O]M\SLSXQ\OQ_VK^SYX]S]YX^ROQY`O\XWOX^t]KQOXNK ]KWOK\OKNO[_K^OKXNaY\USXQOPPOM^S`OVc ]^K^OYPKPPKS\]YP^RO-YWZKXcK]K^7K\MR"KXNYP^RO
=O`O\KV VOKNO\]RSZ Z\YQ\KW] ]_MR K] 3X]^\SNO 1VYLKV -S^SdOX
INTERNAL CONTROL SYSTEM AND ITS ADEQUACY >RO=^K^_^Y\c+_NS^Y\]RK`OS]]_ONKXK_NS^\OZY\^YX^ROKNO[_KMc Z\Y ^]YP^RO-YWZKXcPY\^RK^cOK\%
.O`OVYZWOX^ :\YQ\KW /WO\QSXQ 6OKNO\] :\YQ\KW O^M aO\O
>RO -YWZKXc RK] Z_^ SX ZVKMO KX SX^O\XKV MYX^\YV WOMRKXS]W KXN OPPOM^S`OXO]] YP ^RO SX^O\XKV XKXMSKV MYX^\YV ]c]^OW] Y`O\ MYXN_M^ONN_\SXQ^ROcOK\ M ^ ROcRK`O^KUOXZ\YZO\KXN]_P MSOX^MK\OPY\^ROWKSX^OXKXMO
^RK^ S] MYWWOX]_\K^O aS^R S^] ]SdO KXN XK^_\O YP L_]SXO]] XKXMSKV\OZY\^SXQ
=YWO YP ^RO Y^RO\ XY^KLVO SXS^SK^S`O] SXMV_NO $ Feeder Pool YP KNO[_K^O KMMY_X^SXQ \OMY\N] SX KMMY\NKXMO aS^R ^RO
>RO]O ]c]^OW] Z\Y`SNO K \OK]YXKLVO K]]_\KXMO YX KMRSO`OWOX^ Z\Y`S]SYX] YP ^RO -YWZKXSO] +M^  PY\ ]KPOQ_K\NSXQ ^RO
HUMAN RESOURCES Development Program KSWON K^ KMMOVO\K^SXQ Z\YQ\O]] YP Y_\
YPS^]YZO\K^SYXKVMYWZVSKXMOKXN\OZY\^SXQYLTOM^S`O]SXMV_NSXQ assets of the Company and for preventing and detecting fraud
>RO-YWZKXc \WVcLOVSO`O]^RK^R_WKXMKZS^KVMYX^SX_O]^YLO UOc ^KVOX^ ^YaK\N] VOKNO\]RSZ \YVO] K^ WSNWKXKQOWOX^ VO`OV%
]KPOQ_K\NSXQYPK]]O^]YP^RO-YWZKXcZ\O`OX^SYXKXNNO^OM^SYX KXNY^RO\S\\OQ_VK\S^SO]%
^RON\S`SXQPY\MOYPY_\L_]SXO]]AOOXNOK`Y\^YK^^\KM^\O^KSX Differential Hiring Strategy KSWON K^ SXP_]SXQ NSPPO\OX^SKV
YP P\K_N] KMM_\KMc KXN MYWZVO^OXO]] YP KMMY_X^SXQ \OMY\N] KXN
NO`OVYZKXNNOZVYc^ROLO]^K`KSVKLVO^KVOX^KM\Y]]^ROP_XM^SYX] ^KVOX^ KXN NS`O\]S^c% Sales Management Trainee Program
OX]_\SXQMYWZVSKXMOaS^R^ROMY\ZY\K^OZYVSMSO] N ^ ROcRK`OZ\OZK\ON^RO+XX_KV+MMY_X^]YP^RO-YWZKXcYX
KXN RSO\K\MRc YP ^RO -YWZKXc :\Y`SNSXQ KX OWZYaO\SXQ aY\U KSWON K^ L_SVNSXQ K NS`O\]O KXN ]_ZO\SY\ ^KVOX^ ZYYV PY\ \]^
>RS] WOMRKXS]W S] ]Y_XN SX NO]SQX KXN ^RO P\KWOaY\U S] KQYSXQMYXMO\XLK]S]%
VSXO WKXKQO\]% Sales Leadership Development Program
OX`S\YXWOX^^RK^S]L_SV^_ZYXYZOXXO]]KXN^\KX]ZK\OXMcPY]^O\]
MYX^SX_Y_]Vc O`KV_K^ON PY\ OPPOM^S`OXO]] KXN KNO[_KMc an internal career development program designed to source O ^ ROcRK`OVKSNNYaXKNO[_K^O3X^O\XKV0SXKXMSKV-YX^\YV]
>RO WOMRKXS]W YZO\K^O] ^R\Y_QR aOVVNYM_WOX^ON ]^KXNK\N MYVVKLY\K^S`O ZK\^SMSZK^SYX YP Y`O\  MYWWS^^ON ZOYZVO
^KVOX^ SX^O\XKVVc KXN O]^KLVS]R K MK\OO\ ZK^R PY\ UOc P_XM^SYX] ^Y LO PYVVYaON Lc ^RO -YWZKXc KXN ^RK^ ]_MR 3X^O\XKV
YZO\K^SXQZ\YMON_\O]ZYVSMSO]KXNZ\YMO]]Q_SNOVSXO] ^YaK\N] KNN\O]]SXQ ^RO _XWO^ ROKV^RMK\O XOON] YP S^] M_]^YWO\
\YVO]% Uniform Assessments for First Line and Second Line 0SXKXMSKV -YX^\YV] K\O KNO[_K^O KXN K\O YZO\K^SXQ
_XS`O\]O
>RO3X^O\XKV+_NS^ZVKXS] XKVS]ONLK]ONYXM_\\OX^ZO\MOZ^SYXYP Manager roles KSWON K^ M\OK^SXQ ]_MMO]]SYX ZSZOVSXO PY\ 0S\]^ OPPOM^S`OVc%
SX^O\XKVMYX^\YV\S]UKXNMYWZVSKXMO\O[_S\OWOX^SXMYX]_V^K^SYX 9_\ 2_WKX <O]Y_\MO ^OKW RK] NO`OVYZON KXN NOZVYcON KX 6SXOKXN=OMYXN6SXORSQRZO\PY\WSXQ OVNWKXKQO\]%Executive
aS^RYZO\K^SXQNS`S]SYX]>RO3X^O\XKV+_NS^Y\]K]KZK\^YP^ROS\ SX^OQ\K^ON ^KVOX^ WKXKQOWOX^ WOMRKXS]W aRSMR OXMYWZK]]O] Program in Sales & MarketingKX/bOM_^S`O:\YQ\KWSX=KVO] P  ^ ROcRK`ONO`S]ONZ\YZO\]c]^OW]^YOX]_\OMYWZVSKXMOaS^R
K_NS^] \O`SOa ^RO NO]SQX YP UOc Z\YMO]]O] P\YW KX KNO[_KMc YP ^RO OX^S\O OWZVYcOO VSPOMcMVO x \OM\_S^WOX^ MK\OO\ Z\YQ\O]]SYX KXN7K\UO^SXQP\YW337-KVM_^^KPY\RSQRZY^OX^SKV=OMYXN6SXO ^ROZ\Y`S]SYX]YPKVVKZZVSMKLVOVKa]KXN^RK^]_MR]c]^OW]K\O
MYX^\YV]ZYSX^YP`SOa \OaK\N]KXN\OMYQXS^SYX] 7KXKQO\] KNO[_K^OKXNYZO\K^SXQOPPOM^S`OVc

48 ANNUAL REPORT 2017-18 49


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

RELATED PARTY TRANSACTIONS w  XRKXMSXQ \S]U \O]ZYX]O NOMS]SYX] x <S]U 7KXKQOWOX^


/  7
 ]+XS]RK7Y^aKXS.38$ ##RK]LOOXKZZYSX^ONK] ?XNO\^ROKPY\OWOX^SYXON0\KWOaY\UKXN:YVSMc^ROZO\PY\WKXMO
Policy on dealing with Related Party Transactions and Z\Y`SNO]^RO\SQY\^YSNOX^SPcKXN]OVOM^KWYXQKV^O\XK^S`O\S]U +NNS^SYXKVKXN3XNOZOXNOX^.S\OM^Y\PY\KZO\SYNYP^R\OO O`KV_K^SYX YP ^RO ,YK\N -YWWS^^OO] KXN SXNS`SN_KV .S\OM^Y\]
Materiality \O]ZYX]O]x\S]UK`YSNKXMO\ON_M^SYX]RK\SXQKXNKMMOZ^KXMO cOK\] OPPOM^S`O +Z\SV  " ]_LTOM^ ^Y ^RO KZZ\Y`KV YP ^RO S] MYXN_M^ON ^R\Y_QR ]OVPK]]O]]WOX^ KXN Q\Y_Z NS]M_]]SYX
7OWLO\]K^^ROOX]_SXQ+XX_KV1OXO\KV7OO^SXQ >RO,YK\NWKc\OPO\^YK]_QQO]^ON]O^YP[_O]^SYX]ZK\KWO^O\]^Y
>RO -YWZKXc RK] PY\W_VK^ON K :YVSMc YX NOKVSXQ aS^R <OVK^ON w  ON_MSXQ YZO\K^SYXKV ]_\Z\S]O] KXN VY]]O] x >RO -YWZKXc
<
:K\^c>\KX]KM^SYX]KXN7K^O\SKVS^cSX^O\W]YP\O[_S\OWOX^]YP^RO ]^\S`O]^YQKSXOXRKXMONMKZKLSVS^c^YSNOX^SPcZY^OX^SKVO`OX^] 3X MYWZVSKXMO aS^R =OM^SYX  YP ^RO -YWZKXSO] +M^  Q_SNO^ROS\NS]M_]]SYX]>RO-RKS\WKXYP^RO,YK\N8YWSXK^SYX
-YWZKXSO]+M^KXN^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK KXN O]^KLVS]R \O]ZYX]O] \ON_MSXQ ]_\Z\S]O] KXN K]]YMSK^ON 7\7_XS\=RKSUR.38$# !KXN7\5KScYWK\d7K\PK^SK and Remuneration Committee meet the individual Directors to
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX] MY]^]Y\VY]]O] .38$# !\O^S\OLc\Y^K^SYXK^^ROOX]_SXQ+XX_KV1OXO\KV Z\Y`SNOPOONLKMUSPKXc
 >RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^ 7OO^SXQKXNLOSXQOVSQSLVOYPPO\^ROW]OV`O]PY\\OKZZYSX^WOX^
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV w 3 NOX^SPcSXQKXNWKXKQSXQW_V^SZVOKXNM\Y]]OX^O\Z\S]O\S]U] ._\SXQ^ROcOK\^RO,YK\N^RO8YWSXK^SYXKXN<OW_XO\K^SYX
x>RO-YWZKXcPKMO]K`K\SO^cYP\S]U]KPPOM^SXQNSPPO\OX^ZK\^] 3XKMMY\NKXMOaS^R^ROZ\Y`S]SYX]YP^RO=OM_\S^SO]KXN/bMRKXQO Committee conducted performance evaluation of each
+] ZO\ ^RO ]KSN :YVSMc KVV <OVK^ON :K\^c >\KX]KM^SYX] K\O YP^ROY\QKXS]K^SYXKXN\S]UWKXKQOWOX^PKMSVS^K^O]OPPOM^S`O ,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^] SXNS`SN_KV NS\OM^Y\ KXN ^RO ,YK\N MYXN_M^ON ZO\PY\WKXMO
Z\OKZZ\Y`ON Lc ^RO +_NS^ -YWWS^^OO KXN ,YK\N K] KXN aROX \O]ZYX]O^Y^ROSX^O\\OVK^ONSWZKM^]KXNSX^OQ\K^ON\O]ZYX]O]
\O[_S\ON >RO NO^KSV] YP ]_MR ^\KX]KM^SYX] K\O KV]Y \O`SOaON +WOXNWOX^ <OQ_VK^SYX] " OPPOM^S`O +Z\SV  # O`KV_K^SYX YP ^RO ,YK\N KXN -YWWS^^OO] ^R\Y_QR ]OVP
^YW_V^SZVO\S]U]
Lc ^RO +_NS^ -YWWS^^OO YX K [_K\^O\VcKXX_KV LK]S] 7K^O\SKV KZZ\Y`KV YP 7OWLO\] S] ]Y_QR^ ^R\Y_QR =ZOMSKV <O]YV_^SYX PY\ K]]O]]WOX^KXNQ\Y_ZNS]M_]]SYX]/`KV_K^SYXaK]NYXOLK]ON
>\KX]KM^SYX]^\KX]KM^SYXObMOONSXQYP^ROKXX_KV^_\XY`O\K] w  OSdSXQYZZY\^_XS^SO]x,cMYX]SNO\SXQKP_VV\KXQOYPZY^OX^SKV
= \OKZZYSX^WOX^YP7\7_XS\=RKSURaRYRK]K^^KSXON^ROKQOYP YX ^RO ZK\KWO^O\] ]^K^ON _XNO\ ^RO KPY\O]KSN 0\KWOaY\U
ZO\^ROVK]^K_NS^ON XKXMSKV]^K^OWOX^]SPKXcaS^RKXc<OVK^ON O`OX^]^RO-YWZKXcS]ZY]S^SYXON^YSNOX^SPcKXNZ\YKM^S`OVc =O`OX^c `OcOK\] 3XNOZOXNOX^ .S\OM^Y\] K^ ^ROS\ ]OZK\K^O WOO^SXQ O`KV_K^ON
:K\^SO]K\OZ\OKZZ\Y`ONLc^RO=RK\ORYVNO\] \OKVS]OYZZY\^_XS^SO] ZO\PY\WKXMO YP 8YX3XNOZOXNOX^ .S\OM^Y\] ^RO ,YK\N K] K
,K]ONYX\OMYWWOXNK^SYXYP^RO8YWSXK^SYXKXN<OW_XO\K^SYX
Details of Related Party Transactions w 3 WZ\Y`SXQ NOZVYcWOX^ YP MKZS^KV x 9L^KSXSXQ \YL_]^ \S]U -YWWS^^OO cY_\ .S\OM^Y\] \OMYWWOXN KZZYSX^WOX^ aRYVO KXN ^RO -RKS\WKX +ZZ\YZ\SK^O POONLKMU aK] Z\Y`SNON
SXPY\WK^SYX KVVYa] WKXKQOWOX^ ^Y OPPOM^S`OVc K]]O]] Y`O\KVV \OKZZYSX^WOX^ YP 7\ <KTS` =YXKVUO\ 7] +XS]RK 7Y^aKXS ^Y^RO-RKS\WKXKXN7KXKQSXQ.S\OM^Y\
+VV ^RO <OVK^ON :K\^c >\KX]KM^SYX] SXMV_NSXQ ^RO 7K^O\SKV
>\KX]KM^SYX]OX^O\ONSX^YLc^RO-YWZKXcN_\SXQ^ROcOK\!" MKZS^KVXOON]KXNOXRKXMOMKZS^KVKVVYMK^SYX 7\7_XS\=RKSURKXN7\5KScYWK\d7K\PK^SK
KEY MANAGERIAL PERSONNEL
u]KSN>\KX]KM^SYX]vaO\OSX^ROY\NSXK\cMY_\]OYPL_]SXO]]KXN >RO]O MKZKLSVS^SO] SXRO\OX^ SX ^RS] 0\KWOaY\U OXKLVO ^RO
YXK\Wt]VOXQ^RLK]S]>RO]KSN>\KX]KM^SYX]aO\OZ\OKZZ\Y`ON Declaration of Independence
-YWZKXcKMRSO`SXQ^ROZO\PY\WKXMOKXNZ\Y ^KLSVS^c^K\QO^]KXN 7\ +WLK^S @OX_ 7KXKQSXQ .S\OM^Y\ 7\ <KTS` =YXKVUO\ -RSOP
Lc ^RO +_NS^ -YWWS^^OO ,YK\N KXN =RK\ORYVNO\] aRO\O`O\ Q_K\N KQKSX]^ VY]] YP \O]Y_\MO] 3^ S] KV]Y NS\OM^ON ^Y ROVZ OX]_\O >RO -YWZKXc RK] \OMOS`ON NOMVK\K^SYX] P\YW KVV ^RO 3XNOZOXNOX^ 0SXKXMSKV9P MO\KXN7]5\_ZK+XKXNZK\K-YWZKXc=OM\O^K\c
XOMO]]K\c OPPOM^S`O\OZY\^SXQKXNMYWZVSKXMOaS^RVKa]KXN\OQ_VK^SYX]K`YSN .S\OM^Y\] MYX \WSXQ ^RK^ ^ROc WOO^ aS^R ^RO M\S^O\SK YP K\O^RO5Oc7KXKQO\SKV:O\]YXXOVYP^RO-YWZKXc
.O^KSV] YP ^RO ]KSN >\KX]KM^SYX] K\O Z\Y`SNON SX 8Y^O  ^Y ^RO NKWKQO^Y^ROOX^S^ct]\OZ_^K^SYXKXNK]]YMSK^ONMYX]O[_OXMO] SXNOZOXNOXMO Z\O]M\SLON _XNO\ ]_L]OM^SYX   YP =OM^SYX #
0SXKXMSKV=^K^OWOX^] YP ^RO -YWZKXSO] +M^  KXN ^RO =OM_\S^SO] KXN /bMRKXQO AUDIT COMMITTEE
>RO-YWZKXcYZO\K^SYX]KXNS^],_]SXO]].S`S]SYX]K\OSXMV_NON
SX^RO]MYZOYP^RO<S]U7KXKQOWOX^0\KWOaY\U ,YK\N YP 3XNSK 6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] >RO +_NS^ -YWWS^^OO MYWZ\S]O] 7\ < + =RKR -RKS\WKX
CORPORATE SOCIAL RESPONSIBILITY <OQ_VK^SYX]K]KWOXNONP\YW^SWO^Y^SWO 7\5\S]RXK7YRKX=KRXS7\7_XS\=RKSURKXN7]+XS]RK7Y^aKXS
Corporate Social Responsibility (CSR) Policy ._\SXQ ^RO cOK\ <S]U 7KXKQOWOX^ -Y\O >OKW MYWZ\S]SXQ YP
Number of Meetings of the Board Role of the Committee is provided in detail in the Corporate
\OZ\O]OX^K^S`O] YP `K\SY_] P_XM^SYX] KXN L_]SXO]]O] MK\\SON Y_^
>RO -=< :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^ 1Y`O\XKXMO <OZY\^ PY\WSXQ ZK\^ YP ^RS] <OZY\^ +VV ^RO
\S]U K]]O]]WOX^ ObO\MS]O ^Y SNOX^SPc `K\SY_] ]SQXS MKX^ \S]U] =O`OX,YK\N7OO^SXQ]aO\OROVNN_\SXQ^ROcOK\YX7Kc#!%
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV \OMYWWOXNK^SYX]WKNOLc^RO+_NS^-YWWS^^OON_\SXQ^ROcOK\
K]]YMSK^ONaS^R^ROL_]SXO]]YZO\K^SYX]KXNWS^SQK^SYXZVKX]^Y 4_Vc " !% +_Q_]^ " !% 8Y`OWLO\  !% .OMOWLO\ #
KNN\O]] ]_MR \S]U] 7K^O\SKV \S]U] SNOX^S ON K\O O`KV_K^ON YX K aO\OKMMOZ^ONLc^RO,YK\N
-=<SXS^SK^S`O]_XNO\^KUOXN_\SXQ^RO XKXMSKVcOK\!" !%0OL\_K\c"KXN7K\MR!"
MYX^SX_SXQLK]S]
>RO-YWZKXcSXM_\\ONKXKWY_X^YP ` #6KUR]YX`K\SY_] VIGIL MECHANISM/WHISTLE BLOWER POLICY
Policy on Nomination and Appointment of Directors/ Criteria
-=<KM^S`S^SO]N_\SXQ^RO XKXMSKVcOK\!" 7K^O\SKV \S]U] KXN WS^SQK^SYX ZVKX] aO\O \O`SOaON Lc ^RO <S]U
for appointment of Senior Management and Remuneration >RO@SQSV7OMRKXS]WARS]^VO,VYaO\:YVSMcMKVVONu+LLY^^3XNSK
7KXKQOWOX^ -YWWS^^OO KXN ^ROX Z\O]OX^ON ^Y ^RO ,YK\N KXN
>RO+XX_KV<OZY\^YP-=<KM^S`S^SO]_XNO\^KUOXLc^RO-YWZKXc Policy 6SWS^ON x :\YMON_\O PY\ 3X^O\XKV 3X`O]^SQK^SYX]v VKc] NYaX K
+_NS^-YWWS^^OO
N_\SXQ^RO XKXMSKVcOK\!"S]KXXObONK]u+XXOb_\O3vKXN WOMRKXS]WPY\\OZY\^SXQKXNSX`O]^SQK^SYXYPKVV_XO^RSMKVLORK`SY\
:YVSMcYX8YWSXK^SYXKXN+ZZYSX^WOX^YP.S\OM^Y\]-\S^O\SKPY\
PY\W]ZK\^YP^RS]<OZY\^ DIRECTORS KVVOQON `SYVK^SYX] Y\ ZY^OX^SKV `SYVK^SYX] YP VKa] \OQ_VK^SYX] Y\
appointment of Senior Management and Remuneration Policy as
RISK MANAGEMENT FRAMEWORK AO \OZY\^ aS^R Z\YPY_XN Q\SOP ^RO ]KN KXN _X^SWOVc NOWS]O +LLY^^ -YNO YP ,_]SXO]] -YXN_M^ ZYVSMSO] Z\YMON_\O] Y\ Y^RO\
PY\W_VK^ON _XNO\ =OM^SYX !" YP ^RO -YWZKXSO] +M^  S]
YP 7\ <KXTKX 5KZ_\ aRY ZK]]ON KaKc YX 4KX_K\c ! " ]^KXNK\N]
>RO -YWZKXc \OMYQXS]O] <S]U 7KXKQOWOX^ K] KX SX^OQ\K^ON KXXObONK]u+XXOb_\O33vKXNPY\W]ZK\^YP^RS]<OZY\^
>RO ,YK\N ZVKMO] YX \OMY\N S^] ]SXMO\O KZZ\OMSK^SYX PY\ ^RO
PY\aK\NVYYUSXQKXNZ\YMO]]Y\SOX^ONKZZ\YKMR3^RK]NO`OVYZON SX`KV_KLVO MYX^\SL_^SYX] KXN Q_SNKXMO \OMOS`ON P\YW 7\ 5KZ_\ Performance Evaluation of the Board, Board Committees >RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO aOL]S^O YP ^RO -YWZKXc K^
K <S]U 0\KWOaY\U aRSMR S] NS\OM^ON ^Y OXKLVO WKXKQOWOX^ ^YaK\N]^ROZ\YQ\O]]YP^RO-YWZKXc and Directors R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
^Y OPPOM^S`OVc NOKV aS^R _XMO\^KSX^c KXN K]]YMSK^ON \S]U KXN
>RO,YK\NLK]ONYX^RO\OMYWWOXNK^SYXYP^RO8YWSXK^SYXKXN :_\]_KX^ ^Y ^RO \O[_S\OWOX^] YP ^RO -YWZKXSO] +M^  \OKN /WZVYcOO] RK`O X_WO\Y_] aKc] ^Y `YSMO MYXMO\X] KXN K\O
YZZY\^_XS^c OXRKXMSXQ ^RO MKZKMS^c ^Y L_SVN `KV_O 3^ OXKLVO] ^Y
<OW_XO\K^SYX -YWWS^^OO KZZYSX^ON ^RO PYVVYaSXQ .S\OM^Y\] YX aS^R <_VO] P\KWON ^RO\O_XNO\ KXN ^RO =OM_\S^SO] KXN /bMRKXQO
K`YSNZS^PKVV]KXN]_\Z\S]O]KVYXQ^ROaKc,\YKNVc^RO0\KWOaY\U OXMY_\KQON^Y\OZY\^^RO]KWOSX^O\XKVVcPY\\O]YV_^SYX>RO]KSN
^RO,YK\NYP^RO-YWZKXc_Z^Y^RONK^OYP^RS]<OZY\^ ,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]
OXMYWZK]]O]$ :YVSMc Z\Y`SNO] PY\ KNO[_K^O ]KPOQ_K\N] KQKSX]^ \O^KVSK^SYX KXN
  \ <KTS` =YXKVUO\ .38 $ !#!" RK] LOOX KZZYSX^ON
7 <OQ_VK^SYX]  ^RO -YWZKXc RK] PY\W_VK^ON :O\PY\WKXMO KMMO]]^Y^RO-RKS\WKXYP^RO+_NS^-YWWS^^OO
w  VSQXSXQ\S]UKZZO^S^OKXN]^\K^OQcx>RO-YWZKXcMYX]SNO\]
+ K] +NNS^SYXKV KXN ARYVO^SWO .S\OM^Y\ YP ^RO -YWZKXc PY\ /`KV_K^SYX 0\KWOaY\U KXN :YVSMc aRSMR ]O^] K WOMRKXS]W PY\
S^] \S]U KZZO^S^O SX O`KV_K^SXQ ]^\K^OQSM KV^O\XK^S`O] ]O^^SXQ K ZO\SYN YP  ^aY cOK\] OPPOM^S`O +_Q_]^ " ! ]_LTOM^ ^Y ^RO O`KV_K^SYX YP ^RO ,YK\N ,YK\N -YWWS^^OO] KXN .S\OM^Y\] +Xc MYXMO\X]Q\SO`KXMO MKX LO MYWW_XSMK^ON ^R\Y_QR `K\SY_]
\OVK^ON YLTOM^S`O] KXN NO`OVYZSXQ WOMRKXS]W] ^Y WKXKQO ^ROKZZ\Y`KVYP^RO7OWLO\]K^^ROOX]_SXQ+XX_KV1OXO\KV >RO ]KSN :YVSMc S] K`KSVKLle at R^^Z$aaaKLLY^^MYSXSX`O]^Y\ ]Y_\MO]K]Z\Y`SNON_XNO\^RO]KSN:YVSMcY\`SK^YVVP\OOX_WLO\
\OVK^ON\S]U] 7OO^SXQ% \OVK^SYX]ZYVSMSO]R^WV ""Y\YXVSXOK^R^^Z$]ZOKU_ZKLLY^^MYW

50 ANNUAL REPORT 2017-18 51


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

STATUTORY AUDITORS HEALTH, SAFETY AND ENVIRONMENT Introduction of closed loop system for Chloroform handling Z_\`SOaYPaK]^ONS]ZY]KV3X! YP^ROaK]^OaK]]OX^
=<,--966:-RK\^O\ON+MMY_X^KX^]3-+30S\W<OQS]^\K^SYX Health and Safety : aK] K WKTY\ SXS^SK^S`O _XNO\^KUOX K^ ^RO :VKX^ ^RS] cOK\ PY\ \OMcMVSXQ   PY\ SXMSXO\K^SYXMYZ\YMO]]SXQ KXN  PY\
8Y#"//aO\OKZZYSX^ONK]^RO=^K^_^Y\c+_NS^Y\] >RS]aSVV\ON_MOOWZVYcOOObZY]_\OKXNKMMSNOX^KVSXRKVK^SYX MYWZY]^SXQ9XOYPY_\]SQXS MKX^KMRSO`OWOX^]RK]LOOX^RO
:\Y`SNSXQ K ]KPO aY\UZVKMO KXN UOOZSXQ ^RO OWZVYcOO] ROKV^Rc +NNS^SYXKVVcaORK`OSX`O]^ONSX]O`O\KVOWZVYcOOOXQKQOWOX^ MRKXQSXQ PK^O YP RKdK\NY_] aK]^O ^R\Y_QR Y_\ SXS^SK^S`O] ^RK^
K^^RO=O`OX^SO^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXcROVNYX
S] ^RO -YWZKXct] ^YZ Z\SY\S^c AO K\O MYWWS^^ON ^Y UOOZSXQ Z\YQ\KW] VSUO MOVOL\K^SYX YP 8K^SYXKV =KPO^c aOOU AY\VN MRKXQONP\YW3XMSXO\K^SYX^Y-YZ\YMO]]SXQAS^R^RS]MRKXQO
+_Q_]^PY\K^O\WYPcOK\]SOP\YW XKXMSKVcOK\
KVV ^RY]O aRY aY\U PY\ ^RO -YWZKXc ]KPO Lc Z\O`OX^SXQ /X`S\YXWOX^NKcKXN+LLY^^/2=WYX^R^RK^aSVVROVZL_SVNK aO RK`O OX]_\ON ^RK^ ^RO OXO\Qc P\YW ^RO aK]^O S] \OMY`O\ON
^Y^RO XKXMSKVcOK\"#^YRYVNYP MO^SVV^ROMYXMV_]SYXYP^RO
NKXQO\Y_] SXMSNOX^] SX KXN K\Y_XN ^RO aY\UZVKMO 9_\ /2= ]_]^KSXKLVO/2=M_V^_\O ^R_]MYX^\SL_^SXQ^Y^RO\ON_M^SYXYP-9OWS]]SYXKXNQVYLKV
=O`OX^c P^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXc]_LTOM^^Y
strategy aims to develop a standardised approach to foster aK\WSXQ   YP ]S^O aK]^O aK] SXMSXO\K^ON aS^R OXO\Qc
\K^S MK^SYXK^OKMR+XX_KV1OXO\KV7OO^SXQ
MYX^SX_Y_]SWZ\Y`OWOX^KXNOX]_\OK]KPOKXNOP MSOX^aY\USXQ Environment : \OMY`O\c
3X ^O\W] YP =OM^SYX  YP ^RO -YWZKXSO] +WOXNWOX^ +M^ OX`S\YXWOX^^RK^WSXSWS]O]KXcKN`O\]OOX`S\YXWOX^KVSWZKM^
! XY^S ON YX 7Kc ! " ^RO \O[_S\OWOX^ PY\ \K^S MK^SYX YP 3XON_MK^SXQY_\OWZVYcOO]aOKV]YOWZYaO\^ROW^YZ\YWY^O + \O]ZYX]SLSVS^c ^YaK\N] ^RO OX`S\YXWOX^ S] ZK\^ YP +LLY^^t] CONSERVATION OF ENERGY, TECHNOLOGY
KZZYSX^WOX^ YP =^K^_^Y\c +_NS^Y\] Lc 7OWLO\] K^ O`O\c +XX_KV ]KPO\ KXN ROKV^RSO\ VS`O] SX ^ROS\ aSNO\ MYWW_XS^SO] AO ]^\S`O WKXNK^O AO MYX^SX_Y_]Vc OXNOK`Y\ ^Y WSXSWSdO ^RO _]O YP ABSORPTION AND FOREIGN EXCHANGE EARNINGS
^Y WKSX^KSX ^RO RSQRO]^ ]^KXNK\N] YP /X`S\YXWOX^ 2OKV^R KXN \OXOaKLVO \O]Y_\MO] KXN M_^ NYaX YX MK\LYX OWS]]SYX 3X KVV
1OXO\KV 7OO^SXQ RK] LOOX YWS^^ON KXN KMMY\NSXQVc 7OWLO\] AND OUTGO
KZZ\Y`KV S] XY^ \O[_S\ON PY\ \K^S MK^SYX YP ^ROS\ KZZYSX^WOX^ =KPO^c/2=Z\KM^SMO] Y_\ SXS^SK^S`O] aO KNYZ^ K RYVS]^SM KZZ\YKMR KXN WKUO OPPY\^]^Y
KXX_KVVc M_\^KSV ^RO KN`O\]O OX`S\YXWOX^KV SWZKM^ SP ^RO\O S] KXc N_\SXQ >RO ZK\^SM_VK\] K] \O[_S\ON _XNO\ ^RO Z\Y`S]SYX] YP =OM^SYX
>RO /WZVYcOO 2OKV^R KXN =KPO^c /2= :YVSMc RK] LOOX Z\YN_M^WKX_PKM^_\SXQKXNS^]NS]ZY]KVOS^RO\Lc_]Y_\`OXNY\]  W YP ^RO -YWZKXSO] +M^  \OKN aS^R <_VO " YP ^RO
AUDITORS’ REPORT SWZVOWOX^ON ^R\Y_QR Y_\ 1VYLKV /2= =^KXNK\N] ]_ZZY\^ON Y\ M_]^YWO\] >RO ]S^O MYX^SX_ON ^Y SWZVOWOX^ W_V^SZVO aK^O\ -YWZKXSO]+MMY_X^]<_VO]SX\O]ZOM^YP-YX]O\`K^SYXYP
Lc K aOVVNO XON /2= Y\QKXS]K^SYXKV ]^\_M^_\O /2= =^KXNK\N MYX]O\`K^SYX Z\YTOM^] ^Y ]K`O aK^O\ /bKWZVO]SXMV_NO SWZ\Y`ON /XO\Qc>OMRXYVYQc+L]Y\Z^SYX0Y\OSQX/bMRKXQO/K\XSXQ]KXN
>RO+_NS^Y\]t<OZY\^PY\^RO XKXMSKVcOK\!"NYO]XY^MYX^KSX
9ZO\K^SXQ:\YMON_\O]KXN/2=]ZOMS MZ\YQ\KW]KVVOX]_\SXQaO 9_^QYO^MK\OKXXObONK]u+XXOb_\O3@vKXNPY\W]ZK\^YP^RS]
KXcKN`O\]O\OWK\U][_KVS MK^SYX]Y\\O]O\`K^SYX]Y\NS]MVKSWO\] MYXNOX]K^O \OMY`O\c P\YW LYSVO\] SX]^KVVK^SYX YP
_SN LON N\cO\
WOO^KVV^ROVYMKV\OQ_VK^Y\c\O[_S\OWOX^] <OZY\^
aRSMR\O[_S\OObZVKXK^SYXMYWWOX^]Lc^RO,YK\N V^O\ LKQ aK]RSXQ KXN N\cSXQ WKMRSXO ^Y ]K`O  VS^O\] YP aK^O\
=_QQO]^SYX] P\YW ^RO =KPO^c -YWWS^^OO MYWZ\S]SXQ ZO\ aK]RSXQ McMVO KXN SX^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ
COST AUDITORS WKMRSXO SX]^KVVON ^Y ]K`O  VS^O\] YP aK^O\ ZO\ MYX^KSXO\ EXTRACT OF ANNUAL RETURN
\OZ\O]OX^K^S`O] P\YW ^RO aY\UPY\MO KXN WKXKQOWOX^ K\O
7]5S]RY\O,RK^SK+]]YMSK^O]-Y]^+MMY_X^KX^]<OQS]^\K^SYX implemented promptly to resolve issues impacting Plant safety >RO^\OK^ONaK^O\P\YWY_\aK]^OaK^O\^\OK^WOX^ZVKX^S]\OMcMVON /b^\KM^ YP +XX_KV <O^_\X K] Z\Y`SNON _XNO\ ]_L]OM^SYX  YP
8Y # K\O KZZYSX^ON K] ^RO -Y]^ +_NS^Y\] YP ^RO KXN OWZVYcOO ROKV^R <Y_^SXO ]OVPK_NS^] KXN ^RS\N ZK\^c PY\RY\^SM_V^_\OaS^RSX^RO]S^O =OM^SYX#YP^RO-YWZKXSO]+M^KXN<_VO]P\KWON^RO\O_XNO\
-YWZKXc PY\ ^RO XKXMSKV cOK\ "# K^ K \OW_XO\K^SYX YP ]KPO^c K_NS^] K\O MYXN_M^ON ^Y `O\SPc MYWZVSKXMO aS^R ^RO S]KXXObONK]u+XXOb_\O@vKXNPY\W]ZK\^YP^RS]<OZY\^
>RO -YWZKXc RK] K ]^K^OYP^ROK\^ OP
_OX^ ^\OK^WOX^ ZVKX^ K^
`   6KUR] ZV_] ^KbO] K] KZZVSMKLVO KXN \OSWL_\]OWOX^ YP \OQ_VK^Y\cKXNSX^O\XKV]KPO^c\O[_S\OWOX^]
1YK aS^R ZK\KWO^O\] YP ^\OK^ON OP
_OX^] aOVV LOVYa ^RO VSWS^ DISCLOSURE UNDER SECTION 197(12) OF THE
Y_^YPZYMUO^ObZOX]O] ._\SXQ ^RO cOK\ Z_WZ] aS^RSX ^RO ObS]^SXQ \O RcN\KX^ ]c]^OW ]O^Lc^ROVYMKV=^K^O:YVV_^SYX-YX^\YV,YK\N9_\1YKZVKX^S]K COMPANIES ACT, 2013 AND OTHER DISCLOSURES
>RO ]KSN \OW_XO\K^SYX ^Y ^RO -Y]^ +_NS^Y\] ]RKVV LO ]_LTOM^ aO\O_ZQ\KNON^YMY`O\KNNS^SYXKVObZKX]SYXK\OK^YWS^SQK^O^RO uD/<9vNS]MRK\QOZVKX^ AS PER RULE 5 OF THE COMPANIES (APPOINTMENT
^Y \K^S MK^SYX Lc ^RO 7OWLO\] K^ ^RO OX]_SXQ +XX_KV 1OXO\KV \S]UYP \OK^^RO1YK:VKX^>RO]S^OS]QOK\ON^YRKXNVOKXc^cZO
9`O\^ROZO\SYNYPVK]^cOK\]^RO]S^ORK]KMRSO`ONWY\O^RKX AND REMUNERATION OF MANAGERIAL PERSONNEL)
7OO^SXQ YP \O]S^_K^SYX
 KL]YV_^O aK^O\ \ON_M^SYX SX _]KQO KXN ^RO \KSX aK^O\ RULES, 2014
-Y]^ +_NS^ <OZY\^ KVYXQ aS^R ^RO -YWZVSKXMO <OZY\^ PY\ ^RO >\KSXSXQ Z\YQ\KW] K\O MYXN_M^ON K^ ^RO :VKX^ YX ROKV^R KXN RK\`O]^SXQ Z\YTOM^ aK] OPPOM^S`OVc MYX^SX_ON K^ ^RO :VKX^ ^RS] .S]MVY]_\O] \O[_S\ON SX KMMY\NKXMO aS^R ^RO Z\Y`S]SYX] YP
XKXMSKV cOK\  ! S]]_ON Lc 7] 8 3 7OR^K KXN +]]YMSK^O] ]KPO^c S]]_O] ^Y L_SVN ^OMRXSMKV MKZKLSVS^SO] /WZVYcOO] K\O KV]Y cOK\ aRSMR \O]_V^ON SX  56 YP aK^O\ ]^Y\KQO N_\SXQ ^RO =OM^SYX #! YP ^RO -YWZKXSO] +M^  \OKN aS^R <_VO 
^ROX-Y]^K_NS^Y\]aK] VONYX+_Q_]^!N_ONK^OYP VSXQ OXMY_\KQON^YK^^OXNOb^O\XKV^\KSXSXQZ\YQ\KW]YX`K\SY_]^YZSM] WYX]YYX]OK]YX of the Companies (Appointment and Remuneration of Managerial
aK]=OZ^OWLO\!! ]_MRK]\OQ_VK^Y\c\O[_S\OWOX^]O\QYXYWSM]WKMRSXOQ_K\NSXQ
7KTY\ PYM_] N_\SXQ ^RO cOK\ aK] cSOVN SWZ\Y`OWOX^ :O\]YXXOV <_VO]  S] KXXObON K] u+XXOb_\O @3v KXN PY\W]
RY^aY\U]KPO^c\YKN]KPO^cSXN_]^\SKVRcQSOXOSXN_]^\SKV]KPO^c
ZK\^YP^RS]<OZY\^
INTERNAL AUDITORS KXN]YYX+M\Y]]P_XM^SYXKV^OKW]PY\OWO\QOXMc\O]ZYX]OKXN +VYXQ aS^R SXM\OK]SXQ Z\YN_M^S`S^c ^RS] SXS^SK^S`O RK] ROVZON
\O QR^SXQ S] SX ZVKMO 7YMU N\SVV] PY\ \O QR^SXQ KXN \O]M_O ]K`O ^RO NS]MRK\QO YP \Ka WK^O\SKV] KXN ]YV`OX^] SX^Y ^RO Statement containing Particulars of Employees pursuant
7] 5:71 -RK\^O\ON +MMY_X^KX^] 3-+3 0S\W <OQS]^\K^SYX
YZO\K^SYX] K\O MYXN_M^ON SX K]]YMSK^SYX aS^R VYMKV \O L\SQKNO OX`S\YXWOX^ ^Y =OM^SYX #! YP ^RO -YWZKXSO] +M^  \OKN aS^R
8Y,+ K\O^RO3X^O\XKV+_NS^Y\]YP^RO-YWZKXc3X^O\XKV
^YUOOZ^RO]^KPPSXK]^K^OYPZ\OZK\ONXO]]PY\KXcOWO\QOXMSO] <_VO  YP ^RO -YWZKXSO] +ZZYSX^WOX^ KXN <OW_XO\K^SYX
+_NS^ <OZY\^ ^ROS\ ]SQXS MKX^ XNSXQ] KXN PYVVYa _Z KM^SYX] 1YKZVKX^RK]\OMOS`ON^ROu,O]^/X`S\YXWOX^KV:\KM^SMO]+aK\Nv
>RO -YWZKXc RK] K NO^KSVON ,_]SXO]] -YX^SX_S^c :VKX SX ZVKMO YP7KXKQO\SKV:O\]YXXOV<_VO]PY\W]ZK\^YP^RS]<OZY\^
^KUOXLc^RO7KXKQOWOX^S]\O`SOaONLc^RO+_NS^-YWWS^^OOYX P\YW1YK=^K^O:YVV_^SYX-YX^\YV,YK\N^Y\OMYQXS]O^ROOPPY\^]PY\
AO K\O MYX^SX_Y_]Vc SWZ\Y`SXQ YX ^RO ,ORK`SY\ ,K]ON =KPO^c 2YaO`O\ K] ZO\ ^RO Z\Y`S]SYX] YP =OM^SYX]  KXN   YP ^RO
K[_K\^O\VcLK]S] \OMcMVSXQ^RO_]ONaK^O\P\YWVS[_SNLY^^VOMVOKXSXQWKMRSXO]SX
,,= Z\YQ\KW KXN `S]SLVO SWZ\Y`OWOX^ SX ]KPO^c M_V^_\O S] -YWZKXSO] +M^  ^RO <OZY\^ KXN 0SXKXMSKV =^K^OWOX^] K\O
YL]O\`ON =^YZ PY\ =KPO^c SXS^SK^S`O aK] SXS^SK^ON ^RS] cOK\ ^Y MYYVSXQaK^O\^YaO\]SX_^SVS^c]OM^SYX
SECRETARIAL AUDIT REPORT LOSXQ]OX^^Y^RO7OWLO\]KXNY^RO\]OX^S^VON^RO\O^YObMV_NSXQ
]_ZZY\^ ^RO ,,= Z\YQ\KW >RO :VKX^ RKN XY \OZY\^KLVO Y\ VY]] F_\^RO\WY\O QK] OWS]]SYX] P\YW ^RO LYSVO\ KXN QOXO\K^Y\
>RO =OM\O^K\SKV +_NS^ <OZY\^ S]]_ON Lc 7] 8OOXK ,RK^SK ^RO =^K^OWOX^ MYX^KSXSXQ :K\^SM_VK\] YP /WZVYcOO] aRSMR S]
^SWOSXMSNOX^N_\SXQVK]^cOK\] ]^KMU]K]aOVVK]^ROKWLSOX^KS\[_KVS^cK\OWYXS^Y\ON\OQ_VK\Vc
:\KM^S]SXQ -YWZKXc =OM\O^K\c 7OWLO\]RSZ 8Y$ 0-= ## KXN K`KSVKLVOPY\SX]ZOM^SYXLc^RO7OWLO\]K^^RO<OQS]^O\ON9P MO
-O\^S MK^O YP :\KM^SMO 8Y   PY\ ^RO XKXMSKV cOK\ OXNON >RO:VKX^RK]KaOVVKZZYSX^ON \]^KSN\YYWaS^RKP_VV^SWOX_\]O Lc_]KXN^ROcK\OaOVVLOVYa^ROVSWS^]]O^Lc^RO=^K^O:YVV_^SYX YP ^RO -YWZKXc N_\SXQ L_]SXO]] RY_\] YX KVV aY\USXQ NKc]
7K\MR"NYO]XY^MYX^KSXKXcKN`O\]O\OWK\U[_KVS MK^SYX] KXN 9MM_ZK^SYXKV 2OKV^R :Rc]SMSKX MK^O\SXQ ^Y OWZVYcOO XOON] -YX^\YV,YK\N>RO\OS]KV]YK`O\WSMYWZY]^SXQ_XS^SXZVKMO ObMOZ^ =K^_\NKc] _Z ^Y ^RO NK^O YP OX]_SXQ +XX_KV 1OXO\KV
Y\ \O]O\`K^SYX] Y\ NOMVKSWO\ aRSMR \O[_S\O] KXc ObZVKXK^SYX >RO:VKX^S]KV]YK\WONaS^RKXYX]S^OP_VVcO[_SZZONKWL_VKXMO ^Y MYX`O\^ MKX^OOX aK]^O SX^Y Y\QKXSM WKX_\O aRSMR S] _]ON 7OO^SXQ +Xc 7OWLO\ SX^O\O]^ON SX YL^KSXSXQ K MYZc YP ]_MR
MYWWOX^] Lc ^RO ,YK\N >RO ]KSN <OZY\^ S] KXXObON K] `KX 3^ S] WKXNK^Y\c PY\ KVV ZVKX^ OWZVYcOO] ^Y _XNO\QY \OQ_VK\ SX^ROVKaX]KXNYX^ROZVKX^K^SYXSX]SNO^ROPKM^Y\cZ\OWS]O] =^K^OWOX^WKca\S^O^Y^RO-YWZKXc=OM\O^K\cK^^RO<OQS]^O\ON
u+XXOb_\O333vKXNPY\W]ZK\^YP^RS]<OZY\^ WONSMKVMROMU_ZK]Z\O]M\SLON_XNO\^RO-YWZKXct]:YVSMSO] >RO ]S^O \O^KSX] S^] DO\Y AK]^O ^Y VKXN VV MO\^S MK^SYX SX ^RO 9P MOYP^RO-YWZKXc

52 ANNUAL REPORT 2017-18 53


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

CORPORATE GOVERNANCE REPORT GENERAL ANNEXURE I


+XX_KV<OZY\^YP-=<+M^S`S^SO]PY\^RO XKXMSKVcOK\!"
-Y\ZY\K^O 1Y`O\XKXMO <OZY\^ KVYXQ aS^R K -O\^S MK^O P\YW ^RO 8YNS]MVY]_\OY\\OZY\^SXQS]\O[_S\ONSX\O]ZOM^YP^ROPYVVYaSXQ E3XMYWZVSKXMOaS^R=OM^SYXYP^RO-YWZKXSO]+M^KXN-YWZKXSO]-Y\ZY\K^O=YMSKV<O]ZYX]SLSVS^c<_VO]G
=^K^_^Y\c +_NS^Y\] YP ^RO -YWZKXc aS^R \OQK\N ^Y MYWZVSKXMO S^OW]K]^RO\OaO\OXY^\KX]KM^SYX]\OVK^SXQ^Y^RO]OS^OW]N_\SXQ
1. Brief outline of the Company’s CSR Policy w =_MR Y^RO\ Z\YTOM^] ^RK^ PKVV aS^RSX ^RO Z_\`SOa YP ^RO
YP ^RO MYXNS^SYX] YP -Y\ZY\K^O 1Y`O\XKXMO Z_\]_KX^ ^Y ^RO ^ROcOK\_XNO\\O`SOa$ KM^S`S^SO]SXMV_NONSX=MRON_VO@33YP^RO-YWZKXSO]+M^
Policy Statement :
\O[_S\OWOX^] YP ^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK  3 ]]_OYPO[_S^c]RK\O]aS^RNSPPO\OX^SKV\SQR^]K]^YNS`SNOXN KXN<_VO]P\KWON^RO\O_XNO\K]KWOXNONP\YW^SWO
`Y^SXQY\Y^RO\aS]O% +^ +LLY^^ aO LOVSO`O ^RK^ SXXY`K^S`O \O]ZYX]SLVO KXN ^Y^SWO
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]
]_]^KSXKLVO L_]SXO]] ZVKc] KX SWZY\^KX^ \YVO SX L_SVNSXQ K  >RO -=< ZYVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^
PY\W]ZK\^YP^RS]<OZY\^  3 ]]_OYP]RK\O]SXMV_NSXQ]aOK^O[_S^c]RK\O]^YOWZVYcOO] ROKV^Rc ^R\S`SXQ ]YMSO^c >RO -=< ZYVSMc YP +LLY^^ 3XNSK R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
YP^RO-YWZKXc_XNO\KXc]MROWO% 6SWS^ONS]PYM_]ONYXPY]^O\SXQOMYXYWSMOX`S\YXWOX^KVKXN
BUSINESS RESPONSIBILITY REPORT ]YMSKV aOVVLOSXQ >R\Y_QR Y_\ -=< SXS^SK^S`O] aO ]^\S`O ^Y 2. Composition of CSR Committee :
 >RO -YWZKXc NYO] XY^ RK`O KXc TYSX^ `OX^_\O OXRKXMO ZOYZVOt] ROKV^R KXN aOVVLOSXQ KXN Z\Y`SNO VK]^SXQ 
,_]SXO]] <O]ZYX]SLSVS^c <OZY\^ K] \O[_S\ON _XNO\ <OQ_VK^SYX >RO-=<-YWWS^^OOK]YX^RONK^OYP^RS]<OZY\^S]MYWZ\S]ON
 Y\]_L]SNSK\SO] ]YV_^SYX]^YNO`OVYZWOX^MRKVVOXQO]
YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX] YP^ROPYVVYaSXQ.S\OM^Y\]$
AWARDS AND RECOGNITIONS -Y\O-=<K\OK]SNOX^S ONLc^RO-YWZKXc$
KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]  PY\W] ZK\^ YP Sr. Name of Member Category
3X KMMY\NKXMO aS^R ^RO ]^K^_^Y\c \O[_S\OWOX^] KXN UOOZSXQ No.
this Report ._\SXQ ^RO cOK\ ^RO -YWZKXc aYX ]O`O\KV Z\O]^SQSY_] KaK\N] ^RO -YWZKXc ZRSVY]YZRc K^ Z\SY\S^c ^RO -=< -YWWS^^OO  7\7_XS\=RKSUR-RKS\WKX 8YX/bOM_^S`O.S\OM^Y\
KXN \OMYQXS^SYX] SXMV_NSXQ u,O]^ -YWZKXSO] ^Y AY\U 0Y\v Lc SNOX^S ON ^RO PYVVYaSXQ ^R\_]^ K\OK] SX VSXO aS^R Y_\ -=<
DISCLOSURES OF ORDERS PASSED BY REGULATORS QYKV]$
 Mr Krishna Mohan Sahni Independent Director
,_]SXO]] >YNKc% ,O]^ 7K\UO^SXQ -KWZKSQX PY\ u-YX]^SZK^SYX
OR COURTS OR TRIBUNAL 3 7\+WLK^S@OX_ Managing Director
-YX`O\]K^SYX]v Lc 2OKV^RMK\O 6OKNO\]RSZ +aK\N]% ,O]^ _]O YP  w Enhancing access to healthcare across the country for a
8YY\NO\]RK`OLOOXZK]]ONLcKXc<OQ_VK^Y\Y\-Y_\^Y\>\SL_XKV >OMRXYVYQc PY\ >\KSXSXQ KXN /bMOVVOXMO SX ^RO :\YN_M^SYX YP ROKV^Rc]YMSO^c%MYXN_M^SXQaOVVXO]]MKWZ]PY\SWZ\Y`SXQ  +`O\KQO8O^:\Y ^YP^RO-YWZKXcPY\VK]^^R\OO XKXMSKV
6OK\XSXQ-YX^OX^Lc^RAY\VN>\KSXSXQ.O`OVYZWOX^-YXQ\O]]% VS`O]YP^RO_XNO\Z\S`SVOQONMYWW_XS^c% years* :
aRSMR MKX RK`O SWZKM^ YX ^RO QYSXQ MYXMO\X ]^K^_] KXN ^RO
=SV`O\PY\.SQS^KV7K\UO^SXQ/bMOVVOXMOPY\+LLY^^3XNSK<KNSYLc  w -RK\S^KLVONYXK^SYX]KXNON_MK^SYXKVQ\KX^]PY\]O\`SXQ `#  6KUR]
-YWZKXct]YZO\K^SYX]SXP_^_\O ^RO_XNO\]O\`ON]OM^SYX]YP]YMSO^c%
.313BB  MKVM_VK^ONYX^ROLK]S]YP8O^:\Y ^]PY\^RO XKXMSKVcOK\]
FIXED DEPOSITS  w <OKMRSXQ Y_^ ^Y 1Y`O\XWOX^ ^Y KN`KXMO ]Y_XN Z_LVSM  KXN !
EMPLOYEES ZYVSMcKXNObZKXNZK^SOX^KMMO]]^YROKV^RMK\O%
8Y bONNOZY]S^]aO\OKMMOZ^ONN_\SXQ^ROcOK\  w .S]OK]O KaK\OXO]] Z\YTOM^]KM^S`S^SO] ^RK^ ]_ZZY\^ 4. Prescribed CSR Expenditure (two percent of the amount
CY_\ ,YK\N \OMYQXS]O] ^RO Ob^OX]S`O MYX^\SL_^SYX WKNO Lc KVV ]_L]SNS]ON]M\OOXSXQKXN^\OK^WOX^% as in item 3 above) :
PARTICULARS OF LOANS, INVESTMENTS AND OWZVYcOO] ^YaK\N] ^RO Q\Ya^R YP ^RO -YWZKXc cOK\KP^O\cOK\  w :\YN_M^NYXK^SYX]^R\Y_QR^\_]^ONZK\^XO\]SX^ROMYX^Ob^ `!"!6KUR]
GUARANTEES KXNZVKMO]YX\OMY\NS^]]SXMO\OKZZ\OMSK^SYXPY\^RO]KWO YP+LLY^^t]QVYLKVZYVSMSO]KXNSX^O\XK^SYXKV]^KXNK\N]%  .O^KSV]YP-=<]ZOX^N_\SXQ^RO XKXMSKVcOK\$
 w /b^OXNSXQ ]_ZZY\^ ^Y `K\SY_] 819] ^R\Y_QR WYXO^K\c
._\SXQ^ROcOK\^RO-YWZKXcQ\KX^ONKVYKXYP` 6KUR] ACKNOWLEDGEMENT grants for education healthcare and livelihood of  K >Y^KVKWY_X^]ZOX^N_\SXQ^RO XKXMSKVcOK\x` #
_XNO\Z\S`SVOQONMRSVN\OXKXNaYWOX% 6KUR]
^Y+VO\O7ONSMKV:\S`K^O6SWS^ON3XNSKK<OVK^ON:K\^cK]ZO\^RO CY_\ ,YK\N S] ]SXMO\OVc ^RKXUP_V ^Y KVV L_]SXO]] ZK\^XO\]
Z\Y`S]SYX]YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ  w /X`S\YXWOX^Z\Y^OM^SYXWOK]_\O]%  L +WY_X^_X]ZOX^SPKXc8SV
SX]^S^_^SYX] LKXU] KXN SX ZK\^SM_VK\ ^RO 7OWLO\] PY\ ^ROS\
9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]<OQ_VK^SYX]PY\ YXQYSXQ]_ZZY\^KXN^\_]^SX^RO-YWZKXc  M 7KXXO\SXaRSMR^ROKWY_X^aK]]ZOX^N_\SXQ^RO XKXMSKVcOK\S]NO^KSVONLOVYa
(` in Lakhs)
KZO\SYNYP]SbWYX^R]YX.OMOWLO\ !K^KXSX^O\O]^\K^O
For and on behalf of the Board Sr. CSR Project Name Schedule VII Location Amount Amount spent on the Cumulative Amount Spent :
YPZO\KXX_WZ_\]_KX^^Y^ROZ\Y`S]SYX]YP=OM^SYX" YP^RO
No. Category Outlay projects or programs Expenditure Direct or through
-YWZKXSO]+M^KXN<_VO]P\KWON^RO\O_XNO\^YZKcYPPS^] (Budget) 1) Direct Implementing
Munir Shaikh R A Shah 2) Overheads Agency
ObS]^SXQSX^O\MYWZKXc^\KNOVSKLSVS^c>RO]KSNVYKXS]Q_K\KX^OON Chairman Director  2OKV^R-VSXSM] :\YWY^SXQ2OKV^RMK\O Pan-India    Direct
Lc+LLY^^6KLY\K^Y\SO]?=+SO^RO_V^SWK^ORYVNSXQMYWZKXc .38$# !       .38$#" Implementation
 8S\WKV.RK\K.KS\c:\YTOM^ <_\KV.O`OVYZWOX^ +RWONXKQK\ #" #" #" Direct
:\YWY^SXQ1OXNO\ Maharashtra Implementation
/[_KVS^c3WZ\Y`SXQ
6S`OVSRYYN]
3 =/A+x-\OK^SXQK :\YWY^SXQ2OKV^RMK\O Pan-India       Direct
=_]^KSXKLVO2OKV^RMK\O :\YWY^SXQ1OXNO\ Implementation
Delivery Model through /[_KVS^cKXN
6S`OVSRYYN] /OWZYaO\SXQAYWOX
 iCARE Road Safety Drive Promoting Education Pan-India ""  "" "" Direct
Implementation
 +NWSXS]^\K^S`O/bZOX]O]   
Total 9,12.22 9,12.22 9,12.22
The Responsibility Statement of the CSR Committee of the Board of Directors –
u>ROSWZVOWOX^K^SYXKXNWYXS^Y\SXQYP-=<:YVSMcK\OSXMYWZVSKXMOaS^R-=<9LTOM^S`O]KXN:YVSMcYP^RO-YWZKXcv

Munir Shaikh Krishna Mohan Sahni


           -RKS\WKX-=<-YWWS^^OO   7OWLO\-=<-YWWS^^OO
           .38$# !    .38$"

54 ANNUAL REPORT 2017-18 55


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ANNEXURE II " <OQ_VK\ K^^OXNKXMO K^ LYK\N KXN  ! >


 RO 7KXKQSXQ .S\OM^Y\/bOM_^S`O .S\OM^Y\]8YX
Policy on Nomination and Appointment of Directors/Criteria for Appointment of Senior Management committee meetings /bOM_^S`O .S\OM^Y\]5Oc 7KXKQO\SKV :O\]YXXOV K\O
    " 7KSX^KSXSXQKXSXNOZOXNOX^PKWSVSK\S^c KZZYSX^ONLc^RO,YK\NYP.S\OM^Y\]_ZYX\OMYWWOXNK^SYX
E3XMYWZVSKXMOaS^R^ROZ\Y`S]SYX]YP=OM^SYX!"YP^RO-YWZKXSO]+M^KXN<OQ_VK^SYX#\OKNaS^R=MRON_VO33:K\^.+ P\YW^RO8YWSXK^SYXKXN<OW_XO\K^SYX-YWWS^^OO
YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]<OQ_VK^SYX]G aS^R ^RO Ob^O\XKV OX`S\YXWOX^] SX
aRSMR ^RO -Y\ZY\K^SYX YZO\K^O]  ! =
 OXSY\7KXKQOWOX^:O\]YXXOV]RKVVLOKZZYSX^ONLc^RO
1. Purpose :   9 ^RO\ K\OK] YP ObZO\SOXMO aRSMR K\O NO]S\KLVO PY\ KXN O]ZOMSKVVc SX ^RO NS\OM^Y\t] YaX -YWZKXcK]ZO\-YWZKXcZYVSMSO]
\OZ\O]OX^K^SYXYX^RO+LLY^^LYK\NSXMV_NOL_^K\OXY^ ZK\^SM_VK\ OVN]YPObZO\^S]O 8. Term/Tenure :
  3 X ^O\W] YP ^RO Z\Y`S]SYX] YP =OM^SYX !" YP ^RO
VSWS^ON^Y$
-YWZKXSO] +M^  <_VO] WKNO ^RO\O_XNO\ KXN 4. Other Positive Attributes for Directors :  "  7KXKQSXQ.S\OM^Y\/bOM_^S`O.S\OM^Y\]$
^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ    7ONSMSXO
  3 ^S]NO]S\KLVO^RK^MKXNSNK^O]Z\YZY]ONPY\.S\OM^Y\]RSZ   " 7KXKQSXQ .S\OM^Y\/bOM_^S`O .S\OM^Y\] ]RKVV
9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]    7K\UO^SXQ ZY]]O]]^ROPYVVYaSXQZY]S^S`OK^^\SL_^O]$ \O^S\O K] ZO\ ^RO KZZVSMKLVO Z\Y`S]SYX] YP ^RO
 ^RO 8YWSXK^SYX KXN <OW_XO\K^SYX -YWWS^^OO    7ONSMKV KXN =MSOX^S M <O]OK\MR KXN
S] SX^O\ KVSK \O[_S\ON ^Y NO^O\WSXO ^RO KZZ\YZ\SK^O    +XcZY]^Q\KN_K^SYX[_KVS MK^SYX]P\YW\OZ_^ON -YWZKXSO]+M^Y\<_VO]WKNO^RO\O_XNO\
Development
]SdO KXN MYWZY]S^SYX YP ^RO ,YK\N PY\W_VK^O M\S^O\SK L_]SXO]]]MRYYV]_XS`O\]S^SO]SX3XNSKY\KL\YKN% Y\^ROZ\O`KSVSXQ+LLY^^3XNSK6SWS^ONQ_SNOVSXO]
PY\ SNOX^SPcSXQ ]_S^KLVO MKXNSNK^O] PY\ ^RO ZY]S^SYX YP    0SXKXMO YX\O^S\OWOX^YP.S\OM^Y\]aRSMRO`O\S]OK\VSO\
   /bZO\SOXMO KXN ObZO\^S]O SX NOKVSXQ aS^R
Directors and Senior Management and criteria for    3X^O\XK^SYXKV,_]SXO]] ]^\K^OQSMS]]_O]KXNVYXQ^O\WZO\]ZOM^S`O]%   " >RO,YK\NaSVVRK`O^RONS]M\O^SYX^Y\O^KSX^RO
NO^O\WSXSXQ ^RO [_KVS MK^SYX] ZY]S^S`O K^^\SL_^O] KXN   9^RO\[_KVS MK^SYX]^RK^aY_VNLOROVZP_VSXKNNS^SYX^Y    =^\YXQ VOKNO\]RSZ ObZO\SOXMO K ]_ZO\SY\ retiring Director in the same position even after
SXNOZOXNOXMO YP NS\OM^Y\ NO`S]O ]_MMO]]SYX ZVKX KXN ^ROKLY`OSXMV_NOL_^K\OXY^VSWS^ON^Y$ UXYaVONQO YP L_]SXO]] Z\SXMSZVO] KXN MKZKMS^c K^^KSXSXQ ^RO \O^S\OWOX^ KQO PY\ ^RO LOXO ^ YP
\OMYWWOXN ^Y ^RO ,YK\N KZZYSX^WOX^ KXN \OWY`KV YP    =OXSY\VO`OVQY`O\XWOX^ObZO\SOXMO PY\ SXNOZOXNOX^ ^RY_QR^ KXN ObO\MS]SXQ ^RO-YWZKXc
,YK\NWOWLO\]KXN=OXSY\7KXKQOWOX^ZO\]YXXOV SXNOZOXNOX^T_NQWOX^%
   +MKNOWSMKNWSXS]^\K^SYX   " =ZOMSKV \O]YV_^SYX XOON] ^Y LO ZK]]ON PY\
  >
 RS] :YVSMc ]RKVV KM^ K] K Q_SNOVSXO PY\ NO^O\WSXSXQ    +LSVS^c ^Y ZK\^SMSZK^O MYX]^\_M^S`OVc SX KZZYSX^WOX^ \OKZZYSX^WOX^ YP .S\OM^Y\ SX
   >RO,YK\N]RKVVSXMV_NOK\KXQOYPKQO]KXNKNS`O\]S^cYP
[_KVS MK^SYX] ZY]S^S`O K^^\SL_^O] KXN SXNOZOXNOXMO YP NOVSLO\K^SYX]K^LYK\NWOO^SXQ]% ^RO ZY]S^SYX YP 7KXKQSXQ .S\OM^Y\/bOM_^S`O
O^RXSMS^cQOXNO\KXNQOYQ\KZRc
a Director and matters related to the appointment and .S\OM^Y\]aRYRK`OK^^KSXONKQOYP!cOK\]
\OWY`KVYP.S\OM^Y\]KXN=OXSY\7KXKQOWOX^  ! :\SWK\cMRK\KM^O\S]^SM]\O[_S\ONSXXOaLYK\NMKXNSNK^O]$    ASVVSXQXO]]^YObO\MS]OK_^RY\S^cSXKMYVVOM^S`O
WKXXO\% 9. Independent Director :
2. Objective :   ! >ROcW_]^LO \]^KXNPY\OWY]^KLVOKXNaSVVSXQ
^Y \OZ\O]OX^ ^RO ]RK\ORYVNO\]t ]RY\^^O\W KXN     3X[_S]S^S`O KXN YLTOM^S`O ZO\]ZOM^S`O Z\KM^SMKV  # +
 X3XNOZOXNOX^.S\OM^Y\]RKVVRYVNYP MOPY\K^O\WYP_Z
  >
 RS] :YVSMc aY_VN VKc NYaX M\S^O\SK KXN ^O\W] KXN VYXQ^O\WOMYXYWSMSX^O\O]^] aS]NYWKXNWK^_\OT_NQWOX^% ^Y `OMYX]OM_^S`OcOK\]YX^RO,YK\NYP^RO-YWZKXcKXN
MYXNS^SYX] aS^R \OQK\N ^Y SNOX^SPcSXQ ZO\]YX] aRY K\O   ! =OVPMYX NOXMO ^Y MYX^\SL_^O ^Y LYK\N aSVVLOOVSQSLVOPY\\OKZZYSX^WOX^PY\KXY^RO\^O\WYP_Z
  ! >ROcW_]^LOKLVO^YMYX^\SL_^O^Y^ROO`KV_K^SYX
[_KVS ON^YLOMYWO.S\OM^Y\]/bOM_^S`O8YXObOM_^S`O NOVSLO\K^SYX]KXN]^K^_\O]_MR^RK^Y^RO\LYK\N ^YMYX]OM_^S`OcOK\]YXZK]]SXQYPK]ZOMSKV\O]YV_^SYX
YP^ROObS]^SXQWKXKQOWOX^YP^RO-YWZKXc
KXN 3XNOZOXNOX^ KXN =OXSY\ 7KXKQOWOX^ SXMV_NSXQ WOWLO\]aSVV\O]ZOM^RS]Y\RO\`SOa% Lc ^RO -YWZKXc KXN NS]MVY]_\O YP ]_MR KZZYSX^WOX^ SX
^ROS\[_KVS MK^SYX]ZY]S^S`OK^^\SL_^O]KXNSXNOZOXNOXMO   ! >ROc W_]^ KV]Y LO MYQXSdKX^ YP ^RO
  " -KZKLVOYPNO`Y^SXQ]_P MSOX^^SWOKXNK^^OX^SYX ^RO,YK\Nt]<OZY\^
\O]ZYX]SLSVS^SO]YP^RO-YWZKXc^Y$
3. Criteria for appointment of Directors : ^YRS]RO\Z\YPO]]SYXKVYLVSQK^SYX]PY\SXPY\WON  # 8
 Y3XNOZOXNOX^.S\OM^Y\]RKVVRYVNYP MOPY\WY\O^RKX
Its employees
  >
 RO PYVVYaSXQ MRK\KM^O\S]^SM] ]RKVV LO ^KUOX SX^Y KXNLKVKXMONNOMS]SYXWKUSXQ% ^aY MYX]OM_^S`O ^O\W] L_^ ]_MR 3XNOZOXNOX^ .S\OM^Y\
Its customers
MYX]SNO\K^SYXaROX]OVOM^SXQXYWSXOO]PY\^RO,YK\NYP   # 0YM_]ON ^YaK\N] ^RO -YWZKXc KXN QOXO\Y_] ]RKVV LO OVSQSLVO PY\ KZZYSX^WOX^ KP^O\ ObZS\c YP ^R\OO
Social issues cOK\] YP MOK]SXQ ^Y LOMYWO KX 3XNOZOXNOX^ .S\OM^Y\
.S\OM^Y\]3XNS`SN_KVXYWSXOO]NYXY^XOON^Y]K^S]PcKVV YZOXWSXNON^YaK\N]^RO^OKW%
^RO[_KVS MK^SYX]VS]^ONLOVYaKXN^RO\OS]XY\O[_S\OWOX^ Regulatory authorities :\Y`SNON^RK^KX3XNOZOXNOX^.S\OM^Y\]RKVVXY^N_\SXQ
  ! >ROcW_]^LOaSVVSXQ^Y^KUO^ROXOMO]]K\c^SWO    0S^ KXN Z\YZO\ ZO\]YX YP SWZOMMKLVO SX^OQ\S^c ^RO ]KSN ZO\SYN YP ^R\OO cOK\] LO KZZYSX^ON SX Y\ LO
^RK^KVV[_KVS MK^SYX]LO\OZ\O]OX^ONYX^ROLYK\N \OZ_^K^SYXKXNMRK\KM^O\%KL]OXMOYPMYX`SM^SYX]
^Y Z\YZO\Vc Z\OZK\O PY\ LYK\N KXN MYWWS^^OO K]]YMSK^ONaS^R^RO-YWZKXcSXKXcY^RO\MKZKMS^cOS^RO\
  3 XKNNS^SYX^Y^RO]ZOMS MMRK\KM^O\S]^SM]]O^PY\^RLOVYa WOO^SXQ] K^ K WSXSW_W LK]ON YX K ^RY\Y_QR KXN\O]^\KSX^Y\NO\]%KXNMYWZO^OXMOSXMV_NSXQ NS\OM^VcY\SXNS\OM^Vc
LYK\NWOWLO\]]RY_VNK^KWSXSW_WRK`OLKMUQ\Y_XN] \O`SOa YP ^RO WK^O\SKV ]_ZZVSON LOPY\O OKMR XKXMSKV]YV`OXMcKXNXO^aY\^R
^RK^ aROX MYWLSXON Z\Y`SNO K ZY\^PYVSY YP ObZO\SOXMO 10. Non- Executive Director (other than Independent
LYK\NWOO^SXQ 5. Independence :
KXN UXYaVONQO ^RK^ aSVV ]O\`O +LLY^^t] QY`O\XKXMO KXN Director) :
]^\K^OQSM XOON] ,YK\N MKXNSNK^O] aSVV LO MYX]SNO\ON YX  " :\SWK\c MRK\KM^O\S]^SM] \O[_S\ON PY\ \OXYWSXK^SYX YP   3 X MK]O YP KZZYSX^WOX^ YP 3XNOZOXNOX^ .S\OM^Y\ ^RO
SXM_WLOX^NS\OM^Y\]$   9^RO\XYXObOM_^S`O.S\OM^Y\]]RKVV\O^S\OLc\Y^K^SYXK]
^RO LK]S] YP K \KXQO YP M\S^O\SK SXMV_NSXQ L\YKNLK]ON candidate shall meet the criteria of Independence as set ZO\^ROKZZVSMKLVOZ\Y`S]SYX]YP^RO-YWZKXSO]+M^
L_]SXO]] UXYaVONQO KXN \OVK^SYX]RSZ] Z\YWSXOXMO KXN   " 3XM_WLOX^ NS\OM^Y\] ]RY_VN MYX^SX_O ^Y WOO^ Y_^SX+XXOb_\O3 Y\<_VO]WKNO^RO\O_XNO\K]KWOXNONP\YW^SWO^Y^SWO
ObMOVVOX^\OZ_^K^SYX]SX^ROS\Z\SWK\c OVN]YPOXNOK`Y\ ^ROQOXO\KV[_KVS MK^SYX]Y_^VSXONKLY`OKXNSX
6. Criteria for Appointment of Senior Management : 11. Key Managerial Personnel and Senior Management :
K]aOVVK]KL\YKNL_]SXO]]ZO\]ZOM^S`OKXNMYWWS^WOX^ KNNS^SYX]RY_VNKLSNOLc^ROPYVVYaSXQM\S^O\SK$
^Y QYYN MY\ZY\K^O MS^SdOX]RSZ .S\OM^Y\] ]RY_VN RK`O     " +NO[_K^O Z\OZK\K^SYX PY\ LYK\N KXN   3 XNS`SN_KV] YP RSQR SX^OQ\S^c aRY RK`O K ]YVSN \OMY\N YP  Key Managerial Personnel and Senior Management shall
NOWYX]^\K^ON ObZO\SOXMO KXN KLSVS^c ^RK^ S] \OVO`KX^ ^Y MYWWS^^OO WOO^SXQ] SXMV_NSXQ K KMMYWZVS]RWOX^SX^ROS\MRY]OX OVN]KXNaRYZY]]O]]^RO retire as per the Company policy or their employment
^RO ,YK\N YP .S\OM^Y\]t Y`O\]SQR^ \YVO aS^R \O]ZOM^ ^Y ^RY\Y_QR\O`SOaYPKXNPKWSVSK\S^caS^R [_KVS MK^SYX][_KVS^SO]KXN]USVV]^YOPPOM^S`OVc\OZ\O]OX^ ^O\W]
+LLY^^t]L_]SXO]]KXNKPPKS\] ^RO a\S^^OX WK^O\SKV] ]_ZZVSON LOPY\O ^ROLO]^SX^O\O]^]YPKVV]^KUORYVNO\]-KXNSNK^O]aSVVLO
]OVOM^ONPY\^ROS\KLSVS^c^YObO\MS]OQYYNT_NQWOX^KXN^Y 12. Removal :
  =
 ^\YXQWKXKQOWOX^ObZO\SOXMOSNOKVVcaS^RWKTY\Z_LVSM each meeting
Z\Y`SNOZ\KM^SMKVSX]SQR^]KXNNS`O\]OZO\]ZOM^S`O]  >RO -YWWS^^OO WKc \OMYWWOXN ^Y ^RO ,YK\N aS^R
MYWZKXSO] aS^R ]_MMO]]P_V W_V^SXK^SYXKV YZO\K^SYX]     " :K\^SMSZK^SYX SX KXN MYX^\SL_^SYX]
^Y LYK\N KXN MYWWS^^OO NS]M_]]SYX] 7. Appointment Mechanism : \OK]YX]\OMY\NONSXa\S^SXQ\OWY`KVYPKX3XNOZOXNOX^
SXMV_NSXQL_^XY^VSWS^ON^Y$
through useful and pertinent .S\OM^Y\ KXN 5Oc 7KXKQO\SKV :O\]YXXOV ]_LTOM^ ^Y ^RO
 Active or recently retired Chairman and Chief  ! >
 RO8YWSXK^SYXKXN<OW_XO\K^SYX-YWWS^^OO]RKVVZVKc Z\Y`S]SYX] KXN MYWZVSKXMO YP ^RO -YWZKXSO] +M^ 
]_QQO]^SYX][_O]^SYX]KXNMYWWOX^] KMYX]_V^K^S`O\YVOPY\KXcKZZYSX^WOX^\O[_S\SXQ,YK\N
/bOM_^S`O9P MO\] <_VO]WKNO^RO\O_XNO\KXNY^RO\KZZVSMKLVO\OQ_VK^SYX]
    " :\Y`SNSXQYXQYSXQKN`SMOKXNMY_X]OV KZZ\Y`KVK]]^SZ_VK^ONLcVKaY\\OQ_VK^SYXPY\.S\OM^Y\] KXNKZZVSMKLVOZYVSMSO]YP^RO-YWZKXc
:\O]SNOX^]KXN-RSOP9ZO\K^SXQ9P MO\]
^Y WKXKQOWOX^ YX ^RO NS\OM^Y\t] YaX Key Managerial Personnel and Senior Management
/bOM_^S`OY\1\Y_Z@SMO:\O]SNOX^]aS^R]RY\^^O\W SXS^SK^S`O KXN aROX \O[_O]^ON Lc YP MSKV]3^]RKVVZ\Y`SNOS^]KN`SMOKXN\OMYWWOXNK^SYX]  >RO=OXSY\7KXKQOWOX^:O\]YXXOV]RKVVLO\OWY`ONLc
ZY^OX^SKVPY\WY`OWOX^^YS^OWY\KLY`O management ^Y^RO,YK\N ^RO-YWZKXcK]ZO\-YWZKXcZYVSMSO]

56 ANNUAL REPORT 2017-18 57


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

13. Succession Planning : " + \W YP K_NS^Y\] 3X^O\XKV=^K^_^Y\c Y\    ^RO VO`OV KXN MYWZY]S^SYX YP \OW_XO\K^SYX S]  u5Oc7KXKQO\SKV:O\]YXXOVvWOKX]
company secretaries in practice or cost \OK]YXKLVO KXN ]_P MSOX^ ^Y K^^\KM^ \O^KSX KXN
  =_MMO]]SYX ZVKXXSXQ PY\ +LLY^^t] ]OXSY\ WKXKQOWOX^   w  RSOP/bOM_^S`O9P MO\Y\^RO7KXKQSXQ.S\OM^Y\Y\
-
K_NS^Y\] YP ^RO -YWZKXc Y\ S^] RYVNSXQ WY^S`K^O.S\OM^Y\]YP^RO[_KVS^c\O[_S\ON^Y\_X
ZY]S^SYX] S] M\S^SMKV ^Y +LLY^^t] VYXQ^O\W ]_MMO]] ^RO7KXKQO\%
]_L]SNSK\cY\K]]YMSK^OMYWZKXc% ^ROMYWZKXc]_MMO]]P_VVc%
>RO 8YWSXK^SYX KXN <OW_XO\K^SYX -YWWS^^OO ]RKVV   w -YWZKXc=OM\O^K\c%
KXX_KVVc\O`SOaKXNMYXPO\aS^R^RO7KXKQSXQ.S\OM^Y\    "  XcVOQKVY\KMYX]_V^SXQ \W^RK^RK]Y\RKN
+    \OVK^SYX]RSZ YP \OW_XO\K^SYX ^Y ZO\PY\WKXMO
KXN^RO2<.S\OM^Y\\OQK\NSXQ+LLY^^t]]_MMO]]SYXZVKX] KXc^\KX]KM^SYXaS^R^RO-YWZKXcS^]RYVNSXQ is clear and meets appropriate performance w ARYVO^SWO.S\OM^Y\%
KXN \OZY\^ KXN WKUO \OMYWWOXNK^SYX] YX ^ROW ^Y ^RO ]_L]SNSK\cY\K]]YMSK^O-YWZKXcKWY_X^SXQ^Y LOXMRWK\U]%KXN
  w -RSOP0SXKXMSKV9P MO\%KXN
,YK\NYP.S\OM^Y\] Y\WY\OYP^ROQ\Y]]^_\XY`O\YP]_MR \W%    <OW_XO\K^SYX ^Y ARYVO^SWO .S\OM^Y\] 57:
   " 2YVN]^YQO^RO\aS^RRS]\OVK^S`O]Y\WY\O and Senior Management Personnel involves   w  _MR Y^RO\ YP MO\ K] WKc LO Z\O]M\SLON _XNO\ ^RO
=
14. Review of the Policy : +M^
YP^RO^Y^KV`Y^SXQZYaO\YP^RO-YWZKXc% K LKVKXMO LO^aOOX bON KXN SXMOX^S`O ZKc
  >RS]:YVSMc]RKVVLO]_LTOM^^Y\O`SOaLc^RO-YWWS^^OO \O
OM^SXQ ]RY\^ KXN VYXQ ^O\W ZO\PY\WKXMO   u=OXSY\7KXKQOWOX^vWOKX]ZO\]YXXOVYP^ROMYWZKXc
   " K-RSOP/bOM_^S`OY\.S\OM^Y\LcaRK^O`O\
K^ ]_MR SX^O\`KV] K] WKc LO NOOWON XOMO]]K\c -RKXQO] YLTOM^S`O] KZZ\YZ\SK^O ^Y ^RO aY\USXQ YP ^RO aRYK\OWOWLO\]YPS^]MY\OWKXKQOWOX^^OKWObMV_NSXQ
XKWOMKVVONYPKXcXYXZ\Y ^Y\QKXSdK^SYX
SPKXc\OMYWWOXNONLc^RO-YWWS^^OO]RKVVLOZVKMON -YWZKXcKXNS^]QYKV] ^RO ,YK\N YP .S\OM^Y\] MYWZ\S]SXQ KVV WOWLO\] YP
^RK^ \OMOS`O]  Y\ WY\O YP S^] \OMOSZ^]
LOPY\O^RO,YK\NPY\S^]KZZ\Y`KV P\YW ^RO -YWZKXc KXc YP S^] Z\YWY^O\] 3. Company Philosophy : WKXKQOWOX^ YXO VO`OV LOVYa ^RO /bOM_^S`O .S\OM^Y\]
.S\OM^Y\] Y\ S^] RYVNSXQ ]_L]SNSK\c Y\ SXMV_NSXQ^ROP_XM^SYXKVROKN]
ANNEXURE   >RO -YWZKXct] MYWZOX]K^SYX ZRSVY]YZRc S] LK]ON YX
K]]YMSK^O-YWZKXcY\^RK^RYVN]Y\WY\O ^R\OOZ\SWK\cPKM^Y\]$  u 9^RO\ /WZVYcOO]v WOKX] KVV Y^RO\ OWZVYcOO] YP
1. Criteria for Independence : YP^RO^Y^KV`Y^SXQZYaO\YP^RO-YWZKXc +LLY^^ 3XNSK 6SWS^ON L_^ NY XY^ SXMV_NO OWZVYcOO]
   ,OSXQ MYWZO^S^S`O aS^R ZOO\Q\Y_Z MYWZKXSO] aRY RK`O ]SQXON MYVVOM^S`O Y\ _XSYX KQ\OOWOX^] Y\ YX
  +
 .S\OM^Y\S]MYX]SNO\ON3XNOZOXNOX^SP^RO,YK\NWKUO]   # 2K]XY^ROVNYP MOPY\WY\O^RKXMYX]OM_^S`O LY^R aS^RSX KXN Y_^]SNO YP ROKV^RMK\O aS^R
KXKP \WK^S`ONO^O\WSXK^SYXKP^O\K\O`SOaYPKVV\OVO`KX^ ^O\W]YX^RO,YK\NYP^RO-YWZKXc MYX^\KM^_KVLK]S]
XKXMSKVZO\PY\WKXMO]SWSVK\^Y^RO-YWZKXc%
SXPY\WK^SYX 3X Y\NO\ PY\ K .S\OM^Y\ ^Y LO MYX]SNO\ON    RY_VNXY^LOKWK^O\SKV]_ZZVSO\]O\`SMOZ\Y`SNO\
= 5. Remuneration for Non-Executive Directors (Independent
   7KUSXQ SXNS`SN_KV ZO\PY\WKXMO ^RO Z\SWK\c
3XNOZOXNOX^^RO.S\OM^Y\$ Y\M_]^YWO\Y\KVO]]Y\Y\VO]]OOYP^RO-YWZKXc & Non- Independent Directors) :
N\S`O\YP^Y^KVZKc%
   =RKVVXY^LO7KXKQSXQ.S\OM^Y\Y\KARYVO^SWO    =RKVVXY^LOVO]]^RKXcOK\]YPKQO    6SXUSXQ ZKc ^Y KMRSO`OWOX^ YP ^RO -YWZKXct]  =S^^SXQ0OO]
.S\OM^Y\Y\K8YWSXOO.S\OM^Y\ L_]SXO]]QYKV]
 .O XS^SYXPY\^RO]KSNZ_\ZY]O$    8YX/bOM_^S`O .S\OM^Y\] 8/.] Y^RO\
    RKVV LO K ZO\]YX YP SX^OQ\S^c KXN ]RKVV ZY]]O]]
=   =SWZVc]^K^ON^RO-YWZKXct]MYWZOX]K^SYXS]SX^OXNON ^RKX ^RY]O OWZVYcON aS^R KXc +LLY^^ Q\Y_Z
  u 8YWSXOO .S\OM^Y\v SWZVSO] K .S\OM^Y\ XYWSXK^ON Lc
\OVO`KX^ObZO\^S]OKXNObZO\SOXMO ^Y MYWZK\O PK`Y\KLVc aS^R ^RO ZKc Z\YQ\KW] YP Y^RO\ MYWZKXcaSVVLOZKSN]S^^SXQPOO]PY\K^^OXNSXQ
KXc XKXMSKVSX]^S^_^SYXSXZ_\]_KXMOYP^ROZ\Y`S]SYX]YP
   =RKVV XY^ LO K Z\YWY^O\ YP ^RO -YWZKXc Y\ S^] KXcVKaPY\^RO^SWOLOSXQSXPY\MOY\YPKXcKQ\OOWOX^ VOKNSXQ ROKV^RMK\O MYWZKXSO] K] aOVV K] Y^RO\ RSQR OKMR WOO^SXQ YP ^RO ,YK\N KXN S^] -YWWS^^OO]
RYVNSXQ]_L]SNSK\cY\K]]YMSK^O-YWZKXc Y\KZZYSX^ONLcKXcQY`O\XWOX^Y\KXcY^RO\ZO\]YX^Y performing companies outside of the healthcare arena K]NO^O\WSXONLc^RO,YK\NP\YW^SWO^Y^SWOSX
\OZ\O]OX^S^]SX^O\O]^] ^RK^RK`OK]SWSVK\]SdO]MYZOKXN XKXMSKVZO\PY\WKXMO KMMY\NKXMOaS^R^ROZ\Y`S]SYX]YP^RO+M^>RO
   =RKVVXY^LO\OVK^ON^YZ\YWY^O\]Y\.S\OM^Y\]SX ^Y ^RO -YWZKXc KXN YZO\K^O SX WK\UO^] aRO\O aO ]S^^SXQPOO]ZKcKLVO^Y^RO8/.]PY\K^^OXNSXQ^RO
^RO-YWZKXcS^]RYVNSXQ]_L]SNSK\cY\K]]YMSK^O   u +]]YMSK^O -YWZKXcv SWZVSO] K -YWZKXc aRSMR S] KX MYWZO^OPY\^KVOX^ WOO^SXQ]YP^RO,YK\NKXN`K\SY_]-YWWS^^OO]S]
-YWZKXc uK]]YMSK^Ov K] NO XON SX 3XN += " u3X`O]^WOX^] SX
  ARSVOOWZVYcOO]K\OZKSNLK]ONYX^ROS\]USVV]KXNVO`OV] QS`OXSX^RO+XXOb_\OK^^KMRONK^^ROOXNYP^RS]
+]]YMSK^O]KXN4YSX^@OX^_\O]vS]]_ONLc^RO3X]^S^_^OYP
    ZK\^ P\YW \OMOS`SXQ .S\OM^Y\t] \OW_XO\K^SYX
+ YP ZO\PY\WKXMO OWZVYcOO ZKc K^ ^RO -YWZKXc S] YX :YVSMc;_KX^_WYP]S^^SXQPOO]WKcLO]_LTOM^^Y
-RK\^O\ON+MMY_X^KX^]YP3XNSK
]RKVVXY^RK`OKXcZOM_XSK\c\OVK^SYX]RSZ]aS^R K`O\KQO^K\QO^ON^YLOMYWZO^S^S`OK^^ROWONSKXZKcYP \O`SOaYXKZO\SYNSMLK]S]K]KXNaROX\O[_S\ON
^RO -YWZKXc S^] RYVNSXQ S^] ]_L]SNSK\c S^]   u <OVK^S`OvSWZVSO]KXcYXOaRYS]\OVK^ON^YKXY^RO\SP^ROc Y^RO\VOKNSXQMYWZKXSO] ]_LTOM^^Y^ROKZZVSMKLVO]^K^_^Y\cZ\Y`S]SYX]YP
K]]YMSK^OMYWZKXSO]S^]Z\YWY^O\]Y\.S\OM^Y\] K\OWOWLO\]YP2?0%SP^ROcK\OR_]LKXNKXNaSPO%Y\SP ^RO+M^K]KWOXNONP\YW^SWO^Y^SWO
one person is related to the other in such manner as may   >RO-YWZKXcS]NONSMK^ON^YZ\Y`SNSXQK]YVSNPY_XNK^SYX
N_\SXQ^ROM_\\OX^ XKXMSKVcOK\Y\SWWONSK^OVc YP OWZVYcOO LOXO ^] ^RK^ aSVV KVVYa OWZVYcOO] ^Y WOO^
LOZ\O]M\SLON+ZO\]YX]RKVVLONOOWON^YLO^RO\OVK^S`O   <OSWL_\]OWOX^YP\OK]YXKLVOObZOX]O]
Z\OMONSXQ^aY XKXMSKVcOK\] ^ROS\ ZO\]YXKV KXN PKWSVc XOON] AO \OMYQXSdO ^RO
YPKXY^RO\SPROY\]ROS]\OVK^ON^YKXY^RO\SX^ROPYVVYaSXQ    >RO -YWZKXc WKc ZKc Y\ \OSWL_\]O ^Y ^RO
     OVK^S`O] ]RY_VN XY^ RK`O Y\ RKN ZOM_XSK\c
< WKXXO\ XKWOVc x 0K^RO\ SXMV_NO] ]^OZPK^RO\ 7Y^RO\ SWZY\^KXMO YP XKXMSKV ]OM_\S^c PY\ ^RSXQ] ^RK^ WK^^O\
WY]^ ^Y ^RO OWZVYcOO KXN ^ROS\ PKWSVc 9_\ LOXO ^] 8/.] ]_MR ObZOXNS^_\O K] WKc RK`O LOOX
\OVK^SYX]RSZ]Y\^\KX]KM^SYX]aS^R^RO-YWZKXc SXMV_NO] ]^OZWY^RO\ =YX SXMV_NO] ]^OZ]YX =YXt]
ZRSVY]YZRcS]LK]ONYX^R\OOZ\SWK\cMY\O`KV_O]$ SXM_\\ON Lc ^ROW PY\ K^^OXNSXQ ^RO ,YK\N
S^]RYVNSXQ]_L]SNSK\cY\K]]YMSK^O-YWZKXcY\ aSPO .K_QR^O\ .K_QR^O\t] R_]LKXN ,\Y^RO\ SXMV_NO] -YWWS^^OO WOO^SXQ] >RS] WKc SXMV_NO
^ROS\Z\YWY^O\]Y\.S\OM^Y\]KWY_X^SXQ^Y ]^OZL\Y^RO\=S]^O\SXMV_NO]]^OZ]S]^O\    >RO -YWZKXc MK\O] KXN S] MYXMO\XON PY\ ^RO \OSWL_\]OWOX^YPObZOXNS^_\OSXM_\\ONLc^ROW
or more of its gross turnover or total income or ROKV^R aOVPK\O KXN XKXMSKV aOVVLOSXQ YP S^]
Remuneration Policy PY\KMMYWWYNK^SYX^\K`OVKXNKXcY_^YPZYMUO^
38<6KUR]Y\]_MRKWY_X^K]^RO-YWZKXc OWZVYcOO]aY\VNaSNO
1. Purpose : ObZOX]O] PY\ K^^OXNSXQ ,YK\N-YWWS^^OO
WKc Z\O]M\SLO aRSMRO`O\ S] VYaO\ N_\SXQ ^RO    >RO -YWZKXc RK] O]^KLVS]RON MYWZO^S^S`O WOO^SXQ] 1OXO\KV WOO^SXQ] -Y_\^ MYX`OXON
^aY SWWONSK^OVc Z\OMONSXQ XKXMSKV cOK\] Y\   =
 OM^SYX!"YP^RO-YWZKXSO]+M^KXN=OM_\S^SO] LOXO ^]K]ZK\^YP^RO>Y^KV<OaK\N]YPPO\ON^Y WOO^SXQ]7OO^SXQ]aS^R]RK\ORYVNO\]M\ONS^Y\]
N_\SXQ^ROM_\\OX^ XKXMSKVcOK\ KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ 9LVSQK^SYX] KXN S^]OWZVYcOO] WKXKQOWOX^]S^O`S]S^]SXN_M^SYXKXN^\KSXSXQ
  !  OS^RO\ RSW]OVPRO\]OVP XY\ KXc YP RS]RO\
8 .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]  \O[_S\O] Y\QKXSdONLc^RO-YWZKXcPY\.S\OM^Y\]
  >RO -YWZKXc RK] NO`OVYZON ]^KXNK\N] PY\
relatives shall hold or has held the position of a Key every Nomination and Remuneration Committee
OPPOM^S`O WKXKQOWOX^ YP OWZVYcOO LOXO ^    3X ^RO MK]O YP 3XNOZOXNOX^ .S\OM^Y\] ^RO
7KXKQO\SKV:O\]YXXOVY\S]Y\RK]LOOXOWZVYcOO 8<-^YNO`S]OK:YVSMcYX\OW_XO\K^SYXYP.S\OM^Y\]
Z\YQ\KW]
YP ^RO -YWZKXc Y\ S^] RYVNSXQ ]_L]SNSK\c Y\ 5Oc7KXKQO\SKV:O\]YXXOV57:KXNY^RO\OWZVYcOO] -YWZKXc WKc ZKc\OSWL_\]O KXc ObZOX]O]
  >RO -YWZKXc S] MYWWS^^ON ^Y YPPO\SXQ MYWZ\OROX]S`O SXM_\\ON ]_LTOM^ ^Y \OK]YXKLVO VSWS^] Lc ^RO
K]]YMSK^O MYWZKXc SX KXc YP ^RO ^R\OO XKXMSKV   >
 RO8<-S]\O]ZYX]SLVOPY\\OMYWWOXNSXQ^Y^RO,YK\N
KXN MYWZO^S^S`O LOXO ^ ZKMUKQO] NO]SQXON ^Y WOO^ independent Director for professional advice
cOK\]SWWONSK^OVcZ\OMONSXQ^RO XKXMSKVcOK\SX K :YVSMc \OVK^SXQ ^Y ^RO \OW_XO\K^SYX YP .S\OM^Y\] 5Oc
the changing needs of our employees and our diverse from Independent advisors in the furtherance of
aRSMRROS]Z\YZY]ON^YLOKZZYSX^ON 7KXKQO\SKV:O\]YXXOVKXNY^RO\OWZVYcOO]
L_]SXO]]O] ^ROS\N_^SO]K]3XNOZOXNOX^.S\OM^Y\]
 " 8OS^RO\ RSW]OVPRO\]OVP XY\ KXc YP RS]RO\ 2. Overview :
 .O XS^SYX]$   =^YMU9Z^SYX]
\OVK^S`O]S]Y\RK]LOOXKXOWZVYcOOY\Z\YZ\SO^Y\   8
 <- RK] VKSN NYaX ^RS] :YVSMc ^Y OX]_\O MYWZVSKXMO
Y\ K ZK\^XO\ SX KXc YP ^RO  XKXMSKV cOK\]   u +M^vWOKX]^RO-YWZKXSO]+M^KXN<_VO]P\KWON    3XNOZOXNOX^ .S\OM^Y\] ]RKVV XY^ LO OX^S^VON ^Y
aS^R =OM^SYX !"  YP ^RO -YWZKXSO] +M^  aRSMR
SWWONSK^OVcZ\OMONSXQ^RO XKXMSKVcOK\YP$ ^RO\O_XNO\K]KWOXNONP\YW^SWO^Y^SWO KXc]^YMUYZ^SYX]YP^RO-YWZKXc
]^K^O]^RK^$

58 ANNUAL REPORT 2017-18 59


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

  3X]_\KXMOZYVSMcPY\8YX/bOM_^S`O.S\OM^Y\]    w Periodic surveys of appropriate comparison ANNEXURE III


   ARO\O KXc SX]_\KXMO S] ^KUOX Lc ^RO -YWZKXc MYWZKXSO]% =OM\O^K\SKV+_NS^<OZY\^PY\^RO XKXMSKVcOK\OXNON7K\MR"
YX LORKVP YP S^] 8/.] PY\ SXNOWXSPcSXQ ^ROW    w =KVK\c\KXQO]aRSMR\O
OM^TYLaY\^RLK]ONYX E:_\]_KX^^Y=OM^SYXYP^RO-YWZKXSO]+M^KXN<_VO#YP^RO-YWZKXSO]+ZZYSX^WOX^KXN<OW_XO\K^SYXYP:O\]YXXOV
KQKSX]^KXc]^K^_^Y\cVSKLSVS^c^ROZ\OWS_WZKSN MYWZO^S^S`OMYWZK\S]YX] <_VO]G
YX]_MRSX]_\KXMOaY_VNXY^MYX]^S^_^OZK\^YP
^ROS\\OW_XO\K^SYX  # ,YX_]:O\[_S]S^O]+VVYaKXMO]KXN,OXO ^]
  # 3X KNNS^SYX ^Y ^RO bON ]KVK\c MO\^KSX >Y 3 RK`OKV]YObKWSXONMYWZVSKXMOaS^R^ROKZZVSMKLVOMVK_]O]YP^RO
6. Remuneration for Managing Director (“MD”), Executive PYVVYaSXQ$
Directors (“ED”) : ZO\[_S]S^O] KVVYaKXMO] KXN LOXO ^] K\O >RO7OWLO\]
Z\Y`SNON^Y^RO57:]=OXSY\7KXKQOWOX^KXN  S =
 OM\O^K\SKV=^KXNK\N]S]]_ONLc>RO3X]^S^_^OYP-YWZKXc
  > RO \OW_XO\K^SYX ^Y 7./. KXN KXc MRKXQO ^RO\OYP +LLY^^3XNSK6SWS^ON
Y^RO\OWZVYcOO] =OM\O^K\SO]YP3XNSKK]KWOXNONP\YW^SWO^Y^SWO%
]RKVVLOKZZ\Y`ONLc^RO,YK\NYX^RO\OMYWWOXNK^SYX   # >RO-YWZKXcM_\\OX^VcZ\Y`SNO]KVVOWZVYcOO] 3 8OOXK ,RK^SK KZZYSX^ON K] ^RO =OM\O^K\SKV +_NS^Y\ YP ^RO
YP^RO8<-]_LTOM^^YKZZ\Y`KVLc^RO]RK\ORYVNO\]YP aS^R ]YMSKV ]OM_\S^c SX ^O\W] YP SX]_\KXMO -YWZKXcLc^RO,YK\NYP.S\OM^Y\]RK`OMYXN_M^ON^RO=OM\O^K\SKV  SS >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ
^RO-YWZKXcaS^RSX^ROVSWS^]Z\O]M\SLON_XNO\^RO+M^ ^YaK\N]RY]ZS^KVSdK^SYX7ONSMVKSWSX]_\KXMO +_NS^ YP ^RO MYWZVSKXMO aS^R KZZVSMKLVO ]^K^_^Y\c Z\Y`S]SYX] 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]
KXN-OX^\KV1Y`O\XWOX^KZZ\Y`KVaRO\O`O\\O[_S\ON KMMSNOX^KVNOK^RKXNNS]WOWLO\WOX^ZO\]YXKV KXN ^RO KNRO\OXMO ^Y QYYN MY\ZY\K^O Z\KM^SMO] Lc +LLY^^ 3XNSK 
  0SbON \OW_XO\K^SYX S] ZKcKLVO Lc ^RO aKc YP ]KVK\c KMMSNOX^SX]_\KXMO 6SWS^ON RO\OSXKP^O\ MKVVON u^RO -YWZKXcv =OM\O^K\SKV +_NS^  YLO]^YPWc_XNO\]^KXNSXQ3KWYP^RO`SOa^RK^N_\SXQ^ROZO\SYN
>
ZO\[_S]S^O]KXNKVVYaKXMO]>RO8<-]RKVV\OMYWWOXN   # >RO -YWZKXc Z\Y`SNO] \O^S\OWOX^ LOXO ^] K] aK]MYXN_M^ONSXKWKXXO\^RK^Z\Y`SNONWOK\OK]YXKLVOLK]S] _XNO\ \O`SOa ^RO -YWZKXc RK] MYWZVSON aS^R ^RO Z\Y`S]SYX]
^Y ^RO ,YK\N KXX_KV SXM\OWOX^] SX ]KVK\c OPPOM^S`O ]^ ZO\]^K^_^Y\c\O[_S\OWOX^] PY\O`KV_K^SXQ^ROMY\ZY\K^OMYXN_M^]]^K^_^Y\cMYWZVSKXMO]KXN
+Z\SVOKMRcOK\ YP ^RO +M^ <_VO] <OQ_VK^SYX] KXN 1_SNOVSXO] =^KXNK\N] O^M
  # >RO -YWZKXc Z\Y`SNO] K ZO\PY\WKXMO ObZ\O]]SXQWcYZSXSYX^RO\OYX WOX^SYXONKLY`O
  +ZK\^ P\YW ^RO bON \OW_XO\K^SYX ^RO\O S] K `K\SKLVO VSXUON MK]R LYX_] ^Y KVV OWZVYcOO] LK]ON YX
MYWZYXOX^ YP K ZO\PY\WKXMO VSXUON SXMOX^S`O ,K]ONYXWc`O\S MK^SYXYP^RO-YWZKXct]LYYU]ZKZO\]WSX_^O I further report that :
performance of the Company in general and LYYU PY\W] KXN \O^_\X] VON KXN Y^RO\ \OMY\N] WKSX^KSXON Lc
MYWWS]]SYX aRSMR S] ZKcKLVO YX KX KXX_KV LK]S] ^RO SXNS`SN_KVt] ZO\PY\WKXMO PY\ ^RO \OVO`KX^
^RO -YWZKXc KXN KV]Y SXPY\WK^SYX Z\Y`SNON Lc ^RO -YWZKXc 2K`SXQ \OQK\N ^Y ^RO MYWZVSKXMO ]c]^OW Z\O`KSVSXQ SX ^RO
>ROKWY_X^YPZO\PY\WKXMOLYX_]MYWWS]]SYX]RKVVLO XKXMSKV cOK\ WOK]_\ON KQKSX]^ ]ZOMS M 5Oc
NO^O\WSXONLc^RO,YK\NLK]ONYX^RO\OMYWWOXNK^SYX S^] YP MO\] KQOX^] KXN K_^RY\SdON \OZ\O]OX^K^S`O] N_\SXQ ^RO -YWZKXc KXN YX ObKWSXK^SYX YP ^RO \OVO`KX^ NYM_WOX^] KXN
<O]_V^+\OK]aRSMRK\OKVSQXON^Y^RO-YWZKXct] \OMY\N]SXZ_\]_KXMO^RO\OYPYX^O]^MROMULK]S]^RO-YWZKXc
YP ^RO 8<- KXN SX KVSQXWOX^ aS^R -YWZKXc ZYVSMc YLTOM^S`O]KXNZYVSMSO] MYXN_M^YP=OM\O^K\SKV+_NS^3RO\OLc\OZY\^^RK^SXWcYZSXSYX
>RO\OMKXLOMYWZYXOX^]YPYXO^SWOSXMOX^S`OY\]ZOMSKV ^RO-YWZKXcRK]N_\SXQ^ROK_NS^ZO\SYNMY`O\SXQ^RO XKXMSKV RK]MYWZVSONaS^R^ROPYVVYaSXQVKa]KZZVSMKLVO]ZOMS MKVVc^Y^RO
SXMOX^S`O]LK]S]RS]KQ\OONMYWZOX]K^SYX]^\_M^_\OaS^R   # 57:=OXSY\ 7KXKQOWOX^ :O\]YXXOVY^RO\ -YWZKXc$
OWZVYcOO] K] ZO\ ^ROS\ Q\KNO K\O KV]Y OVSQSLVO cOK\ OXNON YX 7K\MR  " MYWZVSON aS^R ^RO ]^K^_^Y\c
^RO RY]^ MY_X^\SO] SX MK]O YP ObZK^\SK^O] >RO ]KWO aSVV provisions listed hereunder and also that the Company has
PY\6YXQ>O\W3XMOX^S`O]Q\KX^ONLc^RO:K\OX^  K .
 \_Q] KXN -Y]WO^SM] +M^ # KXN .\_Q] KXN -Y]WO^SM]
LO K] \OMYWWOXNON Lc ^RO 8<- KXN KZZ\Y`ON Lc ^RO
-YWZKXc+LLY^^6KLY\K^Y\SO]?=+SX^ROPY\W Z\YZO\ ,YK\N Z\YMO]]O] KXN MYWZVSKXMO WOMRKXS]W SX ZVKMO <_VO#%
,YK\NYP.S\OM^Y\]
YP=^YMU9Z^SYX]KXNY\<O]^\SM^ON=^YMU?XS^] ^Y^ROOb^OX^SX^ROWKXXO\KXN]_LTOM^^Y^RO\OZY\^SXQWKNO
  >RO -YWZKXc ]RKVV Z\Y`SNO \O^S\OWOX^ LOXO ^] K] ZO\  L .
 \_Q]KXN7KQSM<OWONSO]9LTOM^SYXKLVO+N`O\^S]OWOX^
10. Merit Pay : RO\OSXKP^O\$
]^K^_^Y\c\O[_S\OWOX^]+NNS^SYXKVVc^RO\OWKcLOMO\^KSX +M^#%
Y^RO\ \O^S\OWOX^ LOXO ^] ^RK^ WKc LO Z\Y`SNON ^Y 7.   >ROMYWWYXOPPOM^S`ONK^OPY\WO\S^ZKcSXM\OK]OS]YX 3 RK`O ObKWSXON ^RO LYYU] ZKZO\] WSX_^O LYYU PY\W] KXN
 M .\_Q]:\SMO-YX^\YV9\NO\%
/.]_MRK]ZOX]SYXQ\K^_S^c]_ZO\KXX_K^SYXO^M ]^ +Z\SV YP ^RO MKVOXNK\ cOK\ 7O\S^ ZKc S] SX^OXNON ^Y \O^_\X] VONKXNY^RO\\OMY\N]WKSX^KSXONLc^RO-YWZKXcPY\^RO
  7./.K\OKV]YOVSQSLVOPY\6YXQ>O\W3XMOX^S`O]Q\KX^ON focus solely on individual performance against goals and XKXMSKVcOK\OXNONYX7K\MR"KMMY\NSXQ^Y^ROZ\Y`S]SYX] I further report that :
Lc^RO:K\OX^-YWZKXc+LLY^^6KLY\K^Y\SO]?=+SX^RO ObZOM^K^SYX] NO^O\WSXON PY\ KX SXNS`SN_KV N_\SXQ ^RO YP$ >RO,YK\NYP.S\OM^Y\]YP^RO-YWZKXcS]N_VcMYX]^S^_^ONaS^R
PY\WYP=^YMU9Z^SYX]KXNY\<O]^\SM^ON=^YMU?XS^] :O\PY\WKXMO/bMOVVOXMO\O`SOaZ\YMO]]    RO-YWZKXSO]+M^KXN^RO<_VO]WKNO^RO\O_XNO\
> Z\YZO\ LKVKXMO YP /bOM_^S`O .S\OM^Y\] 8YX/bOM_^S`O .S\OM^Y\]
7. Minimum Remuneration : 11. Policy Implementation : K]KWOXNONP\YW^SWO^Y^SWO^RO+M^% KXN3XNOZOXNOX^.S\OM^Y\]
 ! 3 P SX KXc XKXMSKV cOK\ ^RO -YWZKXc RK] XY Z\Y ^]   >RO 8<- S] \O]ZYX]SLVO PY\ \OMYWWOXNSXQ ^RS]   >
 RO =OM_\S^SO] -YX^\KM^] <OQ_VK^SYX +M^ #  =-<+ +NO[_K^O XY^SMO S] QS`OX ^Y KVV .S\OM^Y\] ^Y ]MRON_VO ^RO ,YK\N
Y\ S^] Z\Y ^] K\O SXKNO[_K^O ^RO -YWZKXc ]RKVV ZKc <OW_XO\K^SYX:YVSMc^Y^RO,YK\N KXN^RO<_VO]WKNO^RO\O_XNO\% 7OO^SXQ]+QOXNKKXNNO^KSVONXY^O]YXKQOXNKaO\O]OX^K^VOK]^
\OW_XO\K^SYX ^Y S^] 7.  /.] SX KMMY\NKXMO aS^R ^RO  >RO ,YK\N S] \O]ZYX]SLVO PY\ KZZ\Y`SXQ KXN Y`O\]OOSXQ ]O`OXNKc]SXKN`KXMOKXNK]c]^OWObS]^]PY\]OOUSXQKXNYL^KSXSXQ
Z\Y`S]SYX]YP=MRON_VO@YP^RO+M^   >
 RO.OZY]S^Y\SO]+M^## KXN^RO<OQ_VK^SYX]KXN,cO
SWZVOWOX^K^SYXYP^RS]:YVSMcaS^R^RO]_ZZY\^YP^RO8<- P_\^RO\SXPY\WK^SYXKXNMVK\S MK^SYX]YX^ROKQOXNKS^OW]LOPY\O
VKa]P\KWON^RO\O_XNO\%
8. Provisions for excess Remuneration : 12. Review of this Policy : ^ROWOO^SXQKXNPY\WOKXSXQP_VZK\^SMSZK^SYXK^^ROWOO^SXQ
  0
 Y\OSQX/bMRKXQO7KXKQOWOX^+M^###KXN^RO<_VO]
 " 3 P7./.N\Ka]Y\\OMOS`O]NS\OM^VcY\SXNS\OM^VcLcaKc   >RS] :YVSMc ]RKVV LO ]_LTOM^ ^Y \O`SOa Lc ^RO 8<- K^ .OMS]SYX S] MK\\SON ^R\Y_QR 7KTY\S^c aRSVO ^RO NS]]OX^SXQ
YP \OW_XO\K^SYX KXc ]_MR ]_W] SX ObMO]] YP ^RO VSWS^] KXN<OQ_VK^SYX]WKNO^RO\O_XNO\^Y^ROOb^OX^YP0Y\OSQX
]_MR SX^O\`KV] K] WKc LO NOOWON XOMO]]K\c -RKXQO] .S\OM^3X`O]^WOX^% WOWLO\t] `SOa] SP KXc K\O MKZ^_\ON KXN \OMY\NON K] ZK\^ YP ^RO
Z\O]M\SLON _XNO\ ^RO +M^ Y\ aS^RY_^ ^RO Z\SY\ ]KXM^SYX SPKXc\OMYWWOXNONLc^RO8<-]RKVVLOZVKMONLOPY\O WSX_^O]
YP^RO-OX^\KV1Y`O\XWOX^aRO\O\O[_S\ONRO]RO]RKVV ^RO,YK\NPY\S^]KZZ\Y`KV   >
 RO PYVVYaSXQ <OQ_VK^SYX] KXN 1_SNOVSXO] Z\O]M\SLON
refund such sums to the Company and until such sum is _XNO\ ^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK +M^ 3P_\^RO\\OZY\^^RK^^RO\OK\OKNO[_K^O]c]^OW]KXNZ\YMO]]O]SX
\OP_XNONRYVNS^SX^\_]^PY\^RO-YWZKXc>RO-YWZKXc ANNEXURE TO THE POLICY ##s=/,3+M^t`Sd$ ^RO-YWZKXcMYWWOX]_\K^OaS^R^RO]SdOKXNYZO\K^SYX]YP^RO
]RKVV XY^ aKS`O \OMY`O\c YP ]_MR ]_W \OP_XNKLVO ^Y S^ Sr. Board/Committee Meeting Amount per Meeting -YWZKXc^YWYXS^Y\KXNOX]_\OMYWZVSKXMOaS^RKZZVSMKLVOVKa]
_XVO]]ZO\WS^^ONLc^RO-OX^\KV1Y`O\XWOX^ No. per Director (`)   K >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK \_VO]\OQ_VK^SYX]KXNQ_SNOVSXO]
9. Key Managerial Personnel (“KMP”), Senior Management  ,YK\NYP.S\OM^Y\]SXMV_NSXQ7OO^SXQ]YP  =_L]^KX^SKV +M[_S]S^SYX YP =RK\O] KXN >KUOY`O\
<OQ_VK^SYX]K]KWOXNONP\YW^SWO^Y^SWO% >RS] \OZY\^ S] ^Y LO \OKN aS^R Wc VO^^O\ YP O`OX NK^O aRSMR S]
and Other Employees : 3XNOZOXNOX^.S\OM^Y\]
KXXObONK]+XXOb_\OKXNPY\W]SX^OQ\KVZK\^YP^RS]\OZY\^
 # ,K]O=KVK\c  Audit Committee    L >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK
  # =KVK\SO] ^Y 57: =OXSY\ 7KXKQOWOX^ KXN
3 8YWSXK^SYX<OW_XO\K^SYX-YWWS^^OO  :\YRSLS^SYXYP3X]SNO\>\KNSXQ<OQ_VK^SYX]%
Y^RO\ OWZVYcOO] K\O NOMSNON LK]S] ^RO VO`OV YP  =^KUORYVNO\]<OVK^SYX]RSZ-YWWS^^OO 
  M >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK Neena Bhatia
\O]ZYX]SLSVS^cKXNSXNS`SN_KVZO\PY\WKXMO,K]O  -Y\ZY\K^O=YMSKV<O]ZYX]SLSVS^c 
<OQS]^\K\] ^Y KX 3]]_O KXN =RK\O >\KX]PO\ +QOX^] Practicing Company Secretary
ZKc]^\_M^_\OaY_VNNOZOXN_ZYX$ Committee :VKMO$7_WLKS    7OWLO\]RSZ8Y$0-=##
<OQ_VK^SYX]##\OQK\NSXQ^RO-YWZKXSO]+M^KXN
<S]U7KXKQOWOX^-YWWS^^OO  .K^O$7Kc"   -O\^S MK^OYP:\KM^SMO8Y$ 
   w :Y]S^SYXO`KV_K^SYX]% NOKVSXQaS^RMVSOX^

60 ANNUAL REPORT 2017-18 61


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

+XXOb_\O^Y^RO=OM\O^K\SKV+_NS^<OZY\^YP+LLY^^3XNSK6SWS^ONPY\ XKXMSKVcOK\OXNON7K\MR" ANNEXURE IV


Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo
>Y E3XMYWZVSKXMOaS^R^ROZ\Y`S]SYX]YP=OM^SYXWYP^RO-YWZKXSO]+M^\OKNaS^R<_VO"YP^RO-YWZKXSO]+MMY_X^]<_VO]G
>RO7OWLO\]
A. Conservation of Energy w  Oa`YV_WO^\SMVS[_SN VVSXQVSXOSXM\OK]ON^ROcSOVN]
8
+LLY^^3XNSK6SWS^ON YP -\OWKP X KXN ._ZRKVKM Lc  KXN SWZ\Y`ON
i. The Energy conservation measures taken
7c<OZY\^YPO`OXNK^OS]^YLO\OKNKVYXQaS^R^RS]VO^^O\    /bS]^SXQ 0V_Y\O]MOX^ >_LO 6SQR^ RSQR ZYaO\ 0>6 Y`O\KVVO[_SZWOX^OP MSOXMcLc 
MYX]_WSXQVSQR^]\OZVKMONaS^ROXO\Qc]K`SXQ6SQR^   w  OL\KZ\SX^O\]SX]^KVVONPY\Z\SX^SXQYP]RSZZO\VKLOV]
D
  KSX^OXKXMOYP]OM\O^K\SKV\OMY\NS]^RO\O]ZYX]SLSVS^cYP^RO7KXKQOWOX^YP^RO-YWZKXc7c\O]ZYX]SLSVS^cS]^YObZ\O]]KXYZSXSYX
7 /WS^^SXQ.SYNO6/.VSQR^]SX;_KVS^c-YX^\YVK\OK] SX^KLVO^KXNVS[_SN]OMYXNK\cZKMUSXQK\OK^Y\OZVKMO
YX^RO]O]OM\O^K\SKV\OMY\N]LK]ONYXWcK_NS^ WKX_KVY`O\Z\SX^SXQYP]RSZZO\VKLOV]KVYXQaS^R^aY
   8OaMYXNOX]K^O\OMY`O\cZ_WZSX]^KVVON^YSWZ\Y`O
 3  RK`O PYVVYaON ^RO K_NS^ Z\KM^SMO] KXN Z\YMO]]O] K] aO\O KZZ\YZ\SK^O ^Y YL^KSX \OK]YXKLVO K]]_\KXMO KLY_^ ^RO MY\\OM^XO]] ^ROMYXNOX]K^O\OMY`O\cP\YW^Y" WKXZYaO\]K`SXQ]ZO\]RSP^
YP ^RO MYX^OX^] YP ^RO ]OM\O^K\SKV \OMY\N] >RO `O\S MK^SYX aK] NYXO YX ^O]^ LK]S] ^Y OX]_\O ^RK^ MY\\OM^ PKM^] K\O \O
OM^ON SX   0YVVYaSXQ WOK]_\O] RK`O LOOX ^KUOX K^ ^RO 1YK ZVKX^   w  \OWKP X LK^MR ]SdO SXM\OK]ON P\YW  56 ^Y
-
]OM\O^K\SKV\OMY\N]3LOVSO`O^RK^^ROZ\YMO]]O]KXNZ\KM^SMO]3PYVVYaONZ\Y`SNOK\OK]YXKLVOLK]S]PY\WcYZSXSYX N_\SXQ^ROcOK\!"PY\MYX]O\`K^SYXYPaK^O\x  56 ^Y MYZO _Z aS^R SXM\OK]SXQ WK\UO^ NOWKXN
   /P
_OX^ >\OK^WOX^ :VKX^ ^\OK^ON aK^O\ _]ON PY\ >RS] SXS^SK^S`O \O]_V^ON SX KZZ\YbSWK^OVc  
 3RK`OXY^`O\S ON^ROMY\\OM^XO]]KXNKZZ\YZ\SK^OXO]]YP XKXMSKV\OMY\N]KXNLYYU]YPKMMY_X^]YP^RO-YWZKXc ^YSVO^
_]RSXQSXMRKXQO\YYW] \ON_M^SYXSXVSXOMVOK\KXMO]^SWO\ON_M^SYXSX
   0V_SNLONN\cO\ V^O\LKQaK]RSXQKXNN\cSXQWKMRSXO LK^MR ^O]^SXQ KXN  SXM\OK]O SX VS[_SN VVSXQ VSXO
 A
 RO\O`O\ \O[_S\ON 3 RK`O YL^KSXON ^RO 7KXKQOWOX^ <OZ\O]OX^K^SYX KLY_^ ^RO MYWZVSKXMO YP VKa] \_VO] KXN \OQ_VK^SYX] KXN
RKZZOXSXQYPO`OX^]O^M SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\aK]RSXQMcMVO OP MSOXMc
- Intermediate product container cleaning machine   w  K_XMR YP XOa =5?] -\OWKP X  WV ?NSVS` t]
6
 >
 RO MYWZVSKXMO YP ^RO Z\Y`S]SYX] YP -Y\ZY\K^O KXN Y^RO\ KZZVSMKLVO VKa] \_VO] \OQ_VK^SYX] ]^KXNK\N] S] ^RO \O]ZYX]SLSVS^c YP SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\ XOaZKMU._ZRKVKM6OWYX
K`Y\
7KXKQOWOX^7cObKWSXK^SYXaK]VSWS^ON^Y^RO`O\S MK^SYXYPZ\YMON_\O]YX^O]^LK]S] ii. The steps taken by the Company for utilizing iii. In case of imported technology (imported during the
alternate sources of energy last three years reckoned from the beginning of the
 >
 RO=OM\O^K\SKV+_NS^<OZY\^S]XOS^RO\KXK]]_\KXMOK]^Y^ROP_^_\O`SKLSVS^cYP^RO-YWZKXcXY\YP^ROOP MKMcY\OPPOM^S`OXO]]
aS^RaRSMR^RO7KXKQOWOX^RK]MYXN_M^ON^ROKPPKS\]YP^RO-YWZKXc Nil XKXMSKVcOK\
iii. The Capital Investment on Energy Conservation   K ^RONO^KSV]YP^OMRXYVYQcSWZY\^ON$8SV
Equipment
Neena Bhatia   L ^ROcOK\YPSWZY\^$8SV
` !6KUR]
Practicing Company Secretary   M aRO^RO\^RO^OMRXYVYQcLOOXP_VVcKL]Y\LON$8+
:VKMO$7_WLKS    7OWLO\]RSZ8Y$0-=## B. Technology Absorption
  N S PXY^P_VVcKN]Y\LONK\OK]aRO\OKN]Y\Z^SYXRK]XY^
.K^O$7Kc"   -O\^S MK^OYP:\KM^SMO8Y$  i. The efforts made towards Technology Absorption ^KUOXZVKMOKXN^RO\OK]YX]^RO\OYP$8+
  w 2SQR ]ZOON RKWWO\ WSVV SX]^KVVON ^Y SWZ\Y`O iv. Expenditure on Research & Development
^RO OP MSOXMc YP ]_QK\ WSVVSXQ Z\YMO]] ^Y \ON_MO
O\QYXYWSM\S]UaRSVOWKX_KVRKXNVSXQYP]_QK\KXN Sr. No. Particulars ` in Lakhs
^Y\ON_MO^ROVKLY\RY_\]ZO\LK^MR
K Capital !
  w ,_MUO^ ^cZO ]OVPMVOKXSXQ V^O\ SX]^KVVON SX VS[_SN
WKX_PKM^_\SXQK\OK^Y\ON_MOYZOXRKXNSXQYPVS[_SN L Recurring "!
WK^O\SKV]N_\SXQLK^MRWKX_PKM^_\SXQ M >Y^KV !
  w Pneumatic pumps installed for paste charging in N >Y^KV<.ObZOXNS^_\OK]K:O\MOX^KQO 
VS[_SNWKX_PKM^_\SXQK\OK^Y\ON_MOO\QYXYWSM\S]U YP>Y^KV>_\XY`O\
aRSVO WKX_KV VYKNSXQ YP ZK]^O] SX]SNO ^RO ^KXU]
^R\Y_QRRYZZO\ C. Foreign Exchange Earnings and Outgo
  w Closed loop system installed for chloroform transfer Particulars ` in Lakhs
P\YWYXO^KXU^YKXY^RO\^KXU^Y\ON_MO^RO\S]UYP
WKX_KVRKXNVSXQKXNSXRKVK^SYXYPMRVY\YPY\W A. Total Foreign Exchange used
  w >\KMU^\KMO]c]^OWPY\^O\^SK\cZKMUSXQSX]^KVVON^Y K 9XSWZY\^YP\KaWK^O\SKV] XS]RONQYYN]  
MYWZVcaS^RM_\\OX^\OQ_VK^SYX] MYX]_WKLVO]^Y\O]KXNMKZS^KVQYYN]
w 9XVSXOSX]ZOM^SYX]c]^OWSX]^KVVONYXLVS]^O\ZKMUSXQ L 9XZ\YPO]]SYXKVMRK\QO]]KVO]Z\YWY^SYX !
WKMRSXO]^Y\OTOM^XYX VVONLVS]^O\]YXVSXO ObZOX]O]MYWWS]]SYXYXObZY\^]KVO]
  w 3X]^KVVK^SYXYPNcXKWSM]^K^SMZK]]LYbPY\Z\YZO\ \OQS]^\K^SYXPOO]L_]SXO]]^\K`OV]YP^aK\OO^M
WK^O\SKV
Ya M 9XZ_\MRK]OYP>\KNOWK\U] !!#
 SS >RO LOXO ^] NO\S`ON VSUO Z\YN_M^ SWZ\Y`OWOX^ N For dividend remittance ! 
cost reduction, product development or import B. Total Foreign Exchange earned
substitution
K /bZY\^]YPQYYN] #!
  w 8Oa @SNOYTO^ Z\SX^O\] SX]^KVVON YX VS[_SN KXN ^KLVO^
]OMYXNK\cZKMUSXQVSXO]SXY\NO\^Y\ON_MO^ROZKMUSXQ L Service income  
VSXO]^YZZKQO]YXKMMY_X^YPYVNZ\SX^O\L\OKUNYaX] M <OMY`O\cYPObZOX]O] 
\O]_V^SXQSXSXM\OK]ONOP MSOXMcYPZKMUSXQVSXO]KXN
\ON_M^SYXSX^ROaK]^KQOYPZKMUSXQWK^O\SKV] N Other earnings  

62 ANNUAL REPORT 2017-18 63


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ANNEXURE V Category of No. of Shares held at the beginning of the year No. of Shares held at the end of the year %
/b^\KM^YP+XX_KV<O^_\XK]YX XKXMSKVcOK\OXNON7K\MR" Shareholders Demat Physical Total % of Total Demat Physical Total % of Total Change
Share Shares during
FORM NO. MGT 9 the year
:_\]_KX^^Y=OM^SYX#YP^RO-YWZKXSO]+M^KXN<_VOYP^RO-YWZKXSO]7KXKQOWOX^+NWSXS]^\K^SYX<_VO] B. Public Shareholding
 Institutions
i. REGISTRATION AND OTHER DETAILS
K Mutual Funds #  #   "    
CIN $ 6#72#:6-! L ,KXU]03  " " !!   ## " !  !
Registration Date $ +_Q_]^# M -OX^\KV1Y`^ - - - - - - - - -
Name of the Company $ +LLY^^3XNSK6SWS^ON N =^K^O1Y`^] - - - - - - - - -
-K^OQY\c=_L-K^OQY\cYP^RO-YWZKXc $ -YWZKXc6SWS^ON,c=RK\O]3XNSKX8YX1Y`O\XWOX^-YWZKXc O Venture Capital Funds - - - - - - - - -
+NN\O]]YP^RO<OQS]^O\ONYP MOKXNMYX^KM^NO^KSV] $ -Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKSx! P  Insurance Companies #  - #  #  -   !
>OVOZRYXO8Y$# !#!""""#" # Q FIIs   !    -    
0Kb$# !#!"!!#"  R Foreign Venture
- - - - - - - - -
ARO^RO\VS]^ONMYWZKXc $ Yes Capital Investors
S ;_KVS ON0Y\OSQX
8KWO+NN\O]]KXN-YX^KM^NO^KSV]YP^RO<OQS]^\K\KXN $ 5K\`c-YWZ_^O\]RK\O:\S`K^O6SWS^ON - - - - - - - - -
Investor
=RK\O>\KX]PO\+QOX^$ ?XS^x+LLY^^3XNSK6SWS^ON
+NN\O]]5K\`c=OVOXS_W>YaO\,:VY^1KMRSLYaVS T 9^RO\]]ZOMSPc
0SXKXMSKV.S]^\SM^8KXKU\KWQ_NK2cNO\KLKNx 0Y\OSQX:Y\^PYVSYx-Y\Z #!# - #!# " #"# - #"# " 
>OV8Y$# ! 0Kb8Y$# ! Sub-total (B)(1) : 1887110 708 1887818 8.88 1901062 458 1901520 8.95 +0.07%
 Non-Institutions
ii. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY
K ,YNSO]-Y\Z
 +VV^ROL_]SXO]]KM^S`S^SO]MYX^\SL_^SXQY\WY\OYP^RO^Y^KV^_\XY`O\YP^RO-YWZKXc]RKVVLO]^K^ON$ S Indian  ! #  "  !"    #   
Sr. Name and Description of main Products/ NIC Code of the Product/Service % to total turnover of the Company SS Overseas - - - - - - - - -
No. Services L Individuals
 Pharmaceuticals   S Individual
shareholders
iii. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES holding nominal  #!  #!# #"  ! ! " #   
share capital
Sr. Name and address of the Company CIN/GLN Holding/Subsidiary/ % of shares Applicable section
upto `6KUR
No. Associate held
SS Individual
 +LLY^^-KZS^KV3XNSK6SWS^ON NA 2YVNSXQ   YP^RO-YWZKXSO] shareholders
+NN\O]]$+LLY^^2Y_]O@KX`KVV,_]SXO]]:K\U +M^ holding nominal   ! #"    #! # #" !" " !
7KSNOXROKN,O\U]RS\O=6 B/ share capital in
ObMO]]YP`6KUR
IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)
M 9^RO\]]ZOMSPc
i Category-wise Share Holding Alternative
- - - - "! - "! # #
Category of No. of Shares held at the beginning of the year No. of Shares held at the end of the year % Investment Fund
Shareholders Demat Physical Total % of Total Demat Physical Total % of Total Change >\_]^ ! - ! -   -   - -
Share Shares during 8<3<OZ   #  ! #     !  -
the year -VOK\SXQ7OWLO\  -   " - "  
A. Promoters
8<38YX<OZ "  # !   # #  
 Indian
0Y\OSQX-Y\Z,YNSO] - ! ! - - ! ! - -
K 3XNS`SN_KV2?0 - - - - - - - -- -
L -OX^\KV1Y`^ - - - - - - - -- - Investor Education
and Protection Fund - - - - "# - "#  
M =^K^O1Y`^] - - - - - - - -- -
Authority
N ,YNSO]-Y\Z - - - - - - - -- -
- - - - - - - -- - Unclaimed Suspense
O ,KXU]03 - - - -  ! -  !  
Account
P  Any other - - - - - - - -- -
8,0- - - - -  " -  "  
Sub-total (A)(1) : - - - - - - - -- -
 Foreign 0Y\OSQX8K^SYXKV
- - - - - - - - -
K 8<3]x3XNS`SN_KV] - - - - - - - - - ,YNSO]9-,
L 9^RO\x3XNS`SN_KV] - - - - - - - - - 8=.6SX^\KX]S^ - - - - - - - - -
M ,YNSO]-Y\Z #" - #" !## #" - #" !## - Sub-total (B)(2) : 2816856 610580 3427436 16.13 2885628 528106 3413734 16.07 -0.06%
N ,KXU]03 - - - - - - - - - Total Public Shareholding
4703966 611288 5315254 25.01 4786690 528564 5315254 25.01 -
O Any other - - - - - - - - - (B)=(B)(1)+(B)(2)
Sub-total (A)(2) : #" - #" !## #" - #" !## - C. Shares held by Custodian for
- - - - - - - - -
Total shareholding of GDRs & ADRs
15934048 - 15934048 74.99 15934048 - 15934048 74.99 -
Promoter (A) = (A)(1)+(A)(2) Grand Total (A+B+C) 20638014 611288 21249302 100.00 20720738 528564 21249302 100.00 -

64 ANNUAL REPORT 2017-18 65


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ii. Shareholding of Promoters Sr. Name Shareholding Cumulative shareholding


No during the year (1/04/2017
Sr. Shareholder’s Shareholding at the beginning of the year Shareholding at the end of the Year % change
to 31/03/2018)
No. Name in share
No. of % of total % of Shares No. of % of total % of Shares No. of Shares at % of total Date Increase / Reason No. of % of total
holding
Shares Shares Pledged / Shares Shares of the Pledged / the beginning shares Decrease in Shares shares
during
of the encumbered to Company encumbered of the year of the shareholding of the
the year
Company total shares to total shares (1/04/2017) company company
 +LLY^^-KZS^KV3XNSK6SWS^ON?5 !##!  - !##!  - -
 196.7+8=+-2=38.3+ !# " ! - - !# "
 +LLY^^2OKV^RMK\O:\YN_M^] !# !  - !# !  - - 6373>/. !! !# >\KX]PO\ "#"! "!
6SWS^ON?5
" - - "#"! "!
 ,\S^S]R-YVVYSN]6SWS^ON?5 !  # - !  # - -
 </63+8-/-+:3>+6 !  # ! - - !  #
Total 15934048 74.99 - 15934048 74.99 - -
><?=>//-97:+8C !!  >\KX]PO\  ! !#
iii. No Change in the shareholding of the Promoters during the year. 6373</.+-
!!  >\KX]PO\  # "
</63+8-/73.=7+66
iv. SHAREHOLDING PATTERN OF TOP TEN SHAREHOLDERS (OTHER THAN DIRECTORS, PROMOTERS AND HOLDERS " - -  # "
CAP FUND
OF GDRS AND ADRS)
 =>/38,/<1 ##! " ! - ##! "
Sr. Name Shareholding Cumulative shareholding 38.3+/7/<1381
No during the year (1/04/2017 "! ! >\KX]PO\ ! 
9::9<>?83>3/=0?8.
to 31/03/2018) "! !! >\KX]PO\ !!! !
6373>/.
No. of Shares at % of total Date Increase / Reason No. of % of total "#!  >\KX]PO\ " "
the beginning shares Decrease in Shares shares #! ! >\KX]PO\ "! "
of the year of the shareholding of the
(1/04/2017) company company ##!  ! >\KX]PO\ #" 
 ! !# >\KX]PO\ #!  
 0<+85638>/7:6/>98   ! - -  
7?>?+60?8.+- "!  >\KX]PO\  # !! # >\KX]PO\ #"#  
0<+8563838.3+2312 ! ! >\KX]PO\ ! # !  >\KX]PO\ ## " !
1<9A>2-97:+83/=
#! """ >\KX]PO\   #  ! !#! >\KX]PO\  "
FUND
 ! #" >\KX]PO\  #" !  >\KX]PO\   
 !  >\KX]PO\  ##
!  >\KX]PO\  
# ! #" >\KX]PO\ # 
! - -  
 ! !  >\KX]PO\  
#!  >\KX]PO\     38.3+A23D.970?8. - - ! - - - -
 ! "! >\KX]PO\   "  >\KX]PO\  "
!!  # >\KX]PO\ !# ## "  >\KX]PO\   "
"! "# >\KX]PO\ # # #" "" >\KX]PO\ #"  
!  >\KX]PO\ #"" #
 " # >\KX]PO\ ##! !
! # >\KX]PO\  ! #
" !# >\KX]PO\  "
#!  ! >\KX]PO\  #
" - -  # " " >\KX]PO\ "! #

 </63+8-/-+:3>+6 !"! ! ! - - !"! ! " - - "! #


><?=>//-97:+8C ! " >\KX]PO\ ! ! ! 630/38=?<+8-/  ! ! - -  !
6373>/.+-</63+8-/  !  >\KX]PO\ ! ! -9<:9<+>3989038.3+ ! "! >\KX]PO\  !
:2+<7+0?8.
 ! !! >\KX]PO\ "!"  " - -  !
!! " >\KX]PO\ #  !
" </63+8-/-+:3>+6 - - ! - - - -
!! #" >\KX]PO\ #! #
><?=>//-97:+8C #!   >\KX]PO\   
"!! " >\KX]PO\ ## !  6373>/.+-</63+8-/
"!  " >\KX]PO\ ##  ##! # >\KX]PO\  
1<9A>20?8.
"! " >\KX]PO\ #   !!  >\KX]PO\  
""! "" >\KX]PO\    !  >\KX]PO\ ! 
"!  >\KX]PO\   # " - - ! 
#! # >\KX]PO\ " 
# 3-3-3:<?./8>3+6 !##  ! - - !## 
!!  >\KX]PO\ " 
,+6+8-/.+.@+8>+1/  "  >\KX]PO\ !  
!!  >\KX]PO\ "   FUND
"  >\KX]PO\ "   " !  >\KX]PO\ - -
" - - "   " - - - -

66 ANNUAL REPORT 2017-18 67


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

vi. INDEBTEDNESS
Sr. Name Shareholding Cumulative shareholding
No during the year (1/04/2017 3XNOL^ONXO]]YP^RO-YWZKXcSXMV_NSXQSX^O\O]^Y_^]^KXNSXQKMM\_ONL_^XY^N_OPY\ZKcWOX^
to 31/03/2018) Secured Loans Unsecured Deposits Total
No. of Shares at % of total Date Increase / Reason No. of % of total excluding deposits Loans Indebtedness
the beginning shares Decrease in Shares shares 3XNOL^ONXO]]K^^ROLOQSXXSXQYP^RO XKXMSKVcOK\
of the year of the shareholding of the S :\SXMSZKV+WY_X^
(1/04/2017) company company
SS 3X^O\O]^N_OL_^XY^ZKSN
 196.7+8=+-2=  # ! - -  # SSS 3X^O\O]^KMM\_ONL_^XY^N_O
0?8.=196.7+8 " - -  # Total (i+ii+iii)
=+-2=1<9A>2 -RKXQOSX3XNOL^ONXO]]N_\SXQ^RO XKXMSKVcOK\
/7/<13817+<5/>=
,<9+./;?3>C
Addition
Reduction 836
:9<>09639
Net Change
 @+81?+<./7/<1381 ## " ! - - ## "
3XNOL^ONXO]]K^^ROOXNYP^RO XKXMSKVcOK\
7+<5/>==>9-5 ! # >\KX]PO\ # "
38./B0?8.+=/<3/= S :\SXMSZKV+WY_X^
90@+81?+<. ! # >\KX]PO\ " ! SS 3X^O\O]^N_OL_^XY^ZKSN
38>/<8+>398+6  !  ! >\KX]PO\ !! ! SSS 3X^O\O]^KMM\_ONL_^XY^N_O
/;?3>C38./B0?8.   !  >\KX]PO\ !! ! Total (i+ii+iii)
 ! ! >\KX]PO\  !  
vii. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL
!! " >\KX]PO\  
A. Remuneration to Managing Director, Whole-time Directors and/or Manager
#! "" >\KX]PO\ !   (` in Lakhs)
##! !  >\KX]PO\ - -
Sr. Particulars of Remuneration Name of MD/WTD Total
" - - - - No. Amount
Ambati Venu Rajiv Sonalker
 38@/=>9</.?-+>398 - - ! - - - - Managing Director Whole-time Director
+8.:<9>/->3980?8. ! !## >\KX]PO\ !##  (w.e.f. August 8, 2017)
+?>29<3>C7383=><C
90-9<:9<+>/+00+3<= "!  >\KX]PO\ "#   1\Y]]=KVK\c
" - - "#  K =KVK\cK]ZO\Z\Y`S]SYX]MYX^KSXONSX=OM^SYX!YP^RO3XMYWOx^Kb  # 
 -9,<+38.3+ !  ! - - !  +M^# 
7+?<3>3?=6373>/. L @KV_OYPZO\[_S]S^O]_XNO\=OM^SYX!3XMYWO^Kb+M^#  ! "   
" - - ! 
M :\Y ^]SXVSO_YP]KVK\c_XNO\=OM^SYX!3XMYWO^Kb+M^#  - - -
 =^YMU9Z^SYX - - -
 0<+85638>/7:6/>98  # ! - -  #  =aOK^/[_S^c - - -
7?>?+60?8.+-  ! ! >\KX]PO\ !   Commission - - -
0<+85638,?36.38.3+
FUND  ! 333 >\KX]PO\   K]YPZ\Y ^ - - -
!!! # >\KX]PO\   -others - - -
"! !# >\KX]PO\ !#   Others - - -
""! !# >\KX]PO\    -YX^\SL_^SYX^Y:\Y`SNOX^0_XN   !"
"! # >\KX]PO\   Total (A) 5,85.89 1,61.64 7,47.53
#!  >\KX]PO\    Ceiling as per the Act ` " !6KUR]LOSXQYP^ROXO^Z\Y ^]YP^RO-YWZKXc
#" " >\KX]PO\ #   MKVM_VK^ONK]ZO\=OM^SYX#"YP^RO-YWZKXSO]+M^
" - - #   >RO-YWZKXcNYO]XY^RK`OKXc=^YMU9Z^SYX:VKXPY\S^]OWZVYcOO]2YaO`O\7KXKQSXQ.S\OM^Y\KXNARYVO^SWO.S\OM^Y\K\OOX^S^VON^Y=^YMU9Z^SYX
YP+LLY^^6KLY\K^Y\SO]?=+_XNO\S^]u3XMOX^S`O=^YMU9Z^SYX:\YQ\KWvKXNS]KV]YOVSQSLVO^YZ_\MRK]O]RK\O]YP+LLY^^6KLY\K^Y\SO]?=+_XNO\S^]
v. SHAREHOLDING OF DIRECTORS AND KEY MANAGERIAL PERSONNEL u+P VSK^O/WZVYcOO=^YMU:_\MRK]O:VKXv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O

Sr. For each of the Directors and KMP (along with relatives) Shareholding at the beginning Cumulative Shareholding B. Remuneration to Other Directors
No. of the year during the year (` in Lakhs)
Mr R A Shah (along with relatives) No. of % of total shares No. of % of total shares Sr. Particulars of Remuneration Name of Directors
shares of the Company shares of the Company Total
No. Munir R A Shah Ranjan Krishna
 +^^ROLOQSXXSXQYP^ROcOK\ "!  "!  Amount
Shaikh Kapur Mohan Sahni
 .K^OaS]O3XM\OK]O.OM\OK]OSX=RK\ORYVNSXQN_\SXQ^ROcOK\ - - - -
]ZOMSPcSXQ^RO\OK]YX]PY\SXM\OK]ONOM\OK]OOQKVVY^WOX^
 Independent Directors - - - - -
^\KX]PO\LYX_]]aOK^O[_S^cO^M 0OOPY\K^^OXNSXQ,YK\N-YWWS^^OO7OO^SXQ] - !   
 At the end of the year "!  "!  Commission - - - - -
Others - - - - -
8YXOYP^ROY^RO\.S\OM^Y\]ObMOZ^7\<+=RKRKXNXYXOYP^RO5Oc7KXKQO\SKV:O\]YXXOVRYVN]RK\O]SX^RO-YWZKXc
Total (1) - 17.00 10.50 15.00 42.50

68 ANNUAL REPORT 2017-18 69


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(` in Lakhs) ANNEXURE VI
Sr. Particulars of Remuneration Name of Directors Disclosure under Section 197(12) of the Companies Act, 2013 and other disclosures as per Rule 5 of the Companies
No. Total (Appointment and Remuneration of Key Managerial Personnel) Rules, 2014 :
Munir R A Shah Ranjan Krishna Amount
Shaikh Kapur Mohan Sahni S  K >RO ZO\MOX^KQO SXM\OK]O SX \OW_XO\K^SYX YP OKMR .S\OM^Y\ -RSOP 0SXKXMSKV 9P MO\ KXN -YWZKXc =OM\O^K\c YP ^RO
Company and (b) ratio of the remuneration of each director to the median remuneration of the employees of the Company
 9^RO\8YX/bOM_^S`O.S\OM^Y\] - - - - -
PY\^RO XKXMSKVcOK\!"$
0OOPY\K^^OXNSXQ,YK\N-YWWS^^OO7OO^SXQ]  - - - 
Commission - - - - - Name of the Director % Increase in the remuneration (a) Ratio of remuneration of each Director /
Others - - - - - to median remuneration of employees (b)
Total (2) 13.50 - - - 13.50 7\7_XS\=RKSUR - 
Total (B)=(1+2) 13.50 17.00 10.50 15.00 56.00 8YX/bOM_^S`O-RKS\WKX
Ceiling as per the Act ` " !6KUR]LOSXQYP^ROXO^Z\Y ^]YP^RO-YWZKXcMKVM_VK^ONK]ZO\ 7\<+=RKR - 
=OM^SYX#"YP^RO-YWZKXSO]+M^ 3XNOZOXNOX^.S\OM^Y\
7\<KXTKX5KZ_\ - 
C. Remuneration to Key Managerial Personnel Other than Managing Director
3XNOZOXNOX^.S\OM^Y\
(` in Lakhs)
7\5\S]RXK7YRKX=KRXS - 
Sr. Particulars of Remuneration Key Managerial Personnel
3XNOZOXNOX^.S\OM^Y\
No. Rajiv Sonalker Krupa Anandpara Total
7\+WLK^S@OX_  "!
-RSOP0SXKXMSKV9P MO\ Company Secretary
7KXKQSXQ.S\OM^Y\
 1\Y]]]KVK\c
K =KVK\c K] ZO\ Z\Y`S]SYX] MYX^KSXON SX =OM^SYX ! YP ^RO # !"! " 7\<KTS`=YXKVUO\  " 
3XMYWO^Kb+M^#  -RSOP0SXKXMSKV9P MO\KXNARYVO^SWO.S\OM^Y\
L @KV_OYPZO\[_S]S^O]_XNO\=OM^SYX!3XMYWO^Kb+M^#  " ""  Ms Krupa Anandpara " NA
M :\Y ^]SXVSO_YP]KVK\c_XNO\=OM^SYX!3XMYWO^Kb+M^#  - - - -YWZKXc=OM\O^K\c
 =^YMU9Z^SYX - - -  +ZZYSX^ONK]+NNS^SYXKVKXNARYVO^SWO.S\OM^Y\OPPOM^S`O+_Q_]^"!
3 =aOK^/[_S^c - - -  7\+WLK^S@OX_TYSXONOPPOM^S`O=OZ^OWLO\# KXN^RO\OPY\OSXM\OK]OSXRS]\OW_XO\K^SYXMKXXY^LOMKVM_VK^ON
 Commission - - - /X^S^VONPY\=S^^SXQPOO]YP` PY\K^^OXNSXQOKMR,YK\N+_NS^-YWWS^^OOKXN3XNOZOXNOX^.S\OM^Y\]7OO^SXQ]KXN` PY\
K]YPZ\Y ^ - - - attending each of the other Committee Meetings
- others - - - SS >ROZO\MOX^KQOSXM\OK]OSX^ROWONSKX\OW_XO\K^SYXYPOWZVYcOO]SX^RO XKXMSKVcOK\$
 Others - - -
 #
-YX^\SL_^SYX^Y:\Y`SNOX^0_XN " # 
Total 2,50.00# 58.67 3,08.67 iii. Number of permanent employees on the rolls of the Company :
>RO-YWZKXcNYO]XY^RK`OKXc=^YMU9Z^SYX:VKXPY\S^]OWZVYcOO]2YaO`O\KLY`O57:]K\OOX^S^VON^Y=^YMU9Z^SYXYP+LLY^^6KLY\K^Y\SO]?=+  
_XNO\ S^] u3XMOX^S`O =^YMU 9Z^SYX :\YQ\KWv KXN S] KV]Y OVSQSLVO ^Y Z_\MRK]O ]RK\O] YP +LLY^^ 6KLY\K^Y\SO] ?=+ _XNO\ S^] u+P VSK^O /WZVYcOO =^YMU S` +
 `O\KQOZO\MOX^SVOSXM\OK]OWKNOSX^RO]KVK\SO]YPOWZVYcOO]Y^RO\^RKXWKXKQO\SKVZO\]YXXOVSX^ROVK]^ XKXMSKVcOK\KXN
:_\MRK]O:VKXv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O S^]MYWZK\S]YXaS^R^ROZO\MOX^SVOSXM\OK]OSX^ROWKXKQO\SKV\OW_XO\K^SYXKXNT_]^S MK^SYX^RO\OYP$
+V]YSXMV_NO]]KVK\cK]ARYVO^SWO.S\OM^Y\aS^ROPPOM^P\YW+_Q_]^"!   `O\KQOZO\MOX^KQOSXM\OK]OWKNOSX^RO]KVK\SO]YPOWZVYcOO]Y^RO\^RKX^ROWKXKQO\SKVZO\]YXXOVSX^ROcOK\!"aK]
+
vii. Penalties/Punishment/Compounding of Offences 7KXKQO\SKV\OW_XO\K^SYXS]XY^MYWZK\KLVOaS^RZ\O`SY_]cOK\]SXMO7\+WLK^S@OX_TYSXONOPPOM^S`OP\YW=OZ^OWLO\# KXN
7\<ORKX5RKX\O]SQXONOPPOM^S`O+Z\SV 
Type Section of the Brief Details of Penalty/Punishment/ Authority Appeal made, v. 3 ^ S] KP \WON ^RK^ ^RO \OW_XO\K^SYX ZKSN ^Y .S\OM^Y\] 5Oc 7KXKQO\SKV :O\]YXXOV KXN Y^RO\ /WZVYcOO] S] K] ZO\ ^RO
Companies Act Description Compounding fees imposed [RD/NCLT/ if any Remuneration Policy of the Company.
COURT] (give details)
A. COMPANY
Penalty
Punishment 836
Compounding
B. DIRECTORS
Penalty
Punishment 836
Compounding
C. OTHER OFFICERS IN DEFAULT
Penalty
Punishment 836
Compounding

70 ANNUAL REPORT 2017-18 71


ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BUSINESS RESPONSIBILIT Y REPORT


+^+LLY^^3XNSKaO \WVcLOVSO`O^RK^SXXY`K^S`O\O]ZYX]SLVOKXN  ,c L_SVNSXQ K WY\O SXMV_]S`O L_]SXO]] aO KSW ^Y \OKMR WY\O SECTION C : OTHER DETAILS
]_]^KSXKLVOL_]SXO]]ZVKc]KXSWZY\^KX^\YVOSXL_SVNSXQKROKV^Rc ZOYZVO SX WY\O ZVKMO] ^RKX O`O\ LOPY\O 0\YW ]^\OXQ^ROXSXQ >RO-YWZKXcNYO]XY^RK`OKXc]_L]SNSK\SO]2OXMO^ROY^RO\NO^KSV]ZO\^KSXSXQ^Y]_L]SNSK\cMYWZKXSO]K]\O[_S\ON_XNO\^RS]]OM^SYX
^R\S`SXQ ]YMSO^c AO ]^\S`O ^Y PY]^O\ OMYXYWSM OX`S\YXWOX^KV KXN ^RO MKZKMS^c YP ]_ZZVSO\] ^Y M\OK^SXQ Z\YN_M^] ^RK^ OXKLVO
]YMSKV aOVVLOSXQ ^R\Y_QR Y_\ YZO\K^SYX] KXN SX SX^O\KM^SYX aS^R S]XY^KZZVSMKLVO
ZOYZVO ^Y VS`O ROKV^Rc VS`O] aO K\O KVaKc] XNSXQ XOa
Y_\]^KUORYVNO\] YZZY\^_XS^SO] ^Y ObZKXN ^RO ZY]S^S`O SWZKM^ YP Y_\ ZOYZVO SECTION D : BUSINESS RESPONSIBILITY (BR) INFORMATION
AOVO`O\KQOY_\UXYaVONQOYP]MSOXMOL_]SXO]]KM_WOXKXN_XS[_O Z\YN_M^]KXNL_]SXO]]7Y\OY`O\LOSXQK\O]ZYX]SLVOMY\ZY\K^O
\O]Y_\MO] ^Y Z\Y`SNO VK]^SXQ ]YV_^SYX] ^Y QVYLKV ROKV^R MRKVVOXQO] MS^SdOX Ob^OXN] W_MR LOcYXN ZRSVKX^R\YZc AO KZZVc Y_\ 1. Details of Director/Directors responsible for BR
>ROWY]^SWZY\^KX^Z\SY\S^cK\OK]^YY_\]^KUORYVNO\]KXNPY\Y_\ ]MSOXMO ObZO\^S]O KXN ^OMRXYVYQc ^Y KNN\O]] ^RO _\QOX^ KXN
(a) Details of the Director responsible for implementation of the BR policy/policies :
Q\Ya^RK\O$ _XWO^XOON]SXY_\MYWW_XS^SO]YP^OX^R\Y_QRMYVVKLY\K^S`O
ZK\^XO\]RSZ]AO]OOU^YKM^\O]ZYX]SLVcSXKVVYPY_\WK\UO^] 7\+WLK^S@OX_7KXKQSXQ.S\OM^Y\
w  ELIVERING PRODUCT EXCELLENCE - AO K\O
D
YXLORKVPYPY_\ZK^SOX^]OWZVYcOO]MYX]_WO\]MYWW_XS^SO]
MYWWS^^ON ^Y MYX^SX_Y_]Vc SWZ\Y`O KXN SXXY`K^O ^Y KNN\O]] (b) Details of BR Head :
KXNKVVY^RO\]^KUORYVNO\]
VYMKVKXNQVYLKVROKV^RXOON]aRSVOOX]_\SXQRSQR[_KVS^cKXN
WKX_PKM^_\SXQ]^KXNK\N]YPY_\Z\YN_M^]   ^+LLY^^3XNSKaO]^\S`O^YSWZVOWOX^]_]^KSXKLVOZ\KM^SMO]
+ Particulars Company Information
w I MPROVING ACCESS -AO]OOU^YaY\UaS^RKVV]^KUORYVNO\] ^Y \ON_MO ^RO OX`S\YXWOX^KV SWZKM^ YP Y_\ Z\YN_M^] KXN
YZO\K^SYX] /`O\c NKc aO Z_^ Y_\ _XS[_O ^KVOX^ ^Y aY\U .S\OM^Y\3NOX^S MK^SYX8_WLO\ ! "#
^YOXRKXMOKMMO]]^YMK\O^YSWZ\Y`OROKV^RY_^MYWO]
^YaK\N] L_SVNSXQ K ]^\YXQ L_]SXO]] KXN K ROKV^Rc \YL_]^ 8KWO 7\+WLK^S@OX_
w SAFEGUARDING THE ENVIRONMENT -AOaY\U^YaK\N] ]YMSO^c
\ON_MSXQ^ROOX`S\YXWOX^KVSWZKM^]xP\YW^RO]Y_\MSXQYP\Ka .O]SQXK^SYX 7KXKQSXQ.S\OM^Y\
WK^O\SKV]^Y^ROWKX_PKM^_\OKXNNS]^\SL_^SYXYPY_\Z\YN_M^]   RO-YWZKXct],YK\NKZZ\Y`ON:YVSMSO]KXN-YNOYP-YXN_M^
>
^Y^RO_]OKXNNS]ZY]KVYPY_\Z\YN_M^]LcZK^SOX^]MYX]_WO\] K\O K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O x R^^Z$aaaKLLY^^ >OVOZRYXO8_WLO\ #" 
KXNROKV^RMK\OZ\Y`SNO\] MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV /WKSV3. SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYW
SECTION A : GENERAL INFORMATION ABOUT THE COMPANY aOLWK]^O\*KLLY^^MYSX
Sr. Particulars Company Information 2. Principle-wise (as per National Voluntary Guidelines (NVGs)) Business Responsibility Policy/Policies
No.
 -Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38 6#72##:6-!   K^SYXKV@YV_X^K\c1_SNOVSXO]YX=YMSKV/X`S\YXWOX^KVKXN/MYXYWSM<O]ZYX]SLSVS^SO]YP,_]SXO]]8@1]\OVOK]ONSX4_Vc
8
 <OQS]^O\ONKNN\O]] -Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKSx! aRSMRS]O]]OX^SKVVcK]O^YPXSXOZ\SXMSZVO]^RK^YPPO\L_]SXO]]O]KX3XNSKX_XNO\]^KXNSXQKXNKZZ\YKMR^YSXM_VMK^SXQ\O]ZYX]SLVO
 AOL]S^O aaaKLLY^^MYSX L_]SXO]]MYXN_M^>RO]O:\SXMSZVO]K\O$
 /WKSVSN SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYW
 0SXKXMSKVCOK\ !" Principle 1 ,_]SXO]]O]]RY_VNQY`O\XaS^R/^RSM]>\KX]ZK\OXMcKXN+MMY_X^KLSVS^c
 =OM^Y\]^RK^^RO-YWZKXcS]OXQKQONSXSXN_]^\SKVKM^S`S^cMYNOaS]O 83--YNO$
+M^S`S^c$:RK\WKMO_^SMKV]
! 6S]^^R\OOUOcZ\YN_M^]]O\`SMO]^RK^^RO-YWZKXcWKX_PKM^_\O] ._ZRK]^YX
Principle 2 ,_]SXO]]O] ]RY_VN Z\Y`SNO QYYN] KXN ]O\`SMO] ^RK^ K\O ]KPO KXN MYX^\SL_^O ^Y ]_]^KSXKLSVS^c ^R\Y_QRY_^
Z\Y`SNO]K]SXLKVKXMO]ROO^ >Rc\YXY\W
?NSVS` ^ROS\VSPOMcMVO
8. Total number of locations where business activity is undertaken
K 8_WLO\YP3X^O\XK^SYXKV6YMK^SYX] 836
Principle 3 ,_]SXO]]O]]RY_VNZ\YWY^O^ROaOVVLOSXQYPKVVOWZVYcOO]
L 8_WLO\YP8K^SYXKV6YMK^SYX] 7KX_PKM^_\SXQZVKX^K^1YK<OQS]^O\ON9P MOKXN-Y\ZY\K^O9P MOK^
7_WLKS=KVO]YP MO]KXNNS]^\SL_^SYXR_L]:KXx3XNSK
# 7K\UO^]]O\`ONLc^RO-YWZKXc6YMKV=^K^O8K^SYXKV3X^O\XK^SYXKV :KX3XNSK=\S6KXUK8OZKV7KVNS`O]KXN,R_^KX
Principle 4 ,_]SXO]]O] ]RY_VN \O]ZOM^ ^RO SX^O\O]^] YP KXN LO \O]ZYX]S`O ^YaK\N] KVV ]^KUORYVNO\] O]ZOMSKVVc ^RO
SECTION B : FINANCIAL DETAILS OF THE COMPANY WK\QSXKVS]ONYXO
Sr. Particulars Company Information
No.
 :KSN?Z-KZS^KV `#
Principle 5 ,_]SXO]]O]]RY_VN\O]ZOM^KXNZ\YWY^OR_WKX\SQR^]
 >Y^KV>_\XY`O\ ` !#6KUR]
 >Y^KV:\Y ^+P^O\>Kb `!"6KUR]
Principle 6 ,_]SXO]]O]]RY_VN\O]ZOM^Z\Y^OM^KXNWKUOOPPY\^]^Y\O]^Y\O^ROOX`S\YXWOX^
4. Total Spending on Corporate Social Responsibility (CSR)
K 38` `#6KUR]
L +]KZO\MOX^KQOYP:\Y ^+P^O\>Kb !YP^RO:\Y ^+P^O\>KbPY\^RO XKXMSKVcOK\!"
 6S]^YPKM^S`S^SO]SXaRSMRObZOXNS^_\OSXKLY`ORK]LOOXSXM_\\ON$  2OKV^R -VSXSM]  :\YQ\KW] ^Y ObZKXN +aK\OXO]] KXN +MMO]] ^Y Principle 7 ,_]SXO]]O] aROX OXQKQON SX SX
_OXMSXQ Z_LVSM KXN \OQ_VK^Y\c ZYVSMc ]RY_VN NY ]Y SX K \O]ZYX]SLVO
2OKV^RMK\O WKXXO\
 8S\WKV.RK\K.KS\c:\YTOM^x,_SVNSXQK=_]^KSXKLVO6YMKV=_ZZVc
-RKSXKXN<_\KV.O`OVYZWOX^^R\Y_QR>\KSXSXQYP.KS\c0K\WO\]
KXNAYWOX/WZYaO\WOX^ Principle 8 ,_]SXO]]O]]RY_VN]_ZZY\^SXMV_]S`OQ\Ya^RKXNO[_S^KLVONO`OVYZWOX^
 =/A+ x -\OK^SXQ K =_]^KSXKLVO 2OKV^RMK\O .OVS`O\c 7YNOV
^R\Y_QR6S`OVSRYYN]
 S-+</<YKN=KPO^c.\S`O:\YWY^SYXYP<YKN=KPO^c+aK\OXO]] Principle 9 ,_]SXO]]O] ]RY_VN OXQKQO aS^R KXN Z\Y`SNO `KV_O ^Y ^ROS\ M_]^YWO\] KXN MYX]_WO\] SX K \O]ZYX]SLVO
^R\Y_QRS-+</=KPO^c.Kc WKXXO\

72 ANNUAL REPORT 2017-18 73


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

a. Details of Compliance (Y/N) 3. Governance related to Business Responsibility (BR)


Business Product Wellbeing Stakeholder Human Environment Public CSR Customer  3XPY\WK^SYXaS^R\OPO\OXMO^Y,<<P\KWOaY\U
Question Ethics Responsibility of Employees Engagement Rights Policy Relations
Sr. No. Questions Information
P1 P2 P3 P4 P5 P6 P7 P8 P9
.YcY_RK`OZYVSMcZYVSMSO]PY\) C C C C C C 8 C C  3XNSMK^O^ROP\O[_OXMcYP\O`SOaLc^RO,YK\NYP.S\OM^Y\] +XX_KVVcK^^RO^SWOYPKZZ\Y`SXQ^RO,_]SXO]]<O]ZYX]SLSVS^c<OZY\^
-YWWS^^OOYP^RO,YK\NY\-/9^YK]]O]]^RO,<ZO\PY\WKXMOAS^RSX
2K]^ROZYVSMcLOSXQPY\W_VK^ON C C C C C C 8+ C C WYX^R] WYX^R]+XX_KVVcWY\O^RKXcOK\
SXMYX]_V^K^SYXaS^R^RO\OVO`KX^
]^KUORYVNO\])  .YO]^RO-YWZKXcZ_LVS]RK,<Y\K=_]^KSXKLSVS^c<OZY\^)ARK^S] >RO -YWZKXc Z_LVS]RO] ,_]SXO]] <O]ZYX]SLSVS^c <OZY\^ aRSMR PY\W]
.YO]^ROZYVSMcMYXPY\W^YKXc >RO]OZYVSMSO]K\OKVSQXON^YPY\WZK\^YP+LLY^^-YNOYP,_]SXO]]-YXN_M^KNYZ^ONQVYLKVVcK\OSXMYWZVSKXMO ^RORcZO\VSXUPY\`SOaSXQ^RS]\OZY\^)2YaP\O[_OX^VcS^S]Z_LVS]RON) ZK\^YP^RO+XX_KV<OZY\^>RO]KWOS]K`KSVKLVOK^R^^Z$aaaKLLY^^
XK^SYXKVSX^O\XK^SYXKV]^KXNK\N]) aS^R3XNSKXVKa]KXN\OQ_VK^SYX]KXNWOO^SX^O\XK^SYXKV]^KXNK\N] MYSXSX`O]^Y\\OVK^SYX] XKXMSKV]R^WV
3PcO]]ZOMSPc)
2K]^ROZYVSMcLOOXKZZ\Y`ONLc >RO]OZYVSMSO]K\OKNYZ^ONLc^RO,YK\NYP.S\OM^Y\]KXNK\O]SQXONLc^ROKZZ\YZ\SK^OP_XM^SYXROKN]-=<:YVSMc SECTION E : PRINCIPLE-WISE INFORMATION
^RO,YK\N)3PcO]RK]S^LOOX]SQXON S]]SQXONLc^RO-RKS\WKXYP^RO-=<-YWWS^^OO Principle 1 : Businesses should conduct and govern themselves Principle 2 : Businesses should provide goods and services
Lc7.YaXO\-/9KZZ\YZ\SK^O
,YK\N.S\OM^Y\)
with Ethics, Transparency and Accountability that are safe and contribute to sustainability throughout their
.YO]^RO-YWZKXcRK`OK C C C C C C 8+ C C life cycle
TRO-YWZKXcS]MYWWS^^ON^YMYXN_M^SXQL_]SXO]]SXKXO^RSMKV
]ZOMS ONMYWWS^^OOYP^RO,YK\N
.S\OM^Y\9P MSKV^YY`O\]OO^RO KXN VOQKVVc MYWZVSKX^ WKXXO\ >RO -YWZKXc RK] K \YL_]^ KXN >RO -YWZKXc S] MYWWS^^ON ^Y ^RO Z\Y^OM^SYX YP R_WKX ROKV^R
SWZVOWOX^K^SYXYP^ROZYVSMc) MYWZ\OROX]S`O MY\ZY\K^O MYWZVSKXMO Z\YQ\KW NO]SQXON ^Y ]KPO^c KXN ^RO OX`S\YXWOX^ aRO\O aO MYXN_M^ Y_\ L_]SXO]]
3XNSMK^O^ROVSXUPY\^ROZYVSMc^Y
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV ROVZ WKSX^KSX ^RO RSQRO]^ O^RSMKV KXN MYWZVSKXMO ]^KXNK\N] +^^KSXWOX^YPY_\VYXQ\KXQO^K\QO^]^Y\ON_MOOWZVYcOOSXT_\SO]
LO`SOaONYXVSXO) ^YVYaO\OX`S\YXWOX^KVOWS]]SYX]KXN^Y\ON_MOY_\_]OYPXK^_\KV
2K]^ROZYVSMcLOOXPY\WKVVc C C C C C C 8+ C C
>RO-YWZKXct]9P MOYP/^RSM]-YWZVSKXMOZ\Y`SNO]OWZVYcOO]
\O]Y_\MO]SXKVVK]ZOM^]YPY_\Z\YN_M^NO`OVYZWOX^WKX_PKM^_\SXQ
MYWW_XSMK^ON^YKVV\OVO`KX^ aS^R ^RO SXPY\WK^SYX ^YYV] Q_SNKXMO ^\KSXSXQ KXN ]_ZZY\^ ^ROc
SX^O\XKVKXNOb^O\XKV]^KUORYVNO\]) KXNMYWWO\MSKVYZO\K^SYX]\OWKSX]K^YZZ\SY\S^c
XOON aROX WKUSXQ NKc^YNKc L_]SXO]] NOMS]SYX] ^Y OX]_\O ^RK^
.YO]^RO-YWZKXcRK`OSXRY_]O C C C C C C 8+ C C +LLY^^t]O^RSM]KXN`KV_O]K\OSX^OQ\K^ONSX^YS^]L_]SXO]]Z\KM^SMO] 7OO^SXQY_\^K\QO^]KVYXQaS^RKVVYPY_\Y^RO\OX`S\YXWOX^ROKV^R
]^\_M^_\O^YSWZVOWOX^^ROZYVSMc
YX K MYX]S]^OX^ LK]S] K\Y_XN ^RO aY\VN +NRO\SXQ ^Y ^RO]O ]KPO^c KXN OXO\Qc YLTOM^S`O] S] ^RO MYX^SX_K^SYX YP K VYXQ VOQKMc
ZYVSMSO])
=^KXNK\N]S]KXSWZY\^KX^ZK\^YP^ROMYWWS^WOX^^YYZO\K^OaS^R YP \O]ZYX]SLVO L_]SXO]] Z\KM^SMO] ^RK^ \O
OM^ Y_\ MY\O `KV_O] $
.YO]^RO-YWZKXcRK`OK C C C C C C 8+ C C
Q\SO`KXMO\ON\O]]KVWOMRKXS]W :SYXOO\SXQ +MRSO`SXQ -K\SXQ KXN /XN_\SXQ  >YaK\N ^RS] OXN
RYXO]^cPKS\XO]]KXNSX^OQ\S^c
\OVK^ON^Y^ROZYVSMcZYVSMSO]^Y Y_\M_\\OX^UOcYLTOM^S`O]SXMV_NO$
KNN\O]]]^KUORYVNO\]tQ\SO`KXMO]
9_\ -YNO YP ,_]SXO]] -YXN_M^ u^RO -YNOv OWLYNSO] `KV_O] w  Y]^O\SXQ K aY\U OX`S\YXWOX^ ^RK^ Z\YWY^O] OWZVYcOO ROKV^R
0
\OVK^ON^Y^ROZYVSMcZYVSMSO])
2K]^RO-YWZKXcMK\\SONY_^ C C C C C C 8+ C C KXN Z\Y`SNO] K PY_XNK^SYX PY\ OWZVYcOOt] \O]ZYX]SLSVS^SO] KXN KXNZ\YN_M^S`S^cKXNS]_V^SWK^OVcP\OOYPSXT_\SO]%
SXNOZOXNOX^K_NS^O`KV_K^SYXYP LORK`SY\]^RK^ROVZ^ROWWKUO^ROLO]^MRYSMO]PY\^RO-YWZKXc
^ROaY\USXQYP^RS]ZYVSMcLcKX w  YX^SX_Y_]VcSWZ\Y`SXQ^ROOP MSOXMcKXN]_]^KSXKLSVS^cYPY_\
-
PY\ ^ROW]OV`O] KXN PY\ ^RO ZOYZVO ^ROc ]O\`O >RO -YWZKXct]
SX^O\XKVY\Ob^O\XKVKQOXMc) L_]SXO]] KM^S`S^SO] KXN Z\YN_M^] \O]_V^SXQ SX ^RO VYaO\SXQ YP
,YK\N KXN VOKNO\]RSZ ^OKW] P_VVc ]_ZZY\^ ^RO -YNO KXN ^RO Q\OOXRY_]O QK] OWS]]SYX] aK^O\ _]O KXN WSXSWSdSXQ VKXN VV
b. If answer to Sr. No.1 against any principle is ‘No’, please explain why ZYVSMSO]Z\YMON_\O]KXNZ\SXMSZVO]S^OWLYNSO] aK]^O]%
Question P1 P2 P3 P4 P5 P6 P7 P8 P9 1. Does the policy relating to ethics, bribery and corruption w  bZOM^SXQ ^RK^ MYX^\KM^Y\] NYSXQ aY\U YX LORKVP YP +LLY^^
/
>RO-YWZKXcRK]XY^ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ cover only the company? MYXPY\W ^Y \OQ_VK^Y\c \O[_S\OWOX^] KXN WOO^ KZZVSMKLVO
_XNO\]^YYN^ROZ\SXMSZVO] SX^O\XKV/2=/]^KXNK\N]%
>RO-YWZKXcS]XY^K^K]^KQO 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8Y
w :\YWY^SXQ^RO_]OYP]KPOKXNP_OVOP MSOX^L_]SXO]]`ORSMVO]
aRO\OS^ XN]S^]OVPSXKZY]S^SYX
^YPY\W_VK^OKXNSWZVOWOX^^RO 2. Does it extend to the Group/Joint Ventures/Suppliers/ AOOXNOK`Y_\^YWKSX^KSX^RORSQRO]^VO`OVYP[_KVS^c^R\Y_QRY_^Y_\
ZYVSMSO]YX]ZOMS ONZ\SXMSZVO] Contractors/NGOs/Others? L_]SXO]] 9_\ -YWWS^WOX^ ^Y ROKV^R KXN ]KPO^c YP ^RO ZOYZVO aRY
>RO-YWZKXcNYO]XY^ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ CO] _]OY_\Z\YN_M^]S]KVaKc]K^^ROPY\OP\YX^YPO`O\c^RSXQaONY>RO]O
RK`O XKXMSKVY\WKXZYaO\ OPPY\^] ]^K\^ aS^R ]Y_\MSXQ YP WK^O\SKV] PY\ KXN WKX_PKM^_\O YP Y_\
\O]Y_\MO]K`KSVKLVOPY\^RO^K]U 3. How many stakeholder complaints have been received Z\YN_M^]KXNWY`O]^R\Y_QRRYaaOWK\UO^]OVVKXN]_ZZVc^RO]O
3^S]ZVKXXON^YLONYXOaS^RSX 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ SX ^RO ZK]^ XKXMSKV cOK\ KXN aRK^ ZO\MOX^KQO aK] Z\YN_M^]SXMV_NSXQ^R\Y_QRY_\L_]SXO]]ZK\^XO\]NOVS`O\SXQRSQR
XOb^]SbWYX^R] [_KVS^cS]SWZO\K^S`OO`O\c]^OZYP^ROaKc
satisfactorily resolved by the management? If so, provide
3^S]ZVKXXON^YLONYXOaS^RSX 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+
XOb^YXOcOK\
details thereof. AO K\O MYWWS^^ON ^Y ^SWOVc SNOX^SPcSXQ O`KV_K^SXQ KXN
+XcY^RO\\OK]YX 8+ 8+ 8+ 8+ 8+ 8+ >RO\OS]XY]_MRZYVSMcPY\W_VK^ON 8+ 8+
KNN\O]]SXQ Z\YN_M^ ]KPO^c S]]_O] AO Z\Y`SNO ROKV^RMK\O
  RO-YWZKXcRK]\OMOS`ON]^KUORYVNO\MYWZVKSX^]N_\SXQ
>
ZVOK]O]ZOMSPc >RO -YWZKXc KN`YMK^O] P\YW ^SWO Z\YPO]]SYXKV]KXNSX]^S^_^SYX]aS^R^ROSXPY\WK^SYX^ROcXOONSX
^RO XKXMSKV cOK\ !" 9_^ YP ^RO]O " MYWZVKSX^] aO\O Y\NO\ ^Y _]O -YWZKXc Z\YN_M^] ]KPOVc KXN OPPOM^S`OVc AO ^KUO
^Y^SWOK]KWOWLO\YP`K\SY_]^\KNO
LYNSO] MRKWLO\] KXN K]]YMSK^SYX] SX`O]^SQK^ON SX KMMY\NKXMO aS^R 3X^O\XKV 3X`O]^SQK^SYX] KM^SYX^YZ\O`OX^MY_X^O\POS^SXQSVVOQKVNS`O\]SYXKXN^ROP^YPY_\
^Y KNN\O]] S]]_O] \OVK^ON ^Y ^RO :YVSMcKXN-YWZVSKXMO:\YQ\KWKXNKZZ\YZ\SK^OVc\O]YV`ON Z\YN_M^] AO KNRO\O ^Y KVV KZZVSMKLVO ^\KNO \OQ_VK^SYX] VYMKVVc
ZRK\WKMO_^SMKVSXN_]^\c MYWZVKSX^]K\OZOXNSXQ_XNO\SX`O]^SQK^SYX KXNQVYLKVVc

74 ANNUAL REPORT 2017-18 75


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

AORK`OO]^KLVS]RONa\S^^OXZ\YMON_\O]PY\Z\YN_M^KM^SYX]KXN Sr. Parameter Unit Quantity +VV^ROUOc`OXNY\]PY\^RO-YWZKXcK\OK]]O]]ONPY\/2= Employee Development and Talent Management
\OMKVV]aRSMR\O[_S\OMYWZVO^SYXYPKROKV^RRKdK\NK]]O]]WOX^ No. Z\KM^SMO] KXN MYWZVSKXMO] ^Y OX]_\O ]_]^KSXKLSVS^c KXN K\O
K_NS^ON \OQ_VK\Vc 1YK ]S^O MYX \W] ^RK^ XYXO YP ^RO \Ka ,c ^KUSXQ K Z\YKM^S`O KZZ\YKMR ^Y \OM\_S^WOX^ KXN YPPO\SXQ
WONSMKV K]]O]]WOX^ KXN MY\\OM^S`O KXN Z\O`OX^S`O KM^SYX ZVKX
 >Y^KVaK^O\_]ON KL ! WK^O\SKV] _^SVS]ON K^ ZVKX^ K\O NO\S`ON P\YW ,SYNS`O\]S^c Y\ KN`KXMOWOX^KXNVOKNO\]RSZNO`OVYZWOX^Z\YQ\KW]K^KVVVO`OV]
NO`OVYZWOX^
 AK]^OQOXO\K^ON 7> !# S^]MYWZYXOX^] aOROVZY_\OWZVYcOO]\OKVS]O^ROS\ZY^OX^SKV+VV^ROOWZVYcOO]
AO ^KUO Y_\ \O]ZYX]SLSVS^c ^Y OWLON ^RO RSQRO]^ Z\YN_M^ [_KVS^c RK`O KMMO]] ^Y TYL]ZOMS M ^\KSXSXQ KXN NO`OVYZWOX^ ^Y OX]_\O
 >Y^KV-9O[_S`KVOX^OWS]]SYX] 7>  5. Does the Company have a mechanism to recycle products
KXN ]KPO^c ]^KXNK\N] KM\Y]] Y_\ ]_ZZVc MRKSX `O\c ]O\SY_]Vc ]_MMO]]P_V ZO\PY\WKXMO SX ^ROS\ M_\\OX^ \YVO] KM\Y]] ^RO P_VV
P\YWZ_\MRK]ONOVOM^\SMS^c and waste? If yes, what is the percentage of recycling
AO WKSX^KSX KX O`KV_K^SYX KXN KZZ\Y`KV ]c]^OW ^RK^ \O[_S\O] \KXQOYPTYL]xP\YWMYWWO\MSKVKXNYZO\K^SYX]^Y\O]OK\MRKXN
of products and waste (separately as <5%, 5-10%, >10%).
O`SNOXMO ^RK^ K ]_ZZVSO\ MKX MYX]S]^OX^Vc Z\Y`SNO WK^O\SKV Y\    YVVYaSXQWOK]_\O]RK`OLOOX^KUOXK^^ROZVKX^N_\SXQ
0 NO`OVYZWOX^ K] aOVV K] R_WKX \O]Y_\MO] XKXMO KXN ]_ZZVc
Also, provide details thereof.
]O\`SMO]WOO^SXQ]ZOMS ON[_KVS^cKXN]KPO^c\O[_S\OWOX^] ^ROcOK\!"PY\MYX]O\`K^SYXYP/XO\Qcx MRKSX AO NO`OVYZ M_\\OX^ KXN P_^_\O VOKNO\] ^R\Y_QR K \YL_]^
 O] aRO\O`O\ POK]SLVO ^RO aK]^O] K\O \OMcMVON ,OSXQ
C MYWLSXK^SYX YP ^\KSXSXQ YX^ROTYL ObZO\SOXMO] KXN PY\WKV KXN
    bS]^SXQ0V_Y\O]MOX^>_LO6SQR^RSQRZYaO\0>6
/ ZRK\WKMO_^SMKV] ^RO Z\YN_M^] K\O XY^ \OMcMVON .S]ZY]KV YP
1. List up to 3 of your products or services whose design SXPY\WKV WOX^Y\SXQ >RO\O K\O `K\SY_] MO\^S MK^SYX Z\YQ\KW]
MYX]_WSXQVSQR^]\OZVKMONaS^ROXO\Qc]K`SXQ6SQR^ RKdK\NY_] aK]^O KXN ]V_NQO ^Y ?V^\K^OMR MOWOX^ PKM^Y\SO]
has incorporated social or environmental concerns, LOSXQMYXN_M^ONLc^RO^\KSXSXQP_XM^SYXPY\P\YX^VSXO OVNPY\MO
/WS^^SXQ .SYNO 6/. VSQR^] SX ;_KVS^c -YX^\YV aRSMR S] _^SVS]ON Lc ^ROW K] K P_OV PY\ WKX_PKM^_\SXQ YP
risks and/or opportunities. K\OK] aRSMRROVZ^ROWKM[_S\ORSQRO\VO`OVYPMYWZO^OXMSO]
MOWOX^8YXRKdK\NY_]aK]^OVSUOZKZO\QVK]]O^MK\O]OX^^Y
 w ._ZRKVKMKXN-\OWKP X KZZ\Y`ON`OXNY\] >RO -YWZKXct] \YL_]^ KZZ\YKMR ^Y ^KVOX^ WKXKQOWOX^
   8OaMYXNOX]K^O\OMY`O\cZ_WZSX]^KVVON^YSWZ\Y`O
 w .SQOXO1OVKXN>KLVO^] ^ROMYXNOX]K^O\OMY`O\cP\YW^Y"   RO1YK:VKX^\O^KSX]S^]MO\^S MK^SYXYPDO\YAK]^O^YVKXN VV
> SXMY\ZY\K^O] ]USVV] K]]O]]WOX^] ZO\PY\WKXMO KZZ\KS]KV]
SXZ_\`SOaYPaK]^ONS]ZY]KV3X!" YPY_\^Y^KVaK]^O ]_MMO]]SYX KXN NO`OVYZWOX^ ZVKXXSXQ KXN MK\OO\
 w ,\_POX>KLVO^]    YVVYaSXQWOK]_\O]RK`OLOOX^KUOXK^^ROZVKX^N_\SXQ
0 aK]]OX^PY\\OMcMVSXQaK]MYWZY]^ONYX]S^O YP^RO Z\YQ\O]]SXQ 9_\ SX^OQ\K^ON ^KVOX^ WKXKQOWOX^ Z\YMO]] QS`O]
^ROcOK\!"PY\MYX]O\`K^SYXYPaK^O\x aK]^O aRSMR SXMV_NO] RKdK\NY_] aK]^O aK] MY  Z\YMO]]ON
2. For each such product, provide the following details in SXM\OK]ON `S]SLSVS^c ^Y ^KVOX^ aS^RSX Y_\ Y\QKXS]K^SYX OXRKXMO]
   /P
_OX^ >\OK^WOX^ :VKX^ ^\OK^ON aK^O\ _]ON PY\ aS^ROXO\Qc\OMY`O\caRO\OK] aK]SXMSXO\K^ON
^RO KMM_\KMc YP Y_\ K]]O]]WOX^] KXN N\S`O] MYX]S]^OXMc SX
respect of resource use (energy, water, raw material, etc.)
^YSVO^
_]RSXQSXMRKXQO\YYW]   RO -YWZKXct] ZVKX^ K^ 1YK \OMOS`ON u,O]^ /X`S\YXWOX^KV
> ]USVV]WKZZSXQKM\Y]]^ROY\QKXS]K^SYX
per unit of product :
:\KM^SMO] +aK\Nv P\YW 1YK =^K^O :YVV_^SYX -YX^\YV ,YK\N
   0V_SNLONN\cO\ V^O\LKQaK]RSXQKXNN\cSXQWKMRSXO \OMYQXSdSXQ ^RO OPPY\^] PY\ \OMcMVSXQ ^RO _]ON aK^O\ P\YW @K\SY_]^\KSXSXQKXNVOKNO\]RSZNO`OVYZWOX^Z\YQ\KW]MYXN_M^ON
(a) Reduction during sourcing/production/distribution SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\aK]RSXQMcMVO VS[_SN LY^^VO MVOKXSXQ WKMRSXO] SX MYYVSXQ aK^O\ ^YaO\] SX Lc^RO-YWZKXcN_\SXQ^ROcOK\_XNO\\O`SOaK\O$
achieved since the previous year throughout the
   3X^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ WKMRSXO _^SVS^c]OM^SYX
value chain? - IN-STRIDE
SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\ Principle 3 : Businesses should promote the well-being of
   OSXQ K W_V^SZ\YN_M^ PKMSVS^c Z\YN_M^aS]O \O]Y_\MO
, all employees  3 X=^\SNO Z\YQ\KW S] KSWON K^ ]^\OXQ^ROXSXQ ^RO VOKNO\]RSZ
3. Does the Company have procedures in place for
MYX]_WZ^SYXS]XY^WOK]_\ONcO^^ROZVKX^MYX^SX_Y_]Vc ZSZOVSXO ^YaK\N] ]OXSY\ VOKNO\]RSZ ZY]S^SYX] [_KVS^c KXN
sustainable sourcing (including transportation)? >RO -YWZKXc MK\O] KLY_^ KXN S] MYXMO\XON PY\ ^RO ROKV^R KXN
^KUO] WOK]_\O] ^Y \ON_MO ^RO MYX]_WZ^SYX >RO ZVKX^ [_KX^S^c^YOX]_\OL_]SXO]]MYX^SX_S^cLcM\OK^SXQMYX^SX_Y_]
If yes, what percentage of your inputs was sourced aOVVLOSXQ YP S^] OWZVYcOO] >RO -YWZKXct] ]_MMO]] S] NS\OM^Vc
RK] SXM\OK]ON WKX_PKM^_\SXQ cSOVN] ]Y K] ^Y \ON_MO ^RO VOK\XSXQ YZZY\^_XS^SO] PY\ RSQR ZY^OX^SKV ^KVOX^ ^R\Y_QR
sustainably? Also, provide details thereof. NOZOXNOX^ _ZYX ^RO ]USVV NONSMK^SYX KXN Z\YN_M^S`S^c YP S^]
aK]^KQO YP Z\OMSY_] \Ka WK^O\SKV] ZKMUKQSXQ WK^O\SKV] =SW_VK^SYX] /6OK\XSXQ 1\Y_Z 7OX^Y\SXQ SXNS`SN_KV
  O] ^RO -YWZKXc RK] LOOX aY\USXQ ^Y SXM\OK]O ]Y_\MSXQ YP
C OWZVYcOO] >RO\OPY\O S^ S] SXM_WLOX^ _ZYX ^RO -YWZKXc ^Y ]^\O^MR K]]SQXWOX^]Z\YTOM^] $ WOX^Y\]RSZ KXN PKMO ^SWO
KXN ]YV`OX^] +] K MYWZVSKXMO ^YaK\N] :VK]^SM AK]^O
VYMKVZKMUKQSXQWK^O\SKV]^RO\OLc\ON_MSXQ^RO^\KX]ZY\^K^SYX Z\Y`SNO WOKX] PY\ ^RO OPPOM^S`O M_V^S`K^SYX NO`OVYZWOX^ KXN
7KXKQOWOX^ <_VO] aO K\O aY\USXQ YX _]KQO YP WY\O aS^R^KVOX^MY_XMSV
KXN ^RO \O]_V^KX^ `ORSM_VK\ OWS]]SYX] 0Y\ /bKWZVO aO _^SVS]K^SYXYPS^]R_WKX\O]Y_\MO]
\OMcMVKLVOWK^O\SKV]SXY_\ZKMUKQSXQYPQYYN]
OXMY_\KQON ^RO LY^^VO WKX_PKM^_\O\] ^Y ]O^_Z ^ROS\ _XS^ SX /`O\cYXO aRY aY\U] K^ +LLY^^ 3XNSK OXMY_X^O\] K Z\YPO]]SYXKV - Management Trainee Program
(b) Reduction during usage by consumers (energy, water) 1YK+V]YaS^R^ROXOa1=>\OQSWO^RO]^YMUS]^]K\OLOSXQ OX`S\YXWOX^ P\OO P\YW SX^SWSNK^SYX KXN RK\K]]WOX^ /WZVYcOO   KXKQOWOX^>\KSXOO]K\OSXN_M^ONP\YWZ\O]^SQSY_]MYVVOQO]
7
has been achieved since the previous year? ]O\`SMON P\YW ^RO MVY]O]^ -K\\cSXQ KXN 0Y\aK\NSXQ =O\`SMO ZO\PY\WKXMO KXN KMRSO`OWOX^] K\O OXRKXMON SX KX YZOX KXN aS^RKXYLTOM^S`O^YL_SVNKNS`O\]OKXN]_ZO\SY\^KVOX^ZYYV
:\Y`SNO\]^Y\ON_MO^\KX]ZY\^K^SYXOWS]]SYX] ]_ZZY\^S`O aY\U OX`S\YXWOX^ aRSMR S] MRK\KM^O\S]ON Lc W_^_KV
   ROLYSVO\]RK`OLOOX\_XXSXQYX,SYWK]]^Y\ON_MO^RO
> PY\]KVO]WK\UO^SXQZY]S^SYX]+P^O\^ROS\^\KSXOO]RSZ]_S^KLVO
^\_]^KXN\O]ZOM^
-9 OWS]]SYX] KXN ^RO OX`S\YXWOX^KV SWZKM^ >RO ]S^O 4. Has the Company taken any steps to procure goods MKXNSNK^O]K\OYPPO\ONTYL]K]ZO\^ROS\ObZO\^S]O
Z\KM^SMO]^ROZ\SXMSZVOYP<<ON_MO<OMcMVOKXN<O_]O and services from local & small producers, including A Diverse and Inclusive work place
- Global Citizen Development Program
^Y MYX^SX_Y_]Vc \ON_MO ^RO aK]^O KXN OX`S\YXWOX^KV communities surrounding their place of work?
>Y MYWZO^O OPPOM^S`OVc YX K QVYLKV LK]S] ^RO -YWZKXc XOON]
SWZKM^] +VV ^RO aK]^O S] NS]ZY]ON ^R\Y_QR 1Y`O\XWOX^   VYLKV -S^SdOX .O`OVYZWOX^ :\YQ\KW S] SX^OXNON ^Y L_SVN
1
  RO-YWZKXcNYO]Z\YM_\OQYYN]KXN]O\`SMO]P\YWVYMKVKXN
> NS`O\]O ZO\]ZOM^S`O] ObZO\SOXMO] KXN ]USVV] AO K\O MYWWS^^ON
KZZ\Y`ON KQOXMSO] KP^O\ K_NS^ KXN SX^O\XKV KZZ\Y`KV QVYLKV WSXN]O^ MKZKLSVS^SO] L_]SXO]] KXN WK\UO^ KM_WOX
]WKVVZ\YN_MO\]ZK\^SM_VK\VcVYMK^ONXOK\S^]WKX_PKM^_\SXQ ^Y PY]^O\SXQ KXN ]_ZZY\^SXQ NS`O\]S^c AO LOVSO`O ^RK^ ^RS]
Z\YMO]] ZVKX^K^1YKSXKMMY\NKXMOaS^R^ROO]^KLVS]RONZ\YMON_\O] MYWWS^WOX^ROVZ]_]K^^\KM^KXN\O^KSX^KVOX^aRSVOSXXY`K^SXQ KXNVOKNO\]RSZMKZKLSVS^SO]aRSVOM\OK^SXQKMVY]OXO^aY\UYP
KXN \O[_S\OWOX^] AO RK`O KV]Y SNOX^S ON XOa VYMKV WY\OOPPOM^S`OVcKXNKNKZ^SXQ^Y^ROMRKXQSXQROKV^RMK\OXOON] P_^_\O VOKNO\] 3^ KSW] ^Y NO`OVYZ ]USVV] ^Y ROVZ ZK\^SMSZKX^]
   OVYa ^KLVO ]RYa] aK^O\ MYX]_WZ^SYX -9 OWS]]SYX]
, ]Y_\MO] PY\ ]_ZZVcSXQ `YV_WSXY_] \Ka WK^O\SKV aRSMR S] 9_\ AYWOX 6OKNO\] YP +LLY^^ A6+ OWZVYcOO XO^aY\U S] WKXKQOSXM\OK]SXQVcMYWZVObKXNMRKVVOXQSXQ\O]ZYX]SLSVS^SO]%
KXN aK]^O QOXO\K^ON N_\SXQ ^RO cOK\ !" K^ ^RO _]ON SX Z\YN_M^SYX Z\YMO]] + VYXQ^O\W \OVK^SYX]RSZ S] NO]SQXON ^Y ROVZ POWKVO OWZVYcOO] P_\^RO\ ^ROS\ MK\OO\] KXN YPPO\]YZZY\^_XS^SO]^YaY\UYXM_\\OX^L_]SXO]]MRKVVOXQO]%
ZVKX^ >RO KL]YV_^O X_WLO\] K\O RSQRO\ N_O ^Y SXM\OK]O NO`OVYZONaS^R`OXNY\]KXN^RO>RS\N:K\^c7KX_PKM^_\O\] OWZYaO\^ROS\VOKNO\]RSZK^+LLY^^^R\Y_QR]^\_M^_\ON^\KSXSXQ KMMOVO\K^O]NO`OVYZWOX^YPRSQRZY^OX^SKVOK\VcMK\OO\^KVOX^%
SX Z\YN_M^SYX KXN ]S^O `KVSNK^SYX KM^S`S^SO] KP^O\ WKTY\ ^Y OX]_\O L_]SXO]] MYX^SX_S^c KXN MYX^SX_Y_] K`KSVKLSVS^c NO`OVYZWOX^ KXN XO^aY\USXQ O`OX^] ^KSVY\ON ^Y ^RO ]ZOMS M Z\Y`SNO] K XO^aY\USXQ ZVK^PY\W KXN ]O\`O] K] K `ORSMVO PY\
_ZQ\KNK^SYX YP ^RO Z\YN_M^] ^Y Y_\ UOc ]^KUORYVNO\] SO ^RO ZK^SOX^] XOON] K^^\KM^SXQKXN\O^KSXSXQOK\VcMK\OO\^KVOX^

76 ANNUAL REPORT 2017-18 77


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

- Feeder Pool Development Program w  LLY^^RK]NO`OVYZON]^KXNK\N]PY\OPPOM^S`OWKXKQOWOX^YP


+ - LIVELIFEWELL : @OXNY\] KXN =RK\ORYVNO\] <OQ_VK\ MYWW_XSMK^SYX KXN
OWZVYcOOLOXO ^Z\YQ\KW] OXQKQOWOX^aS^R^RO]O]^KUORYVNO\]OXRKXMOY_\_XNO\]^KXNSXQ
  OONO\ :YYV .O`OVYZWOX^ :\YQ\KW S] KSWON K^ KMMOVO\K^SXQ
0  3@/630/A/66KXSX^OQ\K^ONaOVVXO]]Z\YQ\KWS]YPPO\ON
6 KLY_^^ROS\XOON]KXNROVZ]^Y]O\`O^ROWLO^^O\KXNL_SVN]VYXQ
Z\YQ\O]]YPY_\UOc^KVOX^^Y^KUO_ZVOKNO\]RSZ\YVO]K^WSN >RO -YWZKXc S] MYWWS^^ON ^Y YPPO\SXQ MYWZ\OROX]S`O KXN ^Y ^RO OWZVYcOO]% XOK\Vc ! ZO\MOX^ YP OWZVYcOO] KXN ^ROS\ VK]^SXQ\OVK^SYX]RSZ]
WKXKQOWOX^VO`OVSX^ROP_^_\O MYWZO^S^S`OLOXO ^ZKMUKQO]NO]SQXON^YWOO^^ROMRKXQSXQXOON] ]ZY_]O] ZK\^SMSZK^O SX ^RS] Z\YQ\KW 63@/630/A/66
YPOWZVYcOO] SXMV_NO]$ 1. Has the Company mapped its internal and external
- Differential Hiring Strategy
stakeholders? – CO]
 S^R KX YLTOM^S`O ^Y SXP_]O NSPPO\OX^SKV ^KVOX^ KXN OX]_\O
A >RO -YWZKXct] MYWZOX]K^SYX ZRSVY]YZRc S] ^Y ZKc PY\  w 9XVSXOROKV^RK]]O]]WOX^KXN^YYV]
ZO\PY\WKXMO9_\^Y^KVMYWZOX]K^SYX^K\QO^]\OPO\OXMO^ROWONSKX  9
 _^ YP ^RO KLY`O RK] ^RO -YWZKXc SNOX^S ON ^RO
NS`O\]S^cKZZ\YbSWK^OVcYPP\YX^VSXO]KVO]ZY]S^SYX]K\O  w :O\]YXKVROKV^RMYKMRSXQKXNX_^\S^SYXMY_X]OVVSXQ
YP Y^RO\ VOKNSXQ MYWZKXSO] >RO -YWZKXc RK] ]O^ ^RO PYVVYaSXQ disadvantaged, vulnerable and marginalised stakeholders?
VVONP\YWP\O]RZRK\WKQ\KN_K^O]ZYYV
Q_SNSXQZ\SXMSZVO]PY\/WZVYcOO]>Y^KV-YWZOX]K^SYXZ\YQ\KW]$  w 2OKV^RKaK\OXO]]MKWZKSQX]KXNO`OX^]  RO-YWZKXcRK]LOOXQS`SXQK]ZOMSKVPYM_]^YWK\QSXKVS]ON
>
- Sales Force Career Development (TRACKS)
 w 9X]S^OSWW_XS]K^SYX]KXNROKV^R]M\OOXSXQ] ]^KUORYVNO\] ^R\Y_QR `K\SY_] SXS^SK^S`O] 9XO ]_MR SXS^SK^S`O
w  K]O ]KVK\SO] K\O MYWZO^S^S`O SX ^RO WK\UO^] aRO\O aO
,
  X SX^O\XKV MK\OO\ NO`OVYZWOX^ Z\YQ\KW ^Y ]Y_\MO ^KVOX^
+ aK]+LLY^^3XNSKt]>Y^KV=KXS^K^SYX:\YTOM^SX1_TK\K^aRSMR
MYWZO^O PY\ OWZVYcOO] 3XMOX^S`O ZVKX] K\O NO]SQXON ^Y  w /WZVYcOO+]]S]^KXMO:\YQ\KW]
SX^O\XKVVc KXN O]^KLVS]R MK\OO\ ZK^R PY\ UOc P_XM^SYX]\YVO] PYM_]ONYX^RO]KPO^cKXNZ\S`KMcYPaYWOXAY\USXQaS^RK
LKVKXMO]RY\^KXNVYXQ^O\W XKXMSKVKXN]^\K^OQSMYLTOM^S`O]
>ROWKSXPOK^_\O]YP><+-5=Z\YQ\KWK\OMVOK\KXNYLTOM^S`O 1. Please indicate the total number of employees?x X_WLO\YPVYMKVXYXQY`O\XWOX^KVY\QKXSdK^SYX]819]^RO
^RK^L_SVN]RK\ORYVNO\`KV_OKXN\OaK\NY`O\KVVMYWZKXcKXN
Q_SNOVSXO]PY\MK\OO\WY`OWOX^]%M\Y]]P_XM^SYXKVObZY]_\O^Y -YWZKXc VK_XMRON K MYWZ\OROX]S`O KaK\OXO]] ON_MK^SYX
SXNS`SN_KVZO\PY\WKXMO% 2. Please indicate the total number of employees hired on KXN SXP\K]^\_M^_\O Z\YQ\KW ^Y ROVZ ^RO `SVVKQO] SWZ\Y`O
L_SVNVOKNO\]RSZ]USVV]%PK]^O\WY`OWOX^PY\RSQRZO\PY\WO\]%
temporary/hired on contractual/casual basis?x ]KXS^K^SYXKXNOXKLVOROKV^RSO\VS`O]+]K\O]_V^YP^RS]Z\YTOM^
WO\S^YM\K^SMM_V^_\OKXNNO`OVYZWOX^POONLKMU^YL\SNQO^RO w 3 XMOX^S`O MYWZOX]K^SYX LY^R KXX_KV KXN VYXQ^O\W S]
ObS]^SXQ]USVVQKZ] K UOc MYWZYXOX^ YP ^RO -YWZKXc] ZKcPY\ZO\PY\WKXMO 3. Please indicate the number of permanent women ##aYWOXSX^RO`SVVKQO]MS^ONSWZ\Y`ON]KPO^cKXNZ\S`KMc
K]YXOYP^ROWKTY\LOXO ^]YP^ROZ\YTOM^
ZRSVY]YZRc% employees?x
- Uniform Assessments for First Line and Second Line
  R\Y_QR KXY^RO\ SXS^SK^S`O ^RO 8S\WKV .RK\K .KS\c :\YTOM^
>
Manager roles w  _\ ]^\_M^_\O ^SO] SXNS`SN_KV KaK\N] ^Y LY^R L_]SXO]] KXN
9 4. Please indicate the number of permanent employees with
SX +RWONXKQK\ aO RK`O LOOX OWZYaO\SXQ aYWOX NKS\c
Y\ SXNS`SN_KV \O]_V^] ^Y WY^S`K^O Y_\ OWZVYcOO] ^Y KMRSO`O disabilities?
  ^\_M^_\ON K]]O]]WOX^ Z\YQ\KW] aO\O MYXN_M^ON PY\ ^RO
= PK\WO\]Lc^\KSXSXQ]O]]SYX]KXNSXP\K]^\_M^_\ONO`OVYZWOX^
]_ZO\SY\ZO\PY\WKXMO% >YOVSWSXK^OKXcZY]]SLSVS^SO]YPNS]M\SWSXK^SYX^RO-YWZKXc +] K \O]_V^ YP ^RS] Z\YQ\KW NKS\c SXMYWO] RK`O XOK\Vc
0S\]^ 6SXO KXN =OMYXN 6SXO 7KXKQO\] ^Y M\OK^O ]_MMO]]SYX
ZSZOVSXO w  YWZOX]K^SYXOVOWOX^]K\ONO]SQXON^YOXMY_\KQOLORK`SY\
- NYO] XY^ WKSX^KSX KXc ]OZK\K^O SXPY\WK^SYX ZO\^KSXSXQ ^Y NY_LVON KWYXQ ^RO PK\WO\] aRY aO\O ZK\^ YP ^RO Z\YQ\KW
OWZVYcOONS]KLSVS^SO] >RS] cOK\ ^RO -YWZKXc RK] ]^K\^ON K XOa SXS^SK^S`O ^RK^
^RK^S]MYX]S]^OX^aS^R^ROO^RSMKV`KV_O]O]^KLVS]RONSX+LLY^^
- NEXTGEN Leadership Development Program for First PYM_]O] YX M\OK^SXQ K ]_]^KSXKLVO ROKV^RMK\O NOVS`O\c
Line Managers -YNOYP,_]SXO]]-YXN_M^% 5. Do you have an employee association that is recognized by
WYNOV SX _XNO\]O\`ON K\OK] ^Y QOXO\K^O VS`OVSRYYN] PY\
management?CO] ]OVPOWZVYcON aYWOX SX \_\KV 3XNSK >R\Y_QR KVV Y_\
  \YPO]]SYXKV .O`OVYZWOX^ :\YQ\KW S] VK_XMRON PY\ ^RO 0S\]^
: w  OXO ^] K\O MYWZO^S^S`O SX KXN KZZ\YZ\SK^O PY\ ^RO WK\UO^]
,
aRO\OaOMYWZO^OPY\^KVOX^ 6. What percentage of your permanent employees is SXS^SK^S`O]aORK`OLOOX^\cSXQ^YOWZYaO\WK\QSXKVS]ONKXN
6SXO7KXKQO\]3XVSXOaS^RY_\/WZVYcOO@KV_O:\OZY]S^SYXYP
members of this recognised employee association?" `_VXO\KLVO]^KUORYVNO\]^YSWZ\Y`O^ROS\VS`SXQMYXNS^SYX]
Z\Y`SNSXQLO]^SXMVK]]ObZY]_\OKXNKMMOVO\K^ONNO`OVYZWOX^ Listening to Employees
PY\RSQRZO\PY\WO\] 7. Please indicate the number of complaints relating to   RO -YWZKXc ]^\S`O] ^Y SWZ\Y`O ROKV^RMK\O KXN N\S`O
>
AO`KV_O^ROYZSXSYX]YPY_\OWZVYcOO]KXN\OQ_VK\Vc]OOU^ROS\ child labour, forced labour, involuntary labour, sexual KaK\OXO]] L_SVNSXQ KXN NSKQXY]S] SWZ\Y`OWOX^ ^R\Y_QR
- Executive Program in Sales & Marketing POONLKMU^R\Y_QR`K\SY_]OWZVYcOO]_\`Oc] ON_MK^SYX KXN ROKV^R MVSXSM] KNN\O]]SXQ ^RO XOON PY\ LO^^O\
RK\K]]WOX^ SX ^RO VK]^ XKXMSKV cOK\ KXN ZOXNSXQ K] YX
  RO -YWZKXc MYVVKLY\K^ON aS^R ^RO 3XNSKX 3X]^S^_^O
> ^ROOXNYP^RO XKXMSKVcOK\)836 ROKV^RMK\O NSKQXY]^SM KXN ]KXS^K^SYX PKMSVS^SO] K] ZK\^ YP S^]
Work Life Harmony MYWWS^WOX^^YNYSXQL_]SXO]]\O]ZYX]SLVcKXN]_]^KSXKLVc
YP 7KXKQOWOX^ 337 3XNSKt] Z\OWSO\ ,_]SXO]] KXN
>RO -YWZKXc YPPO\]
ObSLVO aY\U ]MRON_VO] KXN YP MO ^SWSXQ] 8. What percentage of your above mentioned employees were
7KXKQOWOX^ 3X]^S^_^O ^Y VK_XMR K MKZKLSVS^cL_SVNSXQ   RO-YWZKXcaY\U]MYX^SX_Y_]Vc^YaK\N]ROKV^RON_MK^SYX
>
given safety & skill upgradation training in the last year?
Z\YQ\KW PY\ ]KVO] WKXKQO\] =Y PK\ # WKXKQO\] RK`O ^Y OXKLVO Y_\ OWZVYcOO] ^Y KMRSO`O LKVKXMO SX ^ROS\ aY\U KXN \OKMRSXQY_^^Y^ROZ_LVSMK^VK\QO^R\Y_QR`K\SY_]MRKXXOV]
ZK\^SMSZK^ONSX^RO]OZ\YQ\KW]aS^RWKXc]OM_\SXQ^ROS\ \]^ ZO\]YXKV\O]ZYX]SLSVS^SO]KXNKM^S`S^SO]AO`SOa^RO]OSXS^SK^S`O]   VV XOa TYSXOO] K\O SWZK\^ON ^\KSXSXQ K] K ZK\^ YP ^ROS\
+ >RO]O SXS^SK^S`O] K\O ZK\^ YP ^RO -YWZKXct] MYX^SX_ON PYM_]
PY\WKVMO\^S MK^SYX] XY^YXVcK]SWZY\^KX^^YYV]PY\^KVOX^K^^\KM^SYXKXN\O^OX^SYXL_^ SXN_M^SYXZ\YQ\KW KXN_X
SXMRSXQNONSMK^SYX^Y\OKMRSXQY_^^Y^ROWSVVSYX]YP
KV]YK]UOcMYWZYXOX^]SXY_\KZZ\YKMR^YNS`O\]S^cKXNSXMV_]SYX _XKaK\OKXN_X]_]ZOM^SXQZK^SOX^]
-YWZOX]K^SYXKXN,OXO ^] Principle 4 : Businesses should respect the interests of, and be
Healthy Living Initiatives responsive towards all stakeholders, especially those who are 3. Are there any special initiatives taken by the Company
>RO -YWZKXc S] NONSMK^ON ^Y Z\Y`SNSXQ K ]YVSN PY_XNK^SYX YP disadvantaged, vulnerable and marginalized to engage with the disadvantaged, vulnerable and
OWZVYcOOLOXO ^]^RK^aSVVKVVYaOWZVYcOO]^YWOO^^ROS\ZO\]YXKV AO SX]ZS\O KXN WY^S`K^O Y_\ OWZVYcOO] aS^R ]YMSKV XKXMSKV
marginalized stakeholders? - If so, provide details thereof.
KXNPKWSVcXOON]/WZVYcOOLOXO ^ZRSVY]YZRcS]LK]ONYX^R\OO WOX^KV KXN ZRc]SMKV Z\YQ\KW] NO]SQXON PY\ ROKV^Rc VS`SXQ SX ^RO AO \OMYQXS]O ^RK^ VS]^OXSXQ ^Y Y_\ ]^KUORYVNO\] KXN \O]ZYXNSXQ
Z\SWK\cMY\O`KV_O]$ P_VVO]^ZY]]SLVO]OX]O ^RY_QR^P_VVc ^Y ^ROS\ MYXMO\X] KXN SNOK] K\O `S^KV ^Y Y_\ ]_MMO]]  >RO -YWZKXc] SXS^SK^S`O] ]_MR K] -\OK^SXQ K =_]^KSXKLVO
K] K L_]SXO]] KXN ^Y Y_\ Z\YQ\O]] >RO -YWZKXc RK] LOOX 2OKV^RMK\O .OVS`O\c 7YNOV 8S\WKV .RK\K .KS\c :\YTOM^
w  LLY^^ MK\O] KXN S] MYXMO\XON PY\ ^RO ROKV^R aOVPK\O KXN
+ - Exercise across Abbott KXN>Y^KV=KXS^K^SYX:\YTOM^KSW]^YOWZYaO\WK\QSXKVSdON
OXQKQSXQ aS^R L\YKN \KXQO YP ]^KUORYVNO\] YX KX YXQYSXQ LK]S]
XKXMSKVaOVVLOSXQYPS^]OWZVYcOO]% aYWOX >RO VK^^O\ ZK\^SM_VK\Vc OK]ON ^RO VS`O] YP ]^_NOX^]
  OVVXO]] Z\YQ\KW aRO\OSX OWZVYcOO] PY\W] ^OKW
A 9_\ WKTY\ ]^KUORYVNO\] K\O Y_\ :K^SOX^] -YX]_WO\] KXN
w  LLY^^ RK] O]^KLVS]RON MYWZO^S^S`O LOXO ^] K] ZK\^ YP ^RO
+ NOZK\^WOX^aS]O Y\ aS^R Y^RO\ MYVVOKQ_O] ^Y ^\KMU ^ROS\ -_]^YWO\]% 1Y`O\XWOX^] KXN <OQ_VK^Y\]% 2OKV^RMK\O KXN OVNO\Vc aRY NSN XY^ RK`O KMMO]] ^Y ^YSVO^] LOPY\O ^RO
>Y^KV<OaK\N]YPPO\ON^YS^]OWZVYcOO]% WSX_^O]YPNKSVcObO\MS]OKXN^SWO^ROcZ_^SXObO\MS]SXQ :\YPO]]SYXKV]% /WZVYcOO]% 819]% 6YMKV -YWW_XS^SO]% =_ZZVSO\] Z\YTOM^

78 ANNUAL REPORT 2017-18 79


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Principle 5 : Businesses should respect and promote human Principle 6 : Businesses should respect, protect, and make 4. Does the Company have any project related to Clean >RO -YWZKXc OXNY\]O] SXMV_]S`O ZYVSMSO] KXN ]_]^KSXKLVO
rights efforts to restore the environment Development Mechanism? If so, provide details thereof, NO`OVYZWOX^^R\Y_QRZK\^SMSZK^SXQSX-=<PY\_W]KXNNS]M_]]SYX]
in about 50 words or so. Also, if Yes, whether any
>RO -YWZKXc LOVSO`O] SX ^RO NSQXS^c YP O`O\c R_WKX LOSXQ KXN AO K\O MYWWS^^ON ^Y ]KPOQ_K\NSXQ K ROKV^Rc OX`S\YXWOX^ PY\ 1. Is your Company a member of any trade and chamber or
OX`S\YXWOX^KV-YWZVSKXMO\OZY\^S] VON)
\O]ZOM^] SXNS`SN_KV \SQR^] >RO]O Z\SXMSZVO] K\O \O
OM^ON SX O`O\cYXOLc\ON_MSXQ^ROOX`S\YXWOX^KVSWZKM^]YPY_\L_]SXO]] association? If Yes, Name only those major ones that your
^RO -YWZKXct] WS]]SYX KXN MY\O `KV_O] AO MYX^\SL_^O ^Y ^RO >RS] MYWWS^WOX^ ]RKZO] ^RO aKc aO ]Y_\MO WKX_PKM^_\O 8Y Z\YTOM^] K\O _XNO\^KUOX ]ZOMS MKVVc _XNO\ -VOKX business deals with.
P_V VWOX^ YP R_WKX \SQR^] ^R\Y_QR MYWZVSKXMO aS^R VKa] KXN NO]SQX KXN NS]^\SL_^O Y_\ Z\YN_M^] + ]_]^KSXKLVO OX`S\YXWOX^ .O`OVYZWOX^ 7OMRKXS]W RYaO`O\ ^RO\O S] OWZRK]S]
CO] ,OVYa K\O ^RO ^\KNO KXN MRKWLO\ Y\ K]]YMSK^SYX aRSMR
\OQ_VK^SYX]aRO\O`O\aOYZO\K^OK]aOVVK]^R\Y_QRY_\ZYVSMSO] S] O]]OX^SKV PY\ LO^^O\ ROKV^R ]^\YXQO\ MYWW_XS^SO] KXN WY\O YX _]KQO YP MVOKX OXO\Qc VSUO ,SYWK]] K^ 1YK ZVKX^ ^RO-YWZKXcNOKV]aS^R$
P_V VVSXQ VS`O] 9_\ VYXQ^O\W /X`S\YXWOX^ 2OKV^R KXN =KPO^c -9OWS]]SYX\ON_M^SYXYZZY\^_XS^SO]K\OPY\WKVVcK]]O]]ON
KXNZ\YQ\KW]9_\QVYLKVQ_SNOVSXO]SXMV_NO$
/2= ]^\K^OQc KSW] ^Y Z\Y^OM^ Y_\ ZOYZVO Y_\ ZVKXO^ KXN Y_\ KXNOWS]]SYX\ON_M^SYXS]KZK\^YPKXX_KV]S^O^K\QO^]KXNUOc   \QKXSdK^SYX YP :RK\WKMO_^SMKV :\YN_MO\] YP 3XNSK
9
w :\Y`SNSXQKROKV^RcKXN]KPOaY\USXQOX`S\YXWOX^% `KV_OAOKMRSO`O^RS]LcNOVS`O\SXQKM\Y]]KX_WLO\YPMY\OK\OK] ZO\PY\WKXMOSXNSMK^Y\] 9::3
^Y\ON_MOKXNWS^SQK^OOX`S\YXWOX^KV\S]U]%NOVS`O\MY]^OP MSOXMc
w -YWZVcSXQaS^RMRSVNVKLY_\VKa]% 5. Has the Company undertaken any other initiatives on  0ONO\K^SYXYP3XNSKX-RKWLO\]YP-YWWO\MO3XN_]^\SO]
KXNOX]_\OL_]SXO]]MYX^SX_S^c
03--3
MVOKX ^OMRXYVYQc OXO\Qc OP MSOXMc \OXOaKLVO OXO\Qc
w  \YWY^SXQ aY\UPY\MO NS`O\]S^c KXN XY^ NS]M\SWSXK^SXQ KQKSX]^
: AO ^KUO ]^OZ] ^Y \ON_MO Y_\ _]O YP OXO\Qc KXN Y^RO\ XK^_\KV etc.? If yes, please give hyperlink for web page etc. 2. Have you advocated/lobbied through above associations
KXc OWZVYcOO PY\ \OK]YX] ]_MR K] \KMO \OVSQSYX MYVY_\ KQO \O]Y_\MO] AO ]_ZZY\^ Z\YTOM^] ^RK^ QOXO\K^O OXO\Qc P\YW for the advancement or improvement of public good?
QOXNO\O^RXSMS^cNS]KLSVS^cWK\S^KV]^K^_]KXN]Ob_KVY\SOX^K^SYX \OXOaKLVO ]Y_\MO] K^ aY\U KXN SX Y_\ MYWW_XS^SO] AO ]OOU CO]>RO-YWZKXcS]MYWWS^^ON^YOX`S\YXWOX^KVZ\Y^OM^SYX
If yes specify the broad areas (drop box : Governance and
SXKNNS^SYX^YKXcY^RO\]^K^_]Z\Y^OM^ONLcVYMKVVKa% aKc]^Y\ON_MO^ROOX`S\YXWOX^KVSWZKM^YPY_\YZO\K^SYX]]_MR @O\WSMYWZY]^SXQKXN\KSXaK^O\RK\`O]^SXQS]LOSXQZ\KM^SMON
Administration, Economic Reforms, Inclusive Development
K] ^R\Y_QR aK]^O \ON_M^SYX KXN \OMcMVSXQ KXN Y^RO\ KM^S`S^SO] ^Y 1YK]S^OS]DO\YAK]^O^Y6KXN VVDA6MO\^S ONaS^RWY\O
w  Y^^YVO\K^SXQRK\K]]WOX^Y\RK\]RY\SXR_WKXO^\OK^WOX^SX
8 Policies, Energy Security, Water, Food Security, Sustainable
WS^SQK^O OX`S\YXWOX^KV \S]U] AO KNRO\O ^Y ^RO OX`S\YXWOX^KV ^RKX#YP^ROaK]^OOS^RO\LOSXQ\OMcMVONY\MYZ\YMO]]ON
^ROaY\UZVKMO% Business Principles, Others)
VKa]KXN\OQ_VK^SYX]KZZVSMKLVO^YY_\YZO\K^SYX] YPP]S^O PY\ OXO\Qc \OMY`O\c 8Oa 2@+- ]c]^OW RK] LOOX
w :\Y^OM^SXQSXNS`SN_KVZ\S`KMc% SX]^KVVONaS^ROXO\QcOP MSOX^MYWZYXOX^]>ROObS]^SXQ0>6 CO] ,\YKN K\OK] K\O $ :\SMSXQ SWZVOWOX^K^SYX S]]_O]%
1. Does the policy relate to Principle 6 cover only the
RSQR ZYaO\ MYX]_WSXQ VSQR^] \OZVKMON aS^R OXO\Qc ]K`SXQ 8K^SYXKV:RK\WKMO_^SMKV]:YVSMc%>KbK^SYXZYVSMSO]KXN.\_Q
w  \Y`SNSXQMYWZOX]K^SYXKXNLOXO ^]^RK^K\OMYWZO^S^S`OKXN
: Company or extends to the Group/Joint Ventures/
6/.VSQR^]SX;-K\OK]AK^O\MYX]O\`K^SYXWOK]_\O]SXMV_NO <OQ_VK^Y\cWK^^O\]
MYWZVc aS^R KZZVSMKLVO VKa] PY\ WSXSW_W aKQO] Y`O\^SWO Suppliers/Contractors/NGOs/others?
XOa MYXNOX]K^O \OMY`O\c Z_WZ ^Y SWZ\Y`O ^RO MYXNOX]K^O
RY_\]KXNWKXNK^ONLOXO ^]% Principle 8 : Businesses should support inclusive growth and
  RO /2= ZYVSMc YP ^RO -YWZKXc MY`O\] KVV OWZVYcOO] KXN
> \OMY`O\cP\YW^Y"0V_SNLONN\cO\ V^O\LKQaK]RSXQ
equitable development
MYX^\KM^Y\]YP^RO-YWZKXc KXN N\cSXQ WKMRSXO SX]^KVVON ^Y ]K`O  VS^O\] YP aK^O\ ZO\
w  XMY_\KQSXQYZOXMYWW_XSMK^SYXLO^aOOXWKXKQOWOX^KXN
/
aK]RSXQ McMVO KXN SX^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ AO KSW ^Y OWZYaO\ MYWW_XS^SO] ^Y ^KUO MYX^\YV YP ^ROS\ VS`SXQ
OWZVYcOO] 2. Does the Company have strategies initiatives to address
WKMRSXOSX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\ OX`S\YXWOX^] PY\ P_VVO\ ROKV^RSO\ VS`O] >RO -YWZKXct] -=<
global environmental issues such as climate change,
3^ S] ^RO -YWZKXct] ZRSVY]YZRc ^Y WKSX^KSX KX YZOX aY\USXQ ZYVSMcS]PYM_]ONYXPY]^O\SXQOMYXYWSMOX`S\YXWOX^KVKXN]YMSKV
global warming, etc.? Y/N - If yes, please give hyperlink 6. Are the Emissions/Waste generated by the Company
OX`S\YXWOX^^RK^KVVYa]P\OOObMRKXQOYPSXPY\WK^SYXLcaKcYP for webpage etc. aOVVLOSXQ
within the permissible limits given by CPCB/SPCB for the
MYWW_XSMK^SYX MRKXXOV] KM\Y]] ^RO Y\QKXS]K^SYX +VV OWZVYcOO] XKXMSKVcOK\LOSXQ\OZY\^ON)
CO] >RO -YWZKXc S] MYWWS^^ON ^Y OX`S\YXWOX^KV Z\Y^OM^SYX   YO] ^RO -YWZKXc RK`O ]ZOMS ON Z\YQ\KW]SXS^SK^S`O]
.
K\O KVVYaON ^Y ]RK\O ^ROS\ MYXMO\X] Z\YLVOW] [_O]^SYX] Y\
KXNRK]SNOX^S ON^R\OOOX`S\YXWOX^KVZ\SY\S^SO]3XOKMRYXO +VV^RO/WS]]SYX]AK]^OQOXO\K^ONLc^RO-YWZKXcS]aS^RSX projects in pursuit of the policy related to Principle 8?
]_QQO]^SYX]aS^RY_^KXcPOK\YP\O^KVSK^SYXKXNS^S]`S^KV^RK^^RO]O
aORK`O]O^KWLS^SY_]QYKV]PY\\ON_MSXQOX`S\YXWOX^KVSWZKM^ ^ROZO\WS]]SLVOVSWS^]QS`OXLc-:-,=:-,PY\^RO XKXMSKV If yes, details thereof.
MYXMO\X]K\ONS]M_]]ONKXN\O]YV`ONSXK^SWOVcWKXXO\
LcMYWZK\ON^YVO`OV]KXNKNT_]^ONPY\]KVO] cOK\LOSXQ\OZY\^ON>RO]KWZVO]K\O^O]^ONLcSXNOZOXNOX^
iCARE Road Safety Drive
>RO -YWZKXc RK] ZYVSMSO] YX /^RSM] KXN -YWZVSKXMO .S`O\]S^c - -VSWK^O MRKXQO $  \ON_M^SYX SX MK\LYX NSYbSNO 1Y`O\XWOX^KZZ\Y`ONVKLY\K^Y\SO]YXK\OQ_VK\LK]S]
KXN 3XMV_]SYX K] aOVV K] YX :\YRSLS^SYX YP 2K\K]]WOX^ K^ O[_S`KVOX^ -9 OWS]]SYX] SO Q\OOXRY_]O QK] E121G <YKN=KPO^cRK]LOOXKZK\^YP^RO-YWZKXc]PYM_]^K\QO^ONK^
7. Number of show cause/legal notices received from CPCB/
AY\UZVKMO OWS]]SYX] K]]YMSK^ON aS^R Y_\ L_]SXO]] YZO\K^SYX] KXN SPCB which are pending (i.e. not resolved to satisfaction) K`YSNSXQKMMSNOX^]KXNSWZ\Y`SXQVS`O]+LLY^^3XNSKt]S-+</
^ROOVOM^\SMS^caOZ_\MRK]OSO=MYZOKXNOWS]]SYX] as on end of Financial Year. =KPO^c .\S`O S] QOK\ON ^YaK\N] ]Z\OKNSXQ KaK\OXO]] KLY_^
1. Does the policy of the Company on human rights cover
- AK^O\_]KQO$\ON_M^SYXSX^Y^KVaK^O\SX^KUO \YKN]KPO^cWOK]_\O]^YZ\O`OX^\YKNKMMSNOX^]KXN]K`OVS`O]
only the Company or extend to the Group/Suppliers/ 8Y]RYaMK_]OVOQKVXY^SMO]\OMOS`ONP\YW-:-,=:-,K\O 9\SQSXKVVc ]^K\^ON SX  K] KX SX^O\XKV ^\KSXSXQ Z\YQ\KW
Contractors/NGOs/Others? - AK]^OWKXKQOWOX^$\ON_M^SYXSX^Y^KVaK]^O ZOXNSXQ PY\+LLY^^t]OWZVYcOO]S-+</=KPO^c.\S`ORK]O`YV`ONSX^Y
  RO -YWZKXct] -YNO YP ,_]SXO]] -YXN_M^ MY`O\] ^RO
> >RO -YWZKXc S] KV\OKNc aY\USXQ YX SNOX^SPcSXQ UOc /2= :\SXMSZVO ! $ ,_]SXO]]O] aROX OXQKQON SX SX
_OXMSXQ Z_LVSM K XK^SYXaSNO \YKN ]KPO^c KaK\OXO]] N\S`O 6O`O\KQSXQ ^RO
Q_SNOVSXO] YX R_WKX \SQR^] KXN S^ S] KZZVSMKLVO ^Y KVV ^RO PYM_]K\OK]KXN^K\QO^]PY\ and regulatory policy, should do so in a responsible manner ObZO\SOXMO QKSXON KXN ^RO ^\KSXSXQ _]ON N_\SXQ S^] SX^O\XKV
]^KUORYVNO\]YP^RO-YWZKXc OWZVYcOO ]KPO^c MKWZKSQX +LLY^^ 3XNSK S] \OKMRSXQ Y_^ ^Y
3. Does the Company identify and assess potential >RO-YWZKXcLOVSO`O]SXVO`OVZKcSXQ OVNPY\KVVKXNKN`YMK^O] 3XNSKt]Z_LVSM^Y]Z\OKN]KPO^cKaK\OXO]]
environmental risks? Y/N PY\ PKS\ KXN LKVKXMON ZYVSMc NOMS]SYX] ^RK^ K\O LOXO MSKV PY\ ^RO
2. How many stakeholder complaints have been received in
^ROZK]^ XKXMSKVcOK\KXNaRK^ZO\MOX^aK]]K^S]PKM^Y\SVc CO] ^RO\O K\O SX^O\XKV ]^KXNK\N] LK]ON YX 3=9  ZK^SOX^]KXNZRK\WKMO_^SMKVSXN_]^\cSX3XNSK 9`O\^ROcOK\]aORK`O\OKMRONWY\O^RKX6KUR]ZOYZVO
resolved by the Management? /X`S\YXWOX^KV \S]U K]]O]]WOX^] K\O _ZNK^ON KXN \O`SOaON ^R\Y_QR^RS]SXS^SK^S`O3X!"WY\O^RKX7OWLO\]
>RO-YWZKXcS]KWOWLO\YPSXN_]^\cLYNSO]>RO-YWZKXcaY\U]
\OQ_VK\Vc >RO -Y\ZY\K^O /2= ^OKW MYXN_M^] SXNOZOXNOX^ aS^R ^RO]O K]]YMSK^SYX] \OQ_VK\Vc KXN KM^S`OVc KXN ]_LWS^] `SOa] :KX3XNSK YP Y_\ aY\UPY\MO ON_MK^ON ZOYZVO ^ROc WO^ SX
  _\SXQ ^RO cOK\ XY MYWZVKSX^] aO\O \OMOS`ON _XNO\ ^RO
. YX]S^O \O`SOa] KXN ZY^OX^SKV OX`S\YXWOX^KV \S]U] K\O ]RK\ON ^R\Y_QR^ROWaROXK]UONLc^ROZYVSMcWKUO\]\OQ_VK^Y\]YX^RO WONSMKV MVSXSM] RY]ZS^KV] KXN ]MRYYV] KLY_^ ]KPO N\S`SXQ
=Ob_KV2K\K]]WOX^+M^`SYVK^SYXYP2_WKX<SQR^] aS^R^RO^YZWKXKQOWOX^PY\K^^OX^SYX ObS]^SXQY\XOaZYVSMSO]ZO\^KSXSXQ^Y^ROZRK\WKMO_^SMKV]OM^Y\ Z\KM^SMO] >ROc _]ON ^RS] YZZY\^_XS^c ^Y ]RK\O ]SWZVO

80 ANNUAL REPORT 2017-18 81


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

KM^SYXKLVO]^OZ]PY\\ON_MSXQ\YKNKMMSNOX^]KXNSXT_\SO]VSUO dSKQXY]S] KXN KMMO]] ^Y MK\O >RS] SXMV_NO] Z\YQ\KW] 4. What is your Company’s direct contribution to Z\Y`SNO SXPY\WK^SYX ^RK^ S] MYX]S]^OX^ aS^R ]MSOX^S M O`SNOXMO
aOK\SXQKROVWO^KXNK]OK^LOV^]^KcSXQKVO\^YLOcSXQ]ZOON ^Y \KS]O KaK\OXO]] KXN SWZ\Y`O MK\O PY\ OZSVOZ]c KXN community development projects and the details of the VOKNSXQ WONSMKV Z\KM^SMO KXN ^RO KZZ\Y`ON Z\YN_M^ VKLOVVSXQ
VSWS^]KXNK`YSNSXQ^RO_]OYPWYLSVOZRYXOaRSVON\S`SXQ VS`O\ NS]OK]O] 3X ^RO cOK\ !" ^RO]O Z\YQ\KW] \OKMRON projects undertaken)? \O[_S\OWOX^
KZZ\YbSWK^OVc   NS]^\SM^] SX WY\O ^RKX  ]^K^O] \OKMRSXQ
._\SXQ XKXMSKV cOK\ !" ^RO Z\YQ\KW KV]Y Ob^OXNON Particulars ` in Lakhs 1. What percentage of customer complaints/consumer cases
Y_^ ^Y  6KUR] ZOYZVO ^R\Y_QR Y`O\ " KaK\OXO]]
S^] \OKMR Lc MYVVKLY\K^SXQ aS^R ! ]MRYYV] ^Y ON_MK^O "" K\OZOXNSXQK]YX^ROOXNYP XKXMSKVcOK\)
]^_NOX^]YXZONO]^\SKX]KPO^cKXN\YKN]KPO^cKaK\OXO]] MKWZKSQX] 2OKV^R-VSXSM]:\YQ\KW]^YObZKXN 
+aK\OXO]]KXN+MMO]]^Y2OKV^RMK\O
Creating a Sustainable Healthcare Delivery Model -YWZVKSX^]WONSMKVKXNXYXWONSMKVaO\O\OMOS`ONLc
Nirmal Dhara Dairy Development Program
through Livelihoods 8S\WKV.RK\K.KS\c:\YTOM^ #" ^RO-YWZKXcKXN\O]ZYXNONK]ZO\^RO-YWZKXcZYVSMSO]KXN
3XNSKS]^ROaY\VNt]VK\QO]^Z\YN_MO\YPWSVUKXNXOK\VcRKVP Z\YMON_\O]Lc7K\MR"
=/A+-\OK^SXQK=_]^KSXKLVO2OKV^RMK\O  
YP\_\KVRY_]ORYVN]NOZOXNYXNKS\cPK\WSXQPY\K^VOK]^ZK\^ >RO -YWZKXc RK] SXS^SK^ON K XOa Z\YTOM^ SX ZK\^XO\]RSZ
.OVS`O\c7YNOV^R\Y_QR6S`OVSRYYN] 2. Does the Company display product information on the
YP^ROS\SXMYWO.O]ZS^O^RS]WKXcNKS\cPK\WO\]MYX^SX_O^Y aS^R =/A+ =OVP/WZVYcON AYWOXt] +]]YMSK^SYX ^Y
SWZ\Y`OKMMO]]^Y[_KVS^cROKV^RMK\OSX3XNSKAY\USXQaS^R i-+</<YKN=KPO^c.\S`O "" product label, over and above what is mandated as per
LOWK\QSXKVSdONVSWS^ONLcWSNNVOWOXKVKMUYP^OMRXYVYQc
KXN WO^RYN] ^Y Z\YN_MO RSQRO\ [_KVS^c WSVU PY\ K LO^^O\ =/A+ aRSMR \OZ\O]OX^] _XNO\Z\S`SVOQON ]OVPOWZVYcON local laws?
5. Have you taken steps to ensure that this community
Z\SMO + P_\^RO\ Z\YLVOW S] ^RK^ aYWOX K\O YP^OX ObMV_NON aYWOX aY\UO\] aRY OK\X K VS`SXQ ^R\Y_QR ^ROS\ YaX
development initiative is successfully adopted by the CO]>RO-YWZKXcNS]ZVKc]\OVO`KX^SXPY\WK^SYXYXZ\YN_M^
P\YW NOMS]SYXWKUSXQ NO]ZS^O ZVKcSXQ K ]SQXS MKX^ \YVO SX VKLY_\Y\]WKVVL_]SXO]]O]+LLY^^3XNSKS]]OOUSXQ^YM\OK^O
community? Please explain in 50 words, or so. VKLOV]SXKMMY\NKXMOaS^RKZZVSMKLVO]^K^_^Y\c\O[_S\OWOX^]
NKS\cSXQaY\U K ]_]^KSXKLVO ROKV^RMK\O NOVS`O\c WYNOV aS^RSX =/A+
MYWW_XS^SO] 0Y\ -YWW_XS^c6ON >Y^KV =KXS^K^SYX :\YTOM^ 8S\WKV .RK\K  3 ] ^RO\O KXc MK]O VON Lc KXc ]^KUORYVNO\ KQKSX]^ ^RO
AY\USXQaS^R:\KLRK^KVYMKVNKS\c]_ZZVSO\KXN>OMRXY=O\`O
.KS\c :\YTOM^ KXN ^RO Z\YQ\KW ^Y -\OK^O K =_]^KSXKLVO Company regarding unfair trade practices, irresponsible
K XYXZ\Y ^ Y\QKXS]K^SYX aO NO`OVYZON K NOWYX]^\K^SYX >RS] Z\YQ\KW KSW] ^Y SWZ\Y`O ROKV^R Y_^MYWO] QOXO\K^O
WYNOV^RK^]^\OXQ^ROX]VYMKVNKS\c]_ZZVcMRKSXKXNOWZYaO\] 2OKV^RMK\O 7YNOV aO KSWON K^ OWLONNSXQ ]_]^KSXKLSVS^c advertising and/or anti-competitive behaviour during
VS`OVSRYYN] KXN M\OK^O KX OMY]c]^OW aS^R KVV ]^KUORYVNO\]
]WKVVRYVNO\ PK\WO\] ^Y Z\YN_MO SXM\OK]ON `YV_WO] YP SX^Y ^RO MY\O YP Y_\ OXQKQOWOX^ aS^R ^RO LOXO MSK\SO] ^ROVK]^ `OcOK\]KXNZOXNSXQK]YXOXNYP XKXMSKVcOK\)
KXNUOcZK\^XO\].YM^Y\]:RK\WKMSO]6KL]aRSVOOX]_\SXQ
RSQRO\[_KVS^cWSVU >R\Y_QR MYX^SX_Y_] ^\KSXSXQ KXN WYXS^Y\SXQ YP ^RO `K\SY_] If so, provide details thereof.
LY^R KPPY\NKLSVS^c YP ]O\`SMO] PY\ =/A+ WOWLO\] K] aOVV
SX^O\`OX^SYX]aOOX]_\ON^RK^MYWW_XS^SO]XY^YXVcKNYZ^ON
=SXMO   Y_\ Z\YQ\KW RK] NS\OM^Vc \OKMRON Y`O\  K]K XKXMSKVVc]_]^KSXKLVOROKV^RMK\OOMY]c]^OW  MK]O VON KQKSX]^ ^RO -YWZKXc KVVOQSXQ
Y_\ SXS^SK^S`O] L_^ KV]Y OWL\KMON ^RO LOXO ^] ^RK^ ^ROc
]WKVVRYVNO\ NKS\c PK\WO\] RKVP YP aRSMR K\O aYWOX SX >RS]Z\YQ\KWaSVVON_MK^O=/A+WOWLO\]YX`K\SY_]ROKV^R ObZO\SOXMONK]K\O]_V^ KX^SMYWZO^S^S`O Z\KM^SMO] S] ZOXNSXQ SX `K\SY_] ]^KQO]
7KRK\K]R^\K KXN 1_TK\K^ AO NO`OVYZON ^RO SXP\K]^\_M^_\O MYXNS^SYX]aRSVO^\KSXSXQMYWW_XS^cROKV^RMK\OaY\UO\]YX LOPY\O^RO-YWZO^S^SYX-YWWS]]SYXYP3XNSK
\O[_S\ON^YObZKXNMKZKMS^cPY\WSVUZ\YN_M^SYXKXNNOVS`O\ON Principle 9 : Business should engage with and provide value to
Z\Y`SNSXQ MYX]S]^OX^ MYWW_XS^cLK]ON MK\O >RO Z\YQ\KW 4. Did your Company carry out any consumer survey/
\YL_]^^\KSXSXQYX^YZSM]\KXQSXQP\YW^ROLK]SM]YPOX]_\SXQ their customers and consumers in a responsible manner
aSVVKV]YSWZ\Y`OKMMO]]^Y[_KVS ONNYM^Y\]KXNZRK\WKMSO] consumer satisfaction trends?
RSQR[_KVS^c WSVU ^Y ^OMRXSMKV NKS\cSXQ ]USVV] KXSWKV POON AO Z\SY\S^SdO ^RO ROKV^R KXN aOVVLOSXQ YP Y_\ ZK^SOX^] KXN
SXY\NO\^YNO`OVYZKROKV^RMK\OOMY]c]^OW^YZ\Y`SNO[_KVS^c
KXN MK\O PK\W WKXKQOWOX^ KXN ^RO L_]SXO]] YP NKS\cSXQ MYX]_WO\] AO K\O MYWWS^^ON ^Y aY\USXQ aS^R ROKV^R MK\O
KXN KPPY\NKLVO ROKV^RMK\O PKMSVS^SO] KXN O`OX^_KVVc SWZ\Y`O CO]
AO \_X ^\KSXSXQ] ]ZOMS MKVVc PY\ aYWOX PK\WO\] K] aOVV Z\YPO]]SYXKV]^YZ\Y`SNO^ROWaS^R^SWOVcKXNKMM_\K^OSXPY\WK^SYX
ROKV^R]OOUSXQLORK`SY_\SXMYWW_XS^SO]
AO O]^KLVS]RON ^\KX]ZK\OX^ Z\SMSXQ WOMRKXS]W] PY\ ^RO ^Y K]]S]^ ^ROW SX WKUSXQ NOMS]SYX] KXN Z\Y`SNSXQ KN`SMO ^Y ^ROS\ For and on behalf of the Board
PK\WO\]t WSVU ^RK^ MVOK\Vc NOWYX]^\K^O ^RO VSXU LO^aOOX 2. Are the programs/projects undertaken through in- ZK^SOX^]
[_KVS^cKXNZ\SMO house team/own foundation/external NGO/government
structures/any other organisation? 9_\ ]^K^OWOX^] KLY_^ Y_\ Z\YN_M^] SX KVV WK^O\SKV] KXN Munir Shaikh R A Shah
._\SXQ VK]^ cOK\ Y_\ Z\YQ\KW RKN \_X XOK\Vc  ^\KSXSXQ MYWW_XSMK^SYX] K\O LKVKXMON KXN ^\_^RP_V KXN MYX]S]^OX^ -RKS\WKX   .S\OM^Y\
]O]]SYX] PY\ PK\WO\] AO K\O ]OOSXQ K MYX]S]^OX^ SXM\OK]O 2OKV^R-VSXSM]:\YQ\KW]^Y .S\OM^3WZVOWOX^K^SYX aS^R ^RO KZZ\Y`ON VKLOV 3X Z\YWY^SXQ Y_\ Z\YN_M^] aO .38$# !  .38$#"1
SX ^RO `YV_WO YP RSQR[_KVS^c WSVU MYVVOM^ON O`O\c WYX^R ObZKXN+aK\OXO]]KXN+MMO]]^Y
2OKV^RMK\O
NOWYX]^\K^SXQ ^RO SWZKM^ YP Y_\ Z\YQ\KWt] ^\KSXSXQVON
8S\WKV.RK\K.KS\c:\YTOM^x .S\OM^3WZVOWOX^K^SYX
KZZ\YKMR ,K]ON YX ^RS] ]_MMO]] :\KLRK^ S] MYWWS^^ON ^Y
,_SVNSXQK=_]^KSXKLVO6YMKV
ObZKXNSXQ^RS]WYNOV^YKNNS^SYXKV`SVVKQO]SX^RO\OQSYX =_ZZVc-RKSX
Y`O\ ^R\OO cOK\] >RS] aSVV QS`O WY\O ]WKVVRYVNO\ PK\WO\]
=/A+-\OK^SXQK=_]^KSXKLVO .S\OM^3WZVOWOX^K^SYX
KMMO]]^YK^\_]^ONKXN^\KX]ZK\OX^WK\UO^KXN^RO]USVV]KXN 2OKV^RMK\O.OVS`O\c7YNOV
SXP\K]^\_M^_\O^RK^^ROcXOON^Y]_ZZVcS^
i-+</<YKN=KPO^c.\S`O .S\OM^3WZVOWOX^K^SYX
Health Clinics - Programs to expand Awareness and
3. Have you done any impact assessment of your initiative?
Access to Healthcare
-KZ^_\SXQKXN[_KX^SPcSXQSWZKM^S]YP_^WY]^SWZY\^KXMO^Y
+MMO]] ^Y O]]OX^SKV ROKV^RMK\O ]O\`SMO] KXN SXPY\WK^SYX S] K KVV YP +LLY^^t] MS^SdOX]RSZ Z\YTOM^] +VV Y_\ SXS^SK^S`O] RK`O K
MYX^SX_SXQMRKVVOXQOPY\WKXcSX3XNSK XOON]K]]O]]WOX^WSNVSXOKXNOXNVSXOO`KV_K^SYX-_\\OX^Vc
+LLY^^ 3XNSK RK] ]O`O\KV Z\YQ\KW] ^Y KNN\O]] ^RS] QKZ aOK\OMYWZVO^SXQ^ROOXNVSXOO`KV_K^SYXPY\^RO-YWW_XS^c
>R\Y_QR YXO ]_MR OPPY\^ +LLY^^ 3XNSK ]_ZZY\^] [_KVS ON 6ON>Y^KV=KXS^K^SYX:\YTOM^KXNSXS^SK^SXQWSNVSXOO`KV_K^SYX
NYM^Y\] KXN ROKV^RMK\O Z\YPO]]SYXKV] ^Y ObZKXN NS]OK]e PY\8S\WKV.RK\K.KS\c:\YTOM^

82 ANNUAL REPORT 2017-18 83


ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

R E P O R T O N C O R P O R AT E
GOVERNANCE c) During the year under review, 7 Board Meetings were held on MEETING OF INDEPENDENT DIRECTORS
COMPANY’S PHILOSOPHY ON CORPORATE BOARD OF DIRECTORS the following dates : In terms of requirements of the Companies Act, 2013, Rules framed
GOVERNANCE thereunder and Regulation 25(3) of the Securities and Exchange
a) As on the date of this Report i.e. May 14, 2018, the Board May 19, 2017; July 18, 2017; August 8, 2017; November 13, 2017;
The Company’s philosophy on Corporate Governance is to conduct December 19, 2017; February 14, 2018 and March 27, 2018. Board of India (Listing Obligations and Disclosure Requirements)
its business in a manner, which is ethical and transparent with all comprises 7 Directors including 2 Executive and 5 Non-
Executive Directors, of which 3 are Independent Directors. Regulations, 2015, a meeting of Independent Directors was
the stakeholders of the Company, including members, creditors The option for attending Board/Committee Meetings via
and employees. The Company operates in compliance with all The Directors are professionals, having expertise in their held on May 19, 2017. The said Meeting was attended by all the
audio-visual means is provided to the Directors.
regulatory and policy requirements as well as industry ethical respective functional areas and bring a wide range of skills Independent Directors.
guidelines. The Company also has strict guiding principles laid out and experience to the Board. d) Details of the Directors seeking appointment/re-appointment
and communicated through its Code of Business Conduct, which at the forthcoming Annual General Meeting as required AUDIT COMMITTEE
is subject to regular audits to ensure that controls and compliances b) The composition of the Board of Directors, their attendance under Regulation 36(3) of the Securities and Exchange Board
at the Board Meetings held during the year under review The composition, role, terms of reference as well as powers
are maintained at a high standard. The Company’s philosophy on of India (Listing Obligations and Disclosure Requirements)
and at the last Annual General Meeting along with the of the Audit Committee of the Company are in compliance
Corporate Governance is, thus, concerned with the ethics, values Regulations, 2015 and Secretarial Standards issued by the
and morals of the Company and its directors, who are expected to number of directorships and memberships held in various with the provisions of Section 177 of the Companies Act,
committees in other companies, as on March 31, 2018, are Institute of Company Secretaries of India are annexed to the 2013 and Regulation 18 of the Securities and Exchange Board
act in the best interests of the Company and remain accountable to
WOWLO\]KXNY^RO\LOXO MSK\SO]PY\^ROS\KM^SYX] given in the table below : Notice convening the Annual General Meeting, which forms of India (Listing Obligations and Disclosure Requirements)
part of the Annual Report. Regulations, 2015.
Name of the Director Category of Total Attendance at Number of Number of e) There is no inter-se relationship between any of the Directors.
Composition :
Directorship Board Directorships Committee
Meetings Board Annual in other positions f) None of the Directors holds any shares of the Company except
held in Meetings General companies1 in other for Mr R A Shah, who, along with his relatives, holds 6,874 The Committee comprises 3 Independent Directors and
2017-18 held in Meeting companies2 shares as on March 31, 2018. 1 Non-Executive Director as on the date of this Report.
2017-18 (July 18, 2017)
g) As required under the Regulation 30 of the Securities The composition of the Audit Committee, category of its
Mr Munir Shaikh Non-Executive Director 7 6 Yes 2 NIL and Exchange Board of India (Listing Obligations and Members, their attendance at the Committee Meetings held
Chairman of the Board
Disclosure Requirements) Regulations, 2015, the Company during the year under review is given in the table below :
Mr Ambati Venu Executive Director 7 7 Yes NIL NIL RK]P\YW^SWO^Y^SWOXY^S ON^RO,=/6SWS^ON\OQK\NSXQKVV Sr. Name of the Member Category Number of
Managing Director appointments/re-appointments/resignations of Directors No. Meetings
Mr R A Shah Non-Executive, 7 7 Yes 113 73 during the year under review. 2017-18
Independent Director Held Attended
FAMILIARISATION PROGRAMS FOR INDEPENDENT
Mr Kaiyomarz Marfatia Non-Executive Director 7 7 Yes NIL NIL Mr R A Shah Independent
DIRECTORS 1.
Chairman Director
5 5

Mr Krishna Mohan Sahni Non-Executive, 7 7 Yes NIL NIL As a part of Induction and Continuing Education Program for Non-Executive
Independent Director 2. Mr Munir Shaikh 5 4
Independent Directors, periodic presentations are made by the Director
Mr Rajiv Sonalker Executive Director 7 4 NA NIL NIL Managing Director/Commercial Directors/Function Heads at Independent
3. Mr Krishna Mohan Sahni 5 5
Whole-time Director the Board Meetings to apprise the Directors with the Company’s Director
(appointed effective August 8, 2017) business strategies, long term plans, budgets, operations and Independent
4. Ms Anisha Motwani1 NA NA
performance. In addition, these presentations also provide insight Director
Ms Anisha Motwani Non-Executive, 7 NA NA 54 2
(appointed effective April 25, 2018) Independent Director into various growth opportunities for the Company, operational Mr Ranjan Kapur
Independent
and environmental challenges associated with the Company’s 5. (ceased to be a Member 5 3
Director
Mr Sachin Dharap Non-Executive Director 7 2 Yes NIL NIL effective January 27, 2018)
business operations, products, Management’s risk mitigation
(resigned effective August 8, 2017)
plans, human resources updates, etc. 1. appointed as a Member effective May 14, 2018.
Mr Ranjan Kapur Non-Executive, 7 4 Yes 6 5
1 The Directors are regularly briefed on the Company’s policies
(demised on January 27, 2018) Independent Director Ms Krupa Anandpara, Company Secretary is the Secretary of the
and procedures, with regards to distribution channels, business Committee.
Mr Bhasker Iyer Non-Executive Director 7 7 Yes NIL NIL model, cash and treasury management, accounting systems and
(resigned effective March 31, 2018) SX^O\XKV XKXMSKV MYX^\YV] O^M :VKX^ `S]S^ S] K\\KXQON PY\ ^RO Role :
Directors to acquaint them with the manufacturing process and
Ms Nancy Berce Non-Executive Director 7 2 Yes NIL NIL The role of the Committee includes :
(resigned effective March 31, 2018) the products manufactured in-house.
The Company also arranges various knowledge dissemination w  `O\]SQR^ YP ^RO -YWZKXct] XKXMSKV \OZY\^SXQ Z\YMO]] KXN
Y
1. Includes directorship in private companies, alternate directorship and directorship in foreign companies. However, it does not include the directorships in ^RONS]MVY]_\OYPS^] XKXMSKVSXPY\WK^SYX^YOX]_\O^RK^^RO
companies registered under Section 8 of the Companies Act, 2013. sessions by external faculty to keep the Independent Directors
updated with the current happenings, relevant news and legal/ XKXMSKV]^K^OWOX^]K\OMY\\OM^]_P MSOX^KXNM\ONSLVO%
2. Includes Membership/Chairmanship of Audit Committee and Stakeholders Relationship Committee.
regulatory changes. w \ OMYWWOXNK^SYXPY\KZZYSX^WOX^\OW_XO\K^SYXKXN^O\W]YP
3. Mr R A Shah holds directorship in 9 other public companies, 1 private company and 1 foreign company. His directorships include Chairmanship of 3 companies
and Vice-Chairmanship of 1 company and 1 alternate directorship. His Committee positions include Chairmanship of 4 committees.
Details of such programs conducted by the Company for the appointment of auditors of the Company;
4. Ms Anisha Motwani holds directorship in 4 other public companies and 1 private company. XKXMSKVcOK\!"K\OK`KSVKLVOYX^ROaOL]S^OYP^RO-YWZKXc w K ZZ\Y`KV YP ZKcWOX^ ^Y ]^K^_^Y\c K_NS^Y\] PY\ KXc Y^RO\
5. Mr Ranjan Kapur ceased to be Director due to his sad demise on January 27, 2018. He held directorships in 1 other public company and 5 private companies. at http://www.abbott.co.in/investor-relations/policies.html services rendered by them;

84 ANNUAL REPORT 2017-18 85


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ^RO KXX_KV XKXMSKV w discussion with statutory auditors before the audit The composition of the Nomination and Remuneration The Role of the Committee in relation to Remuneration matters
statements and auditor’s report thereon before submission to commences, about the nature and scope of audit as well as Committee, category of its Members and their attendance at the include :
the Board for approval, with particular reference to : post-audit discussion to ascertain any areas of concern; Committee Meetings held during the year under review is given w \ OMYWWOXN^Y^RO,YK\NKZYVSMc\OVK^SXQ^Y^RO\OW_XO\K^SYX
w ^YVYYUSX^Y^RO\OK]YX]PY\]_L]^KX^SKVNOPK_V^]SX^ROZKcWOX^ in the table below : for the Directors, Key Managerial Personnel and other
a) matters required to be included in the Directors’
to the depositors, debenture holders, members (in case of employees. The Committee shall, while formulating the
Responsibility Statement to be included in the Board’s Sr. Name of the Member Category Number of
non-payment of declared dividends) and creditors; policy ensure that :
Report in terms of clause (c) of sub-section 3 of No. Meetings
Section 134 of the Companies Act, 2013; 2017-18 - the level and composition of remuneration is reasonable
w KZZ\Y`KV YP KZZYSX^WOX^ YP -RSOP 0SXKXMSKV 9P MO\ SO ^RO
Held Attended KXN]_P MSOX^^YK^^\KM^\O^KSXKXNWY^S`K^ONS\OM^Y\]YP
b) changes, if any, in accounting policies and practices and Whole-time Finance Director or any other person heading the
the quality, required to run the company successfully;
reasons for the same; XKXMOP_XM^SYXY\NS]MRK\QSXQ^RK^P_XM^SYXKP^O\K]]O]]SXQ^RO 1. Mr R A Shah1 Independent
4 4
Chairman Director - relationship of remuneration to performance is clear and
[_KVS MK^SYX]ObZO\SOXMOKXNLKMUQ\Y_XNO^MYP^ROMKXNSNK^O%
c) major accounting entries involving estimates based on Non-Executive meets appropriate performance benchmarks; and
w \ O`SOaSXQ ^RO P_XM^SYXSXQ YP ^RO @SQSV 7OMRKXS]WARS]^VO 2. Mr Munir Shaikh 4 4
the exercise of judgment by management; Director - remuneration to Directors, Key Managerial Personnel
Blower Mechanism;
 N ] SQXS MKX^KNT_]^WOX^]WKNOSX^RO XKXMSKV]^K^OWOX^] 3. 2 Independent
NA NA
and the Senior Management involves a balance between
Ms Anisha Motwani Director
w M K\\cSXQY_^KXcY^RO\P_XM^SYX]K]WKcLOZ\O]M\SLON_XNO\ bON KXN SXMOX^S`O ZKc \O
OM^SXQ ]RY\^ KXN VYXQ^O\W
K\S]SXQY_^YPK_NS^ XNSXQ]%
the Companies Act, 2013, Rules framed thereunder and Mr Ranjan Kapur performance objectives appropriate to the working of the
Independent
e) compliance with listing and other legal requirements Regulation 18 of the Securities and Exchange Board of 4. (ceased to be a Member
Director
4 3 company and its goals.
\OVK^SXQ^Y^RO XKXMSKV]^K^OWOX^]% effective January 27, 2018)
India (Listing Obligations and Disclosure Requirements) w \ OMYWWOXN^Y^RO,YK\NKVV\OW_XO\K^SYXSXaRK^O`O\PY\W
Regulations, 2015 or as may be delegated by the Board, from Mr Bhasker Iyer payable to the Senior Management;
f) disclosure of any related party transactions; Non-Executive
time to time. 5. (ceased to be a Member 4 4
Director
effective March 31, 2018) w ^YMYX]SNO\KXcY^RO\WK^^O\]K]WKcLONOVOQK^ONLc^RO,YK\N
 Q WYNS ONYZSXSYX]SX^RON\KP^K_NS^\OZY\^% The Committee also reviews various information prescribed
1. appointed as a Chairman effective April 25, 2018. Meetings :
w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ^RO [_K\^O\Vc XKXMSKV under Part C of Schedule II as referred in Regulation 18(3) of the
2. appointed as a Member effective April 25, 2018.
statements before submission to the Board for approval; Securities and Exchange Board of India (Listing Obligations and During the year under review, the Committee met 4 times on the
Disclosure Requirements) Regulations, 2015. Ms Krupa Anandpara, Company Secretary, is the Secretary of the following dates :
w \ O`SOaSXQ KXN WYXS^Y\SXQ ^RO K_NS^Y\t] SXNOZOXNOXMO KXN Committee.
performance and effectiveness of audit process; Meetings : May 19, 2017; July 18, 2017; August 8, 2017 and March 27, 2018.
During the year under review, the Committee met 5 times on the Role :
w K ZZ\Y`KV Y\ KXc ]_L]O[_OX^ WYNS MK^SYX YP ^\KX]KM^SYX] YP Mr Ranjan Kapur, then Chairman of the Committee attended the
the Company with related parties; following dates : The Role of the Committee in relation to Nomination matters Annual General Meeting of the Company to answer the Shareholders’
May 19, 2017; August 8, 2017; November 13, 2017; December 19, include : queries in compliance with the requirements of Regulation 19(3) of
w ]M\_^SXcYPSX^O\MY\ZY\K^OVYKX]KXNSX`O]^WOX^]% the Securities and Exchange Board of India (Listing Obligations and
2017 and February 14, 2018.
w P Y\W_VK^SXQ M\S^O\SK PY\ SNOX^SPcSXQ ]_S^KLVO MKXNSNK^O] PY\ Disclosure Requirements) Regulations, 2015.
w ` KV_K^SYXYP_XNO\^KUSXQ]Y\K]]O^]YP^RO-YWZKXcaRO\O`O\
>RO -RSOP 0SXKXMSKV 9P MO\ \OWKSX] Z\O]OX^ K^ KVV ^RO +_NS^ directors and senior management;
it is necessary; Performance Evaluation Criteria for Independent Directors :
Committee Meetings. All the meetings are attended by the
w O `KV_K^SYXYPSX^O\XKV XKXMSKVMYX^\YV]KXN\S]UWKXKQOWOX^ Statutory Auditors. Internal and Cost Auditors are invited to the w S NOX^SPc ZO\]YX] aRY K\O [_KVS ON ^Y LOMYWO NS\OM^Y\] The Company has devised Board Evaluation Framework and
systems; Meetings, as and when required. and appointed as the senior management in accordance Policy, which sets a mechanism and criteria for the evaluation
with criteria laid down and recommend to the Board their of the Board, Board Committees and Directors, including
w  YXS^Y\SXQ^ROOXN_]OYPP_XN]\KS]ON^R\Y_QRZ_LVSMYPPO\]
W Mr R A Shah, Chairman of the Audit Committee attended the Independent Directors.
appointment and removal;
and related matters; Annual General Meeting held on July 18, 2017 in compliance
with the requirements of Regulation 18(1)(d) of the Securities w P Y\W_VK^SXQ ^RO M\S^O\SK PY\ NO^O\WSXSXQ ^RO [_KVS MK^SYX] Performance Evaluation of the Directors is done through
w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ZO\PY\WKXMO YP ]^K^_^Y\c self-assessment and group discussions, based on suggested
and Exchange Board of India (Listing Obligations and Disclosure positive attributes and independence of a director;
and internal auditors, adequacy of the internal control set of parameters such as Directors’ attendance and effective
Requirements) Regulations, 2015.
systems; w NO`S]SXQZYVSMcYX^RONS`O\]S^cYP^RO,YK\N% participation at Board/Committee Meetings, their contribution
NOMINATION AND REMUNERATION COMMITTEE at the meetings, leveraging on his/her experience to provide the
w \ O`SOaSXQ ^RO KNO[_KMc YP SX^O\XKV K_NS^ P_XM^SYX SP KXc w P Y\W_VK^SXQ ^RO M\S^O\SK PY\ O`KV_K^SYX YP ZO\PY\WKXMO YP necessary insights/guidance on Board discussions and display of
including the structure of the internal audit department, The composition, role, terms of reference as well as powers of the Board, its Committees and individual Directors and review candour in expressing views even when they are in divergence
]^KP XQKXN]OXSY\S^cYP^ROYP MSKVROKNSXQ^RONOZK\^WOX^ Nomination and Remuneration Committee of the Company are in its implementation and compliance and whether to extend or with the rest of the Board, etc.
reporting structure, coverage and frequency of internal audit; compliance with the provisions of Section 178 of the Companies continue the term of appointment of the independent director
Act, 2013 and Regulation 19 of the Securities and Exchange Board STAKEHOLDERS RELATIONSHIP COMMITTEE
w  S]M_]]SYX aS^R SX^O\XKV K_NS^Y\] YP KXc ]SQXS MKX^ XNSXQ]
N on the basis of such assessment;
of India (Listing Obligations and Disclosure Requirements) The composition, role, terms of reference as well as powers of
and follow up thereon;
Regulations, 2015. w O X]_\SXQ^RK^^RO\OS]KXKZZ\YZ\SK^OSXN_M^SYXZ\YQ\KWWOSX the Stakeholders Relationship Committee of the Company are in
w \ O`SOaSXQ ^RO XNSXQ] YP KXc SX^O\XKV SX`O]^SQK^SYX] Lc ^RO place for new directors and reviewing its effectiveness; compliance with the provisions of Section 178 of the Companies
Composition : Act, 2013 and Regulation 20 of the Securities and Exchange
internal auditors into matters where there is suspected fraud
or irregularity or a failure of internal control systems of a w ^ Y MYX]SNO\ KXc Y^RO\ WK^^O\] K] WKc LO NOVOQK^ON Lc ^RO Board of India (Listing Obligations and Disclosure Requirements)
The Committee comprises 2 Independent Directors and
material nature and reporting the matter to the Board; 1 Non-Executive Director as on the date of this Report. Board. Regulations, 2015.

86 ANNUAL REPORT 2017-18 87


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Composition : Summary of Shareholders’ Grievances : Role : Sr. Name of the Member Category Number of
No. Meetings
The Committee comprises 1 Independent Director, A summary of complaints received and resolved by the Company The role of the Committee includes : 2017-18
1 Non-Executive Director and 1 Executive Director, as on the to the satisfaction of the shareholders/investors during the
w P Y\W_VK^O KXN \OMYWWOXN PY\ ^RO KMMOZ^KXMO YP ^RO ,YK\N Held Attended
date of this Report. year under review, is given below :
the Corporate Social Responsibility Policy (“CSR Policy”) Mr Ambati Venu Managing
1. 1 1
The composition of the Stakeholders Relationship Committee, Particulars Number interalia, to include the CSR activities, specify the modalities Chairman Director
category of its Members and their attendance at the Committee of execution, implementation schedules and recommend the Non-Executive
Pending at the beginning of the year - 2. Mr Kaiyomarz Marfatia 1 1
Meetings held during the year under review is given in the same to the Board of Directors; Director
table below : Received during the year 6* Independent
w S NOX^SPc ^RO -=< Z\YTOM^]KM^S`S^SO]Z\YQ\KW] ^Y LO 3. Mr Krishna Mohan Sahni 1 1
Resolved during the year 4 undertaken by the Company (“CSR activities”), in alignment Director
Sr. Name of the Member Category Number of
No. Meetings with Company’s CSR Policy and Schedule VII of the 4. Mr Rajiv Sonalker
Whole-time
1 1
Pending at the end of the year 2
2017-18 Companies Act, 2013; Director
Held Attended * includes 1 letter received from the Ministry of Corporate Affairs and Mr Sachin Dharap
w \ O`SOa LO]^ Z\KM^SMO] SX ^RO UOc -=< K\OK] Lc KZZ\YZ\SK^O Non-Executive
1. Mr Kaiyomarz Marfatia1 Non-Executive 4 4 4 letters from the Securities and Exchange Board of India (SCORES). 5. (ceased to be a Member 1 NA
Director internal/external analysis; Director
Chairman effective August 8, 2017)
Independent As on March 31, 2018, there were no pending share transfers. w \ OMYWWOXN^ROKWY_X^YPObZOXNS^_\O^YLOSXM_\\ONYX^RO
2. Mr R A Shah 4 4 Ms Krupa Anandpara, Company Secretary, is the Secretary
Director
-=<KM^S`S^SO]PY\OKMR XKXMSKVcOK\YP^RO-YWZKXc% of the Committee.
Managing CORPORATE SOCIAL RESPONSIBILITY COMMITTEE
3. Mr Ambati Venu 4 4 w  O`S]O ]_S^KLVO ^\KX]ZK\OX^ 7YXS^Y\SXQ 7OMRKXS]W PY\
N
Director The composition, role, terms of reference as well as powers of Role :
Mr Bhasker Iyer the Corporate Social Responsibility (“CSR”) Committee of the monitoring progress/status of implementation of the CSR
(ceased to be a Chairman/ Non-Executive Company are in compliance with the provisions of Section 135 activities; The role of the Committee includes :
4. 4 4
Member effective Director of the Companies Act, 2013 and Companies (Corporate Social w \ OMOS`O \OZY\^] KXN \O`SOa KM^S`S^SO] P\YW ObOM_^S`O KXN w WYXS^Y\SXQKXNSWZVOWOX^SXQ<S]U7KXKQOWOX^:VKX]%
March 31, 2018) Responsibility Policy) Rules, 2014. specialist groups managing CSR activities;
1. appointed as a Chairman effective May 14, 2018. w O X]_\O^RK^^ROKNO[_KMcYP^RO-YWZKXct]<S]U7KXKQOWOX^
Composition : w  YXS^Y\-=<:YVSMcP\YW^SWO^Y^SWOKXN\O`S]O^RO]KWOK]
W
Ms Krupa Anandpara, Company Secretary, is the Secretary of Framework is being assessed and that action is taken if it is
The Committee comprises 1 Independent Director, and when needed;
^RO -YWWS^^OO =RO KV]Y KM^] K] ^RO -YWZVSKXMO 9P MO\ YP ^RO inadequate;
Company. 1 Non-Executive Director and 1 Executive Director, as on the w M K\\c Y_^ ]_MR Y^RO\ P_XM^SYX] K] WKc LO Z\O]M\SLON Lc ^RO
date of this Report. Companies Act, 2013 or CSR Rules or as may be delegated by w \ OZY\^SXQ <S]U 7KXKQOWOX^ KM^S`S^SO] KXN SXPY\WK^SYX
Role : the Board, from time to time. including top risks and mitigation, to the Audit Committee
The composition of the Corporate Social Responsibility
The role of the Committee includes : and Board;
Committee, category of its Members and their attendance at the Meetings :
w \ O]ZYXN^Y^ROQ\SO`KXMO]SXQOXO\KVKXN\OVK^SXQ^Y^\KX]PO\ Committee Meetings held during the year under review is given w  XNO\]^KXN ^RO ]SQXS MKX^ Y\ RSQR \S]U] KPPOM^SXQ -YWZKXc
_
in the table below : During the year under review, the Committee met 3 times on the and ensuring that processes to mitigate them are effective;
transmission and transposition of shares, non-receipt of
declared dividends, interest, non-receipt of Annual Report, following dates :
Sr. Name of the Member Category Number of w \ O`SOaSXQKXNKWOXNSXQ<S]U7KXKQOWOX^0\KWOaY\UP\YW
duplicate, split, consolidation and re-materialisation of share May 19, 2017; August 8, 2017 and November 13, 2017.
No. Meetings time to time;
MO\^S MK^O]O^MYPKVVWOWLO\]SXK^SWOLY_XNWKXXO\%
2017-18
w  YXS^Y\KXN\O`SOa^ROZO\PY\WKXMOKXN]O\`SMO]^KXNK\N]YP
W RISK MANAGEMENT COMMITTEE w  ^RO\P_XM^SYX]K]WKcLONOVOQK^ONLc^RO,YK\NP\YW^SWO^Y
Y
Held Attended
the Registrar and Share Transfer Agent of the Company and The composition, role, terms of reference as well as powers of time.
1. Mr Munir Shaikh Non-Executive 3 3
provide continuous guidance to improve the service levels for Risk Management Committee of the Company are in compliance Meetings :
Chairman Director
members and other security holders; with the provisions of Regulation 21 of the Securities and
2. Mr Krishna Mohan Sahni Independent 3 3 During the year under review, the Committee met once on
w O X]_\O [_SMU \ON\O]]KV YP ^RO MYWZVKSX^] \OMOS`ON P\YW Exchange Board of India (Listing Obligations and Disclosure
Director
Requirements) Regulations, 2015. February 14, 2018.
Members and other security holders and maintain cordial 3. Mr Ambati Venu Managing 3 3
relations with them; Director REMUNERATION OF DIRECTORS
Composition :
w  YXS^Y\^ROX_WLO\YPQ\SO`KXMO]\OMOS`ON\O]YV`ONY\ZOXNSXQ
W 4. Mr Ranjan Kapur Independent 3 2
at the beginning and end of the quarter and from time to time. (ceased to be a Member Director The Committee comprises 1 Independent Director, Executive Directors
effective January 27, 2018) 1 Non-Executive Director and 2 Executive Directors as on the
Meetings : The Executive Directors are paid remuneration in accordance
5. Mr Sachin Dharap Non-Executive 3 1 date of this Report.
with the limits prescribed under the Companies Act, 2013 and
During the year under review, the Committee met 4 times on the (ceased to be a Member Director
The composition of the Risk Management Committee, the Remuneration Policy of the Company. Such remuneration is
following dates : effective August 8, 2017)
category of its Members, their attendance at the Committee considered and approved by the Nomination and Remuneration
May 19, 2017; August 8, 2017; November 13, 2017 and Ms Krupa Anandpara, Company Secretary, is the Secretary Meetings held during the year under review is given in the Committee, the Board of Directors and the Shareholders of the
February 14, 2018. of the Committee. table below : Company.

88 ANNUAL REPORT 2017-18 89


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Details of remuneration paid to the Executive Directors are as follows : The said Policy is available on the website of the Company at `SS-Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38
(` in Lakhs) http://www.abbott.co.in/investor-relations/policies.html Adequate L24239MH1944PLC007330
safeguards are provided against victimization of director(s) or
Terms of Agreement Mr Ambati Venu Mr Rajiv Sonalker viii) 3X^O\XK^SYXKV=OM_\S^SO]3NOX^S MK^SYX8_WLO\3=38
employee(s) or any other person who raises concerns using such
Managing Director Whole-time Director
mechanism. INE358A01014
(w.e.f. August 8, 2017)
Period of appointment 5 years 2 years No employee has been denied access to the Audit Committee. ix) Stock Code (BSE)
500488
Date of appointment September 29, 2016 August 8, 2017 MEANS OF COMMUNICATION
Salary & Other Allowances 2,94.88 95.29 a) The quarterly, half-yearly and annual results are published x) Market Price Data (High/Low) on BSE
in one English daily newspaper (Business Standard - pan (`)
Perquisites 1,73.33 33.28
India) and one Marathi newspaper (Loksatta) published from Month High Low
Contribution to Provident Fund 12.40 5.41 Mumbai. The quarterly results/shareholding patterns/notice April, 2017 4,863.60 4,356.00
Performance Linked Incentive 1,05.28 27.66 YP,YK\N7OO^SXQ]YP MSKVXOa]\OVOK]OK\OWKNOK`KSVKLVOYX May, 2017 4,441.05 3,996.00
the website of the Company at www.abbott.co.in June, 2017 4,426.95 4,120.00
Notice Period Three Months Three Months
b) During the year under review, the Company has, upon July, 2017 4,615.00 4,170.00
Severance Fees There is no separate provision for payment of severance fees.
request, met a few institutional investors in one-on-one August, 2017 4,478.15 4,151.00
Stock Option The Company does not have any Stock Option Plan for its employees. However, Managing Director and meetings and group meetings. No presentations were made to September, 2017 4,280.00 4,035.00
Whole-time Director are entitled to Restricted Stock Units of Abbott Laboratories, USA under its “Long Term the institutional investors/analysts. October, 2017 4,420.00 4,100.00
3XMOX^S`O:\YQ\KWv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O+V]Y\OPO\XY^O#MYP XKXMSKV]^K^OWOX^]
November, 2017 5,401.30 4,210.15
GENERAL SHAREHOLDER INFORMATION
December, 2017 5,707.20 5,167.05
Non-Executive Directors i) Annual General Meeting January, 2018 5,666.00 5,210.00
During the year under review, Mr Munir Shaikh, Mr R A Shah, Mr Ranjan Kapur and Mr Krishna Mohan Sahni were paid sitting Wednesday, July 18, 2018 at 3.30 p.m. February, 2018 6,109.95 5,243.90
fees amounting to ` 13.50 Lakhs, ` 17.00 Lakhs, ` 10.50 Lakhs and ` 15.00 Lakhs respectively, for attending Board Meetings and RAMA WATUMULL AUDITORIUM, K C College, March, 2018 5,895.00 5,300.00
various Committee Meetings. 124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani
Chowk, Churchgate, Mumbai - 400 020 xi) Performance in comparison to broad based indices
None of the Non-Executive Directors had any pecuniary relationship or transactions with the Company. Mr R A Shah is a Partner of April 1, 2017 to March 31, 2018
M/s Crawford Bayley & Co. During the year, the Company availed various professional services from M/s Crawford Bayley & Co. ii) Financial year
Normalised (100)
and remitted ` 4.93 Lakhs towards the same. The quantum of professional fees received by M/s Crawford Bayley & Co., from the April 1, 2017 to March 31, 2018
Company forms a very small portion of the total revenues of M/s Crawford Bayley & Co and also a marginal portion of total revenue
of the Company. iii) Book Closure Abbo� Stock Price Sensex Healthcare Index
Thursday, July 12, 2018 to Wednesday, July 18, 2018
140
GENERAL BODY MEETINGS (both days inclusive)
130
Financial Date Time Location No. of Special Resolutions iv) E-Voting Period 120
Year 110
From 9.00 a.m. (IST) on Sunday, July 15, 2018
100
2016-17 July 18, 2017 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, - Upto 5.00 p.m. (IST) on Tuesday, July 17, 2018
90
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk,
v) Dividend Payment Date 80
Churchgate, Mumbai – 400 020

8
On and from July 24, 2018

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1
2015-16 July 18, 2016 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, 1

04

05

06

07

08

09

10

11

12

01

02

03
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk, (Re-appointment of Mr R A Shah as vi) Listing on Stock Exchange
Churchgate, Mumbai – 400 020 Independent Director) xii) Registrar and Share Transfer Agent
BSE Limited
2014-15 July 29, 2015 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, 1 Phiroze Jeejeebhoy Towers Karvy Computershare Private Limited
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk, (Approval of Related Party Dalal Street Unit : Abbott India Limited
Churchgate, Mumbai – 400 020 Transactions with Abbott Products Mumbai – 400 001
Operations AG., Switzerland) Karvy Selenium Tower B, B-24, Rajabhadur Mansion,
Telephone No.: +91-22-2272 1233/4, +91-22-6654 5695 Plot 31-32, Gachibowli, 6, Ambalal Doshi Marg,
During the year, no special resolutions were passed through postal ballot. Fax : +91-22-2272 1919 Financial District, Nanakramguda, Behind BSE Limited,
Website : www.bseindia.com Hyderabad – 500 032 Fort, Mumbai - 400 001
As on date, there is no special resolution proposed to be conducted through postal ballot. Tel No: +91-40-6716 2222; Tel No: +91-22-6623 5412
Email : corp.relations@bseindia.com
Fax No: +91-40-2344 0674
VIGIL MECHANISM/WHISTLE BLOWER POLICY   RO KXX_KV VS]^SXQ POO] PY\ ^RO XKXMSKV cOK\ !" aK]
> Email : einward.ris@karvy.com
The Company has the Vigil Mechanism/Whistle Blower Policy called “Abbott India Limited – Procedure for Internal Investigations” paid to the BSE Limited as per Regulation 14 of the of the Website : www.karvycomputershare.com
in place, in terms of the requirements of the Companies Act, 2013 and Regulation 22 of the Securities and Exchange Board of India Securities and Exchange Board of India (Listing Obligations Details of various centres of Karvy are available on
(Listing Obligations and Disclosure Requirements) Regulations, 2015. and Disclosure Requirements) Regulations, 2015. www.karvycomputershare.com

90 ANNUAL REPORT 2017-18 91


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

xiii) Share Transfer System xvi) Disclosure in respect of equity shares transferred in xviii) Dematerialisation of Shares as on March 31, 2018 and OTHER DISCLOSURES
“Abbott India Limited - Unclaimed Suspense Account” liquidity a) There were no Related Party Transactions entered into by the
Share Transfer Committee comprising the Directors
in terms of Regulation 39(4) and Schedule VI of the
KXN YP MSKV] YP ^RO -YWZKXc K^^OXN ^Y ^RO ]RK\O ^\KX]PO\ The shares of the Company are compulsorily traded in -YWZKXcN_\SXQ^ROcOK\^RK^RKNZY^OX^SKVMYX
SM^aS^R^RO
Securities and Exchange Board of India (Listing
formalities at least once in a fortnight. The said Committee electronic mode and are available for trading with both the interests of the Company at large.
Obligations and Disclosure Requirements) Regulations,
KV]Y MYX]SNO\] \O[_O]^] \OMOS`ON PY\ N_ZVSMK^O MO\^S MK^O] depositories in India namely, National Securities Depository
2015 is as under : b) Policies on dealing with Related Party Transactions and
split / consolidation, dematerialisation, rematerialisation, Limited (NSDL) and Central Depository Services (India)
transfer and transmission of shares. Materiality and on Determination of Materiality of Event or
No. of No. of Limited (CDSL).
Information for Disclosure are disclosed on the website of
Share transfer requests received at the Registrar & Share Particulars Shareholders Equity
2,07,20,738 Equity Shares representing 97.51% of the the Company at http://www.abbott.co.in/investor-relations/
Transfer Agent are normally processed and delivered within Shares
Company’s total paid-up share capital were held in policies.html
15 days from the date of lodgement in cases where documents Aggregate number of shareholders 191 24,671 dematerialised mode, as on March 31, 2018.
are complete and in order. Requests for dematerialisation and the outstanding shares in the c) In the preparation of Financial Statements, no differential
YP ]RK\O] K\O Z\YMO]]ON KXN ^RO MYX \WK^SYX S] QS`OX ^Y Unclaimed Suspense Account lying as xix) The Company has not issued any GDR/ADR or Warrants treatment from that prescribed in the Accounting Standards
the depositories within 15 days from the date of receipt of on April 1, 2017 or any other convertible instruments. has been followed.
complete set of documents. Number of shareholders who NIL NIL
xx) Foreign Exchange risk and hedging activities d) Pursuant to the disclosures made by the Senior Management
approached the Company for transfer
xiv) Distribution of Shareholding as on March 31, 2018 of shares and shares transferred from ^Y^RO,YK\N^RO\OaO\OXYWK^O\SKV XKXMSKVKXNMYWWO\MSKV
The Company has foreign exchange exposure and hedging is
Distribution No. of % to Total No. of % to suspense account during the year NYXOPY\K]SQXS MKX^ZY\^SYXYP^RO]KWO transactions entered into by them where they have personal
Shareholders Shares held Total Number of shareholders and aggregate NIL NIL SX^O\O]^ KXN aRSMR MY_VN RK`O ZY^OX^SKV MYX
SM^ aS^R ^RO
xxi) Plant Location
(1) (2) (3) (4) (5) number of shares transferred to the interest of the Company at large.
Upto 500 21,277 94.22 13,81,978 6.50 Unclaimed Suspense Account during L-18/19, Verna Industrial Estate, Goa
the year e) There were no instances of non-compliance by the Company,
501 to 1000 690 3.05 4,94,422 2.33 xxii) Address for correspondence no penalties/strictures imposed on the Company by the Stock
Aggregate number of shareholders 191 24,671
1001 to 2000 351 1.55 5,04,558 2.37 Abbott India Limited Exchange or the Securities and Exchange Board of India or
and outstanding shares in the
2001 to 3000 111 0.49 2,72,548 1.30 Unclaimed Suspense Account lying as CIN : L24239MH1944PLC007330 any statutory authority on any matters related to the capital
3001 to 4000 50 0.22 1,75,228 0.82 on March 31, 2018 markets during the last three years.
4001 to 5000 33 0.15 1,49,769 0.70 <OQS]^O\ONYP MO$ -Y\ZY\K^O9P MO$
+VV LOXO ^] KMM\_SXQ YX ]_MR ]RK\O] ]RKVV LO M\ONS^ON ^Y f) In terms of requirement of Regulation 17(8) of the Securities
5001 to 10000 31 0.14 2,21,167 1.04
Shares Department Shares Department
Unclaimed Suspense Account for a period of seven years. and Exchange Board of India (Listing Obligations and
3, Corporate Park, 16th Floor, Godrej BKC,
ABOVE 10000 40 0.18 1,80,49,632 84.94 >RO\OKP^O\ ^RO ]KSN ]RK\O] SXMV_NSXQ KVV LOXO ^] KMM\_ON Disclosure Requirements) Regulations, 2015, Chief Executive
Sion-Trombay Road, Plot C – 68, ‘’G’’ Block,
TOTAL 22,583 100.00 2,12,49,302 100.00 thereon shall be transferred by the Company to IEPF 9P MO\ -/9 KXN -RSOP 0SXKXMSKV 9P MO\ -09 RK`O WKNO
Mumbai – 400 071 Bandra-Kurla Complex,
Authority in accordance with provisions of Section 124(5) K MO\^S MK^SYX ^Y ^RO ,YK\N YP .S\OM^Y\] SX ^RO Z\O]M\SLON
Tel No: +91-22-6797 8888 Near MCA Club, Bandra (East),
xv) Shareholding Pattern as on March 31, 2018 and (6) of the Companies Act, 2013 and Rules framed format, which has been reviewed by the Audit Committee and
Fax: +91-22-6797 8727 Mumbai – 400 051
thereunder. The voting rights in respect of such shares taken on record by the Board.
Category of Shareholders No. of Shares % to Total Tel No: +91-22-3816 2000
shall remain frozen till the rightful owner claims such
Promoters 1,59,34,048 74.99 Fax: +91-22-3816 2400 g) Code of Business Conduct for Board of Directors and Senior
Equity Shares.
Banks 5,637 0.03 Management lays down various principles of ethics and
Email : investorrelations.india@abbott.com
Financial Institutions 1,00,881 0.47 xvii) In terms of requirements of Section 124(6) of the Companies compliance. The Code has been posted on the Company’s website
Website : www.abbott.co.in
Foreign Institutional Investors 26,442 0.12 Act, 2013 read with the Investor Education and Protection at http://www.abbott.co.in/investor-relations/policies.html
Foreign Portfolio Corporation 5,98,494 2.82 Fund Authority (Accounting, Audit, Transfer and Refund) Karvy Computershare Private Limited
Insurance Companies 39,631 0.19 Rules, 2016, all shares in respect of which dividend has not Unit : Abbott India Limited h) The Company has complied with all the mandatory
Mutual Funds 11,30,435 5.32 been paid or claimed for 7 (seven) consecutive years or more requirements of the Securities and Exchange Board of
are required to be transferred to Investor Education and Karvy Selenium Tower B, B-24, Rajabhadur Mansion, India (Listing Obligations and Disclosure Requirements)
Domestic Companies 1,36,691 0.64
Protection Fund Authority (“IEPF Authority”). Plot 31-32, Gachibowli, 6, Ambalal Doshi Marg, Regulations, 2015.
Non-Domestic Companies 471 00.0
Financial District, Behind BSE Limited,
Non-Resident Indians 82,350 0.39 Accordingly, 51,809 Equity Shares held by 317 Shareholders Nanakramguda, Fort, Mumbai - 400 001 i) The Company has complied with all the Corporate Governance
Directors & Relatives 6,874 0.03 were transferred to the IEPF Authority in November, 2017. Hyderabad – 500 032 Tel No: +91-22-6623 5412 \O[_S\OWOX^]]ZOMS ONSX<OQ_VK^SYX]!^YKXN^Y!KXN
Unclaimed Suspense Account 24,671 0.12 No claims have been received till date. clauses (b) to (i) of sub-regulation (2) of Regulation 46 of the
Tel No: +91-40-6716 2222
Investor Education and Protection 51,809 0.24 Fax No: +91-40-2344 0674 Securities and Exchange Board of India (Listing Obligations
The details of shares so transferred is available on the
Fund (IEPF) Authority and Disclosure Requirements) Regulations, 2015. As the
Company’s website under the Investor Section at http://
Others 31, 10,868 14.64 Email : einward.ris@karvy.com Company does not have any subsidiary, Regulation 24 is not
www.abbott.co.in/investor-relations/other-information/
TOTAL 2,12,49,302 100.00 unclaimed-dividend.html Website : www.karvycomputershare.com
applicable to the Company.

92 ANNUAL REPORT 2017-18 93


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Compliance with Discretionary requirements : >RO 1_SNKXMO 8Y^O YX <OZY\^] Y\ -O\^S MK^O] PY\ =ZOMSKV vi. Performed necessary inquiries with the management and
Purposes requires that we comply with the ethical KV]Y YL^KSXON XOMO]]K\c ]ZOMS M \OZ\O]OX^K^SYX] P\YW
i)  RO[_K\^O\VcKXNRKVPcOK\Vc XKXMSKV\O]_V^]K\OZ_LVS]RON
> ii) Reporting of Internal Auditors is directly to the management.
requirements of the Code of Ethics issued by the Institute of
in two newspapers as prescribed by the Securities Audit Committee. Chartered Accountants of India.
and Exchange Board of India (Listing Obligations SSS >
 RO -YWZKXc RK] S^] XKXMSKV ]^K^OWOX^] aS^R _XWYNS ON The above-mentioned procedures include examining
and Disclosure Requirements) Regulations, 2015, and 6. We have complied with the relevant applicable requirements evidence supporting the particulars in the Corporate
audit opinion.
are also available on the website of the Company at of the Standard on Quality Control (SQC) 1, Quality Control Governance Report on a test basis. Further, our scope of
For and on behalf of the Board
for Firms that Perform Audits and Reviews of Historical work under this report did not involve us performing audit
www.abbott.co.in In view of the above, the results were not
Financial Information, and Other Assurance and Related tests for the purposes of expressing an opinion on the
separately circulated to all the Members. Munir Shaikh R A Shah
Mumbai Chairman Director Services Engagements. PKS\XO]]Y\KMM_\KMcYPKXcYP^RO XKXMSKVSXPY\WK^SYXY\
May 14, 2018 DIN : 00096273 DIN : 00009851 ^RO XKXMSKV]^K^OWOX^]YP^RO-YWZKXc^KUOXK]KaRYVO
7. The procedures selected depend on the auditor’s judgement,
including the assessment of the risks associated in compliance Opinion
of the Corporate Governance Report with the applicable 8. Based on the procedures performed by us as referred in
DECLARATION UNDER SCHEDULE V(D) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA criteria. Summary of key procedures performed include : paragraph 7 above, and according to the information and
(LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 explanations given to us, we are of the opinion that the Company
i. Reading and understanding of the information prepared
As required under Schedule V(D) of the Securities and Exchange Board of India (Listing Obligations and Disclosure has complied with the conditions of Corporate Governance
by the Company and included in its Corporate Governance
<O[_S\OWOX^] <OQ_VK^SYX]  3 RO\OLc MYX \W ^RK^ KVV ^RO ,YK\N 7OWLO\] KXN =OXSY\ 7KXKQOWOX^ :O\]YXXOV YP ^RO as stipulated in the Listing Regulations, as applicable as at
Report;
-YWZKXcRK`OKP \WONMYWZVSKXMOaS^R^RO+LLY^^3XNSK-YNOYP,_]SXO]]-YXN_M^K]KZZVSMKLVO^Y^ROWPY\^ROcOK\OXNON March 31, 2018, referred to in paragraph 1 above.
March 31, 2018.  SS 9
 L^KSXONKXN`O\S ON^RK^^ROMYWZY]S^SYXYP^RO,YK\N
Other matters and Restriction on Use
of Directors w.r.t. Executive and Non-Executive Directors
has been met throughout the reporting period; 9. This report is neither an assurance as to the future viability of
Ambati Venu
March 31, 2018 Managing Director ^RO-YWZKXcXY\^ROOP MSOXMcY\OPPOM^S`OXO]]aS^RaRSMR
iii. Obtained and read the Directors Register as on March 31,
Mumbai DIN : 07614849 the Management has conducted the affairs of the Company.
"KXN`O\S ON^RK^K^VOK]^YXOAYWOX.S\OM^Y\aK]YX
the Board during the year; 10. This report is addressed to and provided to the Members of the
Company solely for the purpose of enabling it to comply with
INDEPENDENT AUDITOR’S REPORT ON COMPLIANCE WITH THE CONDITIONS OF CORPORATE GOVERNANCE iv. Obtained and read the Minutes of the following its obligations under the Listing Regulations with reference to
AS PER PROVISIONS OF CHAPTER IV OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING Committee Meetings held from April 1, 2017 to March 31, Corporate Governance Report accompanied with by a report
OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 2018 : thereon from the Statutory Auditors and should not be used
The Members of (a) Board of Directors Meeting; by any other person or for any other purpose. Accordingly,
Abbott India Limited we do not accept or assume any liability or any duty of care
3, Corporate Park, (b) Audit Committee; or for any other purpose or to any other party to whom it is
Sion-Trombay Road, shown or into whose hands it may come without our prior
(c) Annual General Meeting; consent in writing. We have no responsibility to update this
Mumbai – 400 071.
report for events and circumstances occurring after the date
(d) Nomination and Remuneration Committee;
1. The accompanying Corporate Governance Report prepared by 3. The Management along with the Board of Directors are also of this report.
Abbott India Limited (hereinafter the “Company”), contains responsible for ensuring that the Company complies with (e) Stakeholders Relationship Committee;
details as required by the provisions of Chapter IV of the For S R B C & CO LLP
the conditions of Corporate Governance as stipulated in the
Securities and Exchange Board of India (Listing Obligations (f ) Risk Management Committee; Chartered Accountants
Listing Regulations, issued by the Securities and Exchange
and Disclosure Requirements) Regulations, 2015, as amended ICAI Firm Registration Number: 324982E/E300003
Board of India. (g) Corporate Social Responsibility Committee;
(“the Listing Regulations”) (‘Applicable criteria’) with respect
to Corporate Governance for the year ended March 31, 2018. Auditor’s Responsibility (h) Independent Directors Meeting. per Ravi Bansal
This report is required by the Company for annual submission Partner
to the Stock Exchange and to be sent to the Shareholders of 4. Pursuant to the requirements of the Listing Regulations, our v. Obtained necessary representations and declarations Membership Number: 49365
the Company. responsibility is to express a reasonable assurance in the form from directors of the Company including the independent Place: Mumbai
of an opinion whether the Company has complied with the directors ; Date: May 14, 2018
Management’s Responsibility ]ZOMS M\O[_S\OWOX^]YP^RO6S]^SXQ<OQ_VK^SYX]\OPO\\ON^YSX
2. The preparation of the Corporate Governance Report is the paragraph 1 above.
responsibility of the Management of the Company including
5. We conducted our examination of the Corporate Governance
the preparation and maintenance of all relevant supporting
Report in accordance with the Guidance Note on Reports
records and documents. This responsibility also includes the
Y\ -O\^S MK^O] PY\ =ZOMSKV :_\ZY]O] KXN ^RO 1_SNKXMO 8Y^O
design, implementation and maintenance of internal control
relevant to the preparation and presentation of the Corporate YX -O\^S MK^SYX YP -Y\ZY\K^O 1Y`O\XKXMO Loth issued by
Governance Report. the Institute of Chartered Accountants of India (“ICAI”).

94 ANNUAL REPORT 2017-18 95


ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

INDEPENDENT AUDITOR’S REPORT


To the Members of Abbott India Limited +X K_NS^ SX`YV`O] ZO\PY\WSXQ Z\YMON_\O] ^Y YL^KSX K_NS^  N 3 X Y_\ YZSXSYX ^RO KPY\O]KSN 3XN += XKXMSKV S  RO -YWZKXc RK] NS]MVY]ON ^RO SWZKM^ YP
>
O`SNOXMO KLY_^ ^RO KWY_X^] KXN NS]MVY]_\O] SX ^RO XKXMSKV ]^K^OWOX^] MYWZVc aS^R ^RO +MMY_X^SXQ =^KXNK\N] ZOXNSXQVS^SQK^SYX]YXS^] XKXMSKVZY]S^SYXSXS^]
REPORT ON THE IND AS FINANCIAL STATEMENTS ]^K^OWOX^] >RO Z\YMON_\O] ]OVOM^ON NOZOXN YX ^RO K_NS^Y\t] ]ZOMS ON _XNO\ =OM^SYX  YP ^RO +M^ \OKN 3XN+= XKXMSKV]^K^OWOX^]x<OPO\8Y^O^Y
AORK`OK_NS^ON^ROKMMYWZKXcSXQ3XN+= XKXMSKV]^K^OWOX^] T_NQWOX^ SXMV_NSXQ ^RO K]]O]]WOX^ YP ^RO \S]U] YP WK^O\SKV with Companies (Indian Accounting Standards) ^RO3XN+= XKXMSKV]^K^OWOX^]
of Abbott India Limited (“the Company”), which comprise the WS]]^K^OWOX^YP^RO3XN+= XKXMSKV]^K^OWOX^]aRO^RO\N_O +WOXNWOX^<_VO] K]KWOXNON%
,KVKXMO=ROO^K]K^7K\MR"^RO=^K^OWOX^YP:\Y ^KXN   SS  RO -YWZKXc NSN XY^ RK`O KXc VYXQ^O\W
>
^YP\K_NY\O\\Y\3XWKUSXQ^RY]O\S]UK]]O]]WOX^]^ROK_NS^Y\
6Y]]SXMV_NSXQ^RO]^K^OWOX^YP9^RO\-YWZ\OROX]S`O3XMYWO  O 9
 X ^RO LK]S] YP a\S^^OX \OZ\O]OX^K^SYX] \OMOS`ON MYX^\KM^] SXMV_NSXQ NO\S`K^S`O MYX^\KM^] PY\
MYX]SNO\]SX^O\XKV XKXMSKVMYX^\YV\OVO`KX^^Y^RO-YWZKXct]
^RO -K]R 0VYa =^K^OWOX^ KXN ^RO =^K^OWOX^ YP -RKXQO] SX P\YW ^RO NS\OM^Y\] K] YX 7K\MR  " KXN ^KUOX aRSMR ^RO\O aO\O KXc WK^O\SKV PY\O]OOKLVO
Z\OZK\K^SYX YP ^RO 3XN += XKXMSKV ]^K^OWOX^] ^RK^ QS`O K
/[_S^cPY\^ROcOK\^ROXOXNONKXNK]_WWK\cYP]SQXS MKX^ on record by the Board of Directors, none of the VY]]O]
true and fair view in order to design audit procedures that
KMMY_X^SXQZYVSMSO]KXNY^RO\ObZVKXK^Y\cSXPY\WK^SYX NS\OM^Y\] S] NS][_KVS ON K] YX 7K\MR  " P\YW
K\O KZZ\YZ\SK^O SX ^RO MS\M_W]^KXMO] +X K_NS^ KV]Y SXMV_NO]   SSS >
 RO\O RK] LOOX XY NOVKc SX ^\KX]PO\\SXQ
LOSXQKZZYSX^ONK]KNS\OM^Y\SX^O\W]YP=OM^SYX 
O`KV_K^SXQ ^RO KZZ\YZ\SK^OXO]] YP KMMY_X^SXQ ZYVSMSO] _]ON amounts, required to be transferred, to the
MANAGEMENT’S RESPONSIBILITY FOR THE IND AS KXN ^RO \OK]YXKLVOXO]] YP ^RO KMMY_X^SXQ O]^SWK^O] WKNO Lc
YP^RO+M^%
3X`O]^Y\/N_MK^SYXKXN:\Y^OM^SYX0_XNLc^RO
FINANCIAL STATEMENTS ^RO -YWZKXct] .S\OM^Y\] K] aOVV K] O`KV_K^SXQ ^RO Y`O\KVV  P  A
 S^R\O]ZOM^^Y^ROKNO[_KMcYP^ROSX^O\XKV XKXMSKV -YWZKXc
>RO -YWZKXct] ,YK\N YP .S\OM^Y\] S] \O]ZYX]SLVO PY\ ^RO Z\O]OX^K^SYX YP ^RO 3XN += XKXMSKV ]^K^OWOX^] AO LOVSO`O MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ YP ^RO -YWZKXc
WK^^O\] ]^K^ON SX =OM^SYX  YP ^RO -YWZKXSO] +M^  ^RK^ ^RO K_NS^ O`SNOXMO aO RK`O YL^KSXON S] ]_P MSOX^ KXN aS^R\OPO\OXMO^Y^RO]O3XN+= XKXMSKV]^K^OWOX^] For S R B C & CO LLP
(“the Act”) with respect to the preparation of these Ind AS appropriate to provide a basis for our audit opinion on the Ind KXN ^RO YZO\K^SXQ OPPOM^S`OXO]] YP ]_MR MYX^\YV] Chartered Accountants
XKXMSKV ]^K^OWOX^] ^RK^ QS`O K ^\_O KXN PKS\ `SOa YP ^RO += XKXMSKV]^K^OWOX^] \OPO\^YY_\]OZK\K^O<OZY\^SXu+XXOb_\Ov^Y^RS] 3-+30S\W<OQS]^\K^SYX8_WLO\$#"//
XKXMSKV ZY]S^SYX XKXMSKV ZO\PY\WKXMO SXMV_NSXQ Y^RO\ \OZY\^%
MYWZ\OROX]S`OSXMYWOMK]R
Ya]KXNMRKXQO]SXO[_S^cYP^RO OPINION
-YWZKXcSXKMMY\NKXMOaS^RKMMY_X^SXQZ\SXMSZVO]QOXO\KVVc In our opinion and to the best of our information and Q A
 S^R\O]ZOM^^Y^ROY^RO\WK^^O\]^YLOSXMV_NONSX per Ravi Bansal
KMMOZ^ONSX3XNSKSXMV_NSXQ^RO3XNSKX+MMY_X^SXQ=^KXNK\N] KMMY\NSXQ ^Y ^RO ObZVKXK^SYX] QS`OX ^Y _] ^RO 3XN += ^RO +_NS^Y\t] <OZY\^ SX KMMY\NKXMO aS^R <_VO  YP :K\^XO\
3XN+=]ZOMS ON_XNO\=OM^SYXYP^RO+M^\OKNaS^R^RO XKXMSKV ]^K^OWOX^] QS`O ^RO SXPY\WK^SYX \O[_S\ON Lc ^RO ^RO-YWZKXSO]+_NS^KXN+_NS^Y\]<_VO]SX 7OWLO\]RSZ8_WLO\$# 
-YWZKXSO] 3XNSKX +MMY_X^SXQ =^KXNK\N] <_VO]  K] Act in the manner so required and give a true and fair view our opinion and to the best of our information and :VKMO$7_WLKS
KWOXNON >RS] \O]ZYX]SLSVS^c KV]Y SXMV_NO] WKSX^OXKXMO YP SX MYXPY\WS^c aS^R ^RO KMMY_X^SXQ Z\SXMSZVO] QOXO\KVVc KMMY\NSXQ^Y^ROObZVKXK^SYX]QS`OX^Y_]$ .K^O$7Kc"
adequate accounting records in accordance with the provisions accepted in India, of the state of affairs of the Company as
of the Act for safeguarding of the assets of the Company and K^7K\MR"S^]Z\Y ^SXMV_NSXQY^RO\MYWZ\OROX]S`O
PY\ Z\O`OX^SXQ KXN NO^OM^SXQ P\K_N] KXN Y^RO\ S\\OQ_VK\S^SO]% SXMYWOS^]MK]R
Ya]KXN^ROMRKXQO]SXO[_S^cPY\^ROcOK\
]OVOM^SYX KXN KZZVSMK^SYX YP KZZ\YZ\SK^O KMMY_X^SXQ ZYVSMSO]% OXNONYX^RK^NK^O
WKUSXQ T_NQWOX^] KXN O]^SWK^O] ^RK^ K\O \OK]YXKLVO KXN
Z\_NOX^% KXN ^RO NO]SQX SWZVOWOX^K^SYX KXN WKSX^OXKXMO REPORT ON OTHER LEGAL AND REGULATORY
YP KNO[_K^O SX^O\XKV XKXMSKV MYX^\YV ^RK^ aO\O YZO\K^SXQ REQUIREMENTS
OPPOM^S`OVc PY\ OX]_\SXQ ^RO KMM_\KMc KXN MYWZVO^OXO]] YP   ] \O[_S\ON Lc ^RO -YWZKXSO] +_NS^Y\t] \OZY\^ 9\NO\
+
^RO KMMY_X^SXQ \OMY\N] \OVO`KX^ ^Y ^RO Z\OZK\K^SYX KXN  u^RO9\NO\vS]]_ONLc^RO-OX^\KV1Y`O\XWOX^YP
Z\O]OX^K^SYXYP^RO3XN+= XKXMSKV]^K^OWOX^]^RK^QS`OK^\_O 3XNSKSX^O\W]YP=_L]OM^SYXYP=OM^SYXYP^RO+M^
KXNPKS\`SOaKXNK\OP\OOP\YWWK^O\SKVWS]]^K^OWOX^aRO^RO\ aOQS`OSX^ROu+XXOb_\OvK]^K^OWOX^YX^ROWK^^O\]
N_O^YP\K_NY\O\\Y\ ]ZOMS ONSXZK\KQ\KZR]KXNYP^RO9\NO\

AUDITOR’S RESPONSIBILITY  +]\O[_S\ONLc=OM^SYXYP^RO+M^aO\OZY\^^RK^$


9_\ \O]ZYX]SLSVS^c S] ^Y ObZ\O]] KX YZSXSYX YX ^RO]O 3XN +=  K A
 ORK`O]Y_QR^KXNYL^KSXONKVV^ROSXPY\WK^SYXKXN
XKXMSKV ]^K^OWOX^] LK]ON YX Y_\ K_NS^ AO RK`O ^KUOX SX^Y ObZVKXK^SYX]aRSMR^Y^ROLO]^YPY_\UXYaVONQOKXN
account the provisions of the Act, the accounting and auditing LOVSOPaO\OXOMO]]K\cPY\^ROZ_\ZY]OYPY_\K_NS^%
]^KXNK\N] KXN WK^^O\] aRSMR K\O \O[_S\ON ^Y LO SXMV_NON
in the audit report under the provisions of the Act and the (b) In our opinion, proper books of account as required
<_VO] WKNO ^RO\O_XNO\ AO MYXN_M^ON Y_\ K_NS^ YP ^RO 3XN Lc VKa RK`O LOOX UOZ^ Lc ^RO -YWZKXc ]Y PK\ K] S^
+= XKXMSKV ]^K^OWOX^] SX KMMY\NKXMO aS^R ^RO =^KXNK\N] YX KZZOK\]P\YWY_\ObKWSXK^SYXYP^RY]OLYYU]%
Auditing, issued by the Institute of Chartered Accountants
YP3XNSKK]]ZOMS ON_XNO\=OM^SYXYP^RO+M^>RY]O  M >
 RO ,KVKXMO =ROO^ =^K^OWOX^ YP :\Y ^ KXN 6Y]]
=^KXNK\N] \O[_S\O ^RK^ aO MYWZVc aS^R O^RSMKV \O[_S\OWOX^] SXMV_NSXQ ^RO =^K^OWOX^ YP 9^RO\ -YWZ\OROX]S`O
KXNZVKXKXNZO\PY\W^ROK_NS^^YYL^KSX\OK]YXKLVOK]]_\KXMO 3XMYWO^RO-K]R0VYa=^K^OWOX^KXN=^K^OWOX^YP
KLY_^aRO^RO\^RO XKXMSKV]^K^OWOX^]K\OP\OOP\YWWK^O\SKV -RKXQO] SX /[_S^c NOKV^ aS^R Lc ^RS] <OZY\^ K\O SX
WS]]^K^OWOX^ KQ\OOWOX^aS^R^ROLYYU]YPKMMY_X^%

96 ANNUAL REPORT 2017-18 97


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ANNEXURE 1 TO THE INDEPENDENT AUDITOR’S REPORT OF EVEN DATE ON THE STANDALONE FINANCIAL  L +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_]XY_XNS]Z_^ONKWY_X^]ZKcKLVOSX\O]ZOM^YPZ\Y`SNOX^P_XN
STATEMENTS OF ABBOTT INDIA LIMITED OWZVYcOO]t]^K^OSX]_\KXMOSXMYWO^Kb]O\`SMO^Kb]KVO]^KbN_^cYPM_]^YWN_^cYPObMS]O`KV_OKNNON^Kb1YYN]KXN
S K >RO-YWZKXcRK]WKSX^KSXONZ\YZO\\OMY\N]]RYaSXQP_VVZK\^SM_VK\]SXMV_NSXQ[_KX^S^K^S`ONO^KSV]KXN]S^_K^SYXYP bON =O\`SMO]>Kb1=>MO]]KXNY^RO\]^K^_^Y\cN_O]aO\OY_^]^KXNSXQK^^ROcOK\OXNPY\KZO\SYNYPWY\O^RKX]SbWYX^R]
K]]O^] P\YW^RONK^O^ROcLOMKWOZKcKLVOObMOZ^K]LOVYa$

 L  YWO bONK]]O^]aO\OZRc]SMKVVc`O\S ONLc^ROWKXKQOWOX^N_\SXQ^ROcOK\SXKMMY\NKXMOaS^RKZVKXXONZ\YQ\KWWO


= Name of the Statute Nature of Dues Amount Period to which the Due Date Date of
YP`O\SPcSXQ^ROWYXMOSX^R\OOcOK\]aRSMRSXY_\YZSXSYXS]\OK]YXKLVORK`SXQ\OQK\N^Y^RO]SdOYP^RO-YWZKXcKXN^RO (` in Lakhs) amount relates Payment
XK^_\OYPS^]K]]O^]8YWK^O\SKVNS]M\OZKXMSO]aO\OXY^SMONYX]_MR`O\S MK^SYX >RO4RK\URKXN>KbYX :\YPO]]SYX^Kb  8Y`t =OZt! Various dates ""
:\YPO]]SYX]>\KNO]-KVVSXQ]
 M +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^ROWKXKQOWOX^^RO^S^VONOON]YPSWWY`KLVOZ\YZO\^SO]SXMV_NON KXN/WZVYcWOX^]+M^
SXZ\YZO\^cZVKX^KXNO[_SZWOX^K\OROVNSX^ROXKWOYP^RO-YWZKXcObMOZ^PY\^ROPYVVYaSXQ$ 7KNRcK:\KNO]R:\YPO]]SYX- :\YPO]]SYX^Kb  +Z\t!=OZt! Various dates Yet to be paid
KV>Kb+M^##
Sr. Asset Gross Block at Net Block at Remarks
No. Category March 31, 2018 March 31, 2018
(` in Lakhs) (` in Lakhs)  M +MMY\NSXQ^Y^RO\OMY\N]YP^RO-YWZKXc^RON_O]YPSXMYWO^Kb]KVO]^Kb]O\`SMO^KbN_^cYPM_]^YWN_^cYPObMS]O`KV_O
KNNON^KbKXNMO]]YXKMMY_X^YPKXcNS]Z_^OK\OK]PYVVYa]$
 ,_SVNSXQ] !#!   >RO^S^VONOON]K\OSX^ROO\]^aRSVOXKWOYP^RO-YWZKXc
Name of the Statute Nature of Dues Amount disputed Forum where dispute is Period to which the
 ,_SVNSXQ]   " !! >RO^S^VONOON]K\OSX^ROXKWOYP^ROOX^S^c^RK^aK]WO\QON in ` Lakhs (net of pending amount relates
aS^R^RO-YWZKXc payments)
3XMYWO>Kb+M^#  3XMYWO>Kb "  ITAT +C !
  >ROKLY`OKWY_X^]SXMV_NOs+]]O^]ROVNPY\]KVOt +C#
+C
SS >
 RO WKXKQOWOX^ RK] MYXN_M^ON ZRc]SMKV `O\S MK^SYX YP SX`OX^Y\c K^ \OK]YXKLVO SX^O\`KV] N_\SXQ ^RO cOK\ KXN XY WK^O\SKV
+C
NS]M\OZKXMSO]aO\OXY^SMONYX]_MRZRc]SMKV`O\S MK^SYX +C
SSS +
 MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX ^Y _] ^RO -YWZKXc RK] XY^ Q\KX^ON KXc VYKX] ]OM_\ON Y\ _X]OM_\ON -OX^\KV/bMS]O+M^# /bMS]O._^c  -YWWS]]SYXO\+ZZOKV] ####
^Y MYWZKXSO] \W] VSWS^ON VSKLSVS^c ZK\^XO\]RSZ] Y\ Y^RO\ ZK\^SO] MY`O\ON SX ^RO \OQS]^O\ WKSX^KSXON _XNO\ =OM^SYX "# YP ^RO  Commissioner ####
-YWZKXSO]+M^+MMY\NSXQVc^ROZ\Y`S]SYX]YPMVK_]OSSSKLKXNMYP^RO9\NO\K\OXY^KZZVSMKLVO^Y^RO-YWZKXcKXN  Assistant Commissioner ##KXN##!^Y
ROXMOXY^MYWWOX^ON_ZYX
 ! CESTAT 
S` 3 XY_\YZSXSYXKXNKMMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_]Z\Y`S]SYX]YP=OM^SYX"KXN" YP^RO-YWZKXSO] >RO,YWLKc=KVO]>Kb =KVO]>Kb #"! .OZ_^c-YWWS]]SYXO\YP=KVO] ###
+M^SX\O]ZOM^YPVYKX]^YNS\OM^Y\]SXMV_NSXQOX^S^SO]SXaRSMR^ROcK\OSX^O\O]^ONKXNSX\O]ZOM^YPVYKX]KXNKN`KXMO]QS`OX +M^## >Kb
SX`O]^WOX^]WKNOKXNQ_K\KX^OO]KXN]OM_\S^SO]QS`OXRK`OLOOXMYWZVSONaS^RLc^RO-YWZKXc ?^^K\:\KNO]R@KV_O @KV_O+NNON>Kb  +NNS^SYXKV-YWWS]]SYXO\YP "^Y
+NNON>Kb+M^" -YWWO\MSKV>Kb+ZZOKV]
`  RO-YWZKXcRK]XY^KMMOZ^ONKXcNOZY]S^]aS^RSX^ROWOKXSXQYP=OM^SYX]!^Y! YP^RO+M^KXN^RO-YWZKXSO]+MMOZ^KXMOYP
>
-OX^\KV=KVO]>Kb+M^ =KVO]>Kb " +NNS^SYXKV-YWWS]]SYXO\YP 
.OZY]S^]<_VO]K]KWOXNON+MMY\NSXQVc^ROZ\Y`S]SYX]YPMVK_]O`YP^RO9\NO\K\OXY^KZZVSMKLVO # ?^^K\:\KNO]R -YWWO\MSKV>Kb+ZZOKV]
`S A
 ORK`OL\YKNVc\O`SOaON^ROLYYU]YPKMMY_X^WKSX^KSXONLc^RO-YWZKXcZ_\]_KX^^Y^RO\_VO]WKNOLc^RO-OX^\KV1Y`O\XWOX^ 5O\KVK1OXO\KV=KVO] =KVO]>Kb  =KVO]>Kb+ZZOVVK^O>\SL_XKV 
PY\^ROWKSX^OXKXMOYPMY]^\OMY\N]_XNO\=OM^SYX"YP^RO-YWZKXSO]+M^\OVK^ON^Y^ROWKX_PKM^_\OYPPY\W_VK^SYX] >Kb+M^#  +NNS^SYXKV,OXMR
KXNK\OYP^ROYZSXSYX^RK^Z\SWKPKMSO^RO]ZOMS ONKMMY_X^]KXN\OMY\N]RK`OLOOXWKNOKXNWKSX^KSXONAORK`OXY^RYaO`O\ 1YK@KV_O+NNON>Kb @KV_O+NNON>Kb ! +NNS^SYXKV-YWWS]]SYXO\YP  !
WKNOKNO^KSVONObKWSXK^SYXYP^RO]KWO +M^ -YWWO\MSKV>KbO]
-OX^\KV=KVO]>Kb#  =KVO]>Kb #" +NNS^SYXKV-YWWS]]SYXO\YP  ^Y#
`SS K  XNS]Z_^ON ]^K^_^Y\c N_O] SXMV_NSXQ Z\Y`SNOX^ P_XN OWZVYcOO]t ]^K^O SX]_\KXMO SXMYWO ^Kb ]KVO] ^Kb ]O\`SMO ^Kb N_^c
? 1YK -YWWO\MSKV>KbO]
YP M_]^YW N_^c YP ObMS]O `KV_O KNNON ^Kb 1YYN] KXN =O\`SMO] >Kb 1=> MO]] KXN Y^RO\ WK^O\SKV ]^K^_^Y\c N_O] RK`O   ! Assistant Commissioner of #
QOXO\KVVcLOOX\OQ_VK\VcNOZY]S^ONaS^R^ROKZZ\YZ\SK^OK_^RY\S^SO]^RY_QR^RO\ORK`OLOOXNOVKc]SXPOaMK]O]YPZKcWOX^ -YWWO\MSKV>KbO]:KXKTS1YK
YPZ\YPO]]SYXKV^Kb
-OX^\KV=KVO]>Kb+M^ =KVO]>Kb # Deputy Commissioner of  !
# 1_TK\K^ -YWWO\MSKV>KbO]+ZZOKV]
7KRK\K]R^\K@KV_O @KV_O+NNON>Kb ! !" .OZ_^c-YWWS]]SYXO\YP=KVO] 
+NNON>Kb+M^ >Kb+ZZOKV]
-_]^YW]+M^#  Custom Duty  -YWWS]]SYXO\+ZZOKV] ##
! CESTAT ^Y

98 ANNUAL REPORT 2017-18 99


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

`SSS >RO -YWZKXc NSN XY^ RK`O KXc Y_^]^KXNSXQ VYKX] Y\ SX MYWZVSKXMO aS^R =OM^SYX !! KXN "" YP -YWZKXSO] +M^ ANNEXURE 2 TO THE INDEPENDENT AUDITOR’S REPORT OF EVEN DATE ON THE STANDALONE FINANCIAL
LY\\YaSXQN_O]SX\O]ZOM^YPK XKXMSKVSX]^S^_^SYXY\LKXU  aRO\O KZZVSMKLVO KXN ^RO NO^KSV] RK`O LOOX NS]MVY]ON STATEMENTS OF ABBOTT INDIA LIMITED
Y\ ^Y QY`O\XWOX^ Y\ N_O] ^Y NOLOX^_\O RYVNO\] N_\SXQ ^RO SX ^RO XY^O] ^Y ^RO XKXMSKV ]^K^OWOX^] K] \O[_S\ON Lc ^RO
Report on the Internal Financial Controls under Clause (i) Meaning of Internal Financial Controls Over Financial
cOK\ KZZVSMKLVOKMMY_X^SXQ]^KXNK\N] of Sub-section 3 of Section 143 of the Companies Act, 2013 Reporting
Sb +
 MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^RO bS` +MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX ^Y _] (“the Act”)
+MYWZKXct]SX^O\XKV XKXMSKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQS]
management, the Company has not raised any money by way KXN YX KX Y`O\KVV ObKWSXK^SYX YP ^RO ,KVKXMO =ROO^ ^RO AO RK`O K_NS^ON ^RO SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV KZ\YMO]]NO]SQXON^YZ\Y`SNO\OK]YXKLVOK]]_\KXMO\OQK\NSXQ^RO
YPSXS^SKVZ_LVSMYPPO\P_\^RO\Z_LVSMYPPO\NOL^SX]^\_WOX^] -YWZKXcRK]XY^WKNOKXcZ\OPO\OX^SKVKVVY^WOX^Y\Z\S`K^O reporting of Abbott India Limited (“the Company”) as of \OVSKLSVS^c YP XKXMSKV \OZY\^SXQ KXN ^RO Z\OZK\K^SYX YP XKXMSKV
KXN ^O\W VYKX] ROXMO \OZY\^SXQ _XNO\ MVK_]O Sb S] XY^ ZVKMOWOX^YP]RK\O]Y\P_VVcY\ZK\^VcMYX`O\^SLVONOLOX^_\O] 7K\MR  " SX MYXT_XM^SYX aS^R Y_\ K_NS^ YP ^RO XKXMSKV ]^K^OWOX^] PY\ Ob^O\XKV Z_\ZY]O] SX KMMY\NKXMO aS^R QOXO\KVVc
KZZVSMKLVO^Y^RO-YWZKXcKXNROXMOXY^MYWWOX^ON_ZYX during the year under review and hence, reporting ]^K^OWOX^]YP^RO-YWZKXcPY\^ROcOK\OXNONYX^RK^NK^O KMMOZ^ONKMMY_X^SXQZ\SXMSZVO]
\O[_S\OWOX^] _XNO\ MVK_]O bS` K\O XY^ KZZVSMKLVO ^Y ^RO
b  K]ON_ZYX^ROK_NS^Z\YMON_\O]ZO\PY\WONPY\^ROZ_\ZY]O
, Management’s Responsibility for Internal Financial Controls + MYWZKXct] SX^O\XKV XKXMSKV MYX^\YV Y`O\ XKXMSKV \OZY\^SXQ
-YWZKXcKXNXY^MYWWOX^ON_ZYX
YP\OZY\^SXQ^RO^\_OKXNPKS\`SOaYP^RO XKXMSKV]^K^OWOX^] SXMV_NO] ^RY]O ZYVSMSO] KXN Z\YMON_\O] ^RK^  ZO\^KSX ^Y ^RO
b` +
 MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^RO >RO -YWZKXct] 7KXKQOWOX^ S] \O]ZYX]SLVO PY\ O]^KLVS]RSXQ KXN WKSX^OXKXMOYP\OMY\N]^RK^SX\OK]YXKLVONO^KSVKMM_\K^OVcKXN
KXNKMMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc WKSX^KSXSXQ SX^O\XKV XKXMSKV MYX^\YV] LK]ON YX ^RO SX^O\XKV
management, the Company has not entered into any non- PKS\Vc\O
OM^^RO^\KX]KM^SYX]KXNNS]ZY]S^SYX]YP^ROK]]O^]YP^RO
the management, we report that no fraud by the Company MYX^\YV Y`O\ XKXMSKV \OZY\^SXQ M\S^O\SK O]^KLVS]RON Lc ^RO MYWZKXc%  Z\Y`SNO \OK]YXKLVO K]]_\KXMO ^RK^ ^\KX]KM^SYX] K\O
cash transactions with directors or persons connected with
Y\XYP\K_NWK^O\SKVP\K_NYX^RO-YWZKXcLc^ROYP MO\] -YWZKXcMYX]SNO\SXQ^ROO]]OX^SKVMYWZYXOX^]YPSX^O\XKVMYX^\YV \OMY\NONK]XOMO]]K\c^YZO\WS^Z\OZK\K^SYXYP XKXMSKV]^K^OWOX^]
RSWK]\OPO\\ON^YSX=OM^SYX#YP-YWZKXSO]+M^
KXNOWZVYcOO]YP^RO-YWZKXcRK]LOOXXY^SMONY\\OZY\^ON ]^K^ONSX^RO1_SNKXMO8Y^OYX+_NS^YP3X^O\XKV0SXKXMSKV-YX^\YV] SXKMMY\NKXMOaS^RQOXO\KVVcKMMOZ^ONKMMY_X^SXQZ\SXMSZVO]KXN
N_\SXQ^ROcOK\ b`S +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_] 9`O\ 0SXKXMSKV <OZY\^SXQ S]]_ON Lc ^RO 3X]^S^_^O YP -RK\^O\ON ^RK^\OMOSZ^]KXNObZOXNS^_\O]YP^ROMYWZKXcK\OLOSXQWKNOYXVc
^ROZ\Y`S]SYX]YP=OM^SYX3+YP^RO<O]O\`O,KXUYP3XNSK +MMY_X^KX^] YP 3XNSK >RO]O \O]ZYX]SLSVS^SO] SXMV_NO ^RO NO]SQX in accordance with authorisations of management and directors
bS +
 MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX Lc SWZVOWOX^K^SYX KXN WKSX^OXKXMO YP KNO[_K^O SX^O\XKV XKXMSKV YP ^RO MYWZKXc% KXN  Z\Y`SNO \OK]YXKLVO K]]_\KXMO \OQK\NSXQ
+M^#K\OXY^KZZVSMKLVO^Y^RO-YWZKXc
^RO WKXKQOWOX^ ^RO WKXKQO\SKV \OW_XO\K^SYX RK] LOOX MYX^\YV] ^RK^ aO\O YZO\K^SXQ OPPOM^S`OVc PY\ OX]_\SXQ ^RO Y\NO\Vc Z\O`OX^SYX Y\ ^SWOVc NO^OM^SYX YP _XK_^RY\S]ON KM[_S]S^SYX _]O
ZKSNZ\Y`SNON SX KMMY\NKXMO aS^R ^RO \O[_S]S^O KZZ\Y`KV] For S R B C & CO LLP KXN OP MSOX^ MYXN_M^ YP S^] L_]SXO]] SXMV_NSXQ KNRO\OXMO ^Y ^RO Y\NS]ZY]S^SYXYP^ROMYWZKXct]K]]O^]^RK^MY_VNRK`OKWK^O\SKV
WKXNK^ON Lc ^RO Z\Y`S]SYX] YP =OM^SYX #! \OKN aS^R Chartered Accountants -YWZKXct]ZYVSMSO]^RO]KPOQ_K\NSXQYPS^]K]]O^]^ROZ\O`OX^SYX OPPOM^YX^RO XKXMSKV]^K^OWOX^]
=MRON_VO@^Y^RO-YWZKXSO]+M^ 3-+30S\W<OQS]^\K^SYX8_WLO\$#"// KXNNO^OM^SYXYPP\K_N]KXNO\\Y\]^ROKMM_\KMcKXNMYWZVO^OXO]]
YP ^RO KMMY_X^SXQ \OMY\N] KXN ^RO ^SWOVc Z\OZK\K^SYX YP \OVSKLVO Inherent Limitations of Internal Financial Controls Over
bSS 3 X Y_\ YZSXSYX ^RO -YWZKXc S] XY^ K XSNRS MYWZKXc XKXMSKVSXPY\WK^SYXK]\O[_S\ON_XNO\^RO-YWZKXSO]+M^ Financial Reporting
per Ravi Bansal
>RO\OPY\O^ROZ\Y`S]SYX]YPMVK_]ObSSYP^ROY\NO\K\OXY^ ,OMK_]O YP ^RO SXRO\OX^ VSWS^K^SYX] YP SX^O\XKV XKXMSKV MYX^\YV]
:K\^XO\ Auditor’s Responsibility
KZZVSMKLVO^Y^RO-YWZKXcKXNROXMOXY^MYWWOX^ON_ZYX Y`O\ XKXMSKV \OZY\^SXQ SXMV_NSXQ ^RO ZY]]SLSVS^c YP MYVV_]SYX
7OWLO\]RSZ8_WLO\$# 
9_\ \O]ZYX]SLSVS^c S] ^Y ObZ\O]] KX YZSXSYX YX ^RO -YWZKXct] Y\ SWZ\YZO\ WKXKQOWOX^ Y`O\\SNO YP MYX^\YV] WK^O\SKV
bSSS +MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX Lc :VKMO$7_WLKS
SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ LK]ON YX Y_\ WS]]^K^OWOX^]N_O^YO\\Y\Y\P\K_NWKcYMM_\KXNXY^LONO^OM^ON
^RO WKXKQOWOX^ ^\KX]KM^SYX] aS^R ^RO \OVK^ON ZK\^SO] K\O .K^O$7Kc" +V]YZ\YTOM^SYX]YPKXcO`KV_K^SYXYP^ROSX^O\XKV XKXMSKVMYX^\YV]
K_NS^AOMYXN_M^ONY_\K_NS^SXKMMY\NKXMOaS^R^RO1_SNKXMO
8Y^O YX +_NS^ YP 3X^O\XKV 0SXKXMSKV -YX^\YV] 9`O\ 0SXKXMSKV Y`O\ XKXMSKV\OZY\^SXQ^YP_^_\OZO\SYN]K\O]_LTOM^^Y^RO\S]U^RK^
<OZY\^SXQ ^RO u1_SNKXMO 8Y^Ov KXN ^RO =^KXNK\N] YX +_NS^SXQ ^ROSX^O\XKV XKXMSKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQWKcLOMYWO
K]]ZOMS ON_XNO\=OM^SYXYP^RO-YWZKXSO]+M^^Y inadequate because of changes in conditions, or that the degree of
^ROOb^OX^KZZVSMKLVO^YKXK_NS^YPSX^O\XKV XKXMSKVMYX^\YV]KXN MYWZVSKXMOaS^R^ROZYVSMSO]Y\Z\YMON_\O]WKcNO^O\SY\K^O
LY^R S]]_ON Lc ^RO 3X]^S^_^O YP -RK\^O\ON +MMY_X^KX^] YP 3XNSK
Opinion
>RY]O=^KXNK\N]KXN^RO1_SNKXMO8Y^O\O[_S\O^RK^aOMYWZVc
aS^RO^RSMKV\O[_S\OWOX^]KXNZVKXKXNZO\PY\W^ROK_NS^^YYL^KSX 3X Y_\ YZSXSYX ^RO -YWZKXc RK] SX KVV WK^O\SKV \O]ZOM^]
\OK]YXKLVO K]]_\KXMO KLY_^ aRO^RO\ KNO[_K^O SX^O\XKV XKXMSKV KX KNO[_K^O SX^O\XKV XKXMSKV MYX^\YV] ]c]^OW Y`O\ XKXMSKV
MYX^\YV]Y`O\ XKXMSKV\OZY\^SXQaK]O]^KLVS]RONKXNWKSX^KSXON \OZY\^SXQ KXN ]_MR SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV
KXNSP]_MRMYX^\YV]YZO\K^ONOPPOM^S`OVcSXKVVWK^O\SKV\O]ZOM^] \OZY\^SXQ aO\O YZO\K^SXQ OPPOM^S`OVc K] K^ 7K\MR  " LK]ON
YX^ROSX^O\XKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQM\S^O\SKO]^KLVS]RON
9_\K_NS^SX`YV`O]ZO\PY\WSXQZ\YMON_\O]^YYL^KSXK_NS^O`SNOXMO Lc^RO-YWZKXcMYX]SNO\SXQ^ROO]]OX^SKVMYWZYXOX^]YPSX^O\XKV
KLY_^^ROKNO[_KMcYP^ROSX^O\XKV XKXMSKVMYX^\YV]]c]^OWY`O\ MYX^\YV]^K^ONSX^RO1_SNKXMO8Y^OYX+_NS^YP3X^O\XKV0SXKXMSKV
XKXMSKV \OZY\^SXQ KXN ^ROS\ YZO\K^SXQ OPPOM^S`OXO]] 9_\ K_NS^ -YX^\YV] 9`O\ 0SXKXMSKV <OZY\^SXQ S]]_ON Lc ^RO 3X]^S^_^O YP
YP SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ SXMV_NON -RK\^O\ON+MMY_X^KX^]YP3XNSK
YL^KSXSXQ KX _XNO\]^KXNSXQ YP SX^O\XKV XKXMSKV MYX^\YV] Y`O\
XKXMSKV \OZY\^SXQ K]]O]]SXQ ^RO \S]U ^RK^ K WK^O\SKV aOKUXO]]
ObS]^] KXN ^O]^SXQ KXN O`KV_K^SXQ ^RO NO]SQX KXN YZO\K^SXQ For S R B C & CO LLP
OPPOM^S`OXO]] YP SX^O\XKV MYX^\YV LK]ON YX ^RO K]]O]]ON \S]U >RO Chartered Accountants
Z\YMON_\O]]OVOM^ONNOZOXNYX^ROK_NS^Y\t]T_NQOWOX^SXMV_NSXQ 3-+30S\W<OQS]^\K^SYX8_WLO\$#"//
^RO K]]O]]WOX^ YP ^RO \S]U] YP WK^O\SKV WS]]^K^OWOX^ YP ^RO
XKXMSKV]^K^OWOX^]aRO^RO\N_O^YP\K_NY\O\\Y\ per Ravi Bansal
:K\^XO\
AOLOVSO`O^RK^^ROK_NS^O`SNOXMOaORK`OYL^KSXONS]]_P MSOX^ 7OWLO\]RSZ8_WLO\$# 
and appropriate to provide a basis for our audit opinion on the :VKMO$7_WLKS
SX^O\XKV XKXMSKVMYX^\YV]]c]^OWY`O\ XKXMSKV\OZY\^SXQ .K^O$7Kc"

100 ANNUAL REPORT 2017-18 101


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BALANCE SHEET STATEMENT OF PROFIT AND LOSS


AS A T M A RC H 31, 2018 F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON +VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON
8Y^O] As at March 31, 2018 +]K^7K\MR!
ASSETS For the Year ended For the Year ended
8Y^O] March 31, 2018 March 31, 2017
Non-current Assets
:\YZO\^cZVKX^KXNO[_SZWOX^  78,58.56 !  INCOME
-KZS^KVaY\USXZ\YQ\O]]  2,16.69  Revenue from operations  3307,12.17 #" #
9^RO\SX^KXQSLVOK]]O^]  2,79.60 # 9^RO\SXMYWO ! 116,98.72 ! "
3X^KXQSLVOK]]O^]_XNO\NO`OVYZWOX^  - "
TOTAL INCOME 3424,10.89 ## 
0SXKXMSKVK]]O^]
Loans 15,02.58   EXPENSES
9^RO\ XKXMSKVK]]O^] ! 22,70.67 " # -Y]^YPWK^O\SKV]MYX]_WON " 295,72.38 #!
.OPO\\ON^KbK]]O^]XO^  14,59.96 " :_\MRK]O]YP]^YMUSX^\KNO # 1711,22.00 #! !
9^RO\XYXM_\\OX^K]]O^] " 14,83.65 !!"
-RKXQO]SXSX`OX^Y\SO]YP XS]RONQYYN]]^YMUSX^\KNOKXNaY\USXZ\YQ\O]]  (102,19.94) 
Total Non-current Assets 150,71.71 !!"!
Current Assets /bMS]ON_^cYX]KVO] 8,61.82  
Inventories # 585,32.72   /WZVYcOOLOXO ^]ObZOX]O  393,69.27 !
0SXKXMSKVK]]O^] Finance costs  3,82.21  
>\KNO\OMOS`KLVO]  263,44.30 ! ## .OZ\OMSK^SYXKXNKWY\^S]K^SYXObZOX]O  16,18.54  "
-K]RKXNMK]RO[_S`KVOX^]  37,67.71 "
9^RO\ObZOX]O]  475,56.35 !# 
,KXULKVKXMO]Y^RO\^RKXMK]RKXNMK]RO[_S`KVOX^]  993,67.32 """ "
Loans  205,47.81 # TOTAL EXPENSES 2802,62.63 #"
9^RO\ XKXMSKVK]]O^]  40,21.24 "!! PROFIT BEFORE TAX 621,48.26  #!
-_\\OX^^KbK]]O^]XO^ 15,73.39 " TAX EXPENSES
9^RO\M_\\OX^K]]O^]  89,58.95 !"
"# " -_\\OX^^KbObZOX]O  223,51.00  ""
2231,13.44
+]]O^]ROVNPY\]KVO  34,33.76 - >KbKNT_]^WOX^PY\OK\VSO\cOK\]  (1,62.69) # 
Total Current Assets 2265,47.20 "# " .OPO\\ON^KbM\ONS^  (1,61.83)  
TOTAL ASSETS 2416,18.91  " TOTAL TAX EXPENSES 220,26.48 #"#
EQUITY AND LIABILITIES PROFIT FOR THE YEAR 401,21.78 !  ""
Equity Other Comprehensive Income
/[_S^c]RK\OMKZS^KV ! 21,24.93 # 3^OW]^RK^aSVVXY^LO\OMVK]]S ON]_L]O[_OX^Vc^YZ\Y ^Y\VY]]
9^RO\O[_S^c " 1671,51.12   #!
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX  (1,67.72) " #
Total Equity 1692,76.05 " #
3XMYWO^KbYXKLY`O  60.08 ##
Non-current Liabilities
:\Y`S]SYX] # 55,34.51 !# Total Other Comprehensive Income, net of tax (1,07.64) "! 
Total Non-current Liabilities 55,34.51 !# Total Comprehensive Income for the year, net of tax 400,14.14 !!!!
Current Liabilities EARNINGS PER EQUITY SHARE
0SXKXMSKVVSKLSVS^SO] ,K]SMKXN.SV_^ON`0KMO`KV_OYP`OKMR  188.81 #
>\KNOZKcKLVO] 
=SQXS MKX^KMMY_X^SXQZYVSMSO] 
._O^YWSM\YKXN]WKVVOX^O\Z\S]O] 5,83.88 !#
Due to others 474,78.60 !"
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^]
9^RO\ XKXMSKVVSKLSVS^SO]  48,98.43  #
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\]
9^RO\M_\\OX^VSKLSVS^SO]  32,81.56  "
As per our report of even date
:\Y`S]SYX]  77,46.92 !#"
-_\\OX^^KbVSKLSVS^SO]XO^ " # For S R B C & CO LLP AMBATI VENU R A SHAH
28,18.96
Total Current Liabilities 668,08.35  " Chartered Accountants Managing Director Director
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#"
TOTAL EQUITY AND LIABILITIES 2416,18.91  "
=SQXS MKX^KMMY_X^SXQZYVSMSO]  per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^] :K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] 7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
As per our report of even date
For S R B C & CO LLP AMBATI VENU R A SHAH
Chartered Accountants Managing Director Director :VKMO$7_WLKS :VKMO$7_WLKS
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#" .K^O$7Kc" .K^O$7Kc"

per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA


:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
:VKMO$7_WLKS :VKMO$7_WLKS
.K^O$7Kc" .K^O$7Kc"

102 ANNUAL REPORT 2017-18 103


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

STATEMENT OF CHANGES IN EQUITY STATEMENT OF CASH FLOWS


F O R T H E Y E A R END ED MA R C H 31, 2018 F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON +VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON
A. EQUITY SHARE CAPITAL :
For the Year ended For the Year ended
Equity shares of ` 10 each issued, subscribed and fully paid Number of Amount March 31, 2018 7K\MR!
shares
As at April 1, 2016 # # OPERATING ACTIVITIES
3XM\OK]ONOM\OK]ON_\SXQ^ROcOK\ - - :\Y ^LOPY\O^Kb 621,48.26  #!
As at March 31, 2017 # # +NT_]^WOX^]^Y\OMYXMSVOZ\Y ^LOPY\O^Kb^YXO^MK]R
Ya]$
3XM\OK]ONOM\OK]ON_\SXQ^ROcOK\ - -
.OZ\OMSK^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^ 14,50.20 !"!
As at March 31, 2018 2,12,49,302 21,24.93
+WY\^S]K^SYXYPSX^KXQSLVOK]]O^] 1,68.34 
B. OTHER EQUITY : ?X\OKVS]ONObMRKXQOQKSXVY]]XO^ 1,06.63 !
Items of Other 6Y]]YX]KVOa\S^OYPPYPZ\YZO\^cZVKX^KXNO[_SZWOX^XO^ 28.00 ""
Comprehensive
Reserves and Surplus (Refer Note 18) 1KSXYXK]]SQXWOX^YP^\KNOWK\U] (45,30.26) -
Income Total
(Refer Note 18) Other Finance income (71,39.83) ! "
Amalgamation Capital Capital Share Based General Retained Remeasurement Equity
Reserve Reserve Redemption Compensation Reserve Earnings YPNO XON Finance costs 3,82.21  
Reserve Reserve LOXO ^ZVKX
Balances as at April 1, 2016 !"   " ""  !#"# "#"!!  !#! +WY\^S]K^SYXYPNOPO\\ONVOK]O\OX^KV] 1,39.02 ! 
:\Y ^PY\^ROcOK\OXNON7K\MR! - - - - - !  "" - !  "" +VVYaKXMOPY\NY_L^P_VNOL^] 71.44 "
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX +VVYaKXMOPY\NY_L^P_VKN`KXMO]KXNNOZY]S^] 81.09 !
XO^YP^Kb - - - - - - "!  "! 
Total Comprehensive Income for the year - - - - - !  "" "!  !!!! :\Y`S]SYXPY\VSUOVc]KVO]\O^_\X]NK^OObZS\cKXNNKWKQONZ\YN_M^]XO^ 7,53.69 # 
>\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV =RK\OLK]ONMYWZOX]K^SYXObZOX]O 7,97.57 "
Reserve - - - - ! # ! # - -
.S`SNOXNPY\^ROcOK\OXNON7K\MR  6SKLSVS^SO]Z\Y`S]SYX]XYVYXQO\\O[_S\ONa\S^^OXLKMU - "!
<OPO\8Y^O! - - - - - !!  - !!  9ZO\K^SXQ:\Y ^LOPY\OaY\USXQMKZS^KVMRKXQO] 544,56.36 ##!!
.S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - -  - 
=RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO]
<OPO\8Y^O - - - " - - - " Adjustments for (increase)/decrease in :
Transfer from Share Based Compensation
<O]O\`O^Y1OXO\KV<O]O\`O - - -   - - -
(i) >\KNO\OMOS`KLVO] (87,85.30) # 
Balances as at March 31, 2017 !"   "  # !"#" " "!!   #! (ii) Inventories (84,69.60) "
:\Y ^PY\^ROcOK\OXNON7K\MR" - - - - - !" - !" (iii) 6YKX]Y^RO\ XKXMSKVK]]O^]KXNY^RO\K]]O^] (23,29.64) " 
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX
XO^YP^Kb - - - - - - !  !  Adjustments for increase/(decrease) in :
Total Comprehensive Income for the year - - - - - !" !   (i) >\KNOZKcKLVO] 4,77.76 !#
>\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV
(ii) :\Y`S]SYX]Y^RO\ XKXMSKVVSKLSVS^SO]KXNY^RO\VSKLSVS^SO] 4,10.92 
Reserve - - - - " " - -
.S`SNOXNPY\^ROcOK\OXNON7K\MR! 357,60.50  ###
<OPO\8Y^O! - - - - - "##! - "##!
3XMYWO^KbZKSNSXMV_NSXQ>.=XO^ (204,90.13) "!"
.S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - - ! - !
=RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO] 8O^MK]R
Ya]P\YWYZO\K^SXQKM^S`S^SO]+ 152,70.37 !#
<OPO\8Y^O - - - !#!! - - - !#!!
Transfer from Share Based Compensation
<O]O\`O^Y1OXO\KV<O]O\`O - - - !# !# - - - INVESTING ACTIVITIES
Balances as at March 31, 2018 37.82 5,22.62 2,52.48 20,95.22 337,25.95 1309,12.39 (3,95.36) 1671,51.12 :\YMOON]P\YW]KVOYPZ\YZO\^cZVKX^KXNO[_SZWOX^ 16.90 "#
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^] :_\MRK]OYPZ\YZO\^cZVKX^KXNO[_SZWOX^SXMV_NSXQMKZS^KVaY\USXZ\YQ\O]]KXN
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] MKZS^KVKN`KXMO] (16,74.42)  
As per our report of even date
:_\MRK]OYPY^RO\SX^KXQSLVOK]]O^] (1.32) "
For S R B C & CO LLP AMBATI VENU R A SHAH
Chartered Accountants Managing Director Director :\YMOON]P\YWK]]SQXWOX^YP^\KNOWK\U] 51,42.28 -
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#" :_\MRK]OYP^\KNOWK\U] (7,50.50) -
per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA 3X`O]^WOX^SX bONNOZY]S^]WK^_\SXQLOcYXNWYX^R]XO^ (105,12.79) "# # 
:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary 6YKXQS`OX^YK\OVK^ONZK\^c (200,00.00) -
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
3X^O\O]^\OMOS`ONYXNOZY]S^] XKXMOSXMYWO 62,96.33 
:VKMO$7_WLKS :VKMO$7_WLKS 8O^MK]R
Ya]P\YWSX`O]^SXQKM^S`S^SO], (214,83.52) 
.K^O$7Kc" .K^O$7Kc"

104 ANNUAL REPORT 2017-18 105


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

NOTES TO THE FINANCIAL STATEMENTS


F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON 1. COMPANY INFORMATION    w -K]R Y\ MK]R O[_S`KVOX^ _XVO]] \O]^\SM^ON
  LLY^^ 3XNSK 6SWS^ON s>RO -YWZKXct S] K Z_LVSM VSWS^ON
+ P\YW LOSXQ ObMRKXQON Y\ _]ON ^Y ]O^^VO K
For the Year ended For the Year ended VSKLSVS^c PY\ K^ VOK]^ ^aOV`O WYX^R] KP^O\ ^RO
MYWZKXc NYWSMSVON KXN SXMY\ZY\K^ON SX 3XNSK _XNO\ ^RO
March 31, 2018 7K\MR! Z\Y`S]SYX] YP -YWZKXSO] +M^ # >RO -YWZKXc S] VS]^ON reporting period
FINANCING ACTIVITIES KXN^\KNONYX^RO,YWLKc=^YMU/bMRKXQOKXNKV]Y^\KNON    +VVY^RO\K]]O^]K\OMVK]]S ONK]XYXM_\\OX^
YX^RO8K^SYXKV=^YMU/bMRKXQO>RO\OQS]^O\ONYP MOYP^RO
Interest paid (12.66) !#    +VSKLSVS^cS]M_\\OX^aROX$
-YWZKXcS]-Y\ZY\K^OZK\U=SYX>\YWLKc\YKN7_WLKS
:KcWOX^YPNS`SNOXN (84,99.72) !!  !3XNSK    w 3^S]ObZOM^ON^YLO]O^^VONSXXY\WKVYZO\K^SXQ
.S`SNOXNNS]^\SL_^SYX^Kb (17,30.34)    RO -YWZKXc S] YXO YP ^RO VOKNSXQ W_V^SXK^SYXKV
> McMVO
8O^MK]R
Ya]_]ONSX XKXMSXQKM^S`S^SO]- (102,42.72) "#!  ZRK\WKMO_^SMKV MYWZKXSO] SX 3XNSK KXN YZO\K^O] aS^R KX    w 3^S]ROVNZ\SWK\SVcPY\^ROZ_\ZY]OYP^\KNSXQ
YaXONWKX_PKM^_\SXQPKMSVS^cSX1YKKXN`K\SY_]SXNOZOXNOX^
MYX^\KM^^RS\NZK\^cWKX_PKM^_\O\]LK]ONKM\Y]]^ROMY_X^\c    w 3^ S] N_O ^Y LO ]O^^VON aS^RSX ^aOV`O WYX^R]
Net increase/(decrease) in cash and cash equivalents (A+B+C) (164,55.87)  >RO -YWZKXc ]OVV] S^] Z\YN_M^] ^R\Y_QR SXNOZOXNOX^ after the reporting period
-K]RKXNMK]RO[_S`KVOX^]K^^ROLOQSXXSXQYP^ROcOK\ 202,23.58 #" NS]^\SL_^Y\]Z\SWK\SVcaS^RSX3XNSK    w >RO\O S] XY _XMYXNS^SYXKV \SQR^ ^Y NOPO\ ^RO
Cash and cash equivalents at the end of the year (Refer Note 11) 37,67.71 " 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ]O^^VOWOX^ YP ^RO VSKLSVS^c PY\ K^ VOK]^ ^aOV`O
months after the reporting period
2.1 Basis of preparation
   +VVY^RO\VSKLSVS^SO]K\OMVK]]S ONK]XYXM_\\OX^
=SQXS MKX^KMMY_X^SXQZYVSMSO]<OPO\8Y^O   >
 RO XKXMSKV ]^K^OWOX^] K\O Z\OZK\ON YX ^RO KMM\_KV
basis of accounting and in accordance with the Indian    .
 OPO\\ON^KbK]]O^]KXNVSKLSVS^SO]K\OMVK]]S ONK]
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^]
Accounting Standards (hereinafter referred to as the Ind XYXM_\\OX^K]]O^]KXNVSKLSVS^SO]
Note : +=XY^S ON_XNO\^RO-YWZKXSO]3XNSKX+MMY_X^SXQ b) Foreign currency translation
-K]R0VYa=^K^OWOX^RK]LOOXZ\OZK\ON_XNO\^RO3XNS\OM^7O^RYNK]]O^Y_^SX3XN+=!s=^K^OWOX^YP-K]R0VYa]taRO\OLcZ\Y ^PY\^ROcOK\ =^KXNK\N] <_VO]  KXN \OVO`KX^ KWOXNWOX^]
^RO\OKP^O\ Functional and presentation currency
S]KNT_]^ONPY\^ROOPPOM^]YP^\KX]KM^SYX]YPKXYXMK]RXK^_\OKXcNOPO\\KV]Y\KMM\_KV]YPZK]^Y\P_^_\OYZO\K^SXQMK]R\OMOSZ^]Y\ZKcWOX^]KXN
S^OWYPSXMYWOY\ObZOX]O]K]]YMSK^ONaS^RSX`O]^SXQY\ XKXMSXQMK]R
Ya]>ROMK]R
Ya]P\YWYZO\K^SXQSX`O]^SXQKXN XKXMSXQKM^S`S^SO]   /
 PPOM^S`O +Z\SV    ^RO -YWZKXc RK] KNYZ^ON KVV    3 ^OW] SXMV_NON SX ^RO XKXMSKV ]^K^OWOX^] YP ^RO
YP^RO-YWZKXcK\O]OQ\OQK^ON the Ind AS standards and the adoption was carried out Company are measured using the currency of
SX KMMY\NKXMO aS^R 3XN +=  s0S\]^^SWO KNYZ^SYX YP the primary economic environment in which the
3XNSKX+MMY_X^SXQ=^KXNK\N]taS^R+Z\SVK]^RO -YWZKXc YZO\K^O] ^RO P_XM^SYXKV M_\\OXMc
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] >RO XKXMSKV ]^K^OWOX^] K\O Z\O]OX^ON SX 3XNSKX
As per our report of even date
^\KX]S^SYX NK^O >RO ^\KX]S^SYX aK] MK\\SON Y_^ P\YW
3XNSKX +MMY_X^SXQ :\SXMSZVO] QOXO\KVVc KMMOZ^ON SX Rupee (`aRSMRS]^RO-YWZKXc]P_XM^SYXKVKXN
For S R B C & CO LLP AMBATI VENU R A SHAH Z\O]OX^K^SYXM_\\OXMc
3XNSK K] Z\O]M\SLON _XNO\ =OM^SYX  YP ^RO +M^ \OKN
Chartered Accountants Managing Director Director
aS^R <_VO ! YP ^RO -YWZKXSO] +MMY_X^] <_VO]  Transactions and balances
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#"
aRSMRaK]^ROZ\O`SY_]1++:
   0
 Y\OSQX M_\\OXMc ^\KX]KM^SYX] K\O ^\KX]VK^ON SX^Y
per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA   >
 RO XKXMSKV ]^K^OWOX^] RK`O LOOX Z\OZK\ON YX K ^RO P_XM^SYXKV M_\\OXMc _]SXQ ^RO ObMRKXQO \K^O]
:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary RS]^Y\SMKVMY]^LK]S]ObMOZ^PY\MO\^KSX XKXMSKVK]]O^] K^^RONK^O]YP^RO^\KX]KM^SYX]0Y\OSQXObMRKXQO
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-=  KXNVSKLSVS^SO]WOK]_\ONK^PKS\`KV_OY\KWY\^S]ONMY]^ QKSX] KXN VY]]O] \O]_V^SXQ P\YW ^RO ]O^^VOWOX^
  >
 RO XKXMSKV]^K^OWOX^]K\OKZZ\Y`ONPY\S]]_OLc^RO YP ]_MR ^\KX]KM^SYX] KXN P\YW ^RO ^\KX]VK^SYX YP
:VKMO$7_WLKS :VKMO$7_WLKS -YWZKXct],YK\NYP.S\OM^Y\]YX7Kc" WYXO^K\c K]]O^] KXN VSKLSVS^SO] NOXYWSXK^ON SX
.K^O$7Kc" .K^O$7Kc" PY\OSQXM_\\OXMSO]K^cOK\OXNObMRKXQO\K^O]K\O
  =_WWK\cYP]SQXS MKX^KMMY_X^SXQZYVSMSO] QOXO\KVVc\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^KXN
  K -_\\OX^KXNXYXM_\\OX^MVK]]S MK^SYX 6Y]]
  VV K]]O^] KXN VSKLSVS^SO] K\O Z\O]OX^ON SX ^RO
+    8
 YXWYXO^K\c K]]O^] KXN VSKLSVS^SO] NOXYWSXK^ON
,KVKXMO =ROO^ LK]ON YX M_\\OX^ Y\ XYXM_\\OX^ SX K PY\OSQX M_\\OXMc KXN WOK]_\ON K^ RS]^Y\SMKV
MVK]]S MK^SYXK]ZO\^RO-YWZKXct]XY\WKVYZO\K^SXQ MY]^K\O^\KX]VK^ONK^^ROObMRKXQO\K^OZ\O`KVOX^
McMVO KXN Y^RO\ M\S^O\SK ]O^ Y_^ SX =MRON_VO 333 YP K^^RONK^OYP^RO^\KX]KM^SYX
^RO -YWZKXSO] +M^  ,K]ON YX ^RO XK^_\O YP c) Fair value measurement
products and the time between the acquisition of
K]]O^]PY\Z\YMO]]SXQKXN^ROS\\OKVS]K^SYXSX^YMK]R    >
 RO -YWZKXc WOK]_\O] XKXMSKV SX]^\_WOX^] K^
KXNMK]RO[_S`KVOX^]^RO-YWZKXcRK]K]MO\^KSXON PKS\ `KV_O K^ OKMR ,KVKXMO =ROO^ NK^O 0KS\ `KV_O
S^]YZO\K^SXQMcMVOK]^aOV`OWYX^R]PY\^ROZ_\ZY]O S] ^RO Z\SMO ^RK^ aY_VN LO \OMOS`ON YX ]KVO YP KX
YP M_\\OX^XYXM_\\OX^ MVK]]S MK^SYX YP K]]O^] KXN K]]O^ Y\ ZKSN ^Y ^\KX]PO\ K VSKLSVS^c SX KX Y\NO\Vc
VSKLSVS^SO]+XK]]O^S]^\OK^ONK]M_\\OX^aROXS^S]$ transaction between market participants at the
WOK]_\OWOX^ NK^O >RO PKS\ `KV_O WOK]_\OWOX^
   w /bZOM^ON^YLO\OKVS]ONY\SX^OXNON^YLO]YVN is based on the presumption that the transaction
Y\MYX]_WONSXXY\WKVYZO\K^SXQMcMVO ^Y]OVV^ROK]]O^Y\^\KX]PO\^ROVSKLSVS^c^KUO]ZVKMO
   w 2OVNZ\SWK\SVcPY\^ROZ_\ZY]OYP^\KNSXQ OS^RO\$
   w /bZOM^ON^YLO\OKVS]ONaS^RSX^aOV`OWYX^R]    w 3X ^RO Z\SXMSZKV WK\UO^ PY\ ^RO K]]O^ Y\
after the reporting period VSKLSVS^cY\

106 ANNUAL REPORT 2017-18 107


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

   w 3 X ^RO KL]OXMO YP K Z\SXMSZKV WK\UO^ SX ^RO KXNObMV_NSXQ^KbO]Y\N_^SO]MYVVOM^ONYXLORKVPYP  _\\OX^ SXMYWO ^Kb \OVK^SXQ ^Y S^OW] \OMYQXS]ON
-    >
 RO -YWZKXc SNOX^S O] KXN NO^O\WSXO] MY]^ YP
most advantageous market for the asset or ^ROQY`O\XWOX^>RO-YWZKXcRK]MYXMV_NON^RK^ OS^RO\ SX Y^RO\ MYWZ\OROX]S`O SXMYWO Y\ NS\OM^Vc OKMRMYWZYXOX^ZK\^YP^ROZVKX^KXNO[_SZWOX^
VSKLSVS^c S^S]^ROZ\SXMSZKVSXKVVYPS^]\O`OX_OK\\KXQOWOX^] SXO[_S^cS]KV]Y\OMYQXS]ONSXY^RO\MYWZ\OROX]S`O ]OZK\K^OVcSP^ROMYWZYXOX^ZK\^RK]KMY]^aRSMR
]SXMO S^ S] ^RO Z\SWK\c YLVSQY\ SX KVV ^RO \O`OX_O income or in equity, as appropriate and not in S] ]SQXS MKX^ ^Y ^RO ^Y^KV MY]^ YP ^RO ZVKX^ KXN
   >
 RO Z\SXMSZKV Y\ ^RO WY]^ KN`KX^KQOY_] WK\UO^
K\\KXQOWOX^]K]S^RK]Z\SMSXQVK^S^_NOKXNS]KV]Y ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] 7KXKQOWOX^ O[_SZWOX^ KXN RK] _]OP_V VSPO ^RK^ S] WK^O\SKVVc
W_]^LOKMMO]]SLVOLc^RO-YWZKXc>ROPKS\`KV_O NSPPO\OX^ P\YW ^RK^ YP ^RO \OWKSXSXQ ZVKX^ KXN
ObZY]ON^YSX`OX^Y\cKXNM\ONS^\S]U] ZO\SYNSMKVVc O`KV_K^O] ZY]S^SYX] ^KUOX SX ^RO ^Kb
YP KX K]]O^ Y\ K VSKLSVS^c S] WOK]_\ON _]SXQ ^RO O[_SZWOX^
K]]_WZ^SYX] ^RK^ WK\UO^ ZK\^SMSZKX^] aY_VN _]O    >
 RO-YWZKXcRK]K]]_WON^RK^\OMY`O\cYPObMS]O \O^_\X]aS^R\O]ZOM^^Y]S^_K^SYX]SXaRSMRKZZVSMKLVO
aROX Z\SMSXQ ^RO K]]O^ Y\ VSKLSVS^c K]]_WSXQ ^RK^ N_^c
Ya] ^Y ^RO -YWZKXc YX S^] YaX KMMY_X^ ^Kb \OQ_VK^SYX] K\O ]_LTOM^ ^Y SX^O\Z\O^K^SYX KXN    1
 KSX] Y\ VY]]O] K\S]SXQ P\YW NO\OMYQXS^SYX YP
market participants act in their economic best KXN^R_]\O`OX_OSXMV_NO]ObMS]ON_^c_Z^Y4_XO O]^KLVS]RO]Z\Y`S]SYX]aRO\OKZZ\YZ\SK^O ^KXQSLVO Z\YZO\^c ZVKX^ KXN O[_SZWOX^ K\O
SX^O\O]^  ! K] ^RO ]KWO QY^ ]_L]_WON SX 1YYN] KXN    -
 _\\OX^ ^Kb K]]O^] KXN M_\\OX^ ^Kb VSKLSVS^SO] K\O measured as the difference between the net
=O\`SMO]>Kb1=>aS^ROPPOM^P\YW4_Vc! YPP]O^ aROX ^RO\O S] K VOQKVVc OXPY\MOKLVO \SQR^ NS]ZY]KVZ\YMOON]KXN^ROMK\\cSXQKWY_X^YP^RO
   +
 PKS\`KV_OWOK]_\OWOX^YPKXYX XKXMSKVK]]O^ K]]O^KXNK\O\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^
^KUO]SX^YKMMY_X^KWK\UO^ZK\^SMSZKX^t]KLSVS^c^Y    2
 YaO`O\ ]KVO] ^Kb@KV_O +NNON >Kb @+> to set off the recognised amounts and there is an
SX^OX^SYX ^Y ]O^^VO ^RO K]]O^ KXN ^RO VSKLSVS^c YX K KXN6Y]]aROX^ROK]]O^S]NO\OMYQXS]ON
QOXO\K^O OMYXYWSM LOXO ^] Lc _]SXQ ^RO K]]O^ SX 1YYN] KXN =O\`SMO] >Kb 1=> S] XY^ \OMOS`ON Lc
S^]RSQRO]^KXNLO]^_]OY\Lc]OVVSXQS^^YKXY^RO\ ^RO-YWZKXcYXS^]YaXKMMY_X^<K^RO\S^S]^Kb XO^LK]S] Depreciation is provided, pro-rata for the period
WK\UO^ZK\^SMSZKX^^RK^aY_VN_]O^ROK]]O^SXS^] MYVVOM^ONYX`KV_OKNNON^Y^ROMYWWYNS^cLc^RO YP _]O YX ^RO ]^\KSQR^ VSXO WO^RYN LK]ON YX ^RO
Deferred tax \O]ZOM^S`OO]^SWK^OYP_]OP_VVS`O]K]QS`OXLOVYa
RSQRO]^KXNLO]^_]O ]OVVO\YXLORKVPYP^ROQY`O\XWOX^+MMY\NSXQVcS^
S]ObMV_NONP\YW\O`OX_O    .
 OPO\\ON ^Kb S] \OMYQXS]ON _]SXQ ^RO ,KVKXMO /]^SWK^ON _]OP_V VS`O] YP K]]O^] K\O NO^O\WSXON
   >
 RO -YWZKXc _]O] `KV_K^SYX ^OMRXS[_O] ^RK^ K\O Sheet approach on temporary differences at the LK]ONYX^OMRXSMKVZK\KWO^O\]K]]O]]WOX^]
appropriate in the circumstances and for which Sale of products
\OZY\^SXQNK^OLO^aOOX^RO^KbLK]O]YPK]]O^]KXN    >
 RO WKXKQOWOX^ LOVSO`O] ^RK^ _]OP_V VS`O]
]_P MSOX^NK^KK\OK`KSVKLVO^YWOK]_\OPKS\`KV_O    <
 O`OX_OP\YW]KVOYPZ\YN_M^]S]\OMYQXS]ONaROX VSKLSVS^SO]KXN^ROS\MK\\cSXQKWY_X^]PY\ XKXMSKV M_\\OX^Vc_]ONaRSMRS]K]Z\O]M\SLON_XNO\:K\^
WKbSWS]SXQ ^RO _]O YP \OVO`KX^ YL]O\`KLVO SXZ_^] the risks and rewards of ownership is passed on \OZY\^SXQZ_\ZY]O]K^^RO\OZY\^SXQNK^O -YP=MRON_VO33^Y^RO-YWZKXSO]+M^PKS\Vc
KXN WSXSWS]SXQ ^RO _]O YP _XYL]O\`KLVO SXZ_^] ^Y ^RO M_]^YWO\] <O`OX_O P\YW ]KVO YP Z\YN_M^]
   >
 RO MK\\cSXQ KWY_X^ YP NOPO\\ON ^Kb K]]O^] S] \O
OM^S^]O]^SWK^OYP^RO_]OP_VVS`O]KXN\O]SN_KV
ARO\O\O[_S\ONKZZ\YZ\SK^OOb^O\XKV`KV_O\]K\O S] ]^K^ON ObMV_]S`O YP ]KVO] ^Kb @KV_O +NNON >Kb `KV_O] YP Z\YZO\^c ZVKX^ KXN O[_SZWOX^ ^RY_QR
SX`YV`ON @+> 1YYN] KXN =O\`SMO] >Kb 1=> KXN K\O XO^ reviewed at each reporting date and reduced
^Y ^RO Ob^OX^ ^RK^ S^ S] XY VYXQO\ Z\YLKLVO ^RK^ ^RO]OVS`O]SXMO\^KSXMK]O]K\ONSPPO\OX^P\YWVS`O]
   +
 VV K]]O^] KXN VSKLSVS^SO] PY\ aRSMR PKS\ `KV_O S] YP]KVO]\O^_\X]NS]MY_X^]Z\Y`S]SYXPY\KX^SMSZK^ON Z\O]M\SLON_XNO\=MRON_VO33
\O^_\X]YXObZS\cWKNOYX^ROLK]S]YPWKXKQOWOX^ ]_P MSOX^ ^KbKLVO Z\Y ^ aSVV LO K`KSVKLVO ^Y KVVYa
WOK]_\ONY\NS]MVY]ONSX^RO XKXMSKV]^K^OWOX^] KVVY\ZK\^YP^RONOPO\\ON^KbK]]O^^YLO_^SVS]ON
K\O MK^OQY\S]ON aS^RSX ^RO PKS\ `KV_O RSO\K\MRc ObZOM^K^SYX^KUSXQSX^YKMMY_X^ZK]^ObZO\SOXMO Method of depreciation Straight line
?X\OMYQXS]ON NOPO\\ON ^Kb K]]O^] K\O \OK]]O]]ON
NO]M\SLONK]PYVVYa]LK]ONYX^ROVYaO]^VO`OVSXZ_^ Rendering of Services Type of assets Useful life in years
at each reporting date and are recognised to the
^RK^S]]SQXS MKX^^Y^ROPKS\`KV_OWOK]_\OWOX^K] Ob^OX^ ^RK^ S^ RK] LOMYWO Z\YLKLVO ^RK^ P_^_\O 6OK]ORYVN6KXN 9`O\VOK]OZO\SYNSO
Service income is recognised as per the terms of
KaRYVO$ ^KbKLVOZ\Y ^]aSVVKVVYa^RONOPO\\ON^KbK]]O^^Y #cOK\]
^ROMYX^\KM^]K\\KXQOWOX^]aROX\OVK^ON]O\`SMO]
   w  O`OVy;_Y^ON_XKNT_]^ONZ\SMO]SXKM^S`O
6 K\OZO\PY\WONKXNS]]^K^ONXO^YP]O\`SMO^Kb LO\OMY`O\ON 6OK]ORYVN3WZ\Y`OWOX^] 9`O\Z\SWK\cVOK]O
WK\UO^]PY\SNOX^SMKVK]]O^]Y\VSKLSVS^SO] ZO\SYNSO^YcOK\]
Interest income    .
 OPO\\ON ^Kb K]]O^] KXN VSKLSVS^SO] K\O WOK]_\ON
,_SVNSXQ]
   w  O`OV  SP VO`OV  POON S] XY^ K`KSVKLVO
6    0
 Y\ KVV XKXMSKV SX]^\_WOX^] WOK]_\ON K^ K^ ^RO ^Kb \K^O] ^RK^ K\O ObZOM^ON ^Y KZZVc SX ^RO
KZZ\YZ\SK^O y @KV_K^SYX ^OMRXS[_O] PY\ cOK\ aROX ^RO K]]O^ S] \OKVS]ON Y\ ^RO VSKLSVS^c 0KM^Y\c,_SVNSXQ #cOK\]WYX^R]
amortised cost, interest income is recorded
aRSMR^ROVYaO]^VO`OVSXZ_^^RK^S]]SQXS MKX^ S] ObZOM^ON ^Y LO \OMY`O\ON Y\ ]O^^VON LK]ON YX <O]SNOX^SKV,_SVNSXQ] cOK\]
using the effective interest rate, which is the rate
^Y ^RO PKS\ `KV_O WOK]_\OWOX^ S] NS\OM^Vc Y\ ^RK^ ObKM^Vc NS]MY_X^] ^RO O]^SWK^ON P_^_\O MK]R ^Kb \K^O] KXN ^Kb VKa] ^RK^ RK`O LOOX OXKM^ON Y\ :VKX^KXN/[_SZWOX^
SXNS\OM^VcYL]O\`KLVO \OMOSZ^]^R\Y_QR^ROObZOM^ONVSPOYP^RO XKXMSKV ]_L]^KX^S`OVcOXKM^ONK^^RO\OZY\^SXQNK^O Anaesthetic Equipment cOK\]
   w  O`OVSPVO`OVKXNPOONS]XY^K`KSVKLVO
6 instrument or a shorter period, where appropriate,    .
 OPO\\ON^Kb\OVK^SXQ^YS^OW]\OMYQXS]ONOS^RO\SX 9^RO\] #^YcOK\]
KZZ\YZ\SK^O y @KV_K^SYX ^OMRXS[_O] PY\ ^Y ^RO XO^ MK\\cSXQ KWY_X^ YP ^RO XKXMSKV K]]O^ Y^RO\ MYWZ\OROX]S`O SXMYWO Y\ SX O[_S^c S] KV]Y 0_\XS^_\OKXN0Sb^_\O] cOK\]
aRSMR^ROVYaO]^VO`OVSXZ_^^RK^S]]SQXS MKX^ 3X^O\O]^ SXMYWO S] SXMV_NON SX s9^RO\ 3XMYWOt SX recognised in other comprehensive income or in 9P MO/[_SZWOX^
^Y^ROPKS\`KV_OWOK]_\OWOX^S]_XYL]O\`KLVO ^RO=^K^OWOX^YP:\Y ^KXN6Y]] equity, as appropriate and not in the Statement of Computers cOK\]
   0
 Y\ XKXMSKVK]]O^]KXNVSKLSVS^SO]WK^_\SXQaS^RSX Income from assignment of trademarks :\Y ^KXN6Y]] 9^RO\] cOK\]
YXO cOK\ P\YW ^RO ,KVKXMO =ROO^ NK^O KXN aRSMR Income from assignment of trademarks is    .
 OPO\\ON^KbK]]O^]KXNNOPO\\ON^KbVSKLSVS^SO]K\O @ORSMVO] cOK\]
K\O XY^ MK\\SON K^ PKS\ `KV_O ^RO MK\\cSXQ KWY_X^ \OMYQXS]ON SX ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] YPP]O^SPKVOQKVVcOXPY\MOKLVO\SQR^ObS]^]^Y]O^YPP
KZZ\YbSWK^O]PKS\`KV_ON_O^Y^RO]RY\^WK^_\S^c  3X\O]ZOM^YP^RO]OK]]O^]^ROWKXKQOWOX^O]^SWK^O
YXP_V VWOX^YPYLVSQK^SYX]K]ZO\^RO_XNO\VcSXQ M_\\OX^^KbK]]O^]KQKSX]^M_\\OX^^KbVSKLSVS^SO]
YP^RO]OSX]^\_WOX^] YP _]OP_V VS`O] LK]ON YX ^OMRXSMKV K]]O]]WOX^ S]
KQ\OOWOX^aS^R^ROL_cO\
f) Property, plant and equipment VYaO\^RKX^RO_]OP_VVSPOZ\O]M\SLON_XNO\ZK\^-YP
   >
 RO-YWZKXc\OMYQXS]O]^\KX]PO\]LO^aOOXVO`OV] e) Taxes =MRON_VO33^Y^RO-YWZKXSO]+M^
YP PKS\ `KV_O RSO\K\MRc K^ ^RO OXN YP \OZY\^SXQ    :\YZO\^cZVKX^KXNO[_SZWOX^K\O]^K^ONK^MY]^
ZO\SYNN_\SXQaRSMRMRKXQORK]YMM_\\ON Current income tax YPKM[_S]S^SYXVO]]KMM_W_VK^ONNOZ\OMSK^SYXKXN    >
 RO \O]SN_KV `KV_O] _]OP_V VS`O] KXN WO^RYN] YP
   >
 Kb ObZOX]O MYWZ\S]O] YP M_\\OX^ KXN NOPO\\ON SWZKS\WOX^ SX `KV_O SP KXc -Y]^ PY\ ]_L]O[_OX^ NOZ\OMSK^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^K\O
d) Revenue recognition additions comprises the purchase price and \O`SOaON K^ OKMR XKXMSKV cOK\ OXN KXN KNT_]^ON
^Kb KXN SXMV_NO] KXc KNT_]^WOX^] \OVK^ON ^Y ZK]^
   <
 O`OX_O S] \OMYQXS]ON ^Y ^RO Ob^OX^ S^ S] ZO\SYN]SXM_\\OX^KXNY\NOPO\\ON^KbKNT_]^WOX^] KXc Y^RO\ K^^\SL_^KLVO MY]^ YP L\SXQSXQ ^RO K]]O^ Z\Y]ZOM^S`OVcSPKZZ\YZ\SK^O
Z\YLKLVO ^RK^ ^RO OMYXYWSM LOXO ^] aSVV
Ya that may become necessary due to certain ^Y S^] aY\USXQ MYXNS^SYX PY\ S^] SX^OXNON _]O Advances paid towards the acquisition of property,
^Y ^RO -YWZKXc KXN ^RO \O`OX_O MKX LO \OVSKLVc NO`OVYZWOX^] Y\ \O`SOa] N_\SXQ ^RO \OVO`KX^ =_L]O[_OX^ ObZOXNS^_\O] K\O KNNON ^Y S^] Q\Y]] ZVKX^KXNO[_SZWOX^Y_^]^KXNSXQK^OKMR,KVKXMO
WOK]_\ON\OQK\NVO]]YPaROX^ROZKcWOX^S]LOSXQ ZO\SYN >RO Z\Y`S]SYX PY\ M_\\OX^ ^Kb S] WKNO K^ LYYU`KV_OYXVcSPS^SXM\OK]O]^ROP_^_\OLOXO ^] =ROO^ NK^O S] MVK]]S ON K] MKZS^KV KN`KXMO] _XNO\
WKNO<O`OX_OS]WOK]_\ONK^^ROPKS\`KV_OYP^RO ^RO\K^OYP^KbK]KZZVSMKLVOPY\^ROSXMYWOYP^RO P\YW ^RO ObS]^SXQ K]]O^ LOcYXN S^] Z\O`SY_]Vc s9^RO\ XYXM_\\OX^ K]]O^]t KXN ^RO MY]^ YP K]]O^]
MYX]SNO\K^SYX \OMOS`ON Y\ \OMOS`KLVO ^KUSXQ SX^Y Z\O`SY_] cOK\ K] NO XON _XNO\ ^RO 3XMYWO ^Kb assessed standard of performance and cost of the XY^Z_^^Y_]OLOPY\O]_MRNK^OK\ONS]MVY]ON_XNO\
KMMY_X^ MYX^\KM^_KVVc NO XON ^O\W] YP ZKcWOX^ +M^#  S^OWMKXLOWOK]_\ON\OVSKLVc s-KZS^KVaY\USXZ\YQ\O]]t

108 ANNUAL REPORT 2017-18 109


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

g) Intangible assets    w 3^] SX^OX^SYX ^Y MYWZVO^O KXN S^] KLSVS^c KXN    -
 Y]^ YP aY\USXZ\YQ\O]] KXN XS]RON QYYN] determined by a range of outcomes, taking into
SX^OX^SYX^Y_]OY\]OVV^ROK]]O^ SXMV_NO] NS\OM^ WK^O\SKV] VKLY_\ KXN Z\YZY\^SYX KMMY_X^ ^RO ^SWO `KV_O YP WYXOc KXN Y^RO\
   3 X^KXQSLVO K]]O^] K\O MK\\SON K^ MY]^ XO^ YP
   w 2Ya^ROK]]O^aSVVQOXO\K^OP_^_\OOMYXYWSM YPWKX_PKM^_\SXQY`O\ROKN]LK]ONYX^ROXY\WKV \OK]YXKLVOSXPY\WK^SYXK`KSVKLVOK]K\O]_V^YPZK]^
KMM_W_VK^ONKWY\^S]K^SYXKXNSWZKS\WOX^VY]]O]
YZO\K^SXQ MKZKMS^c aRO\O`O\ KZZVSMKLVO -Y]^ YP events, current conditions and forecasts of future
SP KXc -Y]^ YP KX SX^KXQSLVO K]]O^ MYWZ\S]O] YP LOXO ^]
XS]RON QYYN] SXMV_NO] ObMS]O N_^c KXN Y^RO\ OMYXYWSMMYXNS^SYX]
Z_\MRK]O Z\SMO KXN K^^\SL_^KLVO ObZOXNS^_\O YX    w >ROK`KSVKLSVS^cYP\O]Y_\MO]^YMYWZVO^O^RO costs incurred in bringing the inventories to their 8YX XKXMSKVK]]O^]
WKUSXQ^ROK]]O^\OKNcPY\S^]SX^OXNON_]O asset Z\O]OX^VYMK^SYXKXNMYXNS^SYX
 3 X^KXQSLVOK]]O^]KM[_S\ON]OZK\K^OVcK\OWOK]_\ON >ROMK\\cSXQKWY_X^YPXYX XKXMSKVK]]O^]Y^RO\
   w >RO KLSVS^c ^Y WOK]_\O \OVSKLVc ^RO    -
 Y]^YP]^YMUSX^\KNOSXMV_NO]MY]^YPZ_\MRK]OKXN than inventories are assessed at each reporting
YXSXS^SKV\OMYQXS^SYXK^MY]^3X^KXQSLVOK]]O^]K\O ObZOXNS^_\ON_\SXQNO`OVYZWOX^ other costs incurred in bringing the inventories to date to ascertain whether there is any indication of
KWY\^S]ONY`O\^RO_]OP_VOMYXYWSMVSPOKXNK]]O]]ON
^ROS\Z\O]OX^VYMK^SYXKXNMYXNS^SYX SWZKS\WOX^3PKXc]_MRSXNSMK^SYXObS]^]Y\aROX
for impairment whenever there is an indication TROKWY_X^MKZS^KVS]ONMYWZ\S]O]YPObZOXNS^_\O
^RK^ ^RO SX^KXQSLVO K]]O^ WKc LO SWZKS\ON >RO ^RK^ MKX LO NS\OM^Vc K^^\SL_^ON Y\ KVVYMK^ON YX    8
 O^ \OKVS]KLVO `KV_O S] ^RO O]^SWK^ON ]OVVSXQ Z\SMO KXX_KVSWZKS\WOX^^O]^SXQPY\KXK]]O^S]\O[_S\ON
amortisation period and the amortisation method K \OK]YXKLVO KXN MYX]S]^OX^ LK]S] ^Y M\OK^SXQ SX^ROY\NSXK\cMY_\]OYPL_]SXO]]VO]]O]^SWK^ON ^ROX ^RO K]]O^t] \OMY`O\KLVO KWY_X^ S] O]^SWK^ON
PY\KXSX^KXQSLVOK]]O^K\O\O`SOaONK^VOK]^K^^RO producing and making the asset ready for its MY]^]YPMYWZVO^SYXKXNO]^SWK^ONMY]^]XOMO]]K\c +XSWZKS\WOX^VY]]S]\OMYQXS]ONK]KXObZOX]OSX
OXN YP OKMR \OZY\^SXQ ZO\SYN >RO KWY\^S]K^SYX SX^OXNON _]O :\YZO\^c ZVKX^ KXN O[_SZWOX^ ^Y WKUO ^RO ]KVO 2YaO`O\ WK^O\SKV] KXN Y^RO\ ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] PY\ ^RO KWY_X^
ObZOX]O YX SX^KXQSLVO K]]O^] S] \OMYQXS]ON SX ^RO _^SVS]ON PY\ \O]OK\MR KXN NO`OVYZWOX^ K\O S^OW]ROVNPY\_]OSX^ROZ\YN_M^SYXYPSX`OX^Y\SO] Lc aRSMR ^RO K]]O^t] MK\\cSXQ KWY_X^ ObMOON] S^]
=^K^OWOX^YP:\Y ^KXN6Y]] K\O XY^ a\S^^OX NYaX LOVYa MY]^ SP ^RO XS]RON \OMY`O\KLVO KWY_X^ >RO \OMY`O\KLVO KWY_X^
MKZS^KVS]ONKXNNOZ\OMSK^ONSXKMMY\NKXMOaS^R^RO
Z\YN_M^]SXaRSMR^ROcaSVVLO_]ONK\OObZOM^ON S] ^RO RSQRO\ YP KX K]]O^t] PKS\ `KV_O VO]] MY]^ ^Y
ZYVSMSO] ]^K^ON PY\ Z\YZO\^c ZVKX^ KXN O[_SZWOX^
Method of amortisation Straight Line ^YLO]YVNK^Y\KLY`OMY]^ ]OVV KXN `KV_O SX _]O @KV_O SX _]O S] K]MO\^KSXON
KXNNOZ\OMSK^SYX
through discounting of the estimated future cash
Type of assets Useful life in years l) Impairment
Ya]_]SXQKNS]MY_X^\K^O^RK^\O
OM^]^ROM_\\OX^
j) Leases
Software ^YcOK\] Financial assets WK\UO^K]]O]]WOX^]YP^RO^SWO`KV_OYPWYXOcKXN
The determination of whether an arrangement is a ^RO \S]U ]ZOMS M ^Y ^RO K]]O^] 0Y\ ^RO Z_\ZY]O YP
Trademarks cOK\]
VOK]OS]LK]ONYX^RO]_L]^KXMOYP^ROK\\KXQOWOX^    XKXMSKVK]]O^S]K]]O]]ONK^OKMR\OZY\^SXQNK^O^Y
+ assessing impairment, assets are grouped at the
   1
 KSX] Y\ VY]]O] K\S]SXQ P\YW NO\OMYQXS^SYX YP KX K^^ROSXMOZ^SYXYP^ROVOK]O>ROK\\KXQOWOX^S]Y\ determine whether there is any objective evidence VYaO]^VO`OV]SX^YMK]RQOXO\K^SXQ_XS^]PY\aRSMR
SX^KXQSLVO K]]O^ K\O WOK]_\ON K] ^RO NSPPO\OXMO MYX^KSX]KVOK]OSPP_V VVWOX^YP^ROK\\KXQOWOX^S] ^RK^ S^ S] SWZKS\ON + XKXMSKV K]]O^ S] MYX]SNO\ON ^RO\OK\O]OZK\K^OVcSNOX^S KLVOMK]R
Ya]
LO^aOOX ^RO XO^ NS]ZY]KV Z\YMOON] KXN ^RO NOZOXNOX^YX^RO_]OYPK]ZOMS MK]]O^Y\K]]O^] to be impaired, if objective evidence indicates that
and the arrangement conveys a right to use the one or more events have had a negative effect on  X SWZKS\WOX^ VY]] S] \O`O\]ON SP ^RO\O RK] LOOX
+
carrying amount of the asset and are recognised in
^ROO]^SWK^ONP_^_\OMK]R
Ya]YP^RK^K]]O^ a change in the estimates used to determine the
^RO=^K^OWOX^YP:\Y ^KXN6Y]]aROX^ROK]]O^S] K]]O^ Y\ K]]O^] O`OX SP ^RK^ \SQR^ S] XY^ ObZVSMS^Vc
\OMY`O\KLVOKWY_X^+XSWZKS\WOX^VY]]S]\O`O\]ON
NO\OMYQXS]ON ]ZOMS ONSXKXK\\KXQOWOX^    3 X KMMY\NKXMO aS^R 3XN += # ^RO -YWZKXc YXVc ^Y ^RO Ob^OX^ ^RK^ ^RO K]]O^t] MK\\cSXQ KWY_X^
Company as a lessee KZZVSO] /bZOM^ON -\ONS^ 6Y]] /-6 WYNOV PY\ NYO] XY^ ObMOON ^RO MK\\cSXQ KWY_X^ ^RK^ aY_VN
h) Assets held for sale
WOK]_\OWOX^KXN\OMYQXS^SYXYPSWZKS\WOX^VY]] have been determined, net of depreciation or
  \YZO\^c ZVKX^ KXN O[_SZWOX^ K\O MVK]]S ON K]
:    6
 OK]O]aRO\OVO]]Y\OPPOM^S`OVc\O^KSX]]_L]^KX^SKVVc YX ^RO PYVVYaSXQ XKXMSKV K]]O^] KXN M\ONS^ \S]U KWY\^S]K^SYXSPXYSWZKS\WOX^RKNLOOX\OMYQXS]ON
K]]O^] ROVN PY\ ]KVO SP ^ROS\ MK\\cSXQ KWY_X^] K\O KVV ^RO \S]U] KXN LOXO ^] YP YaXO\]RSZ YP ^RO ObZY]_\O$
VOK]ONS^OW]K\OMVK]]S ONK]YZO\K^SXQVOK]O>RO m) Provisions and contingencies
^Y LO \OMY`O\ON Z\SXMSZKVVc ^R\Y_QR K ]KVO \K^RO\    K  \KNO\OMOS`KLVO]Y\KXcMYX^\KM^_KV\SQR^^Y
>
^RKX ^R\Y_QR MYX^SX_SXQ _]O >RO MYXNS^SYX PY\ -YWZKXc S] K VO]]OO _XNO\ ]_MR K\\KXQOWOX^] Provisions
\OMOS`O MK]R Y\ KXY^RO\ XKXMSKV K]]O^ ^RK^
MVK]]S MK^SYX YP ROVN PY\ ]KVO S] WO^ aROX ^RO XYX 9ZO\K^SXQ VOK]O ZKcWOX^] K\O \OMYQXS]ON K] KX + Z\Y`S]SYX S] \OMYQXS]ON SP K] K \O]_V^ YP K
\O]_V^ P\YW ^\KX]KM^SYX] ^RK^ K\O aS^RSX ^RO
M_\\OX^K]]O^S]K`KSVKLVOPY\SWWONSK^O]KVOKXN^RO ObZOX]O SX ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] YX ZK]^ O`OX^ ^RO -YWZKXc RK] K Z\O]OX^ VOQKV
]MYZOYP3XN+="
]KWO S] RSQRVc Z\YLKLVO YP LOSXQ MYWZVO^ON aS^RSX ]^\KSQR^ VSXO LK]S] Y`O\ VOK]O ^O\W _XVO]] ^RO Y\ MYX]^\_M^S`O YLVSQK^SYX ^RK^ S] \OK]YXKLVc
YXOcOK\P\YW^RONK^OYPMVK]S MK^SYXK]ROVNPY\]KVO ZKcWOX^] ^Y ^RO VO]]Y\ K\O ]^\_M^_\ON ^Y SXM\OK]O    L 9^RO\ XKXMSKVK]]O^]aRSMRK\OWOK]_\ONK^
O]^SWKLVO KXN S^ S] Z\YLKLVO ^RK^ KX Y_^
Ya YP
SXVSXOaS^RObZOM^ONQOXO\KVSX
K^SYX amortised cost
   :
 \YZO\^cZVKX^KXNO[_SZWOX^\O^S\ONP\YWKM^_KV \O]Y_\MO] OWLYNcSXQ OMYXYWSM LOXO ^] aSVV LO
_]OKXNROVNPY\NS]ZY]KVK\O]^K^ONK^^ROVYaO\YP Company as a lessor    >
 RO -YWZKXc PYVVYa] ]SWZVS ON KZZ\YKMR PY\ \O[_S\ON ^Y ]O^^VO ^RO YLVSQK^SYX :\Y`S]SYX] K\O
^ROS\ XO^ LYYU `KV_O KXN XO^ \OKVS]KLVO `KV_O KXN \OMYQXS^SYXYPSWZKS\WOX^VY]]KVVYaKXMOYX>\KNO NO^O\WSXON Lc NS]MY_X^SXQ ^RO ObZOM^ON P_^_\O
Leases in which the Company does not transfer \OMOS`KLVO]>RO-YWZKXc\OMYQXS]O]SWZKS\WOX^ MK]R
Ya] K^ K Z\O^Kb \K^O ^RK^ \O
OM^] M_\\OX^
K\O NS]MVY]ON ]OZK\K^OVc _XNO\ s-_\\OX^ K]]O^]t ]_L]^KX^SKVVcKVV^RO\S]U]KXN\OaK\N]YPKXK]]O^
9XMOMVK]]S ONK]ROVNPY\]KVO^RO]OK]]O^]K\OXY^ VY]] KVVYaKXMO LK]ON YX VSPO^SWO /-6] K^ OKMR WK\UO^K]]O]]WOX^]YP^RO^SWO`KV_OYPWYXOcKXN
K\O MVK]]S ON K] YZO\K^SXQ VOK]O <OX^KV SXMYWO \OZY\^SXQNK^O\SQR^P\YWS^]SXS^SKV\OMYQXS^SYX ^RO\S]U]]ZOMS M^Y^ROVSKLSVS^c
NOZ\OMSK^ON P\YW YZO\K^SXQ VOK]O S] \OMYQXS]ON YX K ]^\KSQR^
   0
 Y\ \OMYQXS^SYX YP SWZKS\WOX^ VY]] YX Y^RO\ Provision for sales return and date expiry :
i) Research and development VSXO LK]S] Y`O\ ^RO ^O\W YP ^RO \OVO`KX^ VOK]O
XKXMSKV K]]O^] KXN \S]U ObZY]_\O ^RO -YWZKXc The Company as per trade practice accepts returns
Contingent rents are recognised as revenue in the
   <
 O`OX_O ObZOXNS^_\O ZO\^KSXSXQ ^Y \O]OK\MR determines that whether there has been a P\YW WK\UO^ aRSMR K\O Z\SWK\SVc SX ^RO XK^_\O
cOK\SXaRSMR^ROcK\OOK\XON
S] MRK\QON ^Y ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] ]SQXS MKX^ SXM\OK]O SX ^RO M\ONS^ \S]U ]SXMO SXS^SKV YP ObZS\ON Y\ XOK\ ObZS\c Z\YN_M^] :\Y`S]SYX]
.O`OVYZWOX^MY]^]YPZ\YN_M^]K\OKV]YMRK\QON^Y k) Inventories \OMYQXS^SYX 3P M\ONS^ \S]U RK] XY^ SXM\OK]ON for such returns are estimated on the basis of
^RO=^K^OWOX^YP:\Y ^KXN6Y]]_XVO]]KZ\YN_M^t] ]SQXS MKX^Vc WYX^R /-6 S] _]ON ^Y Z\Y`SNO RS]^Y\SMKV ObZO\SOXMO WK\UO^ MYXNS^SYX] KXN
   3 X`OX^Y\SO] MYX]S]^] YP \Ka WK^O\SKV] ZKMUSXQ PY\ SWZKS\WOX^ VY]] 2YaO`O\ SP M\ONS^ \S]U RK]
^OMRXSMKVPOK]SLSVS^cRK]LOOXO]^KLVS]RONSXaRSMR WK^O\SKV] aY\USXZ\YQ\O]] ]^YMUSX^\KNO KXN ]ZOMS MMYX^\KM^_KV^O\W]KXNK\OZ\Y`SNONPY\
MK]O]_MRObZOXNS^_\OS]MKZS^KVS]ON SXM\OK]ON]SQXS MKX^VcVSPO^SWO/-6S]_]ON3PSXK
XS]RONQYYN]3X`OX^Y\SO]K\O`KV_ONK^VYaO\YP ]_L]O[_OX^ZO\SYNM\ONS^[_KVS^cYP^ROSX]^\_WOX^ Contingencies
   .
 O`OVYZWOX^ ObZOXNS^_\O] YX KX SXNS`SN_KV MY]^KXNXO^\OKVS]KLVO`KV_O-Y]^S]NO^O\WSXONYX SWZ\Y`O]]_MR^RK^^RO\OS]XYVYXQO\K]SQXS MKX^    +MYX^SXQOX^VSKLSVS^cS]$
Z\YTOM^K\O\OMYQXS]ONK]KXSX^KXQSLVOK]]O^aROX 0S\]^3X0S\]^9_^LK]S] SXM\OK]O SX M\ONS^ \S]U ]SXMO SXS^SKV \OMYQXS^SYX
^RO-YWZKXcMKXNOWYX]^\K^O$    w K ZY]]SLVO YLVSQK^SYX ^RK^ K\S]O] P\YW ZK]^
 Y]^ YP \Ka WK^O\SKV] KXN ZKMUSXQ WK^O\SKV]
- then the entity reverts to recognising impairment O`OX^]KXNaRY]OObS]^OXMOaSVVLOMYX \WON
   w  RO ^OMRXSMKV POK]SLSVS^c YP MYWZVO^SXQ ^RO
> SXMV_NO]MY]^YPZ_\MRK]OKXNY^RO\MY]^]SXM_\\ON VY]]KVVYaKXMOLK]ONYXWYX^R/-6 YXVc Lc ^RO YMM_\\OXMO Y\ XYXYMM_\\OXMO
SX^KXQSLVO K]]O^ ]Y ^RK^ ^RO K]]O^ aSVV LO SXL\SXQSXQ^ROSX`OX^Y\SO]^Y^ROS\Z\O]OX^VYMK^SYX   -6 K\O WOK]_\ON SX K WKXXO\ ^RK^ ^ROc \O
OM^
/ of one or more uncertain future events not
K`KSVKLVOPY\_]OY\]KVO KXNMYXNS^SYX _XLSK]ON KXN Z\YLKLSVS^c aOSQR^ON KWY_X^] aRYVVcaS^RSX^ROMYX^\YVYP^RO-YWZKXc%Y\

110 ANNUAL REPORT 2017-18 111


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

   w K  Z\O]OX^ YLVSQK^SYX ^RK^ K\S]O] P\YW ZK]^  +]\O[_S\ONLc3XN+=#s/WZVYcOO,OXO ^]t^RO p) Share based compensation `KV_O ^R\Y_QR Z\Y ^ Y\ VY]]t Y\ s9^RO\ XKXMSKV
O`OX^]L_^S]XY^\OMYQXS]ONLOMK_]O$ NS]MY_X^ \K^O _]ON ^Y K\\S`O K^ ^RO Z\O]OX^ `KV_O VSKLSVS^SO]t
 LLY^^ 6KLY\K^Y\SO] ?=+ LOSXQ ^RO ?V^SWK^O
+
    S^ S] XY^ Z\YLKLVO ^RK^ KX Y_^
Ya YP YP ^RO NO XON LOXO ^ YLVSQK^SYX] S] LK]ON YX ^RO
2YVNSXQ -YWZKXc RK] QS`OX \O]^\SM^ON ]^YMU    K 0
 SXKXMSKVVSKLSVS^SO]K\OMVK]]S ONK]s0SXKXMSKV
\O]Y_\MO] OWLYNcSXQ OMYXYWSM LOXO ^] 3XNSKX QY`O\XWOX^ ]OM_\S^c cSOVN] Z\O`KSVSXQ K]
YZ^SYXZVKX^Y^ROOWZVYcOO]YP^RO-YWZKXc VSKLSVS^SO]K^PKS\`KV_O^R\Y_QRZ\Y ^Y\VY]]t
aSVVLO\O[_S\ON^Y]O^^VO^ROYLVSQK^SYX%Y\ K^^RO,KVKXMO=ROO^NK^O^RK^RK`OWK^_\S^cNK^O
O[_S`KVOX^^Y^RO^OX_\OYP^ROYLVSQK^SYX    :
 _\]_KX^ ^Y 3XN +=  s=RK\OLK]ON :KcWOX^t SP ^ROc K\O ROVN PY\ ^\KNSXQ Y\ SP ^ROc K\O
    ^RO KWY_X^ YP ^RO YLVSQK^SYX MKXXY^ LO ^RO-YWZKXc\OMYQXS]O]KXObZOX]OLK]ONYX^RO NO]SQXK^ONK] XKXMSKVVSKLSVS^SO]K^PKS\`KV_O
   >
 ROMKVM_VK^SYXS]ZO\PY\WONLcK[_KVS ONKM^_K\c ^R\Y_QR Z\Y ^ Y\ VY]] >RO]O K\O WOK]_\ON
WOK]_\ONaS^R]_P MSOX^\OVSKLSVS^c PKS\`KV_OYP^RO]^YMUYZ^SYX]K]K^Q\KX^NK^O>RO
_]SXQ ^RO Z\YTOM^ON _XS^ M\ONS^ WO^RYN AROX SXS^SKVVcK^PKS\`KV_OaS^R]_L]O[_OX^MRKXQO]
ObZOX]O]K\OKWY\^S]ONY`O\^RO`O]^SXQZO\SYN>RO
  X /WZVYcOOLOXO ^] ^RO MKVM_VK^SYX \O]_V^] SX K XO^ K]]O^ ZY]S^SYX ^RO \OMYQXS]ONSXZ\Y ^Y\VY]]
corresponding credit is given to equity because the
=RY\^^O\WOWZVYcWOX^LOXO ^]$ \OMYQXS]ONK]]O^S]VSWS^ON^Y^ROZ\O]OX^`KV_OYP
award represents in substance equity contribution    L 9
 ^RO\ XKXMSKV VSKLSVS^SO] K\O SXS^SKVVc
OMYXYWSMLOXO ^]K`KSVKLVOSXPY\WYP\ON_M^SYX]
 VV OWZVYcOO LOXO ^] ZKcKLVO aS^RSX  months
+ Lc ^RO :K\OX^ -YWZKXc >RO M_W_VK^S`O ObZOX]O WOK]_\ON K^ PKS\ `KV_O XO^ YP NS\OM^Vc
SXP_^_\OMYX^\SL_^SYX]
YP ]O\`SMO ]_MR K] ]KVK\SO] aKQO] LYX_] ObQ\K^SK recognised for stock options at each reporting date K^^\SL_^KLVO ^\KX]KM^SYX MY]^] =_L]O[_OX^
WONSMKV LOXO ^] O^M K\O \OMYQXS]ON SX ^RO cOK\ SX The Company recognises remeasurements of _X^SV^RO`O]^SXQNK^O\O
OM^]^ROOb^OX^^YaRSMR ^Y SXS^SKV \OMYQXS^SYX ^RO]O K\O WOK]_\ON K^
aRSMR^ROOWZVYcOO]\OXNO\^RO\OVK^ON]O\`SMOKXN KM^_K\SKV QKSX] KXN VY]]O] SX ZY]^ \O^S\OWOX^ ^RO`O]^SXQZO\SYNRK]ObZS\ONKXN^RO-YWZKXct] amortised cost using the effective interest
K\OZ\O]OX^ONK]M_\\OX^OWZVYcOOLOXO ^YLVSQK^SYX WONSMKV LOXO ^ ZVKX] SWWONSK^OVc SX Y^RO\ best estimate of the number of equity instruments
\K^OWO^RYN
aS^RSX^RO,KVKXMO=ROO^>O\WSXK^SYXLOXO ^]K\O MYWZ\OROX]S`OSXMYWOKXNKVV^ROY^RO\ObZOX]O] ^RK^aSVV_V^SWK^OVc`O]^
\OMYQXS]ONK]KXObZOX]OK]KXNaROXSXM_\\ON \OVK^ON ^Y ZY]^ \O^S\OWOX^ WONSMKV LOXO ^ ZVKX] q) Financial instruments Derecognition
K] OWZVYcOO LOXO ^ ObZOX]O] SX ^ROS\ =^K^OWOX^
   =
 RY\^^O\W VOK`O LOXO ^ S] Z\Y`SNON K^    +
  XKXMSKV SX]^\_WOX^ S] KXc MYX^\KM^ ^RK^ QS`O]    +
  XKXMSKV VSKLSVS^c S] NO\OMYQXS]ON aROX ^RO
YP :\Y ^ KXN 6Y]] <OWOK]_\OWOX^] K\O XY^
undiscounted amount during the accounting \OMVK]]S ON ^Y =^K^OWOX^ YP :\Y ^ KXN 6Y]] SX \S]O^YK XKXMSKVK]]O^YPYXOOX^S^cKXNK XKXMSKV YLVSQK^SYX _XNO\ ^RO VSKLSVS^c S] NS]MRK\QON Y\
ZO\SYNLK]ONYX^RO]O\`SMO\OXNO\ONLcOWZVYcOO] ]_L]O[_OX^ZO\SYN VSKLSVS^cYPO[_S^cSX]^\_WOX^YPKXY^RO\OX^S^c MKXMOVVON Y\ ObZS\O] AROX KX ObS]^SXQ XKXMSKV
VSKLSVS^c S] \OZVKMON Lc KXY^RO\ P\YW ^RO ]KWO
.O XONMYX^\SL_^SYXZVKX$    A
 ROX^ROLOXO ^]YP^ROZVKXK\OMRKXQONY\aROX Financial assets VOXNO\YX]_L]^KX^SKVVcNSPPO\OX^^O\W]Y\^RO^O\W]
   -
 YX^\SL_^SYX] ^Y NO XON MYX^\SL_^SYX ]MROWO] KZVKXS]M_\^KSVONY\]O^^VOWOX^YMM_\]^ROZY\^SYX Recognition and measurement YP KX ObS]^SXQ VSKLSVS^c K\O ]_L]^KX^SKVVc WYNS ON
]_MR K] =^K^O QY`O\XON :\Y`SNOX^ 0_XN KXN YP ^RO MRKXQON LOXO ^ \OVK^ON ^Y ZK]^ ]O\`SMO Lc ]_MR KX ObMRKXQO Y\ WYNS MK^SYX S] ^\OK^ON K]
OWZVYcOO] Y\ ^RO QKSX Y\ VY]] YX M_\^KSVWOX^    +
 VV XKXMSKV K]]O^] K\O \OMYQXS]ON SXS^SKVVc K^
/WZVYcOO :OX]SYX =MROWO /WZVYcOO]t =^K^O PKS\ `KV_O ZV_] SX ^RO MK]O YP XKXMSKV K]]O^] XY^ ^RO NO\OMYQXS^SYX YP ^RO Y\SQSXKV VSKLSVS^c KXN ^RO
3X]_\KXMO =MROWO =_ZO\KXX_K^SYX /WZVYcOO]t Y\ ]O^^VOWOX^ S] \OMYQXS]ON SWWONSK^OVc SX ^RO \OMYQXS^SYXYPKXOaVSKLSVS^c>RONSPPO\OXMOSX^RO
=^K^OWOX^YP:\Y ^KXN6Y]] \OMY\NON K^ s0KS\ `KV_O ^R\Y_QR Z\Y ^ Y\ VY]]t
.OZY]S^ 6SXUON 3X]_\KXMO KXN 1\Y_Z 6SPO ^\KX]KM^SYX MY]^] ^RK^ K\O K^^\SL_^KLVO ^Y ^RO respective carrying amounts is recognised in the
3X]_\KXMOK\OMRK\QONK]KXObZOX]OLK]ONYX^RO    9^RO\OWZVYcOOLOXO ^]$ KM[_S]S^SYX YP ^RO XKXMSKV K]]O^ 0SXKXMSKV K]]O^] =^K^OWOX^YP:\Y ^KXN6Y]]
amount of contribution required to be made as and K\O MVK]]S ON K^ SXS^SKV \OMYQXS^SYX K] XKXMSKV
aROX]O\`SMO]K\O\OXNO\ONLc^ROOWZVYcOO]>RO    9
 ^RO\ OWZVYcOO LOXO ^] MYWZ\S]O YP VOK`O    9PP]O^^SXQYP XKXMSKVSX]^\_WOX^]
encashment which is provided for, based on the K]]O^]WOK]_\ONK^PKS\`KV_OY\K]s0SXKXMSKVK]]O^]
KLY`OLOXO ^]K\OMVK]]S ONK]NO XONMYX^\SL_^SYX WOK]_\ONK^KWY\^S]ONMY]^t    0
 SXKXMSKV K]]O^] KXN XKXMSKV VSKLSVS^SO] K\O YPP]O^
]MROWO]KXN^RO-YWZKXcRK]XYP_\^RO\NO XON KM^_K\SKV`KV_K^SYXMK\\SONY_^K]K^^ROOXNYP^RO
cOK\    0
 Y\Z_\ZY]O]YP]_L]O[_OX^WOK]_\OWOX^ XKXMSKV KXN ^RO XO^ KWY_X^ S] \OZY\^ON SX ^RO ,KVKXMO
YLVSQK^SYX]LOcYXN^ROMYX^\SL_^SYX] =ROO^SP^RO\OS]KM_\\OX^VcOXPY\MOKLVOVOQKV\SQR^
K]]O^]K\OMVK]]S ONSXPYVVYaSXQMK^OQY\SO]$
   3 P ^RO MYX^\SL_^SYX ZKcKLVO ^Y ^RO ]MROWO PY\    6
 SKLSVS^SO]\OMYQXS]ONSX\O]ZOM^YPY^RO\VYXQ^O\W to offset the recognised amounts and there is an
]O\`SMO \OMOS`ON LOPY\O ^RO ,KVKXMO =ROO^ NK^O OWZVYcOOLOXO ^]K\OWOK]_\ONK^^ROZ\O]OX^`KV_O    w 0SXKXMSKVK]]O^]K^KWY\^S]ONMY]^ SX^OX^SYX ^Y ]O^^VO YX K XO^ LK]S] ^Y \OKVS]O ^RO
ObMOON] ^RO MYX^\SL_^SYX KV\OKNc ZKSN ^RO NO MS^ YP ^RO O]^SWK^ON P_^_\O MK]R Y_^
Ya] ObZOM^ON    w 0SXKXMSKVK]]O^]K^PKS\`KV_O K]]O^]KXN]O^^VO^ROVSKLSVS^SO]]SW_V^KXOY_]Vc
ZKcKLVO ^Y ^RO ]MROWO S] \OMYQXS]ON K] K VSKLSVS^c to be made by the Company in respect of services
Z\Y`SNONLcOWZVYcOO]_Z^Y^RO\OZY\^SXQNK^O    +
  XKXMSKVK]]O^S]WOK]_\ONK^KWY\^S]ONMY]^XO^ r) Cash and cash equivalents
KP^O\ NON_M^SXQ ^RO MYX^\SL_^SYX KV\OKNc ZKSN of impairment, if the objective of the Company’s
3P ^RO MYX^\SL_^SYX KV\OKNc ZKSN ObMOON] ^RO o) Earnings per equity share L_]SXO]] WYNOV S] ^Y RYVN ^RO XKXMSKV K]]O^    -
 K]R KXN MK]R O[_S`KVOX^] SX ^RO ,KVKXMO =ROO^
contribution due for services received before the ^Y MYVVOM^ ^RO MYX^\KM^_KV MK]R
Ya] KXN ^RO comprise cash at banks and on hand and short-
,KVKXMO=ROO^NK^O^ROXObMO]]S]\OMYQXS]ONK]KX  >RO ,K]SM /K\XSXQ] :O\ O[_S^c =RK\O /:= S] term deposits with a maturity of three months or
MYWZ_^ONLcNS`SNSXQ^ROXO^Z\Y ^KP^O\^KbPY\^RO MYX^\KM^_KV ^O\W] YP ^RO XKXMSKV K]]O^ QS`O \S]O
K]]O^^Y^ROOb^OX^^RK^^ROZ\OZKcWOX^aSVVVOKN YX ]ZOMS ON NK^O] ^Y MK]R
Ya] ^RK^ K\O ]YVOVc VO]] aRSMR K\O ]_LTOM^ ^Y KX SX]SQXS MKX^ \S]U YP
^YK\ON_M^SYXSXP_^_\OZKcWOX^Y\KMK]R\OP_XN cOK\ K^^\SL_^KLVO ^Y ^RO O[_S^c ]RK\ORYVNO\] YP ^RO MRKXQO]SX`KV_O
Company by weighted average number of equity ZKcWOX^]YPZ\SXMSZKVKXNSX^O\O]^YX^ROZ\SXMSZKV
   .O XONLOXO ^ZVKX$ ]RK\O]Y_^]^KXNSXQN_\SXQ^ROcOK\ KWY_X^Y_^]^KXNSXQ    0
 Y\ ^RO Z_\ZY]O YP ^RO =^K^OWOX^ YP -K]R 0VYa]
   >
 RO -YWZKXc RK] NO XON LOXO ^ ZVKX SX ^RO    +
 VVY^RO\ XKXMSKVK]]O^]K\OWOK]_\ONK^PKS\`KV_O MK]RKXNMK]RO[_S`KVOX^]MYX]S]^YPMK]RKXN]RY\^
   .
 SV_^ONOK\XSXQ]ZO\O[_S^c]RK\OK\OMYWZ_^ONLc
PY\W YP 1\K^_S^c 6YXQ =O\`SMO ,OXO ^] KXN :Y]^ ^R\Y_QR=^K^OWOX^YP:\Y ^KXN6Y]] ^O\WNOZY]S^]K]NO XONKLY`OXO^YPY_^]^KXNSXQ
NS`SNSXQ^ROXO^Z\Y ^K^^SL_^KLVO^YO[_S^cRYVNO\]
<O^S\OWOX^ 7ONSMKV ,OXO ^] K] ZO\ ZYVSMSO] YP bank overdrafts, if any, as they are considered as an
of the Company by the weighted average number Derecognition
^RO -YWZKXc >RO -YWZKXct] XO^ YLVSQK^SYX SX of equity shares considered for deriving basic SX^OQ\KVZK\^YP^RO-YWZKXct]MK]RWKXKQOWOX^
\O]ZOM^ YP ^RO NO XON LOXO ^ ZVKX S] MKVM_VK^ON    >
 RO -YWZKXc NO\OMYQXS]O] K XKXMSKV K]]O^ YXVc
OK\XSXQ] ZO\ O[_S^c ]RK\O KXN KV]Y ^RO aOSQR^ON aROX ^RO MYX^\KM^_KV \SQR^] ^Y ^RO MK]R
Ya] s) Dividend distribution to equity shareholders
Lc O]^SWK^SXQ ^RO KWY_X^ YP P_^_\O LOXO ^ ^RK^ K`O\KQO X_WLO\ YP O[_S^c ]RK\O] ^RK^ MY_VN
OWZVYcOORK]OK\XONSXObMRKXQOYP^ROS\]O\`SMO P\YW^ROK]]O^ObZS\O]Y\S^^\KX]PO\]^RO XKXMSKV    >
 RO -YWZKXc \OMYQXS]O] K VSKLSVS^c ^Y WKUO
RK`O LOOX S]]_ON _ZYX MYX`O\]SYX YP KVV NSV_^S`O K]]O^KXN]_L]^KX^SKVVcKVV^RO\S]U]KXN\OaK\N]YP
in the current and prior periods and discounted ZY^OX^SKV O[_S^c ]RK\O] >RO NSV_^S`O ZY^OX^SKV MK]R NS]^\SL_^SYX] ^Y O[_S^c RYVNO\] aROX ^RO
LKMU^Y^ROM_\\OX^`KV_K^SYXNK^O^YK\\S`OK^^RO YaXO\]RSZYP^ROK]]O^ distribution is authorised and the distribution is no
equity shares are adjusted for the proceeds
Z\O]OX^`KV_OYP^RONO XONLOXO ^YLVSQK^SYX>RO \OMOS`KLVO RKN ^RO O[_S^c ]RK\O] LOOX KM^_KVVc Financial liabilities VYXQO\K^^RONS]M\O^SYXYP^RO-YWZKXc+]ZO\^RO
NO XON LOXO ^ YLVSQK^SYX S] NON_M^ON P\YW ^RO S]]_ONK^PKS\`KV_OSO^ROK`O\KQOWK\UO^`KV_OYP MY\ZY\K^OVKa]SX3XNSKKNS]^\SL_^SYXS]K_^RY\S]ON
PKS\`KV_OYPZVKXK]]O^]^YK\\S`OK^^ROXO^K]]O^ Recognition and measurement
^ROO[_S^c]RK\O].SV_^S`OZY^OX^SKVO[_S^c]RK\O] aROX S^ S] KZZ\Y`ON Lc ^RO ]RK\ORYVNO\] +
VSKLSVS^c aRSMR XOON ^Y LO KMMY_X^ON PY\ SX ^RO are deemed converted as of the beginning of the  0SXKXMSKV VSKLSVS^SO] K\O MVK]]S ON K^ SXS^SKV MY\\O]ZYXNSXQ KWY_X^ S] \OMYQXS]ON NS\OM^Vc SX
LYYU]YPKMMY_X^]YP^RO-YWZKXc ZO\SYN_XVO]]S]]_ONK^KVK^O\NK^O \OMYQXS^SYX K] OS^RO\ s0SXKXMSKV VSKLSVS^SO] K^ PKS\ O[_S^cSX^ROcOK\YPKZZ\Y`KV

112 ANNUAL REPORT 2017-18 113


ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

3 PROPERTY, PLANT AND EQUIPMENT 4 OTHER INTANGIBLE ASSETS


Leasehold Leasehold Buildings Plant and Furniture 9P MO Vehicles Total Software Trademarks Total
Land Improve- (Refer Equipment and Equipment
Gross carrying value
ments Note (b) (Refer Fixtures
and (e)) Note (a)) As at April 1, 2016  " -  "
Gross carrying value Additions  " -   "
As at April 1, 2016 ! ! #  #"#    # #" .S]ZY]KV] " - "
Additions -    !" #  - !  As at March 31, 2017 ! - !
.S]ZY]KV] - - ! #     ## Additions " ! " 
As at March 31, 2017 ! ! "  #" "  ! !  .S]ZY]KV] -        
Additions - #  !#    # -  As at March 31, 2018 5,46.53 86.84 6,33.37
9^RO\KNT_]^WOX^]<OPO\8Y^ONLOVYa - -   " - - - -   "
.S]ZY]KV] - -  "     - 
Amortisation
As at March 31, 2018 37.55 84.38 19,99.34 75,90.42 4,51.84 15,73.67 54.67 117,91.87
As at April 1, 2016 # - #
Accumulated depreciation Amortisation for the year  - 
As at April 1, 2016    # !! ! !#   .S]ZY]KV] " - "
Depreciation charge for the year  # ! "!! ## !  !"! As at March 31, 2017 !! - !!
.S]ZY]KV] - -  ##     !# Amortisation for the year "  #  "
As at March 31, 2017  !!  #  "# " !!# .S]ZY]KV] -    
Depreciation charge for the year   "" ##     # 
As at March 31, 2018 3,41.92 11.85 3,53.77
9^RO\KNT_]^WOX^]<OPO\8Y^ONLOVYa - -  - - - - 
.S]ZY]KV] - -    "# "# - 
As at March 31, 2018 1.50 19.82 2,44.41 23,76.51 2,37.66 10,00.06 53.35 39,33.31
Net carrying value
As at March 31, 2018 2,04.61 74.99 2,79.60
Net carrying value As at March 31, 2017 # - #
As at March 31, 2018